The psychosocial and clinical outcomes of surgery for Thyroid Eye Disease (TED) by Wickwar, Sadie
Wickwar, Sadie (2014). The psychosocial and clinical outcomes of surgery for Thyroid Eye Disease 
(TED). (Unpublished Doctoral thesis, City University London) 
City Research Online
Original citation: Wickwar, Sadie (2014). The psychosocial and clinical outcomes of surgery for 
Thyroid Eye Disease (TED). (Unpublished Doctoral thesis, City University London) 
Permanent City Research Online URL: http://openaccess.city.ac.uk/14502/
 
Copyright & reuse
City University London has developed City Research Online so that its users may access the 
research outputs of City University London's staff. Copyright © and Moral Rights for this paper are 
retained by the individual author(s) and/ or other copyright holders.  All material in City Research 
Online is checked for eligibility for copyright before being made available in the live archive. URLs 
from City Research Online may be freely distributed and linked to from other web pages. 
Versions of research
The version in City Research Online may differ from the final published version. Users are advised 
to check the Permanent City Research Online URL above for the status of the paper.
Enquiries
If you have any enquiries about any aspect of City Research Online, or if you wish to make contact 












Submitted by Sadie Wickwar 




Centre for Health Services Research 






THE FOLLOWING PREVIOUSLY PUBLISHED PAPER HAS BEEN 
REDACTED FOR COPYRIGHT REASONS: 
 
pp 291-302: 
Wickwar, S., McBain, H. B., Ezra, D.G., Hirani, S.P., Rose, G.E. and Newman, S.P. (2014), 
‘What are the psychosocial outcomes of treatment for thyroid eye disease? A systematic 





THE FOLLOWING PART OF THIS THESIS HAS BEEN 
REDACTED FOR DATA PROTECTION/CONFIDENTIALITY 
REASONS: 
 







Table of Contents 
3 
 
TABLE OF CONTENTS 
TABLE OF CONTENTS ........................................................................................... 3 
LIST OF TABLES ..................................................................................................... 8 
LIST OF FIGURES ................................................................................................... 9 
ACKNOWLEDGEMENTS ..................................................................................... 11 
DECLARATION ...................................................................................................... 12 
LIST OF ABBREVIATIONS ................................................................................. 13 
ABSTRACT .............................................................................................................. 16 
1. THYROID EYE DISEASE (TED) ................................................................. 17 
1.1 PROLOGUE ....................................................................................................... 17 
1.2 DESCRIPTION .................................................................................................. 17 
1.3 PREVALENCE ................................................................................................... 17 
1.4 AETIOLOGY ..................................................................................................... 18 
1.5 SIGNS AND SYMPTOMS ................................................................................ 19 
1.6 DISEASE ACTIVITY ........................................................................................ 21 
1.7 DISEASE SEVERITY ........................................................................................ 22 
1.8 CLINICAL MANAGEMENT ........................................................................... 23 
1.8.1 Anti-thyroid treatment ...................................................................................... 23 
1.8.2 Steroids ............................................................................................................. 24 
1.8.3 Radiotherapy .................................................................................................... 25 
1.8.4 Alternative drug therapies ................................................................................ 25 
1.8.5 Surgery ............................................................................................................. 26 
1.9 ORBITAL DECOMPRESSION ....................................................................... 26 
1.10 SUMMARY ......................................................................................................... 29 
2. IMPACT OF TED ON QUALITY OF LIFE ................................................ 31 
2.1 PROLOGUE ....................................................................................................... 31 
2.2 CONCEPTUALISATION OF QUALITY OF LIFE ...................................... 31 
2.3 MEASUREMENT OF QUALITY OF LIFE ................................................... 32 
2.3.1 Generic health-related quality of life ............................................................... 32 
2.3.2 Disease-specific quality of life ......................................................................... 33 
2.4 QUALITY OF LIFE IN TED ............................................................................ 36 
2.5 SUMMARY ......................................................................................................... 38 
3. THE IMPACT OF TREATMENT ON PSYCHOSOCIAL OUTCOMES 
IN TED: A SYSTEMATIC REVIEW OF THE LITERATURE ........................ 39 
3.1 PROLOGUE ....................................................................................................... 39 
3.2 BACKGROUND & RATIONALE FOR SYSTEMATIC REVIEW 
METHODOLOGY .......................................................................................................... 39 
3.3 AIMS .................................................................................................................... 41 
3.4 METHODS .......................................................................................................... 41 
3.4.1 Inclusion & exclusion criteria .......................................................................... 41 
3.4.2 Literature search ............................................................................................... 42 
Table of Contents 
4 
 
3.4.3 Study selection ................................................................................................. 43 
3.4.4 Data extraction ................................................................................................. 43 
3.4.5 Quality assessment ........................................................................................... 43 
3.5 RESULTS ............................................................................................................ 45 
3.5.1 Description of the studies ................................................................................. 45 
3.5.2 Quality assessment ........................................................................................... 54 
3.5.3 Methimazole ..................................................................................................... 55 
3.5.4 Orbital radiotherapy ......................................................................................... 55 
3.5.5 Systemic corticosteroids ................................................................................... 56 
3.5.6 Long-acting octreotide (octreotide-LAR) ........................................................ 57 
3.5.7 Pentoxifylline and selenium ............................................................................. 57 
3.5.8 Surgery ............................................................................................................. 58 
3.5.9 The relationship between clinical & psychosocial factors ............................... 65 
3.6 ADDENDUM ...................................................................................................... 65 
3.7 DISCUSSION ...................................................................................................... 67 
3.8 CONCLUSIONS ................................................................................................. 70 
4. ADJUSTMENT TO LIVING WITH A DISFIGURING CONDITION: 
THEORETICAL FOUNDATIONS ....................................................................... 71 
4.1 PROLOGUE ....................................................................................................... 71 
4.2 TERMINOLOGY ............................................................................................... 71 
4.3 A FRAMEWORK TO EXAMINE FACTORS THAT MAY ACCOUNT 
FOR VARIATIONS IN ADJUSTMENT ...................................................................... 72 
4.3.1 Predisposing factors ......................................................................................... 73 
4.3.2 Intervening cognitive processes ....................................................................... 76 
4.3.3 Outcomes.......................................................................................................... 84 
4.4 INVESTIGATING THE PSYCHOSOCIAL IMPACT OF TED .................. 88 
4.5 SUMMARY ......................................................................................................... 88 
5. METHODS ....................................................................................................... 90 
5.1 PROLOGUE ....................................................................................................... 90 
5.2 AIMS .................................................................................................................... 90 
5.3 PREDICTIONS .................................................................................................. 91 
5.4 DESIGN ............................................................................................................... 91 
5.4.1 Rationale for using a mixed methods approach ............................................... 91 
5.5 ETHICAL APPROVAL..................................................................................... 92 
5.6 SAMPLE SIZE CALCULATIONS .................................................................. 92 
5.7 RECRUITMENT ................................................................................................ 93 
5.7.1 Inclusion & exclusion criteria .......................................................................... 93 
5.7.2 Identification procedure ................................................................................... 94 
5.8 ASSESSMENT PROCEDURE FOR THE QUANTITATIVE STUDY ........ 95 
5.8.1 Measures .......................................................................................................... 97 
5.9 ASSESSMENT PROCEDURE FOR THE QUALITATIVE STUDY ......... 109 
5.10 STATISTICAL ANALYSIS ............................................................................ 112 
5.10.1 Data screening ............................................................................................ 112 
5.10.2 Missing data ............................................................................................... 113 
5.10.3 Data exploration ......................................................................................... 114 
5.10.4 Data analysis .............................................................................................. 115 
5.11 QUALITATIVE ANALYSIS........................................................................... 121 
Table of Contents 
5 
 
6. FACTORS ASSOCIATED WITH QUALITY OF LIFE IN PATIENTS 
WITH TED PRESENTING FOR ORBITAL DECOMPRESSION ................. 126 
6.1 PROLOGUE ..................................................................................................... 126 
6.2 SUMMARY OF ANALYSIS ........................................................................... 126 
6.3 RECRUITMENT .............................................................................................. 126 
6.4 MISSING DATA .............................................................................................. 127 
6.5 DATA ASSUMPTIONS ................................................................................... 128 
6.5.1 Scale reliability ............................................................................................... 128 
6.5.2 Normality ....................................................................................................... 129 
6.6 SAMPLE CHARACTERISTICS .................................................................... 129 
6.6.1 Demographic & clinical factors ..................................................................... 129 
6.6.2 Intervening psychosocial factors .................................................................... 131 
6.6.3 Quality of life ................................................................................................. 132 
6.6.4 Expectations of TED Surgery Questionnaire (E-TEDS) ................................ 132 
6.7 FACTORS ASSOCIATED WITH QUALITY OF LIFE IN TED ............... 139 
6.7.1 GO-QOL visual function ................................................................................ 139 
6.7.2 GO-QOL appearance...................................................................................... 142 
6.7.3 Regression assumptions ................................................................................. 144 
6.8 DISCUSSION .................................................................................................... 144 
6.8.1 Representativeness of the study sample ......................................................... 145 
6.8.2 Factors associated with quality of life in TED ............................................... 150 
6.8.3 Strengths and weaknesses of the study .......................................................... 154 
7. A QUALITATIVE STUDY OF PATIENT EXPECTATIONS OF 
ORBITAL DECOMPRESSION SURGERY FOR TED .................................... 156 
7.1 PROLOGUE ..................................................................................................... 156 
7.2 AIMS & OBJECTIVES ................................................................................... 156 
7.3 RESULTS .......................................................................................................... 157 
7.3.1 Sample characteristics .................................................................................... 157 
7.3.2 Interviews ....................................................................................................... 159 
7.3.3 Coding ............................................................................................................ 159 
7.3.4 Themes ........................................................................................................... 159 
7.4 DISCUSSION .................................................................................................... 186 
7.4.1 Consequences of living with TED ................................................................. 186 
7.4.2 Influence of others .......................................................................................... 187 
7.4.3 Impact of information .................................................................................... 188 
7.4.4 The surgical process ....................................................................................... 191 
7.4.5 Recovery ........................................................................................................ 192 
7.4.6 Appearance outcomes .................................................................................... 192 
7.4.7 Functional outcomes ...................................................................................... 194 
7.4.8 Strengths and weaknesses of the study .......................................................... 195 
7.4.9 Summary ........................................................................................................ 197 
7.5 REFLEXIVE ACCOUNT ................................................................................ 197 
8. SYNTHESIS OF THE QUANTITATIVE AND QUALITATIVE 
FINDINGS .............................................................................................................. 200 
8.1 PROLOGUE ..................................................................................................... 200 
8.2 DEMOGRAPHICS ........................................................................................... 200 
Table of Contents 
6 
 
8.3 CLINICAL FACTORS .................................................................................... 201 
8.4 INTERVENING COGNITIVE PROCESSES ............................................... 202 
8.4.1 Appearance related social anxiety and avoidance .......................................... 202 
8.4.2 Salience and valence of appearance ............................................................... 202 
8.4.3 Perceived noticeability ................................................................................... 202 
8.4.4 Mood .............................................................................................................. 203 
8.4.5 Expectations of surgery .................................................................................. 203 
8.5 STRENGTHS AND WEAKNESSES OF USING MIXED METHODS ..... 205 
9. THE PSYCHOSOCIAL AND CLINICAL IMPACT OF ORBITAL 
DECOMPRESSION SURGERY FOR TED ....................................................... 207 
9.1 PROLOGUE ..................................................................................................... 207 
9.2 DATA ASSUMPTIONS ................................................................................... 208 
9.2.1 Scale reliability ............................................................................................... 208 
9.2.2 Normality ....................................................................................................... 210 
9.3 CHARACTERISTICS OF THE STUDY SAMPLE ..................................... 212 
9.3.1 Dropouts & loss to follow-up ......................................................................... 212 
9.3.2 Side effects from surgery ............................................................................... 215 
9.3.3 Patient satisfaction with surgery .................................................................... 216 
9.3.4 Further surgery ............................................................................................... 218 
9.4 WHICH CLINICAL AND PSYCHOSOCIAL FACTORS CHANGE AFTER 
SURGERY? .................................................................................................................... 219 
9.4.1 Clinical outcomes ........................................................................................... 219 
9.4.2 Intervening psychosocial processes ............................................................... 219 
9.5 BASELINE PREDICTORS OF CHANGE IN QUALITY OF LIFE FROM 
PRE- TO POST-SURGERY ......................................................................................... 224 
9.5.1 GO-QOL visual function change ................................................................... 225 
9.5.2 GO-QOL appearance change ......................................................................... 226 
9.5.3 Regression assumptions ................................................................................. 227 
9.6 CHANGES IN CLINICAL AND PSYCHOSOCIAL FACTORS AS 
PREDICTORS OF CHANGE IN QUALITY OF LIFE ............................................ 227 
9.6.1 Change predictors of GO-QOL visual function change ................................. 228 
9.6.2 Change predictors of GO-QOL appearance change ....................................... 230 
9.6.3 Regression assumptions ................................................................................. 232 
9.7 DISCUSSION .................................................................................................... 233 
9.7.1 Demographic variables ................................................................................... 233 
9.7.2 Clinical variables ............................................................................................ 234 
9.7.3 Intervening psychosocial outcomes ............................................................... 236 
9.7.4 Strengths and weaknesses of the study .......................................................... 238 
10. OVERALL DISCUSSION ........................................................................ 241 
10.1 THESIS AIMS .................................................................................................. 241 
10.2 NOVEL CONTRIBUTIONS TO THE LITERATURE ............................... 241 
10.2.1 Factors associated with quality of life in TED ........................................... 241 
10.2.2 Expectations of surgery ............................................................................. 243 
10.2.3 Impact of treatment for TED on psychosocial factors ............................... 244 
10.2.4 Information needs of patients with TED .................................................... 246 
10.3 RECOMMENDATIONS FOR PRACTICE .................................................. 246 
10.4 RECOMMENDATIONS FOR FUTURE RESEARCH ............................... 248 
Table of Contents 
7 
 
10.1 OVERALL STRENGTHS AND WEAKNESSES OF THE THESIS.......... 251 
10.2 OVERALL CONCLUSIONS .......................................................................... 254 
REFERENCES ....................................................................................................... 255 
Appendix A. Systematic Review Search Strategy: Ovid MEDLINE Example 290 
Appendix B. Published Systematic Review .......................................................... 291 
Appendix C. Data Extraction Form ..................................................................... 303 
Appendix D. Results of the Quality Assessment .................................................. 306 
Appendix E. Patient Information Sheet for the Quantitative Study ................. 311 
Appendix F. Consent Form for the Quantitative Study ..................................... 315 
Appendix G. Pre-surgery Questionnaire Pack .................................................... 317 
Appendix H. Letter Sent to Participant’s GP ...................................................... 335 
Appendix I. Patient Information Sheet for the Qualitative Study .................... 337 
Appendix J. Consent Form for the Qualitative Study ........................................ 341 
Appendix K. Clinical Data Form for the Quantitative Study ............................ 343 
Appendix L. Pilot Interview Schedule for Qualitative Study ............................ 345 
Appendix M. Demographic Data Form for Qualitative Study .......................... 346 
Appendix N. Thematic Coding Framework ........................................................ 348 
Appendix O. Screeplot Generated from the Principle Components Analysis 
(PCA) for the Original 26-item E-TEDS Questionnaire .................................... 354 
Appendix P. Pattern and Structure Matrix of the Original 26-item E-TEDS 
following PCA with Oblimin Rotation ................................................................. 355 
26. Relationship with my eye doctor ..................................................................... 356 
Appendix Q. Reflective Diary from Interviews and Thematic Analysis ........... 357 
Appendix R. Boxplots with Error Bars Showing Changes Over Time on 
Continuous Clinical Variables and Outliers ........................................................ 366 
Appendix S. Boxplots with Error Bars Showing Changes Over Time on 
Continuous Psychosocial Variables and Outliers ............................................... 369 
List of Tables 
8 
 
LIST OF TABLES 
Table 1. The Clinical Activity Score (CAS; Mourits et al., 1989) .......................................... 22 
Table 2. Types of orbital decompression and average reduction in proptosis ...................... 28 
Table 3. The main characteristics of the studies included in the systematic review .............. 48 
Table 4. Mean change and SDs from pre- to post-treatment ................................................. 60 
Table 5. Schedule of assessments for the quantitative study .................................................. 96 
Table 6. Reasons given by participants for declining to take part in the study ................... 127 
Table 7. Internal reliability for each scale and subscale in the cross-sectional study ........ 128 
Table 8. Demographic and clinical variables of the sample ............................................... 130 
Table 9. Mean scores for the psychosocial measures .......................................................... 131 
Table.10. Pattern and structure matrix of E-TEDS following PCA ..................................... 135 
Table.11. The final Expectations of TED Surgery questionnaire (E-TEDS) ....................... 170 
Table 12. Internal reliability of the E-TEDS subscales ....................................................... 139 
Table 13. Results of the hierarchical multiple regression for GO-QOL visual function ..... 141 
Table 14. Results of the hierarchical multiple regression for GO-QOL appearance .......... 143 
Table 15. Characteristics of the patients who took part in semi-structured interviews ....... 158 
Table 16. Internal reliability of psychosocial scale variables at all 3 study time points ..... 209 
Table 17. Results of Shaprio-Wilk test of normality for the psychosocial variables ........... 211 
Table 18.Adjusted means for continuous clinical outcomes ................................................ 220 
Table 19.Frequencies of categorical clinical outcomes ...................................................... 221 
Table 20. Adjusted means for continuous psychosocial outcomes ...................................... 222 
Table 21. Results for the hierarchical multiple regression for baseline predictors of change 
in GO-QOL visual function scores....................................................................................... 226 
Table 22. Results for the hierarchical multiple regression for baseline predictors of change 
in GO-QOL appearance scores ........................................................................................... 227 
Table 23. Results of the hierarchical multiple regression for change predictors of change in 
GO-QOL visual function ...................................................................................................... 229 
Table 24. Results of the hierarchical multiple regression for change predictors of change in 
GO-QOL appearance ........................................................................................................... 231 
Table 25. The normality (Shapiro-Wilk) for the residualised change scores used to answer 
research questions (5) and (6) ............................................................................................. 232 
List of Figures 
9 
 
LIST OF FIGURES 
Figure 1. A patient with thyroid-related orbital inflammation and upper eyelid retraction 19 
Figure 2. A diagram of the orbital muscles in a healthy adult eye (Kenny, 2010) _______ 20 
Figure 3. Rundle's (1945) curve illustrating the active and static phases of TED _______ 21 
Figure 4. Computerised tomography (CT) scans showing the movement of orbital tissue 
from pre- to post-orbital decompression _______________________________________ 27 
Figure 5. A flow chart showing each stage of the study selection process _____________ 46 
Figure 6. A working framework containing the constructs demonstrated to be involved in 
psychological adjustment to appearance-altering conditions _______________________ 73 
Figure 7. The 10-point rating scale used to measure side effects ___________________ 108 
Figure 8. The final topic guide used in the qualitative study  ______________________ 111 
Figure 9. The potential variables to be used in the hierarchical multiple regression used for 
the analysis of research questions (1) and (4) __________________________________ 117 
Figure 10. The hierarchical structure used to model the data for research question (3): 
which clinical and psychosocial factors change over time? _______________________ 118 
Figure 11. A screeplot showing the presence of factors for the Principle Component 
Analysis (PCA) __________________________________________________________ 134 
Figure 12. DAS24 scores for men and women at baseline for the current study________ 148 
Figure 13. Bar chart displaying mean HADS subscale scores from this sample compared to 
normative scores from other populations _____________________________________ 149 
Figure 14. GO-QOL subscale scores for the current sample at baseline compared to scores 
from a previously studied TED sample (Terwee et al., 2001) ______________________ 150 
Figure 15. The final themes and sub-themes identified during thematic analysis _______ 160 
Figure 16. The developed thematic map ______________________________________ 161 
Figure 17. A flow diagram showing participation rates and losses to follow-up based on 
CONSORT guidelines (Schultz et al., 2010) ___________________________________ 214 
Figure 18. Severity of side effects from surgery including pain, swelling, scarring and 
redness ________________________________________________________________ 215 
Figure 19. Percentage of each response to item asking patients to compare the experience of 
their symptoms to what was expected prior to surgery ___________________________ 216 
Figure 20. Frequency and percentage of responses to the question "Do you regret having 
surgery?" 6 months post-surgery ____________________________________________ 217 
Figure 21. Frequency and percentage of responses to the item "Would you go through the 
operation again?" 6 months post-surgery _____________________________________ 217 
Figure 22. Frequency and percentage of responses to the item "Would you recommend the 
operation to others?" 6 months post-surgery ___________________________________ 218 
List of Figures 
10 
 
Figure 23. Frequency and percentage of responses to the item "Were you given the right 
amount of information preoperatively?" 6 months post-surgery ____________________ 218 
Figure 24. Graphical representation of change over time in GO-QOL subscale scores with 







I wish to thank my supervisors for all their guidance throughout the PhD process. To 
Professor Stan Newman for the opportunities he has provided me throughout the 
PhD and in my career, for his commitment to this thesis and belief in my ability to 
finish it on time. To Dr Shashi Hirani for his enthusiasm, advice and expertise. 
Thanks are due to all my colleagues in Health Services Research at City for their 
understanding and welcome distractions, but most importantly a huge thank you to 
Hayley McBain for her endless support and encouragement over the last three years.  
 
I'd like to thank everyone at Moorfields Eye Hospital and Birmingham and Midland 
Eye Centre who have made these studies possible. To my collaborators on the study 
for their enthusiasm and investment in this project: Dan Ezra and Geoff Rose for 
their expert guidance and teaching, Jimmy Uddin and David Verity for assisting with 
this project with great enthusiasm and to all the other staff at MEH and BMEC that 
have helped the studies run smoothly. You have all been a pleasure to work with. To 
all the participants who took the time to make such a valuable contribution to this 
research, I can't thank you enough for sharing your experiences. Without financial 
support from City University London and the Special Trustees at Moorfields Eye 
Hospital this research would not have been possible.  
 
To all my friends and family who have supported me throughout this time and who 
have had to repeatedly remind me that life will resume after the PhD. To my parents 
for their tireless encouragements, selflessness, and for believing in me more than I 
have believed in myself at times. To Claire, for calling almost every day for the last 
year just to make sure I’m surviving. Your support will never be forgotten.  
 
Finally, thank you Matt for your kindness, generosity and love. You have kept me 
going. Not only have you been so unbelievably patient through all the tears and 








I, Sadie Wickwar, confirm that the work presented in this thesis is my own. Where 
information has been derived from other sources I confirm this has been indicated in 
the thesis.  
 
List of Abbreviations 
13 
 
LIST OF ABBREVIATIONS 
ACT Acceptance Commitment Therapy 
AR1 First-order Autoregressive Structure 
ARC Appearance Research Collaboration 
ATDs Antithyroid Drugs 
ATSCI Attention to Social Comparison Information 
B-FNE Brief Fear of Negative Evaluation Questionnaire 
BDD Body Dysmorphic Disorder 
BMEC Birmingham and Midland Eye Centre 
CAR Centre for Appearance Research 
CARSAL Centre for Appearance Research Salience of Appearance Scale 
CARVAL Centre for Appearance Research Valence of Appearance Scale 
CAS Clinical Activity Scale 
CASP Critical Appraisal Skills Programme 
CBT Cognitive Behavioural Therapy 
CHI-VFQ-25 Chinese National Eye Institute Visual Function Questionnaire 
CI Confidence Intervals 
CONSORT Consolidated Standards of Reporting Trials 
COREQ Consolidated Criteria for Reporting Qualitative Research 
CT Computerised Tomography 
DAS24 Derriford Appearance Scale 24 Item Version 
DV Dependent Variable 
E-TEDS Expectations of TED Surgery Questionnaire 
E-TEDS AC E-TEDS Appearance Concerns Subscale 
E-TEDS ISR  E-TEDS Intimacy and Social Relationships Subscale 
E-TEDS VF E-TEDS Visual Function Subscale 
EL Eyelid Lengthening 
EMS Eye Muscle Surgery 
EQ-5D European Quality of Life Questionnaire 
ESSQ Expectations of Strabismus Surgery Questionnaire 
EUGOGO European Group on Graves Orbitopathy 
EuroQol European Quality of Life Questionnaire 
FNE Fear of Negative Evaluation Questionnaire 
GC Glucocorticoid  
GD Graves’ Disease 
List of Abbreviations 
14 
 
GO Graves’ Ophthalmopathy 
GO-QLS Graves Ophthalmopathy Quality of Life Scale 
GO-QOL Graves’ Ophthalmopathy Quality of Life Questionnaire 
GP General Practitioner 
HADS Hospital Anxiety and Depression Scale 
HRQL Health-Related Quality of Life 
ICC Intraclass Correlation 
INCOM Iowa-Netherlands Comparison Orientation Measure 
IPA Interpretative Phenomenological Analysis 
IS Intravenous Steroids 
IV Intravenous 
IV Independent Variable 
KMO Kaiser-Meyer-Olkin 
LAR Long-Acting Repeatable  
LogMAR Log of the Minimal Angle of Resolution 
M Mean 
MCAR Missing Completely at Random 
MCID Minimal Clinically Important Difference 
MCS  Mental Component Summary Scale of the SF-36 and SF-12 
MEH Moorfields Eye Hospital London 
MI Multiple imputation 
MLM Multilevel Modelling  
MMAT Mixed Methods Appraisal Tool 
MOS-24 Medical Outcomes Study Short Form General Health Survey 
MRD Marginal Reflex Distance 
MSPSS Multidimensional Scale of Perceived Social Support 
N/A Not Applicable 
NEI VFQ-25 National Eye Institute Visual Function Questionnaire 
NHS National Health Service 
NOSPECS Classification of TED severity tool 
OCD Obsessive-Compulsive Disorder 
OD Orbital Decompression 
OND Optic Nerve Dysfunction 
ONS Office for National Statistics 
OS Oral Steroids 
List of Abbreviations 
15 
 
PAS Patient Administration System 
PCA Principle Component Analysis 
PCS Physical Component Summary Scale of the SF-36 and SF-12 
PPI Patient and Public Involvement 
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
Checklist 
PTSD Post-Traumatic Stress Disorder 
PTX Pentoxifylline  
R&D Research & Development 
RAI Radioiodine  
RAPD Relative Afferent Pupillary Defect 
RCT Randomised Controlled Trial 
REC Research Ethics Committee 
SD Standard Deviation 
SE Standard Error 
SF-12 TM Medical Outcomes Study 12 Item Short Form Survey 
SF-36 TM Medical Outcomes Study 36 Item Short Form Survey 
SIP Sickness Impact Profile 
SIST Social Interaction Skills Training 
SPK Superficial Punctate Keratitis 
SPSS Statistical Package for Social Sciences 
TAO Thyroid-Associated Orbitopathy 
TED Thyroid Eye Disease 
TED-QOL Thyroid Eye Disease Quality of Life Questionnaire 
TEDcT Thyroid Eye Disease Charitable Trust 
ThyPRO Thyroid Specific Patient Reported Outcome Questionnaire 
UK United Kingdom 
VAS Visual Analog Scale 
VIF Variance Inflation Factor 
WHO World Health Organisation 






This study aimed to investigate whether quality of life in patients with thyroid eye 
disease (TED) improves as a result of having orbital decompression surgery and 
whether any demographic, clinical or psychosocial factors can predict which patients 
might benefit from this surgery. 
 
One hundred and twenty three adults with TED were recruited from Moorfields Eye 
Hospital (MEH), London. Clinical measurements were taken by the clinical team at 
MEH and participants completed a range of psychosocial questionnaires prior to 
surgery and again 6 weeks and 6 months after surgery. The Appearance Research 
Collaboration’s (ARC) framework of adjustment to living with a disfiguring 
condition was used to guide the study’s measures and analysis. The Graves’ 
Ophthalmopathy Quality of Life Questionnaire (GO-QOL; Terwee et al., 1998) was 
completed by participants at each time point and was the dependent variable in each 
hierarchical multiple regression model. Semi-structured interviews were conducted 
with fourteen patients from Birmingham and Midland Eye Centre (BMEC) to 
explore expectations of orbital decompression and thematic analysis was performed.  
 
Prior to surgery, the regression model explained 55% of the variance in GO-QOL 
visual function scores and 75% of the variance in GO-QOL appearance scores. 
Although vision-related quality of life was associated with age and asymmetrical 
disease, it was intervening psychosocial processes that were more consistently 
associated with both vision- and appearance-related quality of life. Patients had high 
expectations for surgery to return them to the “normality” of their lives, and 
appearance, before TED. High expectations were often a result of great confidence 
and trust in surgeons and information they had accessed about the surgery online.  
 
Significant improvements were found in all clinical characteristics following surgery 
and in most psychosocial variables. Vision-related quality of life did not change 
significantly until 6 months after surgery whilst appearance-related quality of life 
significantly improved 6 weeks post-surgery and continued to significantly increase 
6 months post-surgery reaching a minimal clinically important difference (MCID). 
Ethnicity and a small number of clinical factors patients presented for surgery were 
unique predictors of the variance in change in vision-related quality of life and 
appearance-related quality of life. None of the changes in clinical or psychosocial 
outcomes significantly predicted change in vision-related quality of life. The 
hierarchical regression model explained 81% of the variance in change in 
appearance-related quality of life however, with improvement in personal evaluation 
of appearance uniquely predicting improvement in appearance-related quality of life. 
 
Further research is required to establish whether expectations are met after surgery. 
Recommendations for clinical practice include routine psychological assessment and 
the provision of clear and comprehensible information about surgery. Patients with 
TED in the future would benefit from interventions targeting the intervening 
psychosocial processes identified by this thesis as amenable to change.




1. THYROID EYE DISEASE (TED) 
1.1 PROLOGUE 
The aim of this thesis is to investigate the psychosocial impact of thyroid eye disease 
(TED) and the clinical and psychosocial outcomes following orbital decompression 
surgery. In this chapter, a description of TED is provided along with information 
regarding its prevalence, the major signs and symptoms and risk factors for 
developing the disease. Clinical management will also be discussed, including 
current recommended clinical guidelines and a description of the surgical procedures 
offered to patients. Surgical approaches to TED will be described later in this chapter 
including orbital decompression surgery, which is the focus of this thesis. 
1.2 DESCRIPTION 
TED, also known as Graves’ ophthalmopathy (GO), thyroid-associated orbitopathy 
(TAO) and dysthyroid orbitopathy, is an autoimmune thyroid disorder that affects 
the eyes. TED is the most common cause of swelling and inflammation of the orbit 
in adults (Leatherbarrow, 2011). It is thought that this inflammation is caused by an 
autoimmune response against one or more autoantigens shared by the thyroid gland 
and orbital tissues (Bahn & Heufelder, 1993; Bahn, 2010) leading to an increase in 
volume of orbital fat, muscles and connective tissue (Orgiazzi & Ludgate, 2010). 
The exact link between thyroid disturbance and the eye tissues remains unclear, 
however, TED has been found to occur at the time of onset of hyperthyroidism in the 
majority of cases (Lazarus, 2012). Hyperthyroidism, or overactive thyroid gland, 
causes a variety of symptoms including sweating, increased metabolic rate 
manifesting as heat intolerance, weight loss, and palpitations (Weetman, 2000). 
Hyperthyroidism has been found to influence mood changes, including anxiety and 
depression (Bunevicius & Prange, 2006). Noticeable changes in the eyes can 
however precede, or develop as long as 5 years after, a diagnosis of hyperthyroidism 
and are not linked to the severity of thyroid problems (Lazarus, 2012). 
1.3 PREVALENCE 
Hyperthyroidism is more common in women than men, with figures estimating 77 
women per 100,000 population per year compared to 14 men per 100,000 population 
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per year developing the condition (Flynn et al., 2004). TED occurs mainly in patients 
with Graves’ disease (GD), which is the most common type of hyperthyroidism 
(Lazarus, 2012). Estimates of the prevalence of TED in GD are between 25% and 
50% (Bahn & Heufelder, 1993). Whilst it has been difficult to define the prevalence 
and incidence of TED in the UK as there are virtually no prevalence studies 
(Lazarus, 2012), TED has been reported to have an incidence of approximately 2.9 to 
16 cases per 100,000 population per year in Olmsted County, Minnesota (Bartley, 
1994) and 400,000 people are estimated to suffer from TED in the UK (Cawood, 
Moriarty, & O’Shea, 2004). As with hyperthyroidism, TED affects five times more 
women than men (Cawood, Moriarty, & O’Shea, 2004) and presents more 
commonly in adults between the ages of 30 and 50 years old (Bartley, 1994).  
1.4 AETIOLOGY 
Whilst the majority of cases of TED have been linked to GD, research into its causes 
continues (Lazarus, 2012). Some studies have found eye disease to develop after 
certain types of treatment for hyperthyroidism. For instance, Tallstedt et al. (1992) 
report the development and worsening of ophthalmopathy in 33% of patients treated 
with radioiodine, a proportion significantly higher than in patients treated with drugs 
and thyroidectomy combined.  
 
A difficulty in diagnosing TED is found in around 5-10% of patients who have never 
had hyperthyroidism but do have other autoimmune thyroid disease, such as 
hypothyroidism (Lazarus, 2012). Hypothyroidism, or underactive thyroid gland, 
causes persistent fatigue and often weight gain (Louwerens et al., 2012).  
 
Other potential factors associated with the development of TED include 
environmental, hormonal, and genetic factors, as well as age (Bartalena, 2010). A 
large body of evidence has also shown close links between smoking and the onset of 
TED (Daumerie, 2010; Bartalena, 2010; Cawood, Moriarty & O’Shea, 2004; 
Thornton et al., 2007), with smokers or ex-smokers being four times more likely to 
develop TED (Cawood, Moriarty & O’Shea, 2004). Thornton et al. (2007) conducted 
a systematic review of the evidence for the link between smoking and TED and 
found a strong association, including a dose-response effect, and worse treatment 
outcomes in patients who smoke. However the mechanisms by which smoking 
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affects TED are still unclear (Bartalena, 2010). Despite the plethora of research, 
studies on the underlying mechanisms for TED remain inconclusive (Bahn, 2000; 
Tallstedt et al., 1992). 
1.5 SIGNS AND SYMPTOMS 
The commonest early sign of TED is a noticeable change in the appearance of the 
eyes including swelling and redness of the orbits (Dickinson, 2010). This swelling of 
the tissues and fat behind the eyes pushes the eyes forward within the orbits, causing 
proptosis, or exophthalmos. Occasionally, the swelling is severe enough to compress 
the optic nerve and impair visual function (optic neuropathy) which, if left untreated, 




Figure 1. A patient with thyroid-related orbital inflammation and upper eyelid 
retraction 
 
TED can occur in one eye (unilateral) or both eyes (bilateral). Kashkouli et al. 
(2011a) suggest that unilateral TED might be less common, but does not show any 
significant difference – in terms of severity of the condition, patient demographics, 
or duration of the disease – to bilateral TED. Wiersinga and colleagues (1989) 
suggest that establishing a diagnosis of unilateral TED may be more difficult, as 
these cases are more likely to resemble other causes of unilateral orbital 
inflammation and proptosis such as infection or orbital tumour. Patients with TED 
frequently face a delay in diagnosis, and experience an understandable level of 
anxiety over the cause of their proptosis. In a recent survey of patient experiences of 
services for TED, Estcourt et al. (2009) found that as many as 58% of patients were 
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given a range of incorrect diagnoses for their eye symptoms, including conjunctivitis 
and allergies.  
 
Upper eyelid retraction, which produces a marked ‘staring’ appearance, affects most 
patients at some stage during the disease (Figure 1). Another common sign is redness 
of the eyes that arises either from drying and irritation of the ocular surface, or from 
vascular congestion due to severe swelling of the orbital muscles causing disruption 
of blood flow (hydraulic orbit) (Rose, 2006). Corneal superficial punctate keratitis 
(SPK) is another sign of TED and involves the death of cells on the surface of the 
cornea causing dry eyes and redness (Miyata et al., 2003). Having severe proptosis, 
eyelid retraction, or both, can prevent an individual from closing their eyelids fully 
(particularly at night when trying to sleep) and this can lead to corneal exposure, 
ocular surface drying, and a propensity for recurrent infections (Schotthoefer & 
Wallace, 2007).  
 
 
Figure 2. A diagram of the orbital muscles in a healthy adult eye (Kenny, 2010) 
 
TED also causes tightness of the orbital muscles (Figure 2), which can restrict eye 
movements and cause double vision, or diplopia, which is the perception of two 
separate images (Perros, Neoh & Dickinson, 2009). Diplopia might occur only in 
secondary gaze when the eyes are deviated vertically or horizontally, in the absence 
of primary-gaze diplopia. For someone with primary gaze diplopia however, double 
vision is also experienced when gaze is fixated straight ahead. The onset of diplopia 
varies: for some patients this will start during progression of inflammation and for 
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others it can first occur after orbital decompression surgery. Orbital decompression 
surgery is described in more detail in section 1.9 of this chapter.  
1.6 DISEASE ACTIVITY 
The duration of the development of TED can vary. The condition is unique amongst 
autoimmune diseases as it is self-limiting, with an “active” phase lasting up to two 
years, followed by an “inactive” phase (Verity & Rose, 2013). Inflammation of the 
orbital tissues underlies the active phase and is often characterised by a worsening of 
the eye condition with symptoms including pain, and ocular and eyelid redness 
(Dickinson, 2010; Terwee, 2000). After the active inflammation has peaked, there is 
generally a gradual decrease in its severity until it reaches stability (Terwee, 2000). 
This process is best illustrated by Rundle’s curve (Rundle, 1945), which describes 
two distinctive phases of the disease where the eyes reach a maximum level of 
protrusion, before a gradual reduction occurs until the eyes remain at a new, but 
stable, configuration (Figure 3).  
 
Figure 3. Rundle's (1945) curve illustrating the active and static phases of TED 
(Bothun et al., 2009) 
 
The rate of development of proptosis and its stabilisation are variable between 
patients, but the eyes generally do not return to their former appearance (Rundle, 
1945). The duration of the active phase varies between patients and as treatment 
decisions are influenced by disease stage, clinicians are advised to regularly monitor 
patients throughout the course of their illness to assess the activity of the disease. 
This is commonly implemented using the Clinical Activity Score (CAS; Mourits et 
al., 1989), which is a 10-item measure covering four of the five classical 
characteristics of inflammation in TED (pain, redness, swelling, and impaired ocular 
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function) and gives a score of between 0 and 10 (Table 1). The development of the 
tool was based on the recognition of different levels of inflammation, different types 
of pain (for example one type can be from stretching the inflamed muscles when 
looking upwards), different areas of swelling (such as swelling overlying the whites 
of the eye) and different levels of impaired function, such as a decrease in eye 
movements (Mourits et al., 1989). 
 
Table 1. The Clinical Activity Score (CAS; Mourits et al., 1989) 
 
Pain   1 Painful, oppressive feeling on or behind the globe,  
   during last 4 weeks 
   2 Pain on attempted up, side or down gaze, during the  
                                               last 4 weeks 
Redness    3 Redness of the eyelid(s) 
   4 Diffuse redness of conjunctiva, covering at least 1  
                                               quadrant 
Swelling  5 Swelling of the eyelid(s) 
   6 Chemosis 
   7 Swollen caruncle 
   8 Increase of proptosis > 2mm during a period of 1-3  
                                               months 
Impaired function 9 Decrease of eye movements in any direction >5 
degrees during a period of 1-3 months 
10 Decrease of visual acuity >1 line(s) on the Snellen 
chart (using a pinhole) during a period of 1-3 months 
 
For each item present, 1 point is given. The sum of these points is the CAS 
 
 
1.7 DISEASE SEVERITY 
In the absence of pain, swelling, redness and double vision, ophthalmologists will 
look for signs of disease severity to establish the diagnosis of TED and indicate need 
for treatment. These include the degree of proptosis, impairment of visual acuity, and 
loss of colour vision (Dickinson, 2010). Normally the presence of optic neuropathy, 
severe proptosis, and/or primary-gaze diplopia is sufficient for the ophthalmologist 
to consider the disease to be severe (Marcocci et al., 2002).   
 
Werner (1977) developed a classification tool to measure the severity of TED 
referred to as ‘NOSPECS’. This tool is widely used for the clinical assessment of 
changes in eye symptoms and signs of TED (Terwee, 2000). The tool classifies 
Chapter 1 Thyroid Eye Disease 
23 
 
clinical signs and symptoms on a scale of 0 to 6; where 0 is No physical signs or 
symptoms, 1 is Only signs, 2 is Soft tissue involvement, 3 is Proptosis of 3 mm or 
more above the normal limit, 4 is Extraocular muscle involvement, 5 is Corneal 
involvement, and 6 is Sight loss due to optic nerve involvement (Werner, 1977; 
Dickinson, 2010). For each class there are 4 grades which indicate the severity of the 
sign or symptom, where 0=0, a=1, b=2 and c=3. For example, under class 4 
‘extraocular muscle involvement’, 0 indicates an absence of diplopia, a indicates 
intermittent (i.e. when tired), b indicates inconstant and c indicates constant. Patients 
can receive a maximum total score of 45 points (Terwee, 2000). It is estimated that 3 
to 5% of patients have the severest forms of TED (Gerding et al., 1997). Being male 
and being over the age of 50 have been found to be associated with increased TED 
severity (Perros et al., 1993; Kendler, Lippa & Rootman, 1993), as has smoking 
(Vestergaard, 2002).  
 
Levels of activity and severity of TED are used as indicators for treatment options. 
However, for patients who are misdiagnosed, or for those that experience a delay in 
their diagnosis, it can be months or in some cases years before they are referred for 
specialist treatment in the UK (Estcourt et al., 2009). Furthermore, it is likely that 
several treatments will be required over the course of TED, particularly if TED 
coincides with GD, and some treatments are ineffective. These issues will be 
discussed further in the following section of this chapter.  
1.8 CLINICAL MANAGEMENT 
1.8.1 Anti-thyroid treatment 
Many patients with TED will have received prior monitoring and treatment for 
hyperthyroidism, which is most commonly treated with antithyroid drugs, partial or 
total removal of the thyroid gland (thyroidectomy) or radioiodine (iodine-131 
therapy) (Yip, Lang & Lo, 2012).  The first recommended action for patients with 
GD who smoke is to stop, so as to significantly reduce the risk of developing eye 
disease. Not only has the response to treatment for TED found to be lower in 
smokers, but it has also been found to be significantly slower (Eckstein et al., 2003).  
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Around 30% of newly referred patients with TED have moderate disease, and around 
5% to 10% have severe disease (Bartalena, 2014). In the moderate to severe cases, a 
complex multidisciplinary disease management regime is usually required. For 
example, in cases where GD and TED overlap, it is necessary for patients to 
maintain simultaneous medical treatment for both aspects of the condition. However, 
there is little consensus over which treatment option works best and the optimum 
methods for measuring treatment efficacy, making it difficult to judge which is 
optimal (Prummel et al., 2003). However, it is considered essential that treatment 
follows a logical plan that aims to produce the best results for the patient (Yang & 
Perros, 2012). Generally ophthalmologists will diagnose TED as either moderate-to-
severe – that is, patients without sight-threatening TED but with disease that 
interferes with daily life thereby justifying further treatment – or severe and sight-
threatening (Prummel et al., 2003; Ezra & Rose, 2013). The types of treatment and 
the order in which they are offered will depend on this diagnosis (Al Mahrouqi, 
2011). 
 
TED will often not worsen once the patient has achieved a stable serum thyroxine 
level, known as the euthyroid state (Tallstedt et al., 2000). The majority of patients 
who subsequently develop TED will have mild ocular symptoms that will not 
necessarily require any further treatment, other than topical ocular lubricants to 
reduce dry eyes (Marcocci et al., 2002). For eyelid retraction and proptosis, patients 
are often recommended to use topical lubricants and, in severe cases, to tape their 
eyes shut at night to avoid corneal drying (Marcocci et al., 2002).  
1.8.2 Steroids 
A group of immunosuppressant steroids, known as glucocorticoids (GCs), are often 
effective at reducing thyroid-related inflammation in TED (Marcocci et al., 2002). 
The use of GCs during the active phase of TED has been found to prevent disease 
progression and reduce the total length of this phase (Terwee, 2000). Clinicians tend 
to initially treat patients with oral GCs (the most common being prednisolone) in 
high doses although the disease activity may increase once the dose has been 
reduced or withdrawn (Marcocci et al., 2002). There is some evidence that sight-
threatening TED is most effectively treated with intravenous methylprednisolone, 
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which is becoming more popular because of reduced side effects compared with oral 
medication (Kahaly et al., 2005; Aktaran et al., 2007).  
1.8.3 Radiotherapy 
Low-dose orbital radiotherapy might be administered alongside GCs, or as an 
alternative treatment if GCs are found to be ineffective (Marcocci et al., 2002). 
Orbital radiotherapy, which targets the soft tissues around the orbits directly, is 
found to be effective in over 60% of cases, particularly for optic neuropathy and 
inflammation (Marcocci et al., 2003). Radiotherapy has been used in the treatment 
for TED for over 60 years, although clinical trials have revealed conflicting results in 
terms of efficacy. A recent review suggests this treatment should be offered early, 
during the active phase, and is most effective when combined with GCs (Dolman & 
Rath, 2012).  
1.8.4 Alternative drug therapies 
In recent years, other drugs have begun to show some evidence of efficacy in 
reducing TED symptoms. Selenium, which is an anti-inflammatory agent and has the 
greatest concentration in the thyroid gland in healthy persons, has recently been 
found to be at reduced levels in patients with TED (Khong et al., 2014). Selenium is 
found at high concentration in brazil nuts and has been reported to increase immune 
functioning in patients with TED (Marcocci et al., 2011). It has been recommended 
as a supplement throughout the course of the condition, particularly in milder cases 
(Marcocci et al., 2011). Somatostatin analogues are growth hormone-inhibitors that 
can help to regulate the endocrine system; one type of somatostatin analogue 
commonly used to treat TED is octreotide (Dickinson et al., 2004) and is 
occasionally used for moderate disease. Rituximab is an antibody that depletes B-
lymphocytes, a cell involved in active inflammation, and initial research has 
indicated its ability to improve TED by reducing inflammation and proptosis, 
(Minakaran & Ezra, 2013). Methotrexate – a drug more commonly used in the 
treatment of cancer or arthritis – has been evaluated for treatment of TED in patients 
who are intolerant to GCs (Strianese et al., 2014). Early findings have shown a 
reduction in CAS scores and improved ocular motility; however, further research is 
required before this medication can be introduced to regular treatment protocols 
(Strianese et al., 2014).  
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1.8.5  Surgery 
Once TED has reached a stable phase, patients might be offered corrective surgery in 
order to preserve sight, improve appearance, or both. The ophthalmologist’s decision 
to operate for TED, and when to do so, is influenced by a number of factors 
including disease activity, severity, and clinical preference.  Most clinicians prefer to 
reduce the activity of TED using drugs or radiotherapy before considering surgery, 
although occasionally surgery might be required earlier in the course of the disease 
(Wiersinga & Kahaly, 2010).  
 
One or more of a number of surgical options are available, depending on the severity 
of TED. Orbital decompression involves removal of some of the bony walls of the 
eye sockets, to make space for the swollen muscles and retrobulbar tissues when the 
disease is inactive (Leong et al., 2009), for treatment of moderate or marked 
proptosis. It is also offered to patients with persistent optic nerve compression in 
order to save their sight (Boboridis & Bunce, 2011). Strabismus surgery, to correct 
ocular misalignment, is offered to patients with diplopia or to those with squint in the 
absence of double vision (Jellema et al., 2014). As the commonest residual sign of 
TED is upper eyelid retraction, many patients will undergo eyelid lengthening 
surgery that either lengthens the upper eyelid, lower eyelid, or both, to improve eye 
closure (Neoh & Eckstein, 2010). Some patients may require all three types of 
surgery and in these cases, the recommended sequence of performing the procedures 
is firstly orbital decompression, followed by strabismus surgery, and finally eyelid 
repositioning (Bartalena et al., 2008; Goldberg, 2008). Orbital decompression can 
affect motility as well as the level of lid retraction, with a number of studies 
reporting the worsening of diplopia after orbital decompression (Tallstedt et al., 
2000; Baldeschi, 2010; EUGOGO et al., 2009), hence the recommendation to 
perform decompression before other types of corrective surgery. 
1.9 ORBITAL DECOMPRESSION 
Orbital decompression is a major procedure involving the removal of fat, bone, or a 
combination of both, from the orbits (EUGOGO et al., 2009), which in turn provides 
additional space to accommodate swollen orbital tissue (Figure 4). In most cases, 
orbital decompression is performed to improve the appearance of the eyes but, for a 
small number of patients with optic neuropathy, the procedure is used to restore sight 
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(Perros et al., 2012; EUGOGO et al., 2009). Decompression is occasionally 
performed to reduce pain with severe orbital inflammation (Tallstedt et al., 2000). 
Orbital decompression is the most common surgery offered to patients with severe 





Figure 4. Computerised tomography (CT) scans showing the movement of orbital 
tissue from pre- to post-orbital decompression 
 
Reduction in proptosis with bony orbital decompression is dependent on whether 
one, two, three or four walls are removed (Table 2). Lateral wall decompression (a 
one-wall approach), is one favoured option for patients with less severe proptosis, as 
it has been found to produce a lower risk of post-operative diplopia (Goldberg, 
2008).  In cases of severe proptosis, removal of bone from two or more walls is more 
appropriate, although four-wall decompression involving removal of the orbital roof 






Chapter 1 Thyroid Eye Disease 
28 
 
Table 2. Types of orbital decompression and average recorded reduction in proptosis 
(adapted from Garrity, 1994) 
 




1 wall Lateral 3-5.7 
Medial 2.25 
Superior (roof) 9 
2 wall Transantral 3.4-5.5 
Translid (lateral + floor) 5 
Transfrontal 4 
Endoscopic (medial + floor) 1.5-4.4 
3 wall Endoscopic 3.2-7.7 
4 wall  3-11.3 
 
Specifically, two-wall decompression involves removal of either the medial wall and 
floor, or the medial and lateral walls and this results in around 3-6mm reduction in 
proptosis. Three-wall decompression involves removal of the medial wall, lateral 
wall and floor, this achieving around 3-8mm reduction in proptosis (Garrity, 1994). 
There are several evolving techniques that might be used during decompression 
surgery (Leong et al., 2009). The European Group for Graves’ Orbitopathy 
(EUGOGO) found favourable results after surgery with a combination of bony wall 
and fat removal, and a larger reduction in proptosis after three-wall, as compared to 
two-wall, approaches (EUGOGO et al., 2009). However, removal of orbital fat has 
been found to result in some hollowing in the orbital structure in a small number of 
cases (Fichter, Krentz & Guthoff, 2013) and performing this type of decompression 
remains a matter of dispute (Boboridis & Bunce, 2011). Leong et al. (2009), in a 
recent systematic review of outcomes after decompression found that the 
transpalpebral-endoscopic approach resulted in the most significant reduction in 
proptosis.  
 
Treatments for TED are not without their risks and side effects. For instance, weight 
gain and gastrointestinal problems are common among patients who are given 
systemic corticosteroids (Aktaran et al., 2007; Kahaly et al., 2005). Similarly, major 
surgery such as decompression can be associated with a number of side effects 
including induced diplopia, eyelid malposition, facial numbness, vision loss and, 
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very rarely, cerebrospinal fluid leakage (Jernfors et al., 2007). EUGOGO et al. 
(2009) found that the three-wall approach had more complications than the two-wall 
(e.g. eyelid swelling), but that the coronal approach resulted in the most 
complications (e.g. paralysis of the frontal muscles lasting at least 3 months after 
surgery).  
 
Further orbital decompression might be required in rare cases as, for example, where 
there has been disease recurrence, where the patient or clinician has a preference for 
sequential unilateral decompression, or where the results of the initial decompression 
are inadequate.  
 
Given the uncertainty around the efficacy of many of the treatments for TED, and 
the cost of major procedures such as orbital decompression, it is important that those 
involved in the management of the disease inform the patient of the expected 
chances, and extent, of rehabilitation. It is also important that patients are aware of 
the risks and complications of proposed treatments. 
1.10 SUMMARY 
TED can cause a variety of unpleasant changes in the eyes that may require complex 
treatment from specialists within a multidisciplinary team. Multiple ophthalmic and 
systemic assessments need to be made by specialist clinicians, particularly 
endocrinologists and ophthalmologists, to gauge the phase and the severity of the 
disease, and to take urgent action where necessary. Patients are often required to 
adhere to a variety of medical treatments for variable periods, depending on disease 
duration and activity, before considering the option of one or more surgical 
interventions. For most patients, eye symptoms are mild and improve spontaneously, 
particularly when they become euthyroid and if they cease smoking.  However, some 
patients develop severe TED, for whom treatments may be ineffective. As it can take 
many years before the disease stabilises and the sight and/or appearance is improved, 
it is important that patients should be aware of this from the time of diagnosis and to 
ensure their continued understanding throughout the course of the illness.  
 
This chapter has introduced the appearance altering and functional symptoms of 
TED and the following chapter will describe and review what is currently known 
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about the quality of life of patients with TED. A systematic review of the efficacy of 
different treatments, as described in this chapter, on patients’ well-being is presented 
in Chapter 3 of this thesis. 
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2. IMPACT OF TED ON QUALITY OF LIFE 
2.1 PROLOGUE 
As clinicians have sought to find out more about the causes of TED and further 
knowledge about how to effectively treat the disease and its symptoms, recent 
research has begun to examine how TED might impact on a patient’s psychological 
state and, ultimately, their quality of life. The aim of this chapter therefore is to 
describe the small body of research to date that has investigated the psychological 
impact of having TED. It does not include the impact of treatment, which will be 
reviewed in the next chapter. This chapter provides a description of the methods and 
measures that have been used by previous studies to examine the impact on both 
health-related quality of life (HRQL) and disease-specific quality of life. 
2.2 CONCEPTUALISATION OF QUALITY OF LIFE 
Quality of life is defined by the World Health Organisation (WHO) as “an 
individual’s perception of their position in life in the context of the culture and value 
systems in which they live and in relation to their goals, expectations, standards and 
concerns” (The WHOQoL Group, 1995, p1405). Quality of life has been 
increasingly recognised by clinicians and researchers as an important measure in 
healthcare. Diseases often cause dysfunction and symptoms that can prevent an 
individual from carrying out activities of daily living (Kaplan & Ries, 2007), thus 
impacting on their overall quality of life.  
 
Most healthcare researchers now conceptualise quality of life as having several 
distinct dimensions, including psychological, social, occupational, physical and 
cognitive (Ogden, 2004). Quality of life is therefore widely considered to be a multi-
faceted concept that, when measured using valid and reliable tools, can quantify 
change in patients over the course of their illness and after treatment (Bradley, 2006) 
as well as provide some basis for cost-effectiveness evaluation (Kaplan & Ries, 
2007). However, there remains disagreement amongst investigators over which 
aspects of quality of life should be evaluated in healthcare (Fayers & Machin, 2007). 
Quality of life, and more specifically HRQL, is now generally conceptualised as 
generic or disease specific. Generic HRQL refers to the study of aspects of quality of 
life that can be applied across patient groups, such as physical functioning, or 
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emotional well-being. Disease-specific quality of life on the other hand refers to the 
aspects of quality of life unique to a particular condition. 
2.3 MEASUREMENT OF QUALITY OF LIFE 
Quality of life has become an increasingly popular construct to evaluate the impact 
of disease and its treatment. Generic HRQL instruments allow researchers to 
quantify the impact of a disease and compare this impact across different disease 
groups and healthy populations (Kaplan & Ries, 2007). Generic HRQL measures are 
useful to capture both physical and social aspects of illness beyond clinical changes 
as the result of medical care (Wilson & Cleary, 1995). By contrast, disease-specific 
quality of life measures do not allow for comparisons between different disease 
groups, but do tend to capture aspects of quality of life more specific to a particular 
disease population.  HRQL encompasses the physical, psychological and social 
domains of health that are influenced by an individual’s perceptions of health (Testa 
& Simonson, 1996) and a comprehensive measure should assess all of these 
domains. The following sections of the chapter will describe some of the HRQL 
measures that have been used to assess quality of life in patients with TED. 
2.3.1 Generic health-related quality of life 
A number of generic HRQL questionnaires have been used to assess quality of life in 
TED. The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36 TM) is 
one such measure that can be classified into the following eight health status 
subscales: physical functioning, role limitations due to physical problems, social 
functioning, bodily pain, emotional well-being, role limitations due to emotional 
problems, fatigue, and general health perception (Ware & Sherbourne, 1992). A 
physical component score (PCS) and a mental component score (MCS) are 
calculated and each is scored out of 100, with higher scores indicating better health 
(Ware, Koskinski & Keller, 1994). This measure has demonstrated high internal 
consistency and good reliability across patient groups (McHorney et al., 1994) 
including in TED as described later in this chapter.   
 
The Sickness Impact Profile (SIP; Bergner et al., 1981) is another generic HRQL 
questionnaire consisting of 136 items that assess performance on a range of daily 
activities, for example; ‘I am doing fewer social activities with groups of people’. It 
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has been demonstrated to have high reliability, as well as good construct, convergent 
and discriminant validity (Bergner et al., 1981) and has been used to evaluate quality 
of life in TED as described in section 2.3.2 in this chapter.  
 
The Euro Quality of Life questionnaire (EQ-5D; The EuroQoL Group, 1990) 
measures 5 domains: mobility, self-care, usual activities, pain/discomfort and 
anxiety/depression. It also includes a Visual Analog Scale (VAS) rating of health 
that ranges between best imaginable health states and worst imaginable health states 
(Hurst et al., 1997). This measure has been validated within a variety of patient 
groups, including rheumatoid arthritis (Hurst et al., 1997), cardiac patients 
(Schweikert, Hahmann, & Leidl, 2006), and inflammatory bowel disease (König et 
al., 2002).  
 
A constraint on all the generic global measures of HRQL is their lack of ability to 
capture the specific limitations that patients with TED might face. These include 
adjustment to the change in their appearance, and functional problems including 
double vision. While vision-specific questionnaires have been developed in recent 
years they, as with generic HRQL measures, tend not to include the issues specific to 
patients with TED, such as double vision. In response to the need for a questionnaire 
that captures such issues, TED-specific quality of life measures have begun to 
emerge, and will be described in the following section of this chapter.  
2.3.2 Disease-specific quality of life 
It is important to measure psychosocial outcomes in TED using comprehensive, 
validated questionnaires, to capture a broad range of issues relevant to the lives of 
patients with TED and to ensure that these constructs are being captured accurately. 
Generic HRQL measures, whilst useful for comparing quality of life outcomes for 
patients with TED to other chronic disease groups, are less helpful for detecting 
small clinically relevant changes in TED (Terwee et al., 1998). They are also often 
found not to include questions that are most important to the quality of life of 
patients with TED, such as changes in appearance, or double vision (Terwee et al., 
1999). 
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A number of vision-specific quality of life questionnaires have recently emerged that 
were developed in the contexts of cataract and glaucoma. For example, the National 
Eye Institute Visual Function Questionnaire (NEI VFQ-25) consists of 25 items that 
measure 12 health domains including general health, general vision, near vision, 
distance vision, and driving, and has been reported to be a reliable and valid measure 
(Mangione et al., 2001).  
 
The Graves’ Ophthalmopathy Quality of Life Questionnaire (GO-QOL) is the first 
tool to measure HRQL in patients with TED. It has two subscales that measure 1) 
visual functioning as a consequence of double vision and reduced visual acuity, and 
2) psychosocial functioning as a result of changed appearance (Terwee et al, 1998). 
The questionnaire consists of 16 items in its original form and has been found to be 
highly reliable (Terwee et al., 1999). Construct validity has been demonstrated by 
correlations with the MOS-24 and SIP, and clinical measurements have been found 
to correlate well with the visual function subscale (Terwee et al., 1998; Terwee et al., 
1999). The GO-QOL has been recommended for use in clinical trials as it is sensitive 
enough to detect a minimal clinically important difference (MCID); changes of 3 to 
4 points can be interpreted as very small effects; 10 points as small to moderate 
effects and 20 points as a large effect (Terwee et al., 2001; EUGOGO et al., 2009).  
 
Yeatts (2005) designed the Graves Ophthalmopathy Quality of Life Scale (GO-
QLS), which measures quality of life related to perceptions of general health, mental 
health, social functioning, general visual functioning, and TED-specific visual 
functioning. Yeatts (2005) developed this 105-item measure by adapting items from 
the Medical Outcomes Study 12-Item Short Form Health Survey (SF-12 TM; Ware, 
Kosinski & Keller, 1996), Dermatology-Specific Quality of Life questionnaire 
(DSQL; Anderson & Rajagopalan, 1998), and the NEI-VFQ (Mangione et al., 2001). 
 
Tehrani et al. (2004) developed a 90-item questionnaire based on 26 questions 
distributed to patients after surgery. Higher scores indicate lower overall 
contentment with surgical outcomes and quality of life. Validity was considered by 
the authors indirectly by the correlation between clinical post-surgical endpoints and 
quality of life scores, but no other reliability or validity testing has been reported in 
this or any other study. Furthermore, patients were not involved in the development 
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of the measure so it is unclear if it captures aspects of post-surgical outcomes 
important to patients and their quality of life. As the questionnaire was not 
administered to patients prior to, as well as after, surgery it is unclear whether the 
questionnaire has captured clinically significant changes as a result of surgery. 
 
One other questionnaire to assess quality of life in TED has recently been developed 
(TED-QOL; Fayers & Dolman, 2011) that consists of three items that ask “How is 
your eye disease currently affecting your overall quality of life/ your ability to carry 
out daily activities/ your satisfaction with your appearance?” The authors report this 
tool to be a valid and reliable measure of quality of life in TED (Fayers & Dolman, 
2011). However, with only 3 items this questionnaire is designed to be used in busy 
hospital clinics as a “snap shot” rather than for developing our understanding of the 
areas of quality of life most impacted upon. This questionnaire also has yet to be 
used in any studies evaluating treatment for TED and therefore no MCID has been 
provided. Son et al. (2014) recently used this questionnaire to measure quality of life 
in Korean patients with TED and found there to be significant and substantial ceiling 
effects on all three items making it difficult to distinguish between the most affected 
patients. In follow-up interviews, two patients suggested a need for additional items 
(Son, Lee & Yoon, 2014).  
 
It has been argued that the GO-QOL is not only the most valid and reliable measure 
of quality of life in TED but it has also been recommended to be used as a primary 
outcome measure in randomised controlled trials (Wiersinga, 2012). Furthermore, in 
a recent review of TED-specific HRQL tools the GO-QOL has been found to be the 
only tool that encompasses all the desired elements of a pre-to post-intervention 
quality of life assessment tool (Ridyard & Inkster, 2014). The GO-QOL is a short 
questionnaire enhancing its suitability for patients to complete in a short amount of 
time before and after their treatment, and its development involved asking patients 
which items they felt were most important to them (Terwee et al., 1999). Originally 
written in Dutch, the GO-QOL has been translated into a number of different 
languages including English, Korean (Choi et al., 2012) and German (Ponto et al., 
2011). It has also been modified to suit the Australian population in a study by Park 
et al. (2004), who replaced an item about the effects of decreased visual function on 
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cycling with two new items; one about effects on work, and another about effects on 
domestic duties.  
2.4 QUALITY OF LIFE IN TED 
It should be noted that the studies described in the following sections of this chapter 
have examined quality of life in patients with TED, rather than patients with Graves’ 
disease (GD). There are mixed reports for quality of life in GD, with studies 
reporting diminished quality of life aspects when measured by the SF-36 TM 
(Abraham-Nordling et al., 2005; 2007) and using a GD-specific questionnaire 
(ThyPRO; Watt et al., 2014). However, Klaver et al. (2013) found no difference in 
the quality of life of people with thyroid dysfunction compared to people with 
normal thyroid levels. Importantly, further evidence suggests that quality of life 
improves after antithyroid drug treatment and thyroidectomy, i.e. when patients have 
become euthyroid (Ljunggren et al., 1998; Watt et al., 2014), with similar findings 
for mood (Kathol, Turner & Delahunt, 1986; Schreckenberger et al., 2006).  
 
The SIP was used as an outcome measure in one of the first published studies to 
examine quality of life in TED. This study found that patients with TED scored 
lower in quality of life than patients with other chronic conditions including diabetes, 
emphysema and heart failure (Gerding et al., 1997).  
 
Using the SF-36 TM, a number of authors have compared the quality of life scores of 
healthy control groups with scores from samples of patients with TED. They found 
that individuals with TED had poorer quality of life on all subscales of the SF-36 TM 
(Kahaly et al., 2002; Gerding et al., 1997; Lee et al., 2010). Egle et al. (1999) have 
reported that patients with TED with double vision are significantly more limited 
than patients without double vision on a number of SF-36 TM subscales. The SF-36 
TM
 has been translated into several languages and the Korean version was used in a 
recent study that found patients with TED showed significantly lower SF-36 TM 
scores than an age- and sex-matched healthy control group (Lee et al., 2010).  
 
Du et al. (2014) used the Chinese version of the NEI-VFQ-25 (CHI-VFQ-25; Du et 
al., 2014) to measure vision-related quality of life in 23 patients with optic 
neuropathy caused by TED and found that these patients were impaired in their daily 
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roles and mental health. Bradley and colleagues (2006) distributed the NEI-VFQ-25 
to 30 patients with TED and found that many scored at the ceiling level on most 
subscales, a finding reproduced by Du et al. (2014), arguing that the NEI VFQ-25 is 
potentially insensitive to detecting the severest ends of visual loss. Furthermore, in a 
qualitative study the authors found that more than two thirds of their sample 
discussed aspects of their TED that did not feature on the NEI VFQ-25. For example 
issues about their appearance were missing, suggesting it might not be a 
comprehensive measure for patients with TED (Bradley et al., 2006). 
 
Using the GO-QLS, Yeatts (2005) found that patients with TED report greater 
impairment in physical and mental health, poorer self-image, more sleep, social and 
work impairment than healthy controls. However there appears to be no later study 
that has used this questionnaire, and validation data are not available. Furthermore, 
the length of this questionnaire makes it unsuitable for use in clinical settings 
(Wiersinga, 2012) and is likely to cause participant burden. This makes it difficult to 
conclude whether the GO-QLS is a suitable tool to measure disease-specific quality 
of life in TED.  
 
Using the TED-QOL, Son et al. (2014) distinguished between the 3 items in this 
scale as conceptualising functional quality of life, appearance-related quality of life 
and “overall” quality of life and found that “overall” quality of life in patients with 
TED was poor. The authors found significant correlations between gender, soft 
tissue inflammation and proptosis and appearance-related quality of life, and 
correlations between age, inflammation and motility disorder and functional quality 
of life (Son, Lee & Yoon, 2014). However, this tool has not been rigorously 
evaluated for factorial structure so it is unclear if these 3 concepts are valid.  
 
Since its development, a number of studies have used the GO-QOL to assess the 
impact of TED on patients’ lives. Such studies have highlighted the detrimental 
impact of TED on activities of daily living not only as a result of visual problems but 
also due to a change in appearance. Studies that have used the GO-QOL have found 
that TED causes limitations in daily functioning including reading, watching TV, 
driving, and moving both around the house and outdoors due to problems in visual 
function (Lin, Lee & Liao, 2014; Choi et al., 2012; Ponto et al., 2011; Park et al., 
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2004). Vision-related quality of life scores have been found to be poorer in moderate 
to severe, and sight-threatening TED (Ponto et al., 2011). The impact of a changed 
appearance due to TED has also been found to reduce quality of life, with GO-QOL 
appearance scores having been consistently found to be lower than visual function 
scores, suggesting that the impact of a change in appearance is even more substantial 
than the impact of visual problems (Lin, Lee & Liao, 2014; Choi et al., 2012; Park et 
al., 2004; Ponto et al., 2011).  
2.5 SUMMARY 
Patients with TED face a difficult journey in the management and treatment of their 
condition and must attend regular assessments from a multidisciplinary team of 
clinicians to ensure that they are given the appropriate treatment. Based on disease 
symptoms and severity alone, TED might not be classed as severe, but subjectively 
patients often report finding it difficult to adjust to the changes in visual function and 
appearance. Patients not only report limitations in their day-to-day activities because 
of visual problems, but also report poorer quality of life due to the change in the 
appearance of their eyes. A patient’s adjustment to their condition might be 
explained by intervening cognitive and psychosocial processes that will be individual 
to each patient. Once these are better understood and evaluated, it might be possible 
to improve psychosocial outcomes for patients with support interventions designed 
to target the appropriate cognitions, and prevent carrying out unnecessary medical 
treatments. There is still little research on the psychological impact of disfigurement 
to the eyes. TED-specific quality of life questionnaires such as the GO-QOL are 
likely to best capture the experiences specific to patients with TED and are 
recommended in research on the impact of the disease as well as its treatment. 
However, the majority of studies that have used the GO-QOL have only investigated 
the relationship with clinical factors; there appear to be no studies to date that have 
evaluated a range of intervening psychosocial factors that might account for some of 
the variability in quality of life.  
 
This chapter has described research to date that has evaluated the impact of TED on 
quality of life and the following chapter will focus on the impact of treatment on 
quality of life outcomes.  
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3. THE IMPACT OF TREATMENT ON PSYCHOSOCIAL OUTCOMES IN 
TED: A SYSTEMATIC REVIEW OF THE LITERATURE  
3.1 PROLOGUE 
The first chapter of this thesis described the clinical features of TED and current 
treatment provisions offered to patients, which aim firstly to reduce symptoms and 
secondly to improve appearance and/or vision in patients with severe disease. 
Chapter 2 described how quality of life has been conceptualised and gave an 
overview of the literature to date that has reported the quality of life of patients with 
TED. These studies have found TED to have a detrimental impact on quality of life, 
due to both an altered appearance and double vision, with reductions found in self-
confidence and daily activities (Terwee et al., 1998; Ponto et al., 2011; Choi et al., 
2012; Kahaly et al., 2002; Gerding et al., 1997; Lee et al., 2010). Patients with TED 
have also been found to have poorer quality of life than other disease groups 
including diabetes, emphysema and heart failure (Gerding et al., 1997).  
 
An important question is whether treatment for TED improves quality of life 
outcomes as well as clinical features. Treatment-induced changes in clinical 
outcomes, including proptosis, inflammation, swelling, and disease activity have 
been well documented in the literature (e.g. Marcocci et al., 2002; Marcocci et al., 
2003; Rajendram et al. 2012; Boboridis & Bunce, 2011; Bartalena et al., 2008) but 
effects of treatment on quality of life have not yet received the same research 
interest. This issue is particularly important as there is some evidence to suggest that 
clinical characteristics do not correlate well with patients’ reports of perceived 
visibility and the impact it has on daily living (Gerding et al., 1997; Terwee et al., 
1998). This chapter therefore presents a systematic review that aimed to investigate 
the literature that has examined the impact of treatment for TED on quality of life 
outcomes. 
3.2 BACKGROUND & RATIONALE FOR SYSTEMATIC REVIEW 
METHODOLOGY 
Although clinical interest has traditionally focused on the improvement of clinical 
outcomes and physical complications of TED after treatment, far less research has 
explored the degree to which treatment improves a patient’s feelings of well-being 
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and their appearance concerns. There has been growing interest in the routine 
measurement of quality of life in patients with TED, with a number of TED-specific 
questionnaires now recommended for use in clinical settings (Fayers & Dolman, 
2011; Terwee et al., 1999; Wiersinga, 2012; Yeatts, 2005) and to evaluate treatment 
efficacy. To date there has been no review that has systematically evaluated quality 
of life outcomes following the variety of treatments for TED.   
 
Research studies vary greatly in their quality and methodological rigour but 
important healthcare decisions need to be made based on current evidence (Pai et al., 
2004). This is best made available through systematic reviews, which synthesise the 
results from a number of sources in a systematic way and rigorously evaluate studies 
for quality. The findings from systematic reviews provide healthcare professionals 
with a clear picture of the evidence in relation to a particular treatment’s efficacy 
and/or effectiveness at improving the outcomes concerned. A systematic review was 
therefore conducted on the research literature concerned with changes in 
psychosocial functioning after treatment for TED.  
 
When this systematic review commenced, a number of narrative reviews were 
identified that had investigated quality of life in patients with TED. Watt et al. 
(2006) reviewed quality of life in patients with benign thyroid disorders including 
TED, and Estcourt and colleagues (2011) evaluated the impact of quality of care on 
quality of life in TED. There are also several reviews that have investigated quality 
of life in TED before and after immunosuppressant therapy, including intravenous 
GCs (Zang, Ponto, & Kahaly, 2011), a combination of GCs and orbital radiotherapy 
(Zoumalan et al., 2007) and various alternative types of immunotherapies (Douglas 
& Gupta, 2011), including one review that did not identify the specific type of 
immunosuppressant therapy (Wiersinga, Prummel & Terwee, 2004).  A number of 
reviews have recently been published that have evaluated a variety of other 
treatments in terms of their impact on quality of life, but these are again narrative, 
not systematic reviews (Coulter et al. 2007; Fichter, Guthoff & Schittkowski, 2012; 
Eichorn et al., 2010; Gillespie, Smith, & Douglas, 2012; Marcocci, Altea, & Leo, 
2012; Marcocci & Marin, 2012; Ponto & Kahaly, 2010; Terwee et al., 2003a; 
Wiersinga, 2012).  
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A number of systematic reviews have been conducted in order to establish the 
impact of radiotherapy (Bradley et al., 2008; Rajendram et al., 2012; Viani et al., 
2012), orbital decompression (Boboridis & Bunce, 2011) and radioiodine therapy 
(RAI) compared to antithyroid drugs on the progression of eye disease for patients 
with GD (Acharya et al., 2008) on the quality of life of patients with TED. However, 
the study that reviewed orbital decompression found no evidence for quality of life 
improvement after surgery in the studies they reviewed (Boboridis & Bunce, 2011). 
Similarly, none of the few studies that examined the impact of radiotherapy on 
quality of life found any improvement (Bradley et al., 2008; Rajendram et al., 2012; 
Viani et al., 2012). In a study of radioiodine therapy patients with TED have not 
been distinguished from patients with GD on their quality of life (Acharya et al., 
2008). However with the most recent study included in these reviews having been 
published in 2005, and with new treatments for TED continually emerging, an 
updated evaluation of the current evidence was deemed necessary for this thesis. 
 
This is therefore the first systematic review to evaluate quality of life outcomes 
following a variety of treatments for TED. The present review only included studies 
that have evaluated such outcomes using validated and reliable measures as 
including such studies will increase the reliability of the evidence for treatment.  
3.3 AIMS 
The aim of the present review was to determine the quality of life outcomes of a 
range of medical treatments for TED including drug treatments, radiotherapy, and 
surgical interventions, and to report the findings using guidance from the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses Checklist (PRISMA; 
Moher et al., 2009).  
3.4 METHODS 
3.4.1 Inclusion & exclusion criteria 
Articles were restricted to those that had recruited adult patients with TED (>16 
years), and had evaluated the impact of some form of clinical treatment for TED on 
quality of life. The tools used to measure quality of life needed to have been 
validated and the article published in a peer-reviewed journal and in English.  
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Studies were excluded from the review if they had been printed in a language other 
than English due to lack of resources to have such studies translated. Studies were 
also excluded if they did not include primary data (e.g. reviews of other studies) and 
if data from patients with TED could not be extracted, for example if a study 
included a sample of GD patients where data for patients with TED had not been 
analysed separately. 
3.4.2 Literature search 
A preliminary literature search was performed to aid the development of an effective 
search strategy. Suitable search terms were defined for the review based on the initial 
search and were discussed with and validated by a Consultant Ophthalmologist 
specialising in TED. The search strategy included terms related to quality of life 
outcomes in TED and medical terms (Appendix A). Relevant electronic databases 
were chosen for the literature search, which included Ovid MEDLINE, EMBASE, 
PubMed, PsycINFO, Web of Science, CINAHL, AMED, PsycARTICLES, and The 
Cochrane Library. SCOPUS was searched using the same search terms for any 
relevant unpublished grey literature including conference abstracts and PhD theses 
so that authors could be contacted in case any potentially relevant work had since 
been published.  
 
The databases were first searched in September 2012. Once searches had been 
carried out, email alerts were implemented and prominent authors found within the 
search were contacted for any further unpublished work in the area, or to retrieve 
hard to find articles. Reviews identified by the searches were hand searched for 
relevant articles. The reference lists of all articles included in the current review were 
searched for any additional studies, as were those of existing similar reviews 
identified.  
 
The current review was performed to inform the thesis, was submitted for 
publication in December 2013, and has since been published (Wickwar et al., 2014; 
Appendix B). As email alerts identified two further relevant papers for the review 
since this time, in August 2014 the search was conducted again using the original 
search terms in order to update the thesis.  Whilst the search in 2012 was not limited 
by date, the 2014 update was restricted to identify papers published between 
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September 2012 and August 2014. The results of this updated search are reported in 
an addendum at the end of the current chapter (page 65).  
 
A quantitative meta-analysis was not conducted as part of this review. Meta-analytic 
methods were considered inappropriate because of the heterogeneity among studies 
in terms of sample characteristics and because of the poor quality of the studies, 
which will be discussed further in section 3.5.2 of this chapter. 
3.4.3 Study selection 
Once searches had been conducted, clearly irrelevant titles were removed and if it 
was unclear from the title alone the abstracts were screened.  All remaining articles 
were retrieved in full and screened for eligibility.  A second reviewer crosschecked 
the relevance of the remaining articles and any disagreements were resolved in 
collaboration with a third reviewer until consensus was reached.  The second and 
third reviewers had extensive experience in conducting and publishing systematic 
reviews.  
3.4.4 Data extraction 
A standardised data extraction form was developed for extraction of the relevant data 
from each of the final articles (Appendix C). This was piloted on five of the final 
articles and necessary amendments were made. Any amendments were applied to the 
first five articles to ensure consistent data were extracted. Once data had been 
extracted from all the articles and in order to validate the data extraction process, a 
second researcher performed data extraction on 20% of the final papers and the 
extractions were compared. Any disagreements were discussed between the two 
researchers until consensus was achieved.   
3.4.5 Quality assessment 
Bias is systematic error within a study’s results or inferences and can lead to 
underestimation or overestimation of the true effect of an intervention (Higgins & 
Altman, 2008). It can be caused by poor study design, misconduct in data collection 
and analysis, and poor quality reporting of methods and results (Centre for Reviews 
and Dissemination, 2009). There is a distinction between ‘risk of bias’ and ‘quality’, 
where a study may have been conducted to high standards yet still have a risk of 
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bias, for example it might have been impossible to blind participants from the 
intervention. There may also be no risk of bias where a study lacks quality reporting 
such as a power calculation (Higgins & Altman, 2008). Assessments of the risk of 
bias are commonly referred to as quality assessments; it is important that alongside 
quality these assessments also consider potential sources of bias, such as attrition 
bias (Higgins & Altman, 2008) and therefore a reliable quality assessment tool 
should be used to assess each study in a systematic review.  
 
A plethora of widely recognised tools exist and a number were considered for the 
present review. These included tools developed by the Critical Appraisal Skills 
Programme (CASP) for a variety of study designs, including CASP tools for RCTs 
and cohort studies (CASP, 2006), and the Mixed Methods Appraisal Tool (MMAT; 
Pluye, 2011). However for the purpose of the present systematic review a tool was 
required that incorporated all types of study design giving one overall quality score, 
where RCTs were considered the gold standard. Whilst the MMAT does provide an 
overall score it was designed for studies that use mixed methods designs, and the 
CASP tools give separate scores depending on study design. Therefore the quality 
index developed by Downs & Black (1998) was chosen as the most appropriate tool 
as it is highly regarded for use in systematic reviews (Wells & Littell, 2009), and it 
incorporates an evaluation of both quality and internal validity (control of bias an 
confounding). It consists of 27 items designed for use with both RCTs and 
observational studies and is composed of five subheadings: reporting, external 
validity, internal validity and power (Downs & Black, 1998). Nine of the items 
included the response options “yes” (1 point) or “no” (0 points), 16 items included 
the additional option “unable to determine” (0 points). One item included the 
response options “yes” (2 points) “partially” (1 point) or “no” (0 points). The final 
item asked “Did the study have sufficient power to detect a clinically important effect 
where the probability value for a difference being due to chance is less than 5%?” 
and scores for this item ranged from 0 to 5 depending on power achieved. The 
software G*Power version 3.1.2 was used for this task where studies did not report a 
power calculation. The highest possible score for quality assessment was 32. The 
quality assessment was crosschecked by a second reviewer and a third reviewer was 
asked to review the process and final scores to reach agreement. 




3.5.1 Description of the studies 
The database searches identified 440 articles and 2 additional citations were 
retrieved from other sources; the email alerts received during the period of 4th June 
2012 and 1st April 2013 identified one article and contact with key authors identified 
a further article. The search for grey literature in SCOPUS identified 88 unpublished 
references. Titles were searched for relevance and one conference abstract was 
identified as potentially relevant for the review. However, contact with the authors 
revealed that this article related only to pre-treatment impact of TED and did not 
include a post-treatment evaluation. A total of 259 titles and abstracts were screened. 
71 citations were excluded at this stage (Figure 5). The full texts of 188 articles were 
retrieved and reviewed for inclusion. After review and consensus, a total of 13 
articles remained with an additional 2 articles that were retrieved from the reference 
lists, resulting in 15 articles.   





Figure 5. A flow chart showing each stage of the study selection process for the original 
search (in September 2012) 
 
The characteristics of the included studies are shown in Table 3. The 15 articles 
included a total of 1433 patients with TED. Most participants were female (1,267; 
88% of those reporting gender) although not all the studies reported genders (e.g. 
Kulig et al, 2009). Six of the studies were RCTs and 5 out of these 6 were double-
Total identified from 
database searches             
n = 440 
Full copies retrieved and 
assessed for inclusion             
n = 188 
Excluded (n= 71) 
 
Title not relevant to GO = 65 
 
Paediatric population = 3 
 
Abstract only (not peer-reviewed 
published article) = 3 
 
Studies identified from 
searching key articles 
reference lists n = 2 
Publications meeting 
inclusion criteria n = 
13 
Excluded (n= 175) 
 
Papers not printed in English = 33  
 
No QoL measure = 42 
 
Reviews = 76 
 
GD not TED = 11 
 
Baseline QoL only = 5 
 
Editorials and commentaries = 8 
 
Non-validated QoL measure used = 3 
Studies included in 
the review n = 15 
Studies identified from 
email alerts n = 1 
 
Studies identified from 
contact with key authors 
n = 1 
 
Duplicates 
removed n = 183 
Titles & abstracts 
screened n = 259 
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blind randomised trials where the patients and treating clinicians were blind to the 
type of treatment (Bartalena et al, 2012; Dickinson et al, 2004; Marcocci et al, 2011; 
Prummel et al, 2004; Wémeau et al, 2005). One of the 6 trials was single-blind due 
to the nature of administering intravenous IV steroids (Kahaly et al., 2005). Three 
out of the final 15 studies compared pre-treatment quality of life in patients with 
TED to a healthy control group (Abraham-Nordling et al., 2010; Kulig et al., 2009; 
Terwee et al., 2002), 5 included a control group of patients with untreated TED 
(Dickinson et al., 2004; Marcocci et al., 2011; Prummel et al., 2004; Wémeau et al., 
2005; Elberling et al., 2004) and the remaining studies had no group for comparison 
In addition, two studies compared patients with GD without eye symptoms to those 
with TED (Abraham-Nordling et al., 2010; Elberling et al., 2004).  
 
Despite 6 RCTs being identified by the searches, a meta-analysis on this RCT sub-
group was not possible due to the heterogeneity of studies, such that different quality 
of life measures were used, one study did not report quality of life data (Wémeau et 
al., 2005) and two studies were described as RCTs but did not include a control 





Table 3. The main characteristics of the studies included in the systematic review 
 
Authors Country Design Control group Sample 
population 












RCT No Moderate to 
severe, active 
TED 
159 CAS <3, optic neuropathy, 
patients not recommended for 
GC therapy, pregnancy, no 
informed consent, increased 
liver enzymes by a factor of 2 
or more above upper normal 
limits.  
Three different doses 
of IV GC: 2.25g (low 
dose), 4.98g (middle 
dose), 7.47g (high 
dose) 
6, 12 and 24 
weeks 




RCT Yes Moderately 
severe, active 
TED 
50 Patients with sight-threatening 
disease (NOSPECS 5b, 5c, or 
6) 
Octreotide-LAR (30 
mg by injection at 4 
week intervals); 
placebo (prepared in 




16, 32, 44, and 
56 weeks 
Kahaly et al., 
(2005) 





Oral GC (cumulative 
dose of 4.0g after 12 
weeks); IV GC 
(cumulative dose of 
4.5g).  
12 and 24 weeks 
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Italy, Greece  
RCT Yes Mild TED 152 NOSPECS class 2c1, 
exophthalmos >22 mm, 
diplopia and/or ocular 
torticollis, mono-ocular 
duction in any direction of < 
20o, optic neuropathy, 
pregnancy, drug and/or 
alcohol abuse, severe 
concomitant illness, inability 
to comply with study 
protocol, no informed 
consent, current use of 
selenium- or PTX-containing 
preparations. 
Selenium (100 μg 
orally twice daily for 
6 months); PTX (600 
mg orally twice daily 
for 6 months); 
placebo (tablets twice 
a day for 6 months 
that looked identical 
to selenium and 
PTX) 
12, 24, and 48 
weeks 
Prummel et al., 
(2004) 
Holland RCT Yes Mild and 
previously 
untreated TED 
88 Severe periorbital swelling, 
proptosis > 25 mm, moderate 
or severe motility 




diabetes), severe concomitant 
disease, no informed consent 
Orbital radiotherapy 
(2 Gy daily over 2 
weeks); sham 
irradiation (patients 
underwent the same 
procedures and the 
sound of the 
accelerator was 
simulated) 
12, 24, and 48 
weeks 
Wémeau et al., 
(2005) 
France RCT Yes Mild, active 
TED 
51 Any other eye problem, 
gallstones, a history of 






treatments by IM 
injection); placebo (2 
ml treatments by IM 
injection) 
4 week intervals 
throughout the 16 
week treatment 
period, and again 
24 weeks after 


















313 GD patients. 
41 patients had 








Previous history of treatments 
with ATDs, I131, thyroid 
surgery, severe TED requiring 
treatment with corticosteroids, 
incipient toxic crisis, large 
goiters, coronary heart 
disease, pregnancy, breast-
feeding, pregnancy planned 
within following 2 years 
Methimazole; 
radioiodine (one dose 
aiming for an 
absorbed dose of 
120Gy) 
12 and 24 weeks, 
24 and 36 months 














52 Corneal involvement 
(exposure keratitis, corneal 
ulceration, clouding or 
necrosis), patients not 
recommended for GC therapy, 
patients who had already been 
treated with GCs, surgery or 
radiotherapy. 
IV GC (cumulative 
dose of 4.5g); high 
dose oral GC 
(cumulative dose  of 
4 g) 
12 weeks 
















OD (17 different 
approaches) 
12 weeks 




No TED 164; radiotherapy 
(n=23), OD for 
sight loss (n=10), 








OD; EMS; EL; 
blepharoplasty (dose 
and administration of 
each not reported) 














at one time 
point) 
Patients with 







oral GC (prednisone); 
a combination of 
both 
immunosuppressive 





calculated as the 
time between the 
first visit to the 
clinic and the 
follow-up visit; 
average follow-
up was 11.7 
years 




No TED  61 Absence of clinical and 
biochemical euthyroid state, 
presence of other chronic 
disorders such as diabetes 
mellitus, incomplete follow-
up, and incomplete 
questionnaires (more than 










No TED  67 Absence of clinical and 
biochemical euthyroid state, 
presence of other chronic 
disorders such as diabetes 






(specific type not 
reported) 
24 weeks 
Elberling et al., 
(2004) 








27 GD patients. 9 
patients with toxic 
GD also had signs 
or symptoms of 
TED as classified 
by NOSPECS on 
entry into study 
Unable to read Danish, prior 
thyroid disease or psychiatric 
disorders, neurologic 
disorders known to influence 
neuropsychiatric functions, 







Kulig et al., 
(2009) 
Not stated - 













29 Other autoimmunological 
disease, administration of oral 
steroids before hospital 
admission, treatment by 
means of orbital irradiation 
only or cyclical administration 
of methylprednisolone only, 
patients whose treatment was 
ceased because of 
complications, cessation of 
oral treatment with 
prednisone, patient’s refusal 
to be examined after 
completing the full therapy, 
relapsing form of TED 
Combined IV GC 
and orbital 
radiotherapy (6 




Beleslin et al.. 
(2014) 
Not stated - 







50 Contraindication to GCs IV GC (500mg 
repeated after 48 
hours). Oral GCs 
started on the 3rd day.  
24 weeks 
Fichter, Krentz & 
Guthoff (2013) 








12 and 24 weeks 
Jellema et al., 
(2014) 
Not stated - 





No Euthyroid TED 28 Patients with pre-existent 
strabismus, suppression 
and/or vision <0.2 in one or 




Between 8 and 16 
weeks 




A total of 14 treatments were evaluated (Table 3): methimazole, radioiodine (RAI), 
intravenous (IV) glucocorticoids (methylprednisolone), oral glucocorticoids 
(methylprednisolone, prednisone and an unspecified corticosteroid), orbital 
radiotherapy, a combination of radiotherapy and oral glucocorticoids, a combination 
of radiotherapy and IV glucocorticoids, octreotide-LAR, selenium, pentoxifylline 
(PTX), orbital decompression, eye muscle surgery (for strabismus), eyelid 
lengthening, and blepharoplasty. Three studies reported administering, in addition to 
the main drug evaluated in the trial, methimazole and other anti-thyroid drugs in 
order to stabilize thyroid function (Dickinson et al., 2004; Prummel et al., 2004; 
Wémeau et al., 2005). Unfortunately the efficacy of the main treatment in each of 
these studies might have been overestimated (or underestimated) if methimazole 
independently alters eye symptoms and quality of life outcomes. The additional 
papers from the August 2014 search did not identify any further treatments. Their 
characteristics have been included in Table 3 in italics.   
 
Quality of life was a primary outcome measure in 7 out of 15 articles (Abraham-
Nordling et al., 2010; Elberling et al., 2004; Kashkouli et al., 2009; Kashkouli et al., 
2011b; Kulig et al., 2009; Terwee et al., 2001; Terwee et al., 2002) and secondary to 
clinical outcomes in the remaining 8 (Aktaran et al., 2007; Dickinson et al., 2004; 
EUGOGO et al., 2009; Kahaly et al., 2005; Marcocci et al., 2011; Prummel et al., 
2004; Wémeau et al., 2005; Bartalena et al., 2012), The SF-36TM was used as an 
outcome measure in 8 studies (Abraham-Nordling et al., 2010; Elberling et al., 2004; 
Kahaly et al., 2005; Kulig et al., 2009; Prummel et al., 2004; Terwee et al., 2001; 
Terwee et al., 2002; Wémeau et al., 2005). Prummel et al. (2004) and Terwee et al. 
(2001) used the Sickness Index Profile (SIP) and each study used only 3 of the 
subscales; social interaction, household management and leisure pastimes and 
recreation. Prummel et al. (2004) used the full version of the EQ-5D and Terwee et 
al. (2001; 2002) used the visual analogue scale. Aktaran et al. (2007) and Kashkouli 
et al. (2009) used the Australian version of the GO-QOL; Kashkouli et al. (2009) 
removed one item about education and counselling. Kashkouli et al. (2011b) 
modified the original version into Farsi. The remaining 8 studies used the original 
version of the GO-QOL (Bartalena et al., 2012; Dickinson et al., 2004; EUGOGO et 
al., 2009; Marcocci et al., 2011; Prummel et al., 2004; Terwee et al., 2001; Terwee et 
al., 2002; Wémeau et al., 2005).   




3.5.2 Quality assessment 
The results of the quality assessment (Downs & Black, 1998) indicated that study 
quality varied considerably (mean = 20/32; range 14/32 to 31/32), with higher scores 
indicating superior quality (Appendix D). The most common issues relating to 
quality were omission of details about recruitment (such as exclusion criteria, 
sources of recruitment, or participant characteristics), the use of incorrect statistical 
analysis or lack of such analysis, the lack of either the reporting of statistical power, 
or inadequate recruitment to reach statistical power and the descriptions of treatment 
and its administration were often inadequate.   
 
In particular, some articles did not clearly describe patient characteristics (e.g. 
smoking status), making it difficult to assess whether those that took part were 
representative of the population they were recruited from. Details that were 
commonly omitted included how many patients were approached to take part and 
why those that declined chose not to take part. For example, “The total number of 
patients that met the inclusion criteria is not known, but the reported cases were 482” 
(Abraham-Nordling et al., 2010, p.652). Dickinson et al. (2004) did not report how 
many patients were recruited from each study site, or any details about the 
recruitment period. It is therefore unclear whether patients in different intervention 
groups were recruited from the same centre or not; if patients in one treatment group 
were recruited from different populations this may have biased the results for that 
particular treatment.  
 
Some studies lacked statistical comparison between treatments making it unclear 
what impact these treatments had on quality of life. For example no statistical 
analysis was conducted in Terwee et al. (2002), while Wémeau et al. (2005) did not 
report which statistical analysis was used to compare quality of life outcomes just 
that no difference was found between octreotide-LAR and placebo. Terwee et al. 
(2002) did not describe how they adjusted for different lengths of treatment follow 
up over 11 years, or indeed whether this was done at all. EUGOGO et al. (2009) also 
failed to report any statistical findings for the difference in GO-QOL subscale scores 
from pre- to post-decompression although they report conducting statistical analyses. 
These authors have also only presented the seven most frequently used procedures; it 




is unclear what the results were for the other ten types of orbital decompression. The 
scale of random variability in the data of the majority of the studies is not clear, as 
SDs were frequently not reported by studies (Abraham-Nordling et al., 2010; 
Aktaran et al., 2007; Dickinson et al., 2004; Kahaly et al., 2005; Kashkouli et al., 
2009; Kashkouli et al.; 2011b).  
3.5.3  Methimazole  
Abraham-Nordling et al. (2010) found no significant difference, at any point 
between baseline and 4 years after treatment, in the physical or mental health-related 
quality of life subscale scores between patients who received RAI and those that 
received methimazole, a standard anti-thyroid drug given to all patients with GD.  
Both groups did, however, experience a significant improvement in quality of life 
after treatment and at 3 to 48 months after treatment the quality of life scores for 
physical health were equal to those of a Swedish general population reference group.  
Notably however, it was not until the 12-month follow-up that mental health 
subscale scores were found to reach the same average for the reference population. 
This study also compared patients with GD with and without TED, and found that 
patients with TED 2 years after methimazole treatment had significantly worse 
physical health-related quality of life as compared to patients without eye disease.  
At one year follow up, the authors found “no clear correlation” (p.655) between 
objective eye scores and physical health or mental health subscale scores, however 
correlation coefficients were not provided. Elberling et al. (2004) found that, after a 
year of methimazole treatment, patients with GD (both those with and those without 
TED) had significantly lower mental and physical quality of life as compared to a 
healthy control group from the general population; these authors did not examine the 
differences between patients with GD with and without TED.  
3.5.4  Orbital radiotherapy  
Using the GO-QOL, Prummel et al. (2004) reported that a year after orbital 
radiotherapy patietns had similar quality of life scores to those receiving placebo 
radiotherapy, although the comparison was only descriptive.  Terwee et al. (2001) 
did not find a significant improvement in the visual functioning subscale of GO-
QOL at 6 months after radiotherapy (p=0.05).  Compared to orbital decompression, 
eye muscle surgery, eyelid lengthening or blepharoplasty, orbital radiotherapy led to 




the least improvement in appearance-related quality of life (Terwee et al., 2001). In a 
cross-sectional study looking at long-term quality of life outcomes (up to 11 years) 
Terwee et al. (2002) compared SF-36TM scores for patients who had received 
radiotherapy, steroids (or both treatments) with the scores for patients who 
completed the SF-36TM before the start of radiotherapy or orbital surgery.  They 
found that the treated group experienced significantly better quality of life than those 
newly diagnosed, except on the physical functioning and general health perceptions 
subscales. The treated group also reported significantly better quality of life on the 
GO-QOL appearance and visual function subscales. Notably these findings are for 
“GO patients after treatment” and are not reported by treatment type. The 
radiotherapy group experienced worse functional quality of life than the steroid 
treated group, but scored better on the GO-QOL appearance subscale.  It is important 
to note, however, that no analysis of statistical significance was reported for this 
finding.  
3.5.5  Systemic corticosteroids 
Using the SF-36™, Kahaly et al. (2005) reported a significant improvement in 
physical and mental health-related quality of life after IV methylprednisolone, but no 
significant changes after oral methylprednisolone.  Bartalena et al. (2012) found that 
after 12 weeks of medium or high-dose IV methylprednisolone, there was a 
significant improvement in the GO-QOL visual function subscale, and a significant 
improvement in appearance-related quality of life for those on low dose therapy.  
Likewise, Aktaran et al. (2007) found that, after 3 months, 85% of the IV steroid 
group experienced significant improvements in vision-related quality of life and 81% 
had an improvement in the appearance subscale.  In a group receiving oral steroids, 
76% showed improvement in visual function subscale scores and 78% showed 
improvement in appearance subscale scores.  IV treatment led to significantly more 
improvements in quality of life scores than oral therapy (Aktaran et al., 2007).  
 
Of the participants in the study by Terwee et al. (2002), 32% received prednisone, 
although it is unclear if this was oral or IV treatment.  As compared to those 
receiving radiotherapy, participants who received prednisone had a better overall 
quality of life, with the exception of the appearance subscale of GO-QOL and the 
SF-36™ vitality score. Kashkouli et al. (2009; 2011b) studied the effects of 




corticosteroids on quality of life, but the method of administration is unclear in both 
studies. In 2009 the authors reported the change in mean scores from baseline to 6 
months after treatment and suggest significant improvement in both GO-QOL 
subscale scores.  In the later study, both GO-QOL visual function and appearance 
subscales significantly improved after steroids, this contrasting with orbital 
decompression whereby only the appearance subscale scores improved.  In both the 
steroid and the decompression groups, over two-thirds achieved the minimum 
clinically important difference in quality of life, with no significant difference 
between the two groups.  In both studies Kashkouli et al. failed to show any 
significant relationship between quality of life scores (before and after treatment) 
and clinical variables (including duration of disease, severity, or activity) (Kashkouli 
et al., 2009; Kashkouli et al., 2011b).  
 
Kulig et al. (2009) reported that patients with TED had significantly reduced quality 
of life, assessed by the SF-36™, as compared with a healthy group of volunteers 
from the general population. They found that radiotherapy, combined with IV 
methylprednisolone, improved quality of life in relation to physical functioning, 
bodily pain and vitality; it is unclear if these changes were statistically significant 
however.  The authors also found no correlation between quality of life and 
demographic or clinical variables. The authors have not reported the correlation 
coefficients found, however.  
3.5.6  Long-acting octreotide (octreotide-LAR)  
Dickinson et al. (2004) reported a significant improvement in visual-related quality 
of life from pre-treatment to 16 weeks after administration of octreotide and a 
significant improvement in appearance-related quality of life at 32 and 54 week 
follow-up, however significance levels were not reported.  Wémeau et al. (2005) 
used both the SF-36™ and GO-QOL but merely report no significant changes in 
either quality of life score after treatment. Exact data was not presented.  
3.5.7  Pentoxifylline and selenium  
Marcocci et al. (2011) found no significant difference between the placebo and 
pentoxifylline on any of the GO-QOL subscales at 6 and 12 months after treatment.  
A significantly greater proportion of patients in the selenium group did exhibit an 




improvement in quality of life at 6 months, compared with those receiving a placebo 
(Marcocci et al., 2011). An improvement of 6 or more points on the appearance 
subscale was reported in 84% of those taking selenium, 72% on the visual function 
subscale and 81% in overall scores. Selenium led to a significant reduction in 
deterioration of quality of life (as compared with those given placebo). Selenium had 
a beneficial effect on quality of life that continued up to 6 months after treatment 
finished, both over time and when compared to the placebo group. However, the 
authors appear not to have analysed the differences in quality of life improvements 
between the pentoxifylline and selenium groups (Marcocci et al., 2011). 
3.5.8  Surgery 
EUGOGO et al. (2009) investigated the impact of 18 different approaches to orbital 
decompression on quality of life using the GO-QOL. They reported improvements in 
the appearance subscale scores of between 17.4 and 39.9 points in all treatments, 
except for the translid and endoscopic approaches to decompression, in which the 
change was no more than 1.8 points. Although no significance testing was 
performed, improvements appear to be substantial for a number of approaches, with 
many changes in scores reaching a minimal clinically important difference (MCID) 
for the GO-QOL (Table 4).  Although the coronal approach led to the biggest 
improvement in appearance related quality of life, this approach caused the most 
frequent and serious complications.  
 
Terwee et al. (2001) reported a significant improvement in the GO-QOL visual 
function subscale where orbital decompression was performed for sight loss and an 
improvement in the appearance subscale when decompression was performed for 
disfiguring proptosis.  The authors have highlighted that improvement on the GO-
QOL can be seen in either the visual function subscale, or appearance subscale, or 
both, depending on the type of treatment (2001). For example the effect size for 
decompression for sight loss in the GO-QOL visual function subscale is 0.9 and the 
effect size for decompression for appearance in the GO-QOL appearance subscale is 
0.45; for the SF-36™ physical and mental health subscales these are 0.15 and 0.13, 
respectively. Eyelid lengthening resulted in a lower mean change in appearance-
related quality of life compared to the other treatments, although this was not 
significant. Blepharoplasty (which included 8 patients who had eyelid lengthening at 




the same surgery) led to significant improvements in the appearance subscale, these 





Table 4. Scores representing the mean change and standard deviations from pre-treatment to post-treatment follow-up for each quality of life 
outcome measure 
 
















Methimazole Abraham-Nordling et 
al. (2010)  
N.B Authors did not 




145 48 months - - 21* 16* - 
  
Elberling et al. 
(2004) 
 
    30 12 months - - 8.1* ** 8.6* ** - 
RAI Abraham-Nordling et 
al. (2010) 
 
163 48 months - - 17* 14* - 
 Radiotherapy Terwee et al. (2001)  
23 6 months 8.1 (18.6)** 2 (17.9) - - - 
  
Prummel et al. 
(2004) 
 
26 12 months 8.2 (15.8) 6.7 (17.2) - - 1.2 (14.5) 
 






Various Not Reported Not Reported Not Reported Not Reported Not Reported 
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IV Methylpred. Bartalena et al. 
(2012) 
N.B HD group 
showed the biggest 




52 3 months 12.8 (7.2; 18.3) 
**  9 (4.5; 13.5) **  - - - 
  
Kahaly et al. (2005)  
35 3 months - - 0.5‡ ** 0.4‡ ** - 
 
Aktaran et al. (2007)      
25 3 months Not Reported Not Reported - - - 
Oral 
Methylpred. 
Aktaran et al. (2007)  
27 3 months Not Reported Not Reported - - - 
  





52 Various Not Reported Not Reported Not Reported Not Reported Not Reported 
  
Kahaly et al. (2005)  
35 6 months - - 0.3 ** 0.1 - 







6 months Not Reported Not Reported - - - 
  
Kashkouli et al. 
(2011b) 
 
61 6 months 20.1 ** 24.4 ** -  -  -  






































































Wémeau et al. (2005) 
 
26 
6 months Not Reported Not Reported Not Reported Not Reported - 
PTX Marcocci et al. 
(2011) 
N.B Authors did not 
















Selenium Marcocci et al. 
(2011) 
N.B Authors did not 







11 (15.3)  12.6 (11.8)  -  -  - 
















34.6  36 **  -  -  - 
OD 
(exophthalmos) 







11 (15.5) **  -  -  - 
 EUGOGO et al. 
(2009) 
Swinging eyelid 






17.5 (20.8)  17.4 (24.5)  -  -  - 







39.9 (27)  -  -  - 
















 Swinging eyelid 








19.9 (22.9)  -  -  - 
























34.5 (30.4)  -  -  - 
 





13.6 (18.7)  22.1 (25.3)  -  -  - 
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34.9**  24**  -  -  - 














 Jellema et al. (2014)  
28 2-4 months 20** 9** - - - 
EL Terwee et al. (2001)  
43 3 months 3.7 (15) 4.2 (13.9) ** - - - 
Bleph. Terwee et al. (2001)  
19 3 months 0.2 (19.7) 10.2 (17.5) ** - - - 
** Findings were statistically significant   Minimal clinically important difference (MCID) achieved 
*Scores include GD and TED patients combined,  
‡ Authors reported change in age- and gender-adjusted z scores for the SF-36 
† Scale runs from 0 to 100 (higher scores indicate better QoL outcomes) 
 
 




3.5.9  The relationship between clinical & psychosocial factors 
A number of the studies investigated the relationship between clinical and 
psychosocial outcomes and all report finding no statistically significant relationship. 
Abraham-Nordling et al. (2010) found that at 1 year post-treatment follow-up, there 
was no significant relationship between SF-36 scores and scores on clinical 
measures, although correlation coefficients were not provided. Kashkouli et al. 
(2009) conducted a linear regression analysis and Spearman’s correlation test finding 
no significant correlation between the duration of thyroid dysfunction, or the 
duration, severity, or activity of TED and quality of life scores both before and after 
treatment.  However, correlation coefficients were not been provided. Kashkouli et 
al. (2011b) reported that they found no statistically significant effect of disease 
duration on TED severity and activity on quality of life scores before or after 
treatment.  
 
Kulig et al. (2009) reported finding no correlation between disease activity as 
measured by the CAS and quality of life; however correlation coefficients were not 
reported in this paper. Terwee et al. (2001) found low correlation coefficients 
between changes in GO-QOL subscale scores and changes in clinical characteristics. 
For the GO-QOL visual function subscale these include r = 0.27 for visual acuity 
and r = 0.27 for diplopia and for the GO-QOL psychosocial function subscale these 
were r = 0.04 for lid aperture, r = 0.25 for proptosis and r = 0.28 for soft tissue 
involvement. Where a correlation coefficient of 0.1 is considered small, 0.3 is 
considered moderate and 0.5 large (Cohen, 1992); these findings suggest that only 
small to moderate relationships exist. Terwee et al. (2002) report that 45% of 
patients with diplopia scored on average 6 points lower on the GO-QOL visual 
function subscale and 7 points lower on the psychosocial function subscale 
compared to patients with no diplopia. However the authors did not use correlational 
statistical tests to examine the relationship between clinical and psychosocial factors 
making it unclear what conclusion can be drawn from these findings. 
3.6 ADDENDUM 
In order to ensure that the systematic review was up to date at the time of the 
submission of the thesis the original search used was repeated and identified a 




further 95 papers. Screening of titles identified 37 clearly irrelevant papers. 
Screening of abstracts identified 1 commentary, 15 reviews, 2 articles published in a 
foreign language and one conference abstract. Of the remaining 39 articles, 16 
investigated aspects of GD that did not include patients with TED, 16 investigated 
TED but did not include quality of life measures, 3 measured quality of life in TED 
but not after treatment and 1 measured patient satisfaction after treatment that did not 
include a validated quality of life measure. The final 3 articles met the original 
inclusion criteria for the systematic review (Fichter, Krentz & Guthoff, 2013; 
Jellema et al., 2014; Beleslin et al., 2014) and were included in this updated version 
of the systematic review to assess whether any conclusion should be revised.   
 
Quality of life was a primary outcome measure in one of the additional studies 
(Jellema et al., 2014) and a secondary outcome measure in the other two additional 
studies (Fichter et al., 2013; Beleslin et al., 2014). All three studies used the original 
Dutch version of the GO-QOL. Using the Downs & Black (1998) quality assessment 
tool, the results of the quality assessment indicated that none of the studies fell 
outside of the range found in the 2012 review (see page 54). Fichter et al. (2013) 
received a score of 16 out of 32 in the quality assessment and the other two studies 
(Beleslin et al., 2014; Jellema et al., 2014) received a score of 18 out of 32.  
 
The results of the three additional studies in terms of mean change scores from pre- 
to post-treatment can be seen in Table 4, with these studies highlighted in italics. 
Beleslin et al. (2014) measured differences in GO-QOL scores pre to post-
administration of systematic GCs and reported a statistically significant 
improvement in GO-QOL visual function scores; but the improvement in GO-QOL 
appearance scores was not found to be statistically significant. However, as this 
study involved administering IV methylprednisolone followed by a tapering of doses 
of oral prednisone (Beleslin et al., 2014), it is unclear which of these two treatments 
was being evaluated in terms of quality of life. Furthermore, it was reported that 
follow up measurements were taken at monthly intervals, but the authors have failed 
to report the follow-up time point at which GO-QOL scores were compared to 
baseline scores. 
 




Fichter et al. (2013) examined the impact of lateral wall decompression on 11 
patients and found significant improvements in both visual-function and appearance 
subscales at 3 month follow-up, with a further statistically significant improvement 
in the visual-function subscale 6 months after surgery.   
 
Jellema et al. (2014) measured quality of life before and after strabismus surgery for 
TED and found statistically significant improvements in both vision-related and 
appearance-related quality of life after strabismus surgery. The largest improvement 
was seen in vision-related quality of life, which was the only subscale to reach a 
MCID (Table 4). A moderate significant correlation was found between the visual-
function score and field of binocular single vision (BSV) after surgery (r = 0.417, p 
=0.034).  
 
These most up-to-date three studies therefore did not substantially alter the 
conclusions of the published systematic review.  
3.7 DISCUSSION 
This is the first systematic review to evaluate the impact of treatment including 
drugs, radiotherapy and surgery on quality of life in patients with TED.   
 
In summary, radiotherapy was found to improve vision-related quality of life but had 
the least improvement in appearance-related quality of life compared to surgery, 
which had the best appearance-related quality of life outcome. IV 
methylprednisolone led to better quality of life outcomes than oral 
methylprednisolone and, even at low doses the former improved appearance-related 
quality of life.  These studies also reported fewer adverse effects for IV 
corticosteroids as compared to oral, thereby making IV steroids a more favourable 
treatment both clinically and psychologically.   
 
Long-term benefits in quality of life were found for octreotide-LAR, methimazole 
and selenium at up to 4 years after treatment. Eyelid lengthening and blepharoplasty 
were both found to improve appearance-related quality of life, although these 
findings need to be considered in light of the poor quality in reporting of these 
studies.  Orbital decompression was found to have a larger effect on vision-related 




quality of life when it was performed for failing vision and a larger effect on 
appearance-related quality of life when surgery was performed for aesthetic 
improvement.  
 
The reporting of participant characteristics varied greatly between studies and this 
potentially introduced bias, with many studies failing to report disease severity 
(Elberling et al., 2004) or previous treatments (Elberling et al., 2004; Kashkouli et 
al., 2009).  The severity of TED and prior treatment are important clinical factors 
that might contribute to a patient’s psychosocial adjustment and their subsequent 
quality of life.  The reporting of smoking status also varied, with only 6 of 15 studies 
reporting this data.  Smoking is an important factor in the onset and severity of TED 
and the response of TED to treatment. Therefore smoking status might affect both 
the clinical and psychological quality of life outcomes. A recent systematic review 
provides some evidence for this contention (Thornton et al., 2007).   
 
Although this is not always possible in health research, the inclusion of a “no 
treatment” control group varied between RCTs, with a third of the RCTs included in 
this review being conducted without a control group. Where particularly important 
confounding variables have not been accounted for – such as whether patients 
smoked, or if they were taking treatments additional to that under investigation – this 
could potentially affect the results of these studies.  Limitations of some of these 
studies make it impossible to give definite recommendations about the most effective 
treatments for improving quality of life.  Furthermore not all of the studies reviewed 
included the TED-specific GO-QOL as a measure of quality of life in the population 
of interest. Generic HRQL measures, such as the SF-36™, include items that are 
considered too broad to capture the specific experiences of patients with TED, unlike 
the GO-QOL, which is able to detect clinically important changes in scores from 
baseline to post-treatment follow-up (Terwee et al., 2001). Despite the GO-QOL 
being recommended as an independent primary outcome measure in TED clinical 
trials (Terwee et al., 2001; Wiersinga, 2012), not all of the reviewed studies included 
this measure.   
 




It is worth noting the limited number of studies that have examined quality of life 
after treatment, particularly in relation to orbital decompression. Given how costly 
and physically invasive such procedures are, this is somewhat surprising.  
 
This review has also shown that the relationship between clinical and psychosocial 
outcomes remains unclear in TED. For instance, Kulig et al. (2009) and Kashkouli et 
al. (2011b) failed to find a relationship between demographic or clinical factors and 
quality of life either before or after treatment, but Terwee et al. (2001) found small to 
moderate relationships. There are a number of early studies that suggest that a 
relationship does exist, for example Yeatts (2005) found a correlation between 
quality of life and the objective severity of TED characteristics such as diplopia and 
dry eye symptoms. However, the tool used to measure quality of life in this 
population – the Graves Ophthalmopathy Quality of Life Scale (GO-QLS) – had 
been developed by choosing the items that correlated highly with clinical severity so 
this finding would be expected (Yeatts, 2005). Park et al. (2004) found that poorer 
quality of life was associated with more severe disease; however the authors 
conclude that their research might have been overrepresented by severe cases. 
Interestingly, Moss (2005) has described a possible ‘U’ shaped curve where at the 
extreme ends of severity, i.e. in the least and most severe cases, objective and 
subjective ratings would be likely to correlate. Choi et al. (2012) provide some 
evidence for this relationship having found that GO-QOL visual function and 
appearance scores were significantly negatively correlated with clinical 
characteristics including soft tissue involvement, proptosis, severity score 
(NOSPECS) and activity (CAS). Although a number of studies included in this 
review searched for relationships between clinical and psychosocial outcomes, no 
such relationship was found either before or after treatment. This supports Terwee et 
al.’s (2003) study that investigated the discrepancy between clinicians’, laypersons’ 
and patients’ ratings of the severity of their TED and found that patients tended to 
overrate, and endocrinologists underrate, TED severity. Between-group agreement 
was found to be highest between ophthalmologists and laypersons; interestingly, not 
between clinicians and the patients themselves (Terwee et al., 2003b). It might be 
that psychological processes rather than objective clinical measurements can better 
explain quality of life variability in patients with visibly disfiguring conditions 
(Thompson, 2012), with some previous research supporting this notion in TED 




(Gerding et al., 1997; Terwee et al., 1998). However, there remain few studies that 
have investigated this relationship specifically in TED and, with mixed findings to 
date, further research is needed.   
 
The exclusion of 33 foreign language articles could be a limitation of this review as 
one of these studies measured quality of life pre- and post-orbital radiotherapy using 
the GO-QOL (Nasr et al., 2010) and may have been eligible to include in the present 
findings if there was capacity to consider studies using languages other than English.   
3.8 CONCLUSIONS 
The present review has brought together the results of a range of treatments for TED 
on quality of life. Whilst major treatments such as surgery do appear to improve 
quality of life, other non-invasive treatments, such as IV steroids, may have a similar 
impact and lead to long-term benefits. There remain only 3 studies that have 
investigated how major surgery impacts on the quality of life of patients over the 
longer term, i.e. after 3 months. It is striking to note how few participants were 
included in these studies.  
 
This is the first systematic review to evaluate the impact of treatment including 
drugs, orbital radiotherapy and surgery on quality of life for patients with TED.  The 
findings of the present review are based on a systematic search for existing literature 
and predefined inclusion and exclusion criteria. The studies included in the review 
have been assessed for quality and a narrative synthesis of the effects of a variety of 
treatments for TED on quality of life outcomes has been provided. The studies that 
have been included have assessed both clinical outcomes (e.g. proptosis, disease 
activity and diplopia) as well as psychosocial outcomes. However, details of the 
clinical changes have not been reported, as the focus of the present review was to 
assess the impact of treatment on psychosocial measures after a variety of treatments 
and not to report clinical changes. What the review has found however is that recent 
findings for the relationship between demographic and clinical characteristics, and 
quality of life, have been mixed and remain inconclusive. 




4. ADJUSTMENT TO LIVING WITH A DISFIGURING CONDITION: 
THEORETICAL FOUNDATIONS 
4.1  PROLOGUE 
One in 111 people are living with a facial disfigurement in the UK today (Changing 
Faces, 2013). Frances MacGregor was one of the first researchers to investigate 
psychological adjustment associated with living with a facial disfigurement using 
mainly qualitative methods. MacGregor made a significant contribution to the area 
through her work dating back to the 1950s that found social prejudices experienced 
by individuals with facial disfigurements had an impact on their psychosocial 
adjustment (MacGregor, 1951; MacGregor, 1990). Ray Bull and colleagues made 
further early contributions to ideas about the social impact of living with a visible 
difference in the late 1970s, including issues of perceived attractiveness (Bull, 1979; 
Bull & Brooking, 1986), stereotyping (Rumsey, Bull & Gahagan, 1986), and impact 
on social interactions (Rumsey & Bull, 1986). Since this, research in the field has 
grown to look not only at the social impact of living with a disfigurement but also 
the psychosocial effects, and the impact of rehabilitative treatment. A number of 
researchers have begun to develop theories, to incorporate the social, clinical, 
demographic and psychosocial factors that help explain adjustment to living with a 
disfiguring condition and this chapter outlines some of these and their relevance to 
this thesis.  
4.2 TERMINOLOGY 
With a rise in societal and media interest in body image and disfigurements, the 
terminology used has changed in recent years. The word ‘deformity’ was commonly 
used to describe an unusual feature in appearance, but has since been thought to have 
negative connotations around being misshapen or abnormal. The term 
‘disfigurement’ is a universal term used amongst researchers in the appearance 
literature as it can be used succinctly to describe a range of changes and differences 
in appearance. However, it is considered important that this term is used as a noun, 
e.g. ‘a facial disfigurement’, rather than an adjective, e.g. ‘a disfigured face’ (Griffey 
& Castle, 2009). Increasingly, people with appearance-altering conditions prefer to 
use the term ‘visible difference’ or the medical name of their condition (Griffey & 
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Castle, 2009). Therefore in the following thesis the term ‘disfigurement’ will be used 
as a noun and used interchangeably with the terms ‘visible difference’ and when 
being specific the term  ‘TED’ will be used.   
4.3 A FRAMEWORK TO EXAMINE FACTORS THAT MAY ACCOUNT 
FOR VARIATIONS IN ADJUSTMENT  
Concern about appearance is widespread across the general population and tends to 
involve concern about a particular body feature; with the nose, weight and skin 
disorders being the most common complaint (Harris & Carr, 2001). It has been 
repeatedly found that people with a visible difference experience higher levels of 
psychosocial distress, including anxiety, depression and social avoidance, than the 
general population (Rumsey, Clarke & Musa, 2002; Rumsey, Clarke & White, 2003; 
Rumsey et al., 2004). However, levels of distress vary between individuals with a 
disfigurement and some even report adjusting positively (Rumsey et al., 2004; 
Thompson, 2012). This chapter will describe some of the main explanatory variables 
that have been found to account for this variability in adjustment to appearance-
altering conditions.  
 
The Appearance Research Collaboration (ARC; 2008) proposed a framework that 
aims to draw together the key constructs believed to explain the variability in 
adjustment to living with a disfigurement, in order to drive further research into 
disfiguring conditions (Thompson, 2012; Figure 6). This framework was seen as a 
useful guide in planning the research into the quality of life in patients with TED 
described in this thesis.  
 




Figure 6. A working framework containing the constructs demonstrated to be involved 
in psychological adjustment to appearance-altering conditions (adapted from ARC, 
2008) 
4.3.1 Predisposing factors 
The first element of the framework is the social context in which adjustment takes 
place, comprising of predisposing factors including demographic characteristics, 
socioeconomic factors, societal and media influence and clinical factors (ARC, 
2008). As these are likely to have varying influences on each individual and thus 
play a part in adjustment, it is argued that these factors are important but are less 
amenable to intervention (Thompson, 2012). It has been argued that the predominant 
focus of research on adjustment to appearance should be the intervening cognitive 
processes and behavioural outcomes, which can be targeted within interventions 
(ARC, 2008; Thompson, 2012).   
4.3.1.1 Demographics  
The level of appearance concern within the general population has been reported to 
be high, with prevalence in both genders being highest during the early twenties. 
However among women in the general population concern often does not reduce 
until older age (Harris & Carr, 2001). In those with a visible difference, as with the 
general population, generalised and appearance-related distress usually reduces with 
age (ARC, 2008), with younger people experiencing the highest levels of anxiety and 
distress (Rumsey et al., 2003; James et al., 2011). Research specific to disfiguring 
eye conditions has however found older age to be associated with greater levels of 
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findings are reflected in a review by Thompson and Kent (2001). They found mixed 
reports for the relationship between age and adjustment, concluding that wide 
variation in individual responses within all age groups have been found (Thompson 
& Kent, 2001; Thompson, 2012).  
 
Women with a disfigurement have been found to experience higher levels of 
appearance related distress than men (Rumsey et al., 2003; James et al., 2011). In the 
largest scale study to date investigating predictors of positive adjustment to living 
with a disfigurement, The ARC (2008) found that women not only had significantly 
more appearance-related distress, but also higher levels of general anxiety and 
depression than men. Research into psychosocial adjustment to burns has suggested 
that the gender difference may be reflected in the meaning the genders attach to 
having a visible difference. Women with burn injuries have been found to be more 
prone to a sense of loss from a changed appearance, whereas men experience more 
difficulty in adjusting to an altered identity from limitations in physical functioning 
(Andreasen & Norris, 1972; Brown et al., 1988).  
 
Findings for these factors have to date been mixed and appearance researchers argue 
that demographic characteristics add little to understanding the process of adjustment 
(Thompson & Kent, 2001). Furthermore they maintain that demographic, societal 
and media influences are either not possible or more difficult to change in 
interventions targeted at increasing psychosocial adjustment (Moss & Rosser, 2012; 
Thompson, 2012).  
4.3.1.2 Clinical factors 
Moss and Rosser (2012) suggest that when searching for explanations for the 
variability in adjustment to a visible difference, it is external characteristics, such as 
size and noticeability that are the first factors that come to mind. This assumption is 
often inherent in clinical practice and patients with more severe conditions might be 
offered surgery to ‘correct’ their appearance by reducing the objective size and 
noticeability of the feature (Moss, 2005). Research has provided some support for 
this claim, for example Tebble, Thomas and Price (2004) found a significant 
relationship between length of facial scar and psychological distress.  
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Moss (2005) has argued that objective (clinical) severity shows a small ‘U’ shaped 
effect whereby those with the minimal and most severe differences in appearance had 
adjusted more positively and were less psychologically distressed than those with 
moderate levels. It was hypothesised that patients with conditions of moderate 
severity face less predictable social interactions as their condition might be noticed 
on some occasions but not others, making it difficult for the individual to develop 
consistent and effective coping strategies (Moss, 2005). Many other studies have 
found that levels of psychosocial distress associated with having a disfigurement are 
not well predicted by severity (Rumsey, Clarke & White, 2003; Rumsey et al., 2004; 
Thompson & Kent, 2001).  
 
The location of a disfigurement has been found in some studies to play a role in 
adjustment. Moss and Rosser (2012) suggest that disfigurements to less visible body 
sites require different methods of interpersonal management to visible sites, such as 
the face. As the face is central to communicating and recognising others, changes to 
facial appearance have been considered a major life crisis (Rumsey, 2004; Lansdown 
et al., 1997). The eyes are the most prominent facial feature and influence perceived 
attractiveness and communication with others (Clarke & Wyn-Williams, 2000; 
Borwick & Khanche, 2012). As the eyes play a central role in communication, 
people who have a disfigurement to the eyes would be expected to have particular 
difficulty in social interaction and this has been supported in the literature (Clarke et 
al., 2003). People with conditions affecting the appearance of the eyes report high 
levels of perceived noticeability (Clarke & Wyn-Williams, 2000; McBain et al., 
2014), and fear of negative evaluations from others (McBain et al., 2013; Richards et 
al., 2014) leading to high levels of social anxiety and social avoidance (Clarke & 
Wyn-Williams, 2000). This may also be the case in TED, where patients report 
difficult social interactions and issues in communicating with others (Jensen & 
Harder, 2011).   
 
Symptoms and their severity tend to guide treatment decisions in the care of patients 
with TED. There are a number of previous studies that have suggested that a 
relationship exists between subjective and objective reports of TED severity (see 
section 3.7, page 67 for a full description). However, limitations in the 
methodologies of some studies make it difficult to conclude the presence of a 
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relationship. For example, quality of life questionnaires have been designed by 
choosing items that correlate highly with clinical severity (e.g. Yeatts, 2005) and 
clinical measurements are not always collected at the same time as quality of life 
scores (e.g. Park et al., 2004).  
 
A number of studies have found that patients’ subjective reports of the severity of 
TED and its impact on daily life are not consistently associated with objective 
measures of symptom severity (Gerding et al., 1997; Terwee et al., 1998). Wiersinga 
(2012) suggested that quality of life outcomes may not correlate with clinical 
characteristics in TED because patients’ perceptions of their health and daily 
functioning are influenced by their individual characteristics and environment and 
less determined by the objective severity of their illness. As clinical and 
demographic factors appear to explain only a small amount of the variance in 
psychosocial adjustment it is therefore possible that psychological processes rather 
than objective clinical measurements may better explain quality of life variability in 
this condition (Thompson, 2012). However there remain few studies that have 
investigated this relationship in TED and further research is needed to examine this 
question.   
4.3.2 Intervening cognitive processes 
The second element of the framework focuses on the intervening psychological 
processes that might contribute to adjustment and help explain the variability seen in 
patients, including appearance-related beliefs and socio-cognitive processes. 
Researchers in this area now commonly accept adjustment as a complex interaction 
of physical, socio-cultural and psychosocial factors (Clarke et al., 2003; James et al., 
2011) and suggest that these factors should be taken into account when treating 
patients with disfiguring conditions. Furthermore, as these factors are more amenable 
to change through psychological interventions they are the key drivers for a body of 
appearance research that is attempting to establish what interventions should focus 
on to improve outcomes for individuals with a disfigurement.  
4.3.2.1 Appearance schemas 
We all form images of our bodies and the processes by which we do have received 
much attention in recent years. Body image has begun to be recognised as a 
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multidimensional concept that includes thoughts, feelings and attitudes towards 
one’s own body (Thompson et al., 1999). Body image has been researched from a 
range of psychological approaches, including cognitive-behavioural theory (Cash, 
2002) and an information-processing perspective (Rosser, Moss & Rumsey, 2010). 
Within these perspectives is the idea that the self-concept is an information-
processing network that is comprised of thoughts about aspects of the self (Moss & 
Carr, 2004). Cash, Melnyk and Hrabosky (2004) have suggested that greater 
schematic investment in appearance leads to larger self-ideal discrepancies (i.e. poor 
psychosocial adjustment), greater idealisation of media or cultural ideals, and 
particularly for women, this can impact on body image quality of life.  
 
Recent research has begun to examine the links between individual body image 
perceptions and images portrayed in the media. For example, body dissatisfaction 
has been found to come from an individual being personally unable to match 
unrealistic body image ideals portrayed in the media (Halliwell & Diedrichs, 2012). 
Another relationship between media exposure and body dissatisfaction has been 
found where higher levels of exposure are associated with increased levels of body 
image disturbance (Botta, 2003). However, the links between the media, body 
dissatisfaction and body image disturbances are beyond the scope of this thesis and 
will not be examined in more detail.   
4.3.2.2 Salience, valence and perceived noticeability 
Preferential attention towards appearance, or attentional biases, can lead to 
appearance-related information being processed more quickly (Rosser, Moss & 
Rumsey, 2010). Some of these have been identified by Moss and Carr (2004) who 
have integrated social-cognitive theories to propose that within the multi-faceted 
self-concept some aspects such as appearance are more central, or salient, leading to 
an increase in the speed of processing of information relevant to these aspects. 
Salience of appearance has been found to inhibit adjustment if there is a discrepancy 
between appearance-related information and the view of one’s own appearance 
(Moss & Rosser, 2012). Interpretative biases towards appearance-related information 
can, for the individual highly concerned about appearance, create a world dominated 
by appearance-relevant information (Rosser, Moss & Rumsey, 2010). The 
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interpretation of ambiguous stimuli as appearance-related has been associated with 
levels of appearance concern (Rosser, Moss & Rumsey, 2010).  
 
According to Moss and Rosser (2012) the appearance self-schema also encompasses 
the emotional evaluation of one’s own appearance (valence), as well as the extent to 
which appearance-related information is more easily processed (salience). Valence 
can be seen in the degree to which an individual invests in the maintenance of their 
appearance (Thompson, 2012). Self-objectification theory (Friedrickson & Roberts, 
1997) has demonstrated the detrimental impact of having a negative internalised 
representation of the self in relation to appearance including continuous monitoring 
of outward appearance, and seeing the self as void of other characteristics unrelated 
to the body (Moss & Rosser, 2012). These biases and beliefs are highly variable 
between individuals. Variation in appearance-related social anxiety and avoidance 
has been found to be significantly associated with variation in subjective evaluation 
of appearance (valence) in patients with ocular prostheses (McBain et al., 2013) and 
ptosis (Richards et al., 2014), and in a large sample of patients with disfiguring 
conditions assessed by The ARC (2008). Furthermore, McBain et al (2014) found 
poorer psychosocial functioning in strabismus to be associated with patients placing 
high value on appearance (salience).   
 
Findings about perceived noticeability to date have been mixed. There is significant 
research that suggests that people with visible differences tend to perceive their 
differences as more noticeable than when measured objectively. For instance 
perceptions of particularly high noticeability have been found amongst individuals 
with head and neck cancer, skin conditions, and those seeking elective plastic 
surgery for appearance concerns, but less so for people with burns (Rumsey, Clarke 
& White, 2003). Perceptions of high noticeability have also been found in patients 
with strabismus (Jackson, Morris & Gleeson, 2013; McBain et al., 2014). More 
specifically to the current population, Terwee et al. (2003b) found that patients with 
TED tend to overrate and clinicians underrate the severity of their eye symptoms, 
including severe eyelid swelling and proptosis. Moss (2005) argues that surgery for a 
disfiguring condition would only result in patient satisfaction and reduced 
appearance-related distress if it reduced the individual’s perception of the 
noticeability of their condition, such that their appearance became “normal”.  Some 
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initial findings for treatment in the context of disfiguring eye conditions suggest that 
patients’ perceived noticeability of their condition is significantly reduced after 
strabismus surgery (Jackson, Moss & Gleeson, 2013); however when compared to 
clinician ratings of improvement, clinicians rate improvement after this surgery as 
far greater than patients themselves (Beauchamp et al., 2005).  
4.3.2.3 Fear of negative evaluation from others 
The negative evaluation of an individual based on one of their personal 
characteristics is likely to result in stigma. Stigma is a powerful social concept that 
involves a person being “disqualified from full social acceptance” (Goffman, 1963 
p9). Stigma can influence an individual’s social identity. Felt stigma refers to the 
fear of discrimination and can result in feelings of embarrassment and shame, 
whereas enacted stigma refers to actual discrimination from others in society 
(Scambler, 2007). Stigmatisation of an individual may arise from a number of 
perceptions including fear of contamination, pity, reduced competence of the 
individual or reduced morality (West & Hardy, 2007). A number of these 
perceptions have been found to contribute to the stigmatisation of individuals with 
facial disfigurements. For example, the “what is beautiful is good” stereotype has 
been demonstrated where subjects have assigned more favourable personality traits 
and successful life outcomes to individuals perceived as highly attractive (Dion, 
Berscheid &Walster, 1972). This effect has been observed more recently in the 
context of disfigurement to the eyes. When shown photographs, lay people have 
rated individuals with strabismus unfavourably, perceiving them as less competent, 
less likely to find a partner (Mojon-Azzi et al., 2008), and, for women in particular, 
less likely to succeed in job applications (Mojon-Azzi & Mojon, 2009). Furthermore, 
Pilivian and colleagues (1975) found that bystanders were significantly less likely to 
help an individual with a visible birthmark they observed collapsing on a New York 
subway than an unmarked individual.  
 
It is therefore unsurprising that people with disfiguring conditions fear the negative 
evaluations of others, particularly if they have had prior experience of feeling or 
actually being discriminated against. Fearing negative evaluations can have a 
significant impact on psychological adjustment. This fear has been found to 
significantly predict appearance-related adjustment in people with head and neck 
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cancer (Clarke et al., 2014). Leary et al. (1998) also found that perceptions of 
stigmatisation interacted with severity of psoriasis, concluding that the impact of 
severity of psoriasis was moderated by the extent to which patients were concerned 
about others’ negative evaluations. 
 
In particular, disfigurements to the eyes have been linked to high levels of concern 
about the negative perceptions of other people (Richards et al., 2014). Studies 
evaluating the impact of disfiguring eye conditions have found that it is 
predominantly a combination of the appearance-related cognitive processes 
described above that are associated with and predict adjustment, including perceived 
noticeability, fear of negative evaluations, subjective evaluation of appearance and 
the value placed on appearance (McBain et al., 2013; McBain et al., 2014; Clarke & 
Wyn-Williams, 2000; Clarke et al., 2003). Indicating that psychosocial adjustment to 
living with a disfiguring eye condition is not well predicted by clinical severity, 
aetiology, or duration of the condition, but rather intervening cognitive processes, 
individual to each person.        
4.3.2.4 Social comparisons 
As well as appearance-related processes, socio-cognitive processes have also been 
found to significantly impact on adjustment to living with a disfigurement. The 
majority of people engage in some form of self-comparison in order to acquire 
further information about the self (Gibbons & Buunk, 1999). However, researchers 
have suggested that interest in the self can increase with uncertainty, and periods of 
stress or change in particular have been found to increase the frequency with which 
people compare themselves to others (Aspinwall & Taylor, 1993; Taylor, Buunk & 
Aspinwall, 1990; Aspinwall, 1997). It could be argued that acquiring a disfiguring 
condition as TED could be such a time and in turn that an increase in social 
comparisons could impact on adjustment. In support of this hypothesis, Halliwell 
(2002) found poorer psychological adjustment to be associated with a greater 
tendency to make appearance-related comparisons with others (Halliwell, 2002). 
Some research has even supported this finding in the context of ophthalmology: a 
greater tendency to make social comparisons has been found in patients with ptosis, 
TED, strabismus, ocular cancer and trauma (James et al., 2011). Furthermore, 
women with disfiguring eye conditions have been found to demonstrate a greater 
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tendency to make social comparisons than men (James et al., 2011).  However, 
James et al.’s (2011) study only recruited four patients with TED, and with no 
indication of the association between social comparisons and quality of life. Further 
research in this area is required to establish the relationship between adjustment and 
social comparison in TED.  
 
When individuals feel under threat, social comparison processes can include explicit 
self-evaluation against another less fortunate (downward comparisons) or seeking 
affiliation with more fortunate others (upward comparisons) which serve to 
ameliorate self-esteem, and help individuals feel more hopeful about their situation  
(Taylor & Lobel, 1989). Commonly reported by people who show positive 
adjustment to having a disfigurement is the use of downward comparisons, which 
have been found to boost self-regard (DeVellis et al., 1990; Egan et al., 2011).  
4.3.2.5 Perceptions of social support 
Although people with a disfigurement report negative social interactions, perceptions 
of positive social support have been found to improve adjustment (Rumsey et al., 
2004). Rumsey et al. (2004) found that when people with a disfigurement feel more 
supported by others, the less visible they feel their condition is to other people and 
the less worried they are about their appearance. Similarly, The ARC (2008) found 
that greater satisfaction with social support was associated with less appearance-
related social anxiety and avoidance, and to significantly predict lower levels of 
anxiety and depression. However, findings within specific conditions have been 
mixed, and the types of social support received might impact on subsequent 
adjustment to living with a visible difference. For example Egan et al. (2011) found 
that for people who had been living with a visible difference since childhood, a lack 
of support from family had formed an increased sense of independence, and social 
support from friends and significant partners had increased a sense of acceptance and 
boosted self-esteem. Deno et al. (2012) also found that whilst social support from 
friends lowered social distress in patients affected by head and neck cancer, it also 
increased emotional distress (Deno et al., 2012).  
 
Specific to those with a disfiguring eye condition, having less support from friends 
but more support from family was found to predict greater levels of anxiety and 
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depression in strabismus; however social support did not predict the variability in 
quality of life in this population (McBain et al., 2014). No studies to date have 
examined perceptions of social support in patients with TED and how this might 
help to explain variability in quality of life in this patient group. Therefore, further 
research in this area is warranted to establish whether the various areas of social 
support impact on quality of life in TED.     
4.3.2.6 Coping strategies 
A number of categorisations of coping strategies have been proposed in psychology, 
including emotion-focused and problem-focused styles (Lazarus, 1993). However, 
further coping strategies have been identified in relation to adjustment to a 
disfiguring condition. Thompson and Kent (2001) have described ‘self-presentation’ 
coping strategies that include behavioural and cognitive strategies that involve 
attempting to maintain self-esteem against the impact of others’ comments, for 
example by dealing with the comments, avoiding social situations altogether, or 
concealing the disfigurement. Egan et al. (2011) reported that patients who adjust 
positively to living with a visible difference use active coping strategies that involve 
distractions, practical solutions, and focusing on other aspects of their lives than 
appearance. Other coping strategies used by some individuals with a visible 
difference are proactive social skills including staying calm, politely confronting 
negative reactions, and trying to educate others about their noticeable feature 
(Partridge, 1990). One study that evaluated coping styles used by patients with TED 
reported that negative coping styles were used, including depressive coping, 
withdrawal, and trivialising and that these were associated with poorer quality of life 
(Kahaly et al., 2005).  
4.3.2.7 Expectations of treatment outcomes 
Expectations of healthcare outcomes are complex psychological processes 
influenced by a range of individual perceptions, and as a consequence are likely to 
vary from patient to patient. What an individual with a disfiguring disease expects 
from their treatment could be a significant predictor of not only their quality of life 
but also how they adjust to changes in their appearance. Although this variable was 
not included in the ARC (2008) framework, some initial research has begun to make 
links between expectations of rehabilitative surgery for disfiguring conditions and 
psychological wellbeing.  




Most patients attend a clinical appointment with specific expectations about the 
medical care they are about to receive (Dawn & Lee, 2004) and such expectations 
have been linked to satisfaction with treatment outcomes, particularly in situations 
when these have not been met. When patients are listed for surgery to alter 
appearance it is normally because they cannot be treated with alternative, less 
invasive treatments and as such patients are likely to have pre-conceptions and 
expectations about the effectiveness of surgery and its impact. Indeed, patients’ 
expectations before surgery have been linked to satisfaction with post-surgical 
outcomes (Dawn & Lee, 2004; Finlay, Atkinson & Moos, 1995; Finlay et al., 1995; 
Pager, 2004; Bhty, 1999). Research suggests that unrealistic expectations, for 
example in orthognathic surgery that aims to restructure the jaw can lead to 
dissatisfaction (Kiyak, Vitaliano & Crinean, 1988). Clinical outcomes such as more 
scarring than expected, can also lead to patient dissatisfaction with their treatment 
(Dawn & Lee, 2004). Conversely, patients who are highly anxious preoperatively 
about the outcome may find that surgery exceeds their expectations (Pager, 2004). 
Hence expectations appear to play an important role in psychosocial well-being and 
the impact of treatment. 
 
With regards to living with a visible difference, what a patient expects from their 
treatment in terms of changes in their appearance could therefore be a major factor in 
the variability in patients’ quality of life. Previous research on expectations has 
focused on a variety of surgical procedures, including cataract surgery, orthognathic 
surgery and surgeries for cancer treatment, but to date few studies have examined the 
expectations of patients with disfiguring eye conditions. One recent study has 
examined the expectations of patients with strabismus seeking to have their eyes 
realigned through strabismus surgery and found that less than 3% of their sample 
expected surgery to worsen their condition, despite the fact that typically only 24% 
of patients are realigned after surgery and 61% still report double vision post-surgery 
(McBain et al., in press). One qualitative study in TED reported that patients can 
have unrealistic expectations that surgery will enable them to go back to the life they 
had before their TED (Estcourt et al., 2008), but no further research has been 
conducted in this condition. 




The final element of the ARC framework (ARC, 2008; Thompson, 2012) is the 
observable impact of disfiguring conditions in behaviour or psychosocial adjustment. 
In the original version of the framework described by ARC (2008) levels of 
appearance-related social anxiety, social avoidance, and mood are considered key 
outcomes along with psychological well-being.  
4.3.3.1 Social anxiety and social avoidance 
Not only are cognitive factors related to the self-concept associated with adjustment, 
but research also indicates that individual factors associated with social interactions 
also play a part in adjustment. The majority of difficulties that people with a visible 
difference are faced with relate to social interactions (Rumsey et al., 2004). Some 
authors argue that people are simply curious or feel unskilled in coping with a social 
situation with someone who has a visible difference (Partridge, 1990; Rumsey et al., 
2004). However, studies have found extremely negative perceptions of people with 
facial disfigurements, including that they are less honest, less trustworthy, less 
intelligent, and less capable (Rankin & Borah, 2003) among other perceptions 
described in section 4.3.2.3 of this chapter. Thus, stigmatisation has a number of 
implications for social interaction. Studies have shown that individuals with visible 
differences face stigmatisation and as a result both feel and display awkwardness in 
social situations (Newell, 2000). Frances Macgregor, over decades of research on the 
social implications of having a facial disfigurement, found that many people 
experienced distress and damage to their self-esteem as a result of the reactive 
behaviour of others they came into contact with (1974; 1990).  Individuals with an 
unusual facial appearance are labelled as different from other members of society 
and treated as such (MacGregor, 1974). The felt stigma of individuals with facial 
disfigurements may therefore translate into the avoidance of social situations. 
 
The type of condition causing a visible difference has also been found to influence 
levels of social anxiety. People with burns have been found to report lower levels of 
worry about their appearance and less appearance-related social anxiety than patients 
with variable dermatological conditions, maxillofacial injuries, and those seeking 
elective plastic surgery (Rumsey et al., 2003; Rumsey et al., 2004). Particularly high 
levels of appearance-related anxiety and low mood have been found in populations 
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electing to have cosmetic surgery on a feature they are concerned with (Rumsey et 
al., 2004). In a number of cases this has been linked to a psychiatric disorder that is 
associated with preoccupation with parts of the body that are objectively non-
impaired or have minimal irregularity known as “body dysmorphic disorder”, or 
BDD (Castle, Honigman & Phillips, 2002).  
 
Conversely, the positive adjustment of a number of people with long-standing burns 
has been linked to the development of positive coping strategies (Rumsey et al., 
2004; Partridge, 2006). People with disfiguring eye conditions report considerable 
appearance-related social anxiety and avoidance (Clarke et al., 2003), which is often 
associated with a fear of negative evaluation from others and poorer subjective 
evaluation of appearance (McBain et al., 2013; Richards et al., 2014). 
 
Thompson and Kent (2001) suggest that social avoidance is common amongst 
individuals with a visible difference. Rumsey, Clarke and Musa (2002) have found 
that as many as 72% report avoiding a number of activities that involve exposing 
their condition, including swimming and socialising. Newell (2000) proposed the 
fear avoidance model to explain this behaviour, whereby avoidance is prompted by 
fear of negative social situations and leads to a reduction in social activities, with 
more and more situations that might be trivial to others being deemed as threatening, 
such as walking outdoors. This explanation has been supported in a number of 
contexts, including facial disfigurements caused by cancer (Bonanno & Esmaeli, 
2012; Konradsen et al., 2012), and skin, eye, and rheumatic conditions (Rumsey et 
al., 2004). 
 
Rumsey et al. (2000) found high levels of social avoidance in patients with visible 
eye conditions including avoiding having photos taken and situations that required 
them to make eye contact with others, such as meeting new people. These ideas have 
recently been supported in studies involving patients with TED. Using interviews, 
Jensen and Harder (2011) found that the change in appearance caused by TED had 
affected central aspects of patients’ lives including facial communication, 
involvement with others, and maintenance of social relationships, leading to social 
withdrawal. Respondents felt that their eyes had become ‘uncontrollable’ due to 
protrusion and reduced mobility, making simple activities such as shopping or 
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walking through crowds difficult and an inability to express emotions during 
interactions with others often misinterpreting their facial expressions (Jensen & 
Harder, 2011). Estcourt et al. (2008) also found that TED leads to an altered sense of 
identity, which in some cases caused depression, and in many cases social isolation.  
 
The concept of appearance concern in relation to social anxiety and social avoidance 
has been captured in a recent tool that has been developed to measure levels of 
appearance-related distress. The Derriford Appearance Scale (DAS24; Carr, Moss & 
Harris, 2005) is a 24-item scale measuring the impact of appearance-related distress 
on social anxiety and social avoidance. In a recent study investigating mood and 
quality of life in patients with strabismus, the DAS24 was found to predict anxiety, 
depression, and both functional and psychosocial quality of life (McBain et al., 
2014).  
4.3.3.2 Mood 
Mood is placed in the ARC (2008) framework as an observable outcome of adjusting 
to having a visible difference. The impact of having a disfigurement on mood has 
been evaluated in strabismus, where higher levels of anxiety were associated with 
more concerns about treatment, greater fear of negative evaluation from others, 
greater social anxiety and social avoidance, and less support from friends.  Greater 
levels of depression were predicted by greater social anxiety and social avoidance, 
less support from friends and more support from family (McBain et al., 2014).  
 
Levels of anxious and depressed mood have been widely investigated in patients 
with TED, although specific predictors of mood have not yet been considered. Wong 
and Yu (2013) found the current prevalence of anxiety or depressive disorders in a 
sample of 124 patients with TED as 19%. Kahaly et al. (2005) used the Hospital 
Anxiety and Depression Scale (HADS) and found clinical levels of anxiety in as 
many as 40.2% and clinical levels of depression in 22% of patients with TED.  
 
Mood has been found to be a strong, significant predictor of quality of life in the 
contexts of other health conditions, including multiple sclerosis (Karatepe et al., 
2011), diabetes (Goldney et al., 2004), and myocardial infarction (Mayou et al., 
2000) as well as in strabismus (McBain et al., 2014). It has also been found to be 
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significantly associated with quality of life in patients with TED (Kahaly et al., 
2005). Because mood appears central to quality of life, it is necessary to gain a full 
understanding of influences on quality of life, including evaluating mood as a 
predictor of quality of life. It is possible that low mood could lead to poorer quality 
of life as it interferes with the ability and desire to engage in activities of daily living. 
An alternative explanation of the relationship is that poor quality of life drives mood, 
and this relationship requires further evaluation in TED in order to establish links.   
4.3.3.3 Quality of life 
Whilst the original framework considers social anxiety and avoidance, and mood, as 
outcomes of adjustment, it can be argued that these are also cognitions that might 
influence quality of life. They could therefore be used to try to explain overall 
quality of life by including them as intervening psychosocial processes in the ARC 
framework (2008). The authors of the framework argue that appearance-related 
social anxiety and avoidance, and mood, could be equally well placed as intervening 
cognitive processes in stage two of the model (Figure 6, page 73) when applying the 
model to research investigating the impact of living with a visible difference on 
quality of life (Thompson, 2012).  
 
The ARC (2008) framework has recently been used to explore which of the above 
factors might help to explain variability in quality of life across a number of 
disfiguring eye conditions including ocular prosthesis (McBain et al., 2013) 
strabismus (McBain et al., 2014) and ptosis (Richards et al., 2014), but to date has 
not been used to explore the psychosocial impact of TED, or outcomes after orbital 
decompression surgery. McBain et al. (2013) and Richards et al. (2014) investigated 
the association of a number of the constructs described in this chapter with social 
anxiety and avoidance, and mood.  McBain et al. (2014) investigated their ability to 
predict quality of life in strabismus and found poorer visual function-related quality 
of life to be associated with greater fear of negative evaluations, and greater social 
anxiety and avoidance. Psychosocial quality of life was significantly associated with 
more perceived noticeability, greater social anxiety and avoidance, and placing a 
higher value on appearance (McBain et al., 2014), as mentioned previously. 
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4.4 INVESTIGATING THE PSYCHOSOCIAL IMPACT OF TED 
Whilst quality of life measures have been developed to encapsulate patient life 
experiences, as described in Chapter 2, a number of other psychosocial variables 
might also play a role in adjustment to TED. Literature on the psychological impact 
of disfiguring conditions might help to indicate some of the factors that could be 
associated with patients’ adjustment to TED and the variability in adjustment. The 
framework developed by the ARC (2008) captures the possible relationship between 
constructs that have been developed in recent years in relation to appearance 
schemas, appearance processing, and social anxiety and social avoidance, and how 
these might interact to influence quality of life outcomes. With the exception of 
James et al.’s (2011) study that included a small number of patients with TED, there 
has been no research to date that has used the ARC framework as a model to 
investigate the specific pathways that predict adjustment to living with TED.  
4.5 SUMMARY 
It has been widely documented that having a visible disfigurement can have a 
profound psychological impact, but there are some who adjust positively. The 
experience of living with a disfigurement appears to be multifaceted and involves 
cultural, societal and individual factors. For this reason there is wide variability in 
adjustment and research has moved towards understanding what factors might 
predict how well, or indeed poorly, patients with a range of disfiguring conditions, 
might adjust.  
 
A number of theories and models have been developed from health, social and 
clinical psychology research that attempt to explain individual differences in 
appearance concern and subjective adjustment to changes in appearance. Moss and 
Rosser (2012) have encouraged researchers to integrate the empirical evidence and 
theories described in this chapter in order to construct more holistic models that can 
be applied in context. The socio-cultural environment has been found to impact on 
levels of appearance concern in the general population and in populations of people 
with disfiguring conditions, however these factors are relatively impermeable and 
difficult to target in interventions to improve outcomes. There have been mixed 
findings in the ability of clinical severity to predict adjustment. This relationship 
certainly requires further exploration in TED. Particularly as emphasis is placed on 
Chapter 4 Adjustment to Disfiguring Conditions: Theoretical Foundations 
89 
 
surgical procedures to reduce the noticeability of the condition and improve 
objective measures of appearance. Research investigating the impact of the type and 
location of the disfigurement has been mixed, although there is some evidence that 
more prominent conditions affecting the face, and in particular the eyes, may lead to 
higher levels of social anxiety and social avoidance. Therefore, for individuals living 
with a visible difference such as TED, appearance schemas and social-cognitions 
might better explain adjustment than demographic or clinical factors. There remains 
less evidence as yet for the role that intervening cognitive processes in adjustment to 
a change in appearance due to TED. 
 
The framework proposed by the ARC (2008) is intended to drive further research 
that will test specific pathways and to determine precise relationships between 
predictor variables (Thompson, 2012). Developers of this framework argue that its 
ability to predict both short-term and longer-term adjustment to a sudden change in 
appearance needs to be explored further, in a range of appearance-altering conditions 
(ARC, 2008; Harcourt & Rumsey, 2012). An adapted version of the ARC (2008) 
framework will therefore be used in this thesis to investigate other factors that might 
predict quality of life of patients with TED. Specifically, some initial research has 
supported the conceptualisation of appearance-related social anxiety and avoidance, 
and mood, to be cognitive processes that can predict adjustment and therefore the 
studies within this thesis has conceptualised these as predictors of quality of life, 
rather than as outcomes.  





The systematic review in Chapter 3 of this thesis highlighted the limited research 
into the psychosocial outcomes of treatment for TED, particularly the impact of 
major surgery that aims to improve appearance and vision. Orbital decompression 
surgery has to date been assessed in terms of changes in quality of life from pre- to 
post-surgery in only 5 studies. Three of these studies included small sample sizes 
(Terwee et al., 2001; Kashkouli et al., 2011b; Fichter et al., 2013), one study failed to 
use a validated TED-specific quality of life outcome measure (Tehrani et al., 2004), 
and one study excluded patients with optic neuropathy (EUGOGO et al., 2009). 
Considering the cost of performing major surgery such as orbital decompression, and 
the lack of evidence to date for the effectiveness of this surgery in terms of quality of 
life and psychosocial improvement, this was considered an important area for further 
investigation.  
5.2 AIMS  
The overall aim of this thesis was to understand the impact that TED and 
decompression surgery have on quality of life.  
 
Through the use of both quantitative and qualitative methods, this study aimed to 
answer the following research questions: 
(1) What demographic, clinical and psychosocial factors are associated with 
quality of life in patients presenting for orbital decompression surgery? 
(2) What are patients’ expectations of orbital decompression surgery, what 
influences these expectations, and do they impact on quality of life?  
(3) Does quality of life change from pre- to post-surgery? 
(4) Which clinical and intervening psychosocial factors change from pre- to post- 
surgery? 
(5)  What demographic, clinical and psychosocial patient characteristics at 
baseline predict change in quality of life from pre- to post- surgery? 
(6) Which changes in clinical and psychosocial factors from pre- to post-surgery 
predict change in quality of life from pre- to post-surgery? 




Based on the literature described in Chapters 2, 3 and 4 of this thesis, and utilising 
the ARC (2008) framework of adjustment to disfiguring conditions the following 
predictions were made: • There will be large variations in quality of life between patients with TED 
and that intervening psychosocial processes will better explain this variation 
than demographic or clinical factors. • Both vision-related and appearance-related quality of life will improve 
significantly from pre- to post-decompression surgery in patients with TED.  • It is expected that both clinical and psychosocial factors will improve 
significantly postoperatively.  • However, as double vision has been found to worsen in some post-
decompression, it is expected that in this sub-group of patients, vision-related 
quality of life may not improve significantly.  • Improvements in intervening psychosocial processes will drive 
improvements in appearance-related quality of life. As there may not be 
improvements in double vision, it is not expected that changes in these areas 
will drive changes in vision-related quality of life.  
5.4 DESIGN 
A mixed methods design was employed for the pre-surgical assessment. A 
prospective cross-sectional design was used to answer research question (1). 
Qualitative methods were employed to answer question (2), which involved the use 
of semi-structured interviews. Within-subjects repeated measures designs were used 
to answer questions (3), (4), (5) and (6).  
5.4.1  Rationale for using a mixed methods approach 
Combining quantitative and qualitative methodology to explore the same research 
problem has increased in popularity in healthcare research over recent years (Curry 
et al., 2013). A recent review has attempted to define mixed methods research, with 
over 19 different definitions currently being used (Johnson, Onwuegbuzie & Turner, 
2007). Based on the analysis of the definitions, Johnson and colleagues (2007) 
proposed that mixed methods research “combines elements of qualitative and 
quantitative research approaches (e.g. use of qualitative and quantitative viewpoints, 
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data collection, analysis, inference techniques) for the broad purposes of breadth and 
depth of understanding” (Johnson et al., 2007, p.123).  
 
The emphasis in the current study has been on the results of the quantitative study, 
with the qualitative study embedded within the quantitative research, in order to 
complement and enhance the findings. Curry and colleagues (2013) have described 
this method as the concurrent embedded approach, whereby quantitative and 
qualitative data collection occurs simultaneously, and one component is more 
dominant. Following the data collection and analysis of each study, interpretation of 
the embedded results is required. O’Cathain, Murphy and Nicholl (2008) argue that 
integration of the findings from each method is a key part of using mixed methods 
and one that is often missing in mixed methods healthcare research. Triangulation is 
one advantage of embedding qualitative studies within quantitative research as it 
involves the researcher using multiple methods and comparing the results of each 
method to see what similarities and differences have emerged (Guion, Diehl & 
McDonald, 2011).  
5.5 ETHICAL APPROVAL 
Full ethical approval for both the quantitative and qualitative studies was obtained 
from the North London Research Ethics Committee (REC reference 11/H0724/6). 
Relevant approvals were also gained from the Research & Development (R&D) 
teams at the two research sites: Moorfields Eye Hospital (MEH) and Birmingham 
and Midland Eye Centre (BMEC). All participants provided written informed 
consent.  
5.6 SAMPLE SIZE CALCULATIONS 
For the research questions (1), (5) and (6) an a priori sample size calculation was 
performed using the software G*Power (version 3.1.7; Faul et al., 2009). Effect sizes 
of 0.45 and 0.9 were specified for the GO-QOL appearance and GO-QOL visual 
function subscales, respectively, and α at 0.05. Between 64 and 97 patients would 
need to be recruited to achieve a power of 90% when using linear multiple regression 
analysis (to find the R2 deviation from zero) with 33 predictor variables. Assuming 
an attrition rate of 20% at each follow-up a sample size of between 90 and 135 was 
recommended. The effect size and attrition rate estimation was based on a group of 
Chapter 5 Methods 
93 
 
48 patients with TED using the GO-QOL to evaluate quality of life pre- and post-
orbital decompression (Terwee et al., 2001). The number of predictor variables was 
based on the number measured for the cross-sectional pre-surgery study described in 
this thesis. Another suggestion for study designs involving multiple regression 
analysis is to recruit 10 participants per predictor variable (Field, 2009). Therefore 
330 participants would be required for the present study if all the variables assessed 
at baseline were to be included into the analysis.  
 
For research questions (3) and (4), literature was consulted for guidance on 
appropriate sample sizes for measuring change over time using multilevel modelling 
(MLM) analyses. Calculating the sample size required for MLM and subsequent 
power achieved is complicated by the various factors involved in this type of 
analysis and as such there is currently no rule of thumb (Field, 2009). However, 
Kreft and de Leuuw (1998) suggest that there should be no less than 20 patients for 
every level introduced into the model, whilst Tabachnick and Fidell (2007) suggest 
60 for each level. As the data was structured to account for two levels (see section 
5.10.4.2 of this chapter), a sample size of between 40 and 120 was required.  
 
The sample size for the qualitative study used to explore research question (2) was 
determined by the saturation of themes during the interviews. In order to ensure a 
reasonable sample size was achieved for the aims of the research, guidance for 
operationalising data saturation from Francis et al. (2010) was followed. This 
involved setting an initial recruitment target and estimating how many further 
interviews would be needed before no new themes emerged, and applying a 
‘stopping criterion’ of the number of consecutive interviews that elicited no new 
themes or ideas (Francis et al., 2010). Therefore for this study, an initial target of 10 
interviews was set, with an estimation that a further 5 would be needed before no 
new themes emerged and a ‘stopping criterion’ of 2 consecutive interviews that did 
not elicit any new themes or ideas before recruitment ended.  
5.7 RECRUITMENT 
5.7.1 Inclusion & exclusion criteria 
To be eligible to take part in the studies the following inclusion criteria were used: 
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• Patients diagnosed with TED by a Consultant Ophthalmologist • Aged 18 years or over  • Patients listed for orbital decompression surgery • A comprehensive understanding of written and spoken English, as 
determined by the patient’s Consultant Ophthalmologist. 
Patients were excluded if they were identified as suffering from psychiatric or co-
morbid health conditions that rendered them too ill or distressed to take part in the 
study, as determined by their Consultant Ophthalmologist.  
5.7.2  Identification procedure 
All participants included in the quantitative studies were patients at MEH, under the 
care of one of three Consultant Ophthalmologists. Eligible patients were initially 
identified either by the consultant who listed them for surgery or from surgery lists 
that were screened weekly on the electronic Patient Administration System (PAS) at 
MEH. Potential participants were either approached on the day of their outpatient 
appointment when they were listed for surgery, or contacted directly after this 
appointment. All eligible patients who agreed to take part in the study, were given a 
study information sheet that they kept (Appendix E), along with a consent form that 
was to be given to the researcher once signed (Appendix F) and stored in a locked 
cabinet in a secured office. Participants were also given a questionnaire pack 
(Appendix G) that they were given the option of completing at home or in the 
waiting room. Three participants completed the questionnaire in the waiting room 
and the remainder completed it at home. Participants recruited during their 
outpatient’s appointment took the information and questionnaire pack home, giving 
them time to decide if they wanted to take part, and were able to call the researcher 
with any questions about the study. Information and questionnaire packs were posted 
to patients identified from surgery lists; this was followed by a telephone call 7 to 14 
days later. All patients were given a Freepost envelope to return the signed consent 
form and completed questionnaire pack. 
 
Patients who did not return the consent form and questionnaire within 4 weeks of 
invitation were followed up with a telephone call before their surgery. Any patients 
that could not be contacted by telephone were sent a reminder letter about the study 
from the researcher and then again 6 weeks later from their Consultant 
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Ophthalmologist, at which point if they still did not respond it was assumed they did 
not want to take part. General Practitioners (GPs) were informed of their patients’ 
participation in the study by letter (Appendix H).  
 
With approximately 80 orbital decompression operations being performed at MEH 
per year (MEH Performance Information, 2013) and a sample size requirement for 
the quantitative study of 141, it was decided that every eligible patient recruited at 
MEH would be required for the quantitative study. Furthermore, it was felt that the 
questionnaires included in the quantitative study might influence participants’ 
responses during an interview about their surgery for TED. Therefore BMEC was 
enrolled as an additional recruitment site for the qualitative study and approval from 
BMEC R&D to carry out the research onsite was received on 17th October 2012.  
 
The inclusion and exclusion criteria described in section 5.7.1 were applied to the 
identification of patients for the qualitative study. Eligible patients were identified by 
a clinical researcher at BMEC and asked if they wished to take part in the study 
during the outpatient appointment in which they were listed for orbital 
decompression surgery. Participants were given an information sheet (Appendix I) 
and consent form (Appendix J) to take home and asked if they minded being 
contacted to arrange an interview. Any patients that verbally expressed an interest in 
taking part in this initial consultation were followed up with a telephone call 2 to 7 
days later to arrange a suitable time for interviewing. 
5.8 ASSESSMENT PROCEDURE FOR THE QUANTITATIVE STUDY 
Participants were asked to complete questionnaires at 3 time points; before surgery, 
6 weeks after surgery, and 6 months after surgery. The follow-ups coincided with the 
usual protocol for post-surgery outpatient appointments. Patients who attended these 
appointments were given questionnaire packs in clinic to fill in either in the waiting 
room or at home. Follow-up questionnaire packs were posted to patients who did not 
attend their outpatient appointment. The same reminder protocol described in section 
5.7.2 was used for any participants who did not respond to post-surgery 
questionnaires.  
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Clinical measures were first obtained by a Consultant Ophthalmologist at the 
outpatient appointment where patients were listed for surgery (a copy of the data 
collection form can be found in Appendix K). A post-surgery version of the form 
was completed by an ophthalmologist at the 6 week and 6 month follow-up 
appointments. This included some additional items described in section 5.8.1.4 of 
this chapter. The schedule of the assessments can be seen in Table 5 below.  
 
Table 5. Schedule of assessments for the study including measures taken at each time 
point 
  Baseline 6 weeks 6 months 
Demographics Gender, Age, Marital Status, Ethnicity x   
Clinical 
variables 
Thyroid function x   
 Treatment history x   
 Duration of disease x   
 Laterality of disease and surgery x   
 Corneal SPK x x x 
 Visual acuity x x x 
 Disease activity x x x 
 Double vision x x x 
 Eyelid retraction x x x 
 Optic neuropathy x x x 
 Hydraulic orbit x x x 
 Lagophthalmos x x x 
 Proptosis in mm x x x 
 Smoking x x x 
 Further surgery  x x 
Psychosocial 
variables 
Fear of negative evaluation (BFNE) x x x 
 Social comparison (INCOM) x x x 
 Perceptions of social support (MSPSS) x x x 
 Expectations of outcome (E-TEDS) x x x 
 Appearance-related distress (DAS24) x x x 
 Appearance valence and salience 
(CARSAL & CARVAL) 
x x x 
 Perceived visibility x x x 
 Mood (HADS) x x x 
 Quality of life (GO-QOL) x x x 
 Satisfaction with surgery   x 
 Side effects from surgery   x 
 Satisfaction with pre-operative 
information 
  x 
 




As the theoretical underpinnings for the study lay within appearance and socio-
cognitive approaches, the analysis framework and selection of measures to include in 
the study were based on these. 
5.8.1.1 Predisposing factors 
5.8.1.1.1 Demographics 
The ARC (2008) framework suggests that demographic factors might play an 
important role in psychological adjustment to living with a disfiguring condition. 
The questionnaire pack given to patients prior to surgery asked them to answer the 
following demographic questions at this time point only: • Age • Gender • Ethnic background: The options were based on the Office for National 
Statistics (ONS) 11 categories of ethnicity classification (ONS, 2003). • Relationship status: This was recorded using 6 response options: married, 
divorced, widowed, single, living with partner, other.  
5.8.1.1.2 Clinical  
The following measures were taken by an Ophthalmologist at baseline only for 
each eye: 
 
Thyroid function: Thyroid function was measured according to stability with a yes 
or no response.  
 
Disease duration: This was determined by the participants’ medical files and was 
recorded in months. 
 
Treatment history:  Whether patients had previously received 1) 
immunosuppressants (e.g. steroids), 2) radiotherapy, 3) orbital surgery (e.g. eyelid 
surgery or orbital decompression) was recorded with a yes or no response for each. 
 
Laterality of TED & planned surgery: Whether disease was in one eye (unilateral), 
or both eyes (bilateral) was measured. Patients with bilateral disease usually undergo 
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bilateral orbital decompression; however at MEH patients are able to opt to have 
surgery in one eye at a time, so laterality of surgery was also measured. 
 
Smoking: Current smoking status was measured with a yes or no response.  
 
It was important to measure the presence, or change, in a number of clinical factors. 
The following were therefore measured at all 3 time points: 
 
Disease activity: The Clinical Activity Scale (CAS; Mourits et al., 1997) was used to 
provide a score on the presence and level of disease activity (Table 1, Chapter 1, 
page 22).  
 
Visual acuity: Visual acuity was measured for each eye using a Snellen Chart 
(Snellen, 1862); a universally accepted tool that involves reading letters of different 
sizes on each line, one eye at a time, from a 6 metre distance (Hussain et al., 2006). 
The result was converted to the log of the minimal angle of resolution (LogMAR) as 
recent studies have suggested this measurement is more accurate and lends itself 
better to statistical analysis (Hussain et al., 2006; Rosser, Laidlaw & Murdoch, 
2001). LogMAR values range between -0.20 and 2.1 when converted from Snellen 
scores. A score of 2.2 was assigned to patients with vision only of counting fingers, 
hand movements, perception of light and non-perception of light. A “worst eye 
analysis” was conducted on the visual acuity data in order to control the number of 
variables in the study.  Numerous previous studies in eye research have performed a 
worst eye analysis to deal with large amounts of ophthalmic data (McBain et al., 
2014; Miserocchi et al., 2011; Katz, Zeger & Liang, 1994). The worst eye was 
identified using the highest exophthalmometry reading and using subsequent 
measurements for this eye only for exophthalmometry, LogMAR and eyelid 
retraction.  
 
Optic neuropathy: Whether sight had been lost due to compression of the optic 
nerve was measured using the Ishihara colour test, which has been found to be 
highly effective at detecting colour deficiency (Birch, 1997). The most widely used 
colour deficiency test, it involves patients identifying a number printed in coloured 
dots that is surrounded by dots of a different colour and elicits colour blindness. In 
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addition, testing for a relative afferent pupillary defect (RAPD) was used, known as 
the ‘swinging light test’. This test measures differences in the response of the pupils 
of the eyes to light. In a normal swinging light test (no RAPD) the pupils of both 
eyes constrict equally. In an abnormal test (presence of a RAPD) there is less pupil 
constriction in the eye with optic nerve disease (Broadway, 2012).  
 
Proptosis: Projection of eyes from the lateral rim of the eye socket was measured in 
millimetres (mm) using an exophthalmometer. Exophalmometry readings for the 
worst eye were used in the analysis.  
 
Marginal reflex distance: Marginal reflex distance 1 (MRD1), or upper eyelid 
retraction, was measured using the distance from the pupil centre to the upper eyelid 
in mm. Marginal reflex distance 2 (MRD2), or lower eye lid retraction, was 
measured using the distance from pupil centre to lower eyelid in mm. These 
measurements indicate the level of exposure of the whites of the eyes (scleral show) 
and the inability to close the eyes fully (lagophthalmos). MRD1 and MRD2 for the 
worst eye were used in the analysis. As described for LogMAR (page 122), the worst 
eye was identified using the highest exophthalmometry reading. 
 
Corneal superficial punctate keratitis (SPK): The presence or absence of cell death 
on the surface of the cornea causing dry eyes and redness was detected using 
fluorescein staining.  
 
Hydraulic orbit: Hydraulic orbit, or raised pressure behind the eyes caused by 
tightening and swelling of the orbital muscles and tissue, was measured in terms of 
presence or absence. 
 
Double vision: Double vision, or diplopia, was measured in terms of presence 
(including constant diplopia, or in up or down gazes only), or absence.  
 
The following measure was taken at the 6 week and 6 month post-surgery follow-
ups only: 
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Further surgery: It was recorded whether patients where likely to need further 
surgery after their orbital decompression, including strabismus surgery to correct 
misalignment of the eyes and double vision, eyelid surgery, or further decompression 
in the non-operated eye if unilateral surgery was performed.  
5.8.1.2 Intervening cognitive processes 
A number of self-report questionnaires were chosen for this study that were based on 
the ARC (2008) framework of adjustment to living with a disfigurement (described 
in Chapter 4, section 4.3). These questionnaires were all completed by the 
participant. Section 4.4 of Chapter 4 (page 88) provides a rationale for the particular 
variables chosen for this study. 
5.8.1.2.1 The Brief Fear of Negative Evaluation scale (BFNE; 
Leary, 1983) 
The BFNE examines the extent to which an individual is concerned by other 
peoples’ opinions of them. A validated brief 12-item version of the full Fear of 
Negative Evaluation scale (FNE), originally developed by Watson & Friend (1969), 
was used. This brief version correlates highly with the original scale (α = 0.96; 
Leary, 1983). Example items include “I am afraid that others will not approve of me” 
and “I am frequently afraid of people noticing my shortcomings”. Responses are on a 
5 point Likert scale from 1 (‘Not at all characteristic of me’) to 5 (‘Extremely 
characteristic of me’). Four of the items are positively worded and are reverse 
scored. One total score is calculated, with a lowest possible score of 12 and highest 
score of 60. Higher scores indicate greater fear of negative evaluation from others.  
 
This brief version of the original scale was preferred in order to keep the length of 
the questionnaire pack to a minimum and reduce participant burden. There has been 
some criticism that, because of the complexity of some items, the BFNE may be 
more appropriate as a two-factor measure of positively worded items (BFNE-S) and 
negatively worded items (BFNE-R) (Rodenbaugh et al., 2004). However, the inter-
item correlation for the BNFE-S is poorer than the 12-item BFNE (r = .72; Carleton 
et al., 2011). The 12-item measure has been found to have excellent inter-item 
reliability (α= .97) and test-retest reliability (r = .94) and the ability to discriminate 
between patients with social phobia than a group of non-clinical community controls 
(Collins et al., 2005). The BFNE has also been used in previous studies that have 
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evaluated the psychosocial impact of living with a disfiguring eye condition (ARC, 
2008; James et al., 2011; McBain et al., 2014) and was therefore considered most 
appropriate for use in the current study. 
5.8.1.2.2 Iowa-Netherlands Comparison Orientation Measure 
(INCOM; Gibbons & Buunk, 1999)  
The INCOM is an 11-item scale that measures how well respondents feel they are 
doing in life when comparing his or herself to others. Example items include “I 
always like to know what others in a similar situation would do” and “I often like to 
talk with others about mutual opinions and experiences”. Responses are on a 5-point 
Likert scale ranging from ‘strongly disagree’ (1 point) to ‘strongly agree’ (5 points), 
2 items are reverse scored. A total score is calculated, with a lowest possible score of 
11 and the highest 55. Higher scores indicate a greater tendency to make social 
comparisons. The scale has been demonstrated to have good internal consistency (α 
= 0.83) and correlates well with similar measures, including the Attention to Social 
Comparison Information (ATSCI) Scale (r=0.66) (Gibbons & Buunk, 1999). The 
INCOM has also previously been used in the literature examining adjustment to 
living with a visible difference (ARC, 2008; James et al., 2011; McBain et al., 2014).  
5.8.1.2.3 Multidimensional Scale of Perceived Social Support 
(MSPSS; Zimet et al., 1988) 
This 12-item scale measures subjective levels of social support from three sources: 
family, friends and significant others. Example items include “I get the emotional 
help and support I need from my family” and “There is a special person in my life 
who cares about my feelings”. Responses are on a 7-point Likert scale ranging from 
1 (‘Very strongly disagree’) to 7 (‘Very strongly agree’). There are three subscales, 
with possible scores ranging from 4 to 20 on each subscale (friends, family, and 
significant others), with higher scores indicating greater perceived social support. 
The overall scale has good internal consistency (α=0.88) and test-retest reliability 
(r=0.85) (Zimet et al., 1988), and the factor structure has been supported with 
excellent internal reliability of each of the 3 subscales: α’s of .91, .89, and .91 were 
found for the Friends, Family and Significant Others subscale, respectively (Canty-
Mitchell & Zimet, 2000). This measure has been used in a study that used the ARC 
(2008) framework to explore adjustment to strabismus (McBain et al., 2014).  
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5.8.1.2.4 Development of an Expectations of TED Surgery 
Questionnaire (E-TEDS) 
In the absence of a disease specific measure, assessment of patients’ expectations of 
post-surgical outcomes was undertaken using an adapted version of the Expectations 
of Strabismus Surgery Questionnaire (ESSQ; McBain et al., in press). The ESSQ has 
three subscales and has been found to have high internal reliability in all subscales 
(Cronbach’s alphas range from 0.76 to 0.89; McBain et al., in press). No similar 
questionnaire currently exists in TED.   
 
One aim of this part of the thesis was therefore to develop a brief measure to 
quantitatively assess patient expectations before TED surgery. A description of the 
initial stages of the questionnaire’s development will be provided in this chapter and 
the results of the final questionnaire will be presented in Chapter 6, section 6.6.4. 
 
Three phases of questionnaire development were implemented: item generation and 
selection, reduction of the items to produce a reliable questionnaire, and validation of 
the measure. Similar measures developed for other facial disfigurements were 
consulted for important areas and for item wording (McBain et al., in press; Finlay, 
Atkinson & Moos, 1995). Relevant issues pertaining to expectations of corrective 
surgery were extracted and these extractions were used to generate items for the new 
questionnaire. For the present thesis, a literature review of adjustment to living with 
TED (Chapter 3) was conducted. This identified key articles that reported areas 
specific to the impact TED has on patients’ lives and that were used to establish 
relevance of the items generated for the TED-specific expectations questionnaire. 
Participants were asked to complete the new questionnaire as part of the cross-
sectional study described in this chapter.   
 
Responses from participants were subjected to a principle component analysis (PCA) 
using IBM SPSS for Windows (version 21). A PCA helps the analyst determine the 
number of psychological concepts, or factors, present in a questionnaire. The 
suitability of the data for factor analysis was investigated prior to performing the 
PCA. The Kaiser-Meyer-Olkin (KMO; Kaiser, 1970) measure of sampling adequacy, 
Bartlett’s Test of Sphericity and the correlation matrix provided in the SPSS output 
are used to indicate whether characteristics of the dataset are appropriate for PCA. 
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Guidelines suggest that correlation coefficients for each item in the correlation 
matrix should not be below 0.3 (Pallant, 2007). 
 
Another way of determining the number of factors to retain is Parallel Analysis, 
which involves inspection of the eigenvalues obtained and comparing them with a 
randomly generated dataset the same size. The statistical programme Monte Carlo 
PCA for Parallel Analysis 2.3 (Watkins, 2000) was used to generate the random 
dataset. The number of items was entered into the programme, along with the 
number of participants, and the number of replications. It has been recommended to 
specify 100 replications for PCA (Pallant, 2007).   
 
Once the number of factors had been established, these were interpreted using a 
factor rotation. Ideally the rotation will show a simple structure where each item 
loads strongly onto one factor, and that each factor is represented by a number of 
strongly loading items (i.e. more than 3) (Pallant, 2007). A number of methods of 
rotation are available and a balance between interpretability and reliability is sought. 
Orthogonal rotation does not provide correlations between factors but offers easier 
interpreting and describing of the results (Tabachnick & Fidell, 2007). Oblique 
rotation is recommended for use when constructs are likely to be correlated 
(normally based on previous theory), but can have disadvantages when trying to 
interpret the results (Tabachnick & Fidell, 2007). The most commonly used rotation 
technique is direct oblimin, which offers a range of correlations between factors and 
is recommended by Pallant (2007). Therefore the direct oblimin rotation was chosen 
for the PCA of the current questionnaire.  
 
Once the structure of the questionnaire had been established using PCA, the internal 
consistency was checked by ensuring that Cronbach’s alphas were above 0.7 
(Pallant, 2007). To ensure that the questionnaire measured what it aimed to measure 
conceptually, content validity analysis was employed, i.e. the extent that the items 
represented each construct being measured and covered the potential range of that 
construct (Field, 2009). This was achieved through a review of the questionnaire by 
experts in the area: four Consultant Ophthalmic Surgeons, a Professor of Health 
Psychology a Health Psychologist, and a patient with TED.  
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The final questionnaire was composed of 23 items and three subscales: expectations 
of post-surgery visual functioning (11 items), intimacy and social relationships (5 
items), and appearance-related concerns (7 items). A full description of the results 
for the development of the measure is provided in Chapter 6, section 6.6.4. 
Participants were instructed to rate how they expected surgery to change the various 
aspects of their lives including for instance “my vision” and “the appearance of my 
eyes” on a Likert scale from 1 (‘Made considerably worse’) to 5 (‘Considerably 
improve’). The total score for each subscale was a mean of the responses, such that 
the possible scores for each subscale ranged from 1 to 5. As this assessed pre-surgery 
expectations participants only completed the questionnaire at baseline. Cronbach’s 
alpha and other reliability assessments to ensure the suitability of this questionnaire 
in TED are also reported in Chapter 6, section 6.6.4.3.  
5.8.1.2.5 Derriford Appearance Scale short form (DAS24; Carr, 
Moss & Harris, 2005) 
The DAS24 is a 24-item scale measuring the impact of appearance related distress 
and concern on social anxiety and social avoidance. Responses for each item range 
from 0 to 4, with response options varying between items. Where an item relates to 
the intensity of emotional response, the categories ‘extremely’ to ‘not at all’ are 
used, whereas other items relate to the frequency of behaviours brought on by self-
consciousness require an ‘almost always’ to ‘never/almost never’ response (Moss, 
Harris & Carr, 2004). For example, the item “I am self-conscious about my feature” 
has response options on a Likert scale from 0 (‘Never/ almost never’) to 4 (‘Almost 
always’), and the item “How distressed do you get when going to social events?” 
ranges from 0 (‘Not at all’) to 4 (‘Extremely’). 
 
A total score is calculated and ranges from 11 to 96, with lower scores representing 
lower levels of social anxiety and social avoidance. As the focus of the present study 
was the impact of the appearance of the eyes, respondents were told to focus on this 
area. It was made clear to participants in the questionnaire instructions that some 
items might not be relevant to them and to circle the “N/A” if this was the case.  
This measure demonstrates high internal consistency (α = .92), good test-retest 
reliability (r=0.82) (Carr, Moss & Harris, 2005) and excellent criterion validity with 
the DAS59 (r=0.88) (Moss, 2010).  It also discriminates well between those 
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concerned, and those not concerned, about their appearance in different patient 
groups and between clinical and non-clinical samples (Moss, 2010). The DAS24 has 
been used widely in previous studies evaluating the impact of living with disfiguring 
conditions (ARC, 2008; James et al., 2011; Jackson et al., 2006; Clarke et al., 2003).  
5.8.1.2.6 Valence of Appearance scale (CARVAL; Moss & Rosser, 
2012) 
The CARVAL is an 8-item measure of how an individual evaluates his or her own 
physical appearance. Example items include “I don’t like the way I look” and “The 
way I look makes me feel good about myself”. Responses range from 1 (‘Strongly 
disagree’) to 6 (‘Strongly agree’), five of the items are reverse scored, and one total 
score is calculated that can range from 6 to 36. Higher scores indicate a more 
negative self-evaluation of appearance. The scale has been found to demonstrate 
high internal consistency (Pearson’s r correlations between 0.72 and 0.84), good 
construct validity, and strong test-retest reliability (r=0.89) (Moss & Rosser, 2012).   
5.8.1.2.7 Salience of Appearance scale (CARSAL; Moss & Rosser, 
2012) 
The CARSAL is a 5-item measure of the extent to which physical appearance is 
important to the individual. Example items include “I am usually conscious of my 
appearance” and “I don’t usually give much thought to my appearance”. Responses 
are on a 6-point Likert scale ranging from 1 (‘Strongly disagree’) to 6 (‘Strongly 
agree’), three items are reverse scored. A total score is calculated and ranges from 5 
to 30; higher scores indicate greater value placed on appearance. The CARSAL has 
demonstrated good internal consistency (Pearson’s r correlations between 0.74 and 
0.81), construct validity, and good test-retest reliability (r=0.74) (Moss & Rosser, 
2012).  
5.8.1.2.8 Perceived Visibility of TED 
This is a single item measure of how visible participants feel their proptosis is to 
other people: Responses were on a 7-point Likert scale ranging from 1 (‘Not at all 
visible’) to 7 (‘Extremely visible’). Similar single item measures have been used to 
assess visibility in other disfiguring conditions (Moss, 2005; ARC, 2008), including 
strabismus (Jackson et al., 2006; McBain et al., 2014).  
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5.8.1.2.9 Hospital Anxiety & Depression scale (HADS; Zigmond & 
Snaith, 1983) 
The HADS is a 14-item questionnaire designed to screen for depression and anxiety 
in patients with physical health problems. It is made up of two subscales; anxiety and 
depression. Example items include “I look forward with enjoyment to things” and “I 
get sudden feelings of panic”. Responses range from 0 to 3 for each item; 8 items 
were reverse scored.  
 
The two subscale scores are calculated and the total scores for each range from 0 to 
21. Higher scores indicating greater levels of anxious or depressed mood. For each 
subscale scores of 0 to 7 are considered to be in the ‘normal’ range, scores of 8 to10 
suggest moderate levels of anxiety or depression and scores of 11 or over are 
considered as highly indicative of cases of clinical anxiety or depression (Zigmond 
& Snaith, 1983). This tool has demonstrated high internal consistency (r=0.76 to 
0.41 for anxiety scale items and r=0.60 to 0.30 for depression scale items) and good 
reliability (Zigmond & Snaith, 1983).  
 
The HADS has been used previously in studies evaluating the impact of living with a 
disfigurement (Jackson et al., 2006; James et al., 2011; Clarke et al., 2003). Whilst 
mood has been used in previous studies as an outcome of adjustment, including the 
ARC (2008) study, the HADS anxiety and depression subscales scores were used as 
predictors of quality of life in the present study. This has been discussed in more 
detail in section 4.3.3.2.  
5.8.1.3 Primary outcome measure 
5.8.1.3.1 Graves Ophthalmopathy Quality of Life questionnaire 
(GO-QOL; Terwee et al., 1998) 
The 17-item GO-QOL measures quality of life in patients with TED (Terwee et al., 
1998; 1999). Example items include “During the past week, to what extent were you 
limited in reading, because of your thyroid eye disease?” and “Do you feel that you 
are stared at in the streets because of your thyroid eye disease?” The measure 
consists of two subscales: vision-related quality of life and appearance-related 
quality of life. Responses for each item are on a 3-point Likert scale; ‘severely 
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limited’ (1 point), ‘a little limited’ (2 points) or ‘not at all limited’ (3 points); with a 
higher score on each subscale indicating better health.  
 
The GO-QOL has been translated from Dutch into eight other languages including 
English, French, German, Greek, Italian, Spanish, Russian and more recently, 
Korean (Wiersinga et al., 2012; Choi et al., 2012). Being able to cycle is important 
for Dutch patients but in a recent translation for the Australian population, Park et al. 
(2004) replaced the item about bicycling with two items about limitations in work 
and carrying out domestic duties. These authors also recognised that not all patients 
have a driving licence or current employment and in such cases respondents were 
able to answer ‘not applicable’ (Park et al., 2004). Therefore in this study for the two 
items “During the past week, to what extent were you limited in driving/ at work?” it 
was possible to answer ‘not applicable’.  
 
The present study has therefore used the GO-QOL Australian version (Park et al., 
2004) but excluded the additional two items in this version about patient education 
and counselling, which are not included in total scores. Subscales were calculated 
following guidelines from the authors (Terwee et al., 2001). These are: raw score - 
number of items in subscale / (2 x number of items in subscale) x 100 (Park et al., 
2004). Where data were missing, the guidelines from the original authors of the 
questionnaire (Terwee et al., 2001) were followed to calculate total scores for the 
remaining completed items. These are: where there are missing values for some 
items, total scores are calculated for the remaining completed items. The 
transformation used for the present study was adjusted to: total score = (raw score – 
#)/2 X # X 100 where # is the number of completed items. When more than half of 
the items within a subscale were missing the total score was not calculated. The GO-
QOL has been found to be a valid and reliable measure with high internal 
consistency (α=0.86 for the visual function scale and α=0.82 for the appearance 
scale; Terwee et al., 2001). The GO-QOL has many advantages over using a generic 
quality of life measure as it is designed to capture issues specific to patients with 
TED (Terwee et al., 1998), including the ability to detect a MCID in changes in 
scores from pre- to post-treatment. A change in GO-QOL scores of 10 to 20 points 
after decompression surgery is suggested as the MCID (Terwee et al., 2001).  
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5.8.1.4 Individual follow up items 
A small number of single items were used at the end of the 6 month post-surgery 
questionnaire to assess patient satisfaction with their surgical outcomes in 3 areas: 
satisfaction with surgery, satisfaction with pre-operative information, and side 
effects from surgery. These items were used for descriptive purposes to complement 
the main findings from the study.  
5.8.1.4.1 Satisfaction with surgery:  
Three single items measured overall regret (“Do you regret having surgery?”), 
satisfaction with the procedure (“Knowing what you do now, would you go through 
the operation again?”), and likelihood of recommending the operation (“Would you 
recommend the operation to others?”). Responses for each item ranged from 1 (‘Yes 
definitely’, or ‘Yes, with no hesitation’) to 4 (‘Not at all’ or ‘Certainly not’). 
5.8.1.4.2 Side effects:  
Side effects were measured using 4 items, each asked patients how much pain, 
swelling, scarring, and redness they experienced as a result of surgery. Likert scale 
responses ranged from 0 (‘No pain/ swelling/ scars/ redness’) to 10 (‘Severe pain/ 
swelling/ scars/ redness’), shown in Figure 7. Participants were also asked how they 
would compare each of the side effects to what was expected before surgery, from 1 
(‘Much less than expected’) to 5 (‘Much worse than expected’).  
  






0 1 2 3 4 5 6 7 8 9 10 Severe  
pain  
 
Figure 7. The 10-point rating scale used to measure side effects 
 
5.8.1.4.3 Preoperative information:  
Participants were also asked if they were given the right amount of information 
preoperatively, with response options of ‘Too much’, ‘The right amount’, or ‘Too 
little’.   
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5.9 ASSESSMENT PROCEDURE FOR THE QUALITATIVE STUDY 
5.9.1.1 Location of the interviews 
All interviews were either held in a seminar room in the research department at 
BMEC, or at the patient’s home if they could not easily access the hospital. Safety 
protocols were carried out when interviews were conducted in the patient’s home: 
the researcher called a member of the supervisory panel before and after each 
interview. A code word was agreed that the researcher would use if there were any 
concerns that alerted the supervisor. Fortunately, there were no safety concerns at 
any time during these interviews. A total of 11 interviews took place in the research 
department at BMEC and 3 interviews took place in participants’ homes. Two of the 
participants interviewed at BMEC brought their partner, who contributed to the 
interviews. During one of the home interviews the participants’ daughter came into 
the room for a short while, but did not contribute to the interview.  
5.9.1.2 Topic guide 
Semi-structured interviewing methods were chosen for this study. Semi-structured 
interviews allow for more elaboration from the respondent and are favoured by 
researchers for their balance of the ability of participants to discuss matters important 
to them and the interviewer having some control through the use of topic guides 
(Shauver & Chung, 2010). The researcher in collaboration with the supervisory team 
developed an interview schedule (Appendix L) that included topics based on 
previous research on patient expectations of surgery (Klassen et al., 2008; Bhty, 
1999; Bramwell, Morland & Garden, 2007) and from experience gained whilst 
recruiting patients with TED for the quantitative study described in this chapter. The 
use of the interview schedule provided some structure to the interview but questions 
were designed to be used as prompts rather than a specific format for the interview. 
This enabled the interview to be directed by ideas brought forward by the participant 
(Murray & Chamberlain, 1999). Prior to their interview participants were instructed 
that the researcher had some prompting questions but that these were not fixed and 
that further questioning depended on their answers to previous questions. The first 
pre-surgery interview was used to test the utility of the interview schedule, and some 
changes were made as a result of this first interview (Figure 8). The pilot interview 
was included in the analysis for this study to avoid losing any valuable data.  
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All interviews were conducted by the researcher and digitally recorded using an 
Olympus DS-30 digital voice recorder. The length of the interview depended greatly 
on the willingness of the interviewee to go into detail about their views and 
experiences. Prompts were used to elicit further detail about particularly important 
areas, but equally participants were free to give as much detail as they chose and 
were not pushed into any topic that they were uncomfortable or unwilling to talk 
about.  
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Topics: current impact of illness on daily activities; current feelings about appearance; 
treatment options; personal reasons for having surgery; goals for surgery/ outcomes; 
motivation for going forward with surgery; any influences that others have had on their 
decision to go for surgery; any events related to appearance that might have had an impact 
on decision to have surgery; what preparations might they have made for surgery; what 
are they expecting about outcomes 
 
Example questions (to be used as a general guideline): 
Introduction 
1) Can you tell me about the impact TED might have had on your daily life? 
Prompt: Can you tell me about the impact TED might have had on your 
appearance? 
Prompt: Can you tell me about the impact that TED might have had on how you 
feel about yourself? 
Motivation(s) for having surgery 
2) When did you first start thinking about having surgery? 
3) Did you consider alternative treatment options? If so, reasons for choosing surgery 
over others 
4) What do you feel your reasons might be for having surgery? 
5) Could you tell me what is motivating you to have this surgery? 
6) Are there any particular goals you hope to achieve by having surgery? 
7) Can you tell me if anything has influenced your decision to have surgery?  
8) Could you tell me about what you might have done to prepare for your surgery, or 
that you plan on doing to prepare before your surgery? 
Information about surgery 
9) Can you tell me about the information you have been given about your surgery? 
Prompt: By your doctor/ surgeon, nurses, any other healthcare professional? 
10) Can you tell me if you have tried to find out more about orbital decompression 
surgery? If so, where did you look? 
11) What do you feel about the information you have been given, or that you have 
found, about your surgery? 
Prompt: What about the quantity?  
12) Can you describe what you expect from the surgery based on the information you 
have been given, or that you have found? 
Prompt: On the day of surgery, leaving hospital, recovery? 
Expectations of surgery 
13) Can you tell me what outcomes you might be expecting from your surgery? 
Prompt: Appearance outcomes? Daily life outcomes?  
Figure 8. The final topic guide used in the qualitative study to explore patients' 
expectations of orbital decompression 




Participants were asked to bring their consent forms on the day of their interviews 
and were asked to sign these if they were happy to take part in the study. At the 
beginning of each pre-surgery interview, participants were also given a demographic 
details questionnaire, which asked for their gender, age, ethnic background, 
relationship status, employment status, highest qualification, duration of TED, and 
surgical history (Appendix M).  
 
Although this information was provided in the information sheet given to patients 
when they were approached for the study (Appendix I) participants were reminded at 
the beginning of each interview that any their interviews would be kept confidential, 
data would be stored in a locked cabinet in a secured office and that any names they 
gave during interviews would be kept anonymous during transcriptions. All 
participants were asked for permission to audio record the interview and given an 
alternative option for the interviewer to make notes if they weren’t happy to be audio 
recorded. All patients gave their consent to interviews being recorded digitally, 
however.   
5.10 STATISTICAL ANALYSIS 
All statistical analyses were performed using the statistical package IBM SPSS for 
Windows (version 21) for the quantitative study.  
5.10.1 Data screening 
A process of data cleaning was carried out after all the data had been entered and 
before any data analysis was performed. Guidelines for data screening and cleaning 
by Pallant (2007) were used, which involved examining the ranges of scores for each 
continuous variable to check they fell within possible ranges for each questionnaire 
item, and checking frequencies of categorical variables to ensure these were within 
normal limits. Missing data was flagged using the code ‘999’. For the GO-QOL ‘not 
applicable’ responses, the code ‘555’ was used to distinguish these scores from 
genuine item omissions. Any potential errors in the data were corrected where 
necessary during the screening process, for example by returning to raw data if 
required.    
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5.10.2 Missing data 
Missing data is a common problem in medical and social science research, especially 
with longitudinal designs. Levels of missing data were analysed using Little’s 
Missing Completely at Random (MCAR) test (Pallant, 2007) to check that there 
were no systematic differences between the missing values and the observed values.  
 
A missing value analysis conducted at item level involved analysing patterns of 
missing data to find out how much information would be lost if a listwise deletion 
was used at baseline; i.e. how much data is to be imputed. The results of the missing 
data analysis are reported in Chapter 6, section 6.4, page 127. The DAS24 was 
introduced into the questionnaire pack approximately 6 months into the study 
following an ethics amendment and therefore items from this measure were missing 
for a number of participants at baseline.  
 
At baseline multiple imputation (MI) was used to retain as much data as possible 
(Koutroumanou & Wade, 2012; Rubin, 1987). Any participants with over 50% 
missing data at baseline however were removed from the analysis on research 
question (1). In addition, any participants with over 50% missing data for the entire 
dataset were removed from the analyses concerned with research questions (3), (4), 
(5) and (6). MI at item level was performed on the data for the cross-sectional study. 
This was to enhance the accuracy of the re-calculated scale scores, and constraints 
and rounding were used to ensure that the imputed item level data was meaningful 
and corresponded to possible values. Analysis using a multiply imputed data set 
allows for uncertainty about missing data by using several plausible datasets, and 
appropriately combining the results obtained from all the datasets (Sterne et al., 
2009). MI is an iterative approach that calculates imputations based on the 
information available from scores available for each participants; using 10 
imputations therefore increases the accuracy of the study results (Rubin & Schafer, 
1990).  
 
For this study a total of 10 imputed datasets were produced and pooled results from 
all 10 datasets were used in the baseline analysis. Subscale scores were re-calculated 
using the imputed items. For the GO-QOL, answers of ‘not applicable’ were retained 
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and subscale raw scores and transformations were calculated as guided by the 
original authors of this measure (Terwee et al., 2001).  
5.10.3 Data exploration 
5.10.3.1 Normality and outliers 
Normality was assessed using histograms and normal probability plots. Pallant 
(2007) describes normal data as having a symmetrical, bell-shaped curve with the 
greatest frequency of scores in the middle, i.e. around the mean. Normal probability 
plots display the observed value for each score plotted against the expected value 
from the normal distribution, and a straight line should be seen if the distribution is 
normal (Pallant, 2007).  
 
Normality was also assessed in terms of skewness and kurtosis in the data. Skewness 
refers to the symmetry in the distribution and kurtosis provides information about 
how peaked in the middle the data are (Pallant, 2007). The Shapiro-Wilk test, which 
is recommended for smaller samples, was used to assess whether the distribution 
deviated from a comparable normal distribution (Field, 2009), with a significant 
result indicating non-normality. However, Field (2009) warns of the sensitivity of 
this test to capture even small deviations from normality and a significant result may 
not be enough to indicate bias in statistical analyses. Therefore the results of this test 
were considered alongside distribution plots and histograms. One option for dealing 
with non-normality is to perform transformations on these scales. However by 
transforming the data you do not only change the hypothesis being tested but also the 
constructs that were originally measured and this reduces the interpretability of the 
results (Grayson, 2004). Therefore, transformations were avoided for this study and 
non-parametric statistical analyses were used instead, which are widely 
recommended (Field, 2009). 
 
The imputed dataset generated 10 histograms in total: one for each dataset. 
Assessing normality data for 10 imputations therefore involved checking the results 
from the first imputation, provided that there were no great differences between the 
results from each imputation. 
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Outliers were assessed by first checking the tail ends of the distribution from each 
histogram. Boxplots were also generated for each scale score and assessed for 
extreme values more than 1.5 box-lengths from the edge of the box, indicated by an 
asterisk (Pallant, 2007). Outliers can pose a problem if they influence overall results, 
however there is disagreement amongst researchers about how to deal with outliers 
and a number of options are available (Tabachnick & Fidell, 2007). Removing the 
participants from the analyses is one option but this would only be beneficial if it is 
certain that the case is not from the population intended to sample (Field, 2009). 
Furthermore, removing participants due to random outlying scores would result in a 
significant reduction in sample size and it was felt for this study that the data may 
still provide useful information about relationships between variables and therefore 
any outliers were retained in the analyses.  
5.10.3.2 Internal reliability of scales and subscales 
All the measures included in the study were assessed for reliability using Cronbach’s 
alpha with scores above 0.7 indicating acceptable levels of reliability (Pallant, 2007).  
5.10.4 Data analysis  
5.10.4.1 Research question (1): Which factors are associated with 
quality of life in patients with TED presenting for surgery? 
Hierarchical multiple regressions were used to investigate research question 1. 
Hierarchical multiple regressions require that all predictor variables are either 
continuous or categorical with two categories, or they are dummy coded to be made 
binary. Therefore categorical predictor variables with more than two groups were 
dummy coded where appropriate. If there were extremely few participants in a third 
group, the groups were collapsed into two, for example “white” and “non-white” for 
ethnicity.  
 
The hierarchy used to enter the predictors into the regression was based on the ARC 
(2008) framework of adjustment to disfiguring conditions (Figure 9). Entered into 
block 1 were the demographic variables, clinical variables formed block 2, socio-
cognitive processes (fear of negative evaluation, social comparisons and perceived 
social support) were entered in block 3, expectations were entered in block 4 and 
appearance related cognitions (social anxiety and social avoidance, salience and 
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valence of appearance, and perceived visibility of TED) were entered in block 5. 
Levels of anxiety and depression were entered into block 6. Each of the GO-QOL 
subscales were the outcome variables, or dependent variables (DVs).  
 
Entry rather than stepwise methods were used as stepwise methods will not 
necessarily produce the best model if there are redundant predictors, rather the model 
is purely statistically driven and carries an inflated risk of creating results from 
chance features in the data (Judd, Clelland & Ryan, 2009; Tabachnick & Fidell, 
2007). Effect sizes for multiple regression (Cohen’s f2) were calculated: a value of 
0.02 is considered a small effect, 0.15 is considered a medium effect, and 0.35 is 
considered a large effect (Cohen, 1992).  
 
Thirty six predictor variables in total were measured in the quantitative study and 
guidelines suggest 10 participants per predictor variable are required to reach power 
for hierarchical multiple regression (Field, 2009). Following guidelines that suggest 
reducing the number of predictor variables when using smaller sample sizes (Harrell, 
Lee & Mark, 1996), univariate linear regression analyses were first performed to 
determine whether a predictor variable (IV) was significantly associated with each 
dependent variable (DV) and thus should be entered into the hierarchical regression.   
 
The IVs were examined for multicollinearity, linearity and homoscedasticity. 
Multicollinearity occurs when two predictor variables are highly correlated (r > .90) 
and poses a problem in multiple regression as it becomes impossible to assess the 
individual importance of a predictor (Field, 2009). Multicollinearity is also identified 
using the VIF scores provided in SPSS output from the regression analyses. VIF 
values above 10 indicate multicollinearity and it is advised that the variable with the 
highest VIF value is removed from the regression (Field, 2009). A further 
requirement of hierarchical multiple regression is that each IV has a linear 
relationship with the DV (Field, 2009). After each hierarchical regression was 
performed, assumptions of the model were checked to ensure that the model 
generalised beyond the sample (Field, 2009). This involved assessing the histograms 
and normal probability plots of the saved residuals to check for normal distributions. 
Violations of these assumptions would weaken the results of the regression analyses, 
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Figure 9. The potential variables to be used in the hierarchical multiple regression used for the analysis of research questions (1) and (4). Note 
that the analysis for research question (5) did not include the E-TEDS subscales. Framework adapted from ARC (2008) 




5.10.4.2 Research questions (3) and (4): Which clinical and 
intervening psychosocial factors change after surgery? 
To assess change over time from pre- to post-surgery, a multilevel modelling (MLM) 
approach was employed. This method of analysis takes into account the non-
independence of scores given on the same questionnaire by the same participant at 
different time points, i.e. that data points are more similar within individuals over 
time than they are between individuals (Cartwright, Traviss & Blance, 2012). MLM 
approaches are recommended when data has been collected from individuals on 
more than one occasion, as multilevel models imply that scores are clustered within 






Figure 10. The hierarchical structure used to model the data for research question (3): 
which clinical and psychosocial factors change over time? 
 
Heck and colleagues (2014) have made recommendations for dealing with 
longitudinal data using MLM in SPSS that were used to guide this analysis. Firstly, 
data was restructured into a higher level (level 2, or participant-level) arrangement 
that recognised the hierarchical structure of the data (Figure 10) which resulted in 
each participant having three rows of observations, each row indicating a time point.  
 
For the continuous scales, an unconditional model (that did not account for the 
effects of time) was first applied that allowed intercepts to vary by participants and 
simultaneously allowed assessment of the proportion of variance at level 2 (the 
participant level). The intraclass correlation (ICC) estimates the amount of variance 
in the outcome that can be explained by between-participant variance and the higher 
this statistic, the more similar the units (i.e. substantial variability exits between 
participants) (Heck, Thomas & Tabata, 2014). The ICC indicates whether the higher 
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cut-off score of 0.05 is used, with an ICC smaller than this suggesting little 
advantage in conducting MLM (Heck, Thomas & Tabata, 2014). MLM was 
performed for all variables with ICCs higher than 0.05, with each scale score as the 
dependent variable and with the effect of time controlled for. To measure the 
standardised effect size of the fixed effect of time, partial eta squared (ŋ2p) was 
calculated, which is recommended for use when no other covariates are entered 
(Lakens, 2013).  
 
As effects of repeated measures (i.e. time) were used in the MLM, a covariance 
structure was chosen to specify the model parameters. A number of options for this 
were available in SPSS, including the diagonal variance structure, which assumes all 
variances at each time point are heterogenous, the unstructured option, which 
assumes covariance are unpredictable, and the first-order autoregressive structure 
(AR1), which takes into account the correlation between repeated measures and 
assumes that whilst scores between the first two time points are likely to be 
correlated, scores become less correlated over time (Field, 2009). An autoregressive 
structure (AR1) was therefore chosen to model the correlation structure of within 
participant effects for this analysis, as scores at adjacent time points were likely to be 
correlated and are not assumed to be heterogeneous or unpredictable within each 
participant. 
 
Change over time within each of the intervening psychosocial process variables and 
continuous clinical variables (exophthalmos, asymmetry, visual acuity, disease 
activity, and eyelid retraction) were also assessed using adjusted mean scores with 
time entered as a categorical variable in the SPSS command. Effect sizes were 
calculated for the effects of time again using partial eta squared (ŋ2p), as described 
above. To examine whether significant change was seen between baseline and 6 
week follow-up, baseline and 6 month follow-up, and between the 6 week and 6 
month follow-ups, pairwise comparisons were performed on the adjusted mean 
scores. Pairwise comparisons can compare all possible time point combinations 
whilst controlling for family wise error rates (i.e. the inflated error from conducting 
several statistical tests on the same data) by correcting the level of significance for 
each test so that the overall Type 1 error rate across comparisons remains at 0.05 
(Field, 2009). When MLM is performed SPSS provides standard error values rather 




than standard deviations. Standard deviations were therefore manually calculated 
using the formula: [SE * √n] where the standard error was multiplied by the square 
root of the sample size (Higgins & Green, 2011). 
 
To assess change over time in the categorical variables (optic neuropathy, diplopia, 
hydraulic orbit and corneal SPK), a variation of MLM designed specifically for 
repeated measures categorical outcomes was applied. This also involved calculating 
ICCs and entering time into the model as an ordinal variable. The log odds of the 
intercept was used to identify the predicted probability of having optic neuropathy, 
diplopia, hydraulic orbit and corneal SPK at each time point, a significant result 
would indicate whether the likelihood of having one of these clinical factors at 
baseline and 6 weeks, or baseline and 6 months, decreased (Heck, Scott & Tabata, 
2012). SPSS produced a β value, which represents the log odds coefficients, and the 
effect size for odds ratios, Exp(β), which represents exponentiated log odds (Field, 
2009). These two values were used to assess the probability of any of these variables 
being present from one time point to another (Heck, Scott & Tabata, 2012). Results 
of these analyses are reported in Chapter 9. 
5.10.4.3 Research question (5): Do baseline factors predict change 
on quality of life from pre- to post-surgery? 
Change over time was calculated using residualised change scores. This involved 
conducting a linear regression in which the 6-month score on a variable was 
predicted from the baseline score and the standardised residuals produced by SPSS 
were saved as new variables. This method has been used widely in health research to 
measure relationships between variables over time (e.g. Crocker et al., 2006; Sallis et 
al., 1999; Barerra, Toobert & Strrycker, 2012). Residualised change scores are 
recommended over raw change scores as they are able to describe the direction or 
magnitude of change from baseline to follow-up whilst removing the dependency 
from the baseline score. By contrast, raw scores mean that participants are more 
likely to have a positive direction of change if they start low and a negative direction 
of change if they start high (Fleeson, 2007).  
 
In order to establish pre-surgical predictors of change in quality of life, residualised 
change scores were calculated for vision- and appearance-related quality of life. 




Following this, two further hierarchical multiple regressions were performed, with 
change in quality of life subscale as the DV and baseline predictors as the IVs. 
Baseline variables that were found to be significantly associated with the changes in 
quality of life in univariate linear regressions were entered into the model. Again, the 
ARC (2008) framework was used as a guide to model entry into the regression and 
predictors were entered in the same blocks as for research question (1), and shown in 
Figure 9. 
 
Assumptions of multicollinearity, linearity and homoscedasticity were checked 
following these regressions as described in section 5.10.4.  
5.10.4.4 Research question (6): Which changes over time in clinical 
and psychosocial factors predict change in quality of life over time? 
Residualised change scores were calculated for each of the intervening psychosocial 
variables from pre- to post-surgery. These were then assessed for significant 
predictive value against change in the DVs. Baseline variables that were not 
expected to change but may expect to have some effect on quality of life, including 
age, gender, ethnicity, thyroid function, previous treatment, laterality of TED and 
surgery, and smoking, were entered into the first stage of the regression if they were 
found to be associated with a change in quality of life in the univariate regressions 
described in section 5.10.4.3 to control for any significant effects of these variables 
at baseline. 
  
The same model was applied for entering predictors into the regression as for 
research questions (1) and (4). The procedures to check the assumptions of the 
regression models for research question (1) (described in section 5.10.4) were 
repeated after the analysis for research question (5). 
 
Results of the analysis for questions (4), (5) and (6) are reported in Chapter 9.  
5.11 QUALITATIVE ANALYSIS 
The data generated from the semi-structured interviews were analysed using 
thematic analysis (Braun & Clarke, 2006).  
 




Thematic analysis was chosen as the most appropriate method for this study. 
Interpretative Phenomenological Analysis (IPA) was not chosen as it is concerned 
with capturing in-depth the lived experience of an individual (Smith, 1996) and is 
suited to smaller numbers of homogenous participants (between 3 and 6) due to the 
depth of understanding individuals rather than a group of patients (Smith et al., 
2009). Grounded theory aims to develop a new theory from the data (Strauss & 
Corbin, 1990), which was not the overall aim of this study. Framework analysis 
(Ritchie & Spencer, 1994) involves a similar set of phases as thematic analysis to 
systematically identify themes, however thematic analysis has been widely used in 
previous qualitative research on patient expectations of surgery and hospital care 
(Estcourt, 2008; Bhty, 1999; Bramwell, Morland & Garden, 2007) and was deemed 
a well-suited approach for this topic and the aims of this research study.  
 
There exist two approaches to thematic analysis: an inductive, data-driven approach 
that allows the research question to evolve through the coding process, and a 
theoretical, top-down approach that uses previous theory to code the data (Braun & 
Clarke, 2006). A theory-driven approach was taken for this study as previous 
research was used to generate specific research questions and objectives. Theory-
driven code development is the most common approach in social science research 
(Boyatzis, 1998). 
 
Thematic analysis involves searching across the dataset to identify, analyse and 
report patterns within the data (Braun & Clarke, 2006). The specific steps used to 
analyse the data are described in the following sections. Clarke and Braun (2013) 
urge investigators not to view these steps as linear, where one phase needs to be 
completed before moving onto the next; rather the analysis is a recursive process. 
5.11.1.1 Familiarisation with the data 
Firstly, audio files were played back to ensure accuracy of the written transcriptions 
and for familiarisation of the data. At this point any identifiable names were 
changed. Any reference to other individual’s names that could potentially identify 
them was replaced with a generic description, for example [the surgeon] replaced 
any reference to surgeon’s names and [daughter] replaced the interviewee’s 
daughter’s name. All medical terms were checked against published clinical articles 




to ensure correct spellings. Transcriptions were read and re-read, initially to become 
familiar with the breadth and depth of the content, and later to read the data in an 
active way, where any initial meanings and possible patterns were noted. Transcripts 
were uploaded into NVivo version 10 for Windows (QSR International, 2014).  
5.11.1.2 Coding 
The coding process was considered part of the data analysis as it involved the 
production of initial codes from features in the data that the researcher found 
interesting (Braun & Clark, 2006). Data items that appeared across the data set were 
considered ‘patterns’ and were thus coded (Marks & Yardley, 2004). To collate data 
extracts within each code, NVivo version 10 was used by adding extracts of text to 
‘nodes’ defined by the researcher. Individual extracts were coded into as many codes 
as they fitted.  
 
Boyatzis (1998) describes a good thematic code as one that “captures the qualitative 
richness of the phenomenon” (p.31) and that would be likely to produce high inter-
rater reliability and validity. Five key elements of the good thematic code are the use 
of a label, a definition of the characteristic of concern, a description of when to use 
the code, a description of any qualifications or exclusions to identify the code and 
giving examples of the code to avoid confusion (Boyatzis, 1998). Therefore these 
guidelines were followed during coding for the present study. 
 
Using Boyatzis’ (1998) guidelines each label was conceptually meaningful, clear, 
concise and close to the data, i.e. one that avoided any interpretation of the data at 
this stage. Marks and Yardley (2004) also suggest that coding categories form a 
hierarchy with higher-level categories and sub-categories within these. For example, 
for the present study a higher level category was ‘impact of having TED’ (reduced to 
‘impact’), as this was commonly discussed by interviewees, and the lower level 
category was the particular area of impact, such as ‘employment’, which formed the 
code ‘impact-employment’.  
 
Each transcript was examined a second time to identify any further codes (Braun & 
Clarke, 2006). The resulting codes were collated into a thematic coding framework 
and labels, descriptions, qualifications or exclusions and examples were given for 




each. The transcripts were then read a third time to check the accuracy of the first 
stage of coding and to apply any codes identified during later transcripts. After this 
process the thematic coding framework was reviewed and any entirely overlapping 
codes merged to form one code. The descriptions for each code within the ‘Thematic 
Coding Framework’ (Appendix N) were used to guide consistency in meaning 
within each code. Any clearly irrelevant extracts at this stage were ‘uncoded’ using a 
command in NVivo in order to keep the data within each code consistent. The data 
within each code was finalised and ready for the process of identifying themes.  
 
In order to validate the coding process, a second researcher with experience in 
thematic analysis was asked to independently code 20% of the interviews. These 
codes were compared to the original coding and any discrepancies were discussed 
until consensus was reached.  
5.11.1.3 Searching for themes 
Codes were reviewed and combined into broader, overarching themes. A theme was 
defined as a coherent and meaningful pattern within the data relevant to the research 
question (Clarke & Braun, 2013).  An initial thematic map was drawn to organise 
codes into themes that they fitted into (Braun & Clarke, 2006). At this point any 
relationships between codes, themes, and different levels of themes, or sub-themes 
were identified. This phase ended with candidate themes, sub-themes, and all the 
data extracts that were coded into these.  
5.11.1.4 Reviewing themes 
The next phase involved reviewing these themes against the data extracts to ensure 
that data within themes cohered together meaningfully (Braun & Clark, 2006).  
The entire dataset was read again to check that the themes accurately described the 
patterns in the data, and to code any additional data within themes that was missed in 
earlier coding stages (Braun & Clark, 2006). A final thematic map was developed 
that visually represented the themes and the relationship between themes (Figure 16).  
5.11.1.5 Defining and naming themes 
Once the thematic map was finalised theme names were checked for accuracy in 
defining what each theme was about. Braun and Clark (2006) suggest that names of 
themes should be concise and immediately give a sense of what the theme is about 




and this guideline was implemented for the current study. This phase continued into 
conducting and reporting the detailed analysis.   
5.11.1.6 Validation of the methodology 
Validity has a different meaning in qualitative research and rather than judge the 
statistical validity of a qualitative study, it is more useful to judge how rigorous 
methodology has been applied (Shauver & Chung, 2012). There is a need for 
qualitative researchers to be transparent in their methods. Tong, Sainsbury and Craig 
(2007) developed the Consolidated Criteria for Reporting Qualitative Research 
(COREQ); a 32-item checklist designed to guide quality reporting of qualitative 
methods and results. The COREQ was used for the present study. As is good 
practice for most qualitative approaches, notes were taken during interviews and the 
analytic process that identified the position of the researcher in the research process 
and any factors that might have influenced participants’ responses (Mauthner & 
Doucet, 2003).   
 
A reflexive account has been reported in Chapter 7, section 7.5. The researcher used 
this account to recognise their own values, interests and views when transcribing and 
analysing the data. A reflexive account can increase the validity of qualitative 
findings as the researcher is encouraged to be transparent in all their decisions 
regarding data collection and analysis (Mauthner & Doucet, 2003). The researcher 
kept notes during each interview and the analytic process that described any factors 
that the researcher felt might have influenced the interviewee, and their own analysis 
of the data (Appendix Q).  
 
The results of this study have been provided in Chapter 7.  
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6. WHAT FACTORS ARE ASSOCIATED WITH QUALITY OF LIFE IN 
PATIENTS WITH TED PRESENTING FOR ORBITAL 
DECOMPRESSION SURGERY? 
6.1 PROLOGUE 
This chapter presents the results from a cross-sectional study investigating the 
demographic, clinical and psychosocial factors associated with quality of life in 
people with TED. Baseline characteristics of the patients approached and recruited to 
the study are presented, including the sample size and reasons for not taking part, 
followed by the demographic and clinical characteristics of those who completed a 
baseline questionnaire. The missing data analysis will also be provided, along with 
normality of the scales and subscales and internal reliability of each measure.  
 
As there is currently no questionnaire that assesses the expectations of patients with 
TED about their upcoming surgery, the development and validation of a 
questionnaire designed to measure this area will also be described below (Section 
6.6.4) 
6.2 SUMMARY OF ANALYSIS 
Two multiple hierarchical regression analyses were conducted in order to establish 
whether the variables measured prior to surgery were significantly associated with 
vision-related and appearance-related quality of life. The results from these analyses 
will be reported in section 6.7 of this chapter.   
6.3 RECRUITMENT  
During the recruitment period (from September 2011 to July 2013), a total of 192 
potentially eligible patients were identified and were invited to take part in the study. 
Of these, 119 (62%) patients were approached in the outpatient clinic and all took 
home the information sheet, consent form and baseline questionnaire. An additional 
73 patients were identified on surgery lists from the PAS system at MEH and were 
contacted by telephone about the study. Patients who expressed an interest in taking 
part over the phone were posted information sheets, consent forms and baseline 
questionnaire packs. Of all the patients approached (n=192), 60 (31.3%) were 
followed up by phone or letter as they did not respond to the initial invitation within 
4 weeks. A number of the invited patients did not take part in the study. Fourteen 
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(7.3%) had their surgery cancelled and not re-booked during the period of 
recruitment, 15 (7.8%) declined to take part giving reasons such as not having time 
or feeling too ill to take part (see Table 6 for specific reasons), and 28 (14.6%) did 
not return consent forms despite confirming their willingness to take part in the 
study. One patient (0.5%) was misclassified as being listed for orbital decompression 
for TED on the PAS system.   
 
Table 6. Reasons given by participants for declining to take part in the study 
 
Reasons given by patients for declining to take 
part 
Number (%) 
Too ill from TED and other health problems 2(13.3%) 
Emergency surgery, too little time to complete 
questionnaire  
2(13.3%) 
Partner did not feel patient would be well enough 1(6.7%) 
Not interested in taking part in research 2(13.3%) 





Of the 135 (70.3%) patients who consented; 3 (1.6%) did not return their baseline 
questionnaire despite responding positively to reminders, 1 (0.7%) did not have time 
to fill in the questionnaire as their surgery for optic neuropathy was an emergency 
and occurred on the following day, 1 (0.7%) patient had their surgery cancelled and 
not re-booked, 5 (2.6%) baseline questionnaires were lost in the post, and two (1%) 
patients had their surgery cancelled as they were found to have a condition other than 
TED during biopsies. A total of 123 (64%) participants consented to take part in the 
study and returned the questionnaire prior to surgery. 
6.4 MISSING DATA 
A total of 149 items were to be completed for the cross-sectional study; 131 by the 
participant and 18 by the consultant ophthalmologist. The item level analysis 
revealed that a total of 2,183 values were missing (11.91%). Two participants (1.6%) 
were found to have high levels of missing data (i.e. greater than 50%); 9 (7.32%) 
participants had no missing data. The two participants with high levels of missing 
data were removed from the analyses as there was a risk that imputing over 50% 
missing data would give inaccurate results.  




The MCAR test was not significant at item level (χ2 = 7126.656, df = 8177, p = 
1.000) meaning that the data were missing completely at random. Therefore multiple 
imputation at item level was considered appropriate (IBM, 2011). Following the data 
imputations, scale scores for the psychosocial variables were re-calculated. The 
analyses described in this chapter were conducted on each of the 10 imputed datasets 
and the results were pooled. This provides valid inferences as this process averages 
over the distribution of the missing data given the observed values (Sterne et al., 
2009).  
6.5 DATA ASSUMPTIONS 
6.5.1 Scale reliability 
All scales and subscales of the psychosocial questionnaires used in the study showed 
excellent internal reliability as Cronbach’s α scores were over 0.7 (Table 7). 
Therefore no items needed to be removed and original scales and subscales were 
retained for the analysis. The internal reliability of the subscales for the E-TEDS are 
presented in Table 12, page 139. 
 
Table 7. Number of items and internal reliability for each scale and subscale in the 
cross-sectional 
 
Scale & subscale N No. of items Cronbach’s 
α 
HADS Anxiety 121 7 0.88 
HADS Depression 121 7 0.83 
DAS24 121 24 0.86 
GOQOL Visual function 121 9 0.90 
GOQOL Appearance 121 8 0.86 
CARSAL 121 5 0.82 
CARVAL 121 8 0.83 
MSPSS Friends 121 4 0.93 
MSPSS Family 121 4 0.92 
MSPSS Significant other 121 4 0.97 
BFNE 121 12 0.86 
INCOM 121 11 0.86 
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6.5.2  Normality 
The histograms and normal probability plots indicated that normal distributions were 
observed for the majority of the variables; however for the CARSAL, CARVAL, 
perceived visibility, and the three MSPSS subscales, data appeared skewed to the 
right (towards higher scores). The Shapiro-Wilk statistic was also significant 
(p<0.05) for all scales and subscales apart from age, BFNE and INCOM, suggesting 
a violation of the assumption of normality. As transformations are often complex and 
result in non-interpretable data (as described in section 5.10.3.1, page 114), scores 
were not transformed and therefore non-parametric tests were undertaken where 
necessary.  
6.6 SAMPLE CHARACTERISTICS 
6.6.1 Demographic & clinical factors 
The age of the participants ranged from 22 to 79 years, with a mean of 47.1 years 
(SD=12.32). The majority of the sample was female (72.7%). Ethnicity was 
originally categorised into 11 groups as described in Chapter 5 section 5.8.1.1.1. 
However due to small numbers of participants in some groups this was collapsed 
into three groups: White, Asian and Black. The majority of participants were White 
(78.5%), married or living with a partner (60%), and had bilateral disease and stable 
thyroid function. Twenty-two (18.2%) patients with bilateral disease were having 
unilateral surgery due to either a preference to have one eye operated on at a time, or 
because their bilateral TED was asymmetrical and consultations with their surgeon 
resulted in the decision to operate on the most severely proptosed eye first in an 
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Table 8. Descriptive statistics of the demographic and clinical variables of the sample 
(n=121) 
 
Variable n (%) Range Mean±SD 
Age (years)  22-79 47.1±12.32 
Gender    
Male 33(27.3)   
Female 88(72.7)   
Ethnicity    
Asian 11(9.1)   
White British/Irish/Other 95(78.5)   
Black African/Caribbean/Other 15(12.4)   
 
Relationship Status 
   
Married/Living with partner 73(60)   
Single/Other 48(40)   
Disease duration (months)  4-336 62.01±42 
Laterality of TED    
Bilateral 101(83.4)   
Unilateral 20(16.6)   
Laterality of planned surgery    
Bilateral 79(65)   
Unilateral 42(35)   
Treatment history     
Previous immunosuppressants 58(48)   
Previous radiotherapy 18(15)   
Previous surgery 14(11.6)   
Thyroid function     
Stable 106(87.6)   
Unstable 15(12.4)   
Visual acuity (LogMAR conversion)  0-2 0.1±0.4 
Corneal SPK 39(32)   
Hydraulic orbit  25(21)   
Optic neuropathy 15(12.4)   
Diplopia 62(51.2)   
Marginal reflex distance 1 (mm)  1.5-13 5.92±2.1 
Marginal reflex distance 2 (mm)  4-11 6.73±1.4 
Exophthalmometry (mm)  15-33 23.7±2.67 
Asymmetry (mm)  0-8 1.8±1.8 
CAS   0-9 1.12±1.9 
Smokers 38(31.4)     
 
Disease duration ranged from 4 to 336 months (median 42 months, or 3.5 years). 
Almost half the sample (48%) had previously received immunosuppressant therapy, 
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a small group of patients had received previous radiotherapy (15%) and previous 
surgery (11.6%); with 8 having had previous eyelid lowering (6.6%) and 6 previous 
orbital decompression (5%). Half the sample was experiencing double vision at the 
time of surgery (51.2%), around a third had corneal SPK, (32%), and just over 10% 
had optic neuropathy. Around a third of the sample was smokers (31.4%). The mean 
CAS score for this sample was low, with 84.3% of the sample scoring between 0 and 
3which indicates non-active TED.  
6.6.2 Intervening psychosocial factors 
Table 9 summarises the mean scores on each of the intervening cognitive 
psychosocial variables, and the outcome variables.  
 
Table 9. Mean scores for the psychosocial measures the present sample (n=121) 
 
Variable Min Max Max 
Possible 
M SD 
BFNE 14 60 60 38 9.16 
INCOM 16 54 55 36 7.2 
MSPSS Family 4 20 20 15.3 4.5 
MSPSS Friends 4 20 20 15.2 4.2 
MSPSS Significant 
other 
4 20 20 15.6 5.2 
CARSAL 5 30 30 25.2 4.7 
CARVAL 11 48 48 38.7 8.4 
DAS24 22 83 96 51.3 13.1 
Men (n=33) 22 83 96 50.7 15 
Women (n=88) 22 83 96 51.6 12.4 
Visibility 1 7 7 5.7 1.5 
HADS Depression 1 21 21 9.2 4.9 
HADS Anxiety 0 19 21 7.6 4.7 
GOQOL 
Appearance 
0 93.8 100 36.3 24.1 
GOQOL Visual 
function 
2.8 100 100 64 26.7 
 
Mean scores indicate this sample generally experienced fear of negative evaluation 
from others, a high tendency to make social comparisons, and high levels of 
appearance-related social anxiety and avoidance. There was no significant difference 
between men and women in their appearance-related social anxiety and social 
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avoidance (DAS24) t(223) = -0.29, p = 0.772, which was found to have a small 
effect r = 0.05. The mean score for depression in this sample was 9.2 (SD=4.9) and 
anxiety was 7.6 (SD=4.7). It was found that 25.6% of the sample experienced 
probable clinically relevant levels of depression and over a third (37%) experienced 
probably clinically relevant levels of anxiety. Twenty-five (20.7%) of the sample 
were experiencing clinical levels of both anxiety and depression.  
6.6.3  Quality of life 
This sample was found to have relatively low mean GO-QOL appearance scores, 
although vision-related quality of life was not as low. Of note are the large standard 
deviations for these subscales indicating that the variation in scores between 
participants was considerable, with some patients scoring on the extremely low end 
of the scale, particular for GO-QOL appearance.  
6.6.4  Expectations of TED Surgery Questionnaire (E-TEDS) 
6.6.4.1 Item generation 
Following the item selection process described in Chapter 5, section 5.8.1.2.4 of this 
thesis, a total of 26 items were pooled that covered three different conceptual areas 
of expectation: visual functioning, intimacy and social relationships, and appearance-
related concerns.  All 121 participants completed these items on a 5-point Likert 
scale ranging from 1 (‘Considerably improve’) to 5 (‘Made considerably worse’). 
The questionnaire instructed participants to “rate how you expect surgery to change 
various aspects of your life”.  
6.6.4.2 Item reduction 
The KMO for the original 26 items was 0.95, exceeding the recommended value of 
0.6 (Pallant, 2007). Bartlett’s Test of Sphericity was statistically significant 
(p<0.001) and the correlation matrix revealed coefficients that were all above 0.3, 
supporting the factorability of the correlation matrix. The only exception to this was 
in the case of the item “The relationship with my eye doctor” which showed slightly 
weaker correlations with the other scale items (rs were between 0.26 and 0.50). 
The PCA revealed the presence of three factors with eigenvalues above 1 and an 
inspection of the screeplot (Appendix O) showed a clear break between the second 
and third factors, further indicating the presence of three factors. The 26 items 
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loaded relatively strongly onto three distinct factors in the component matrix, with 
more than three items on each, which further supported the three factor solution. To 
aid the interpretation of these factors an oblimin rotation was performed, which 
showed that all items loaded strongly onto three distinct factors (Appendix P). It was 
felt that these factors confirmed the three key areas for expectations of upcoming 
surgery; visual function, appearance-related concerns and intimacy and social 
relationships, also reflecting the previous measures of expectations that were 
consulted in the item generation phase (McBain et al., in press; Finlay, Atkinson & 
Moos, 1995).  
 
Inspecting the pattern matrix further, two items loading onto the factor representing 
expectations about appearance-related concerns did not fit well conceptually. These 
were “My dry eyes” and “My headaches/ eye pain”, which are more likely 
representations of visual functioning. Along with the item “The relationship with my 
eye doctor”, which showed slightly weaker correlations with the other items in the 
correlation matrix, these items were removed. In order to assess the suitability and 
factorability of the 23 items, the PCA process was repeated. Inspection of the 
correlation matrix this time showed that all coefficients were 0.3 and above. KMO 
was 0.94 and Bartlett’s Test of Sphericity reached significance (p <0.001), 
supporting the factorability of the correlation matrix. The PCA again revealed the 
presence of three factors with eigenvalues above 1 and the total variance explained 
by this three factor solution was 76%.  




Figure 11. A screeplot showing the presence of factors for the Principle Component 
Analysis (PCA) 
 
The majority of the items loaded strongly onto only one factor, however the item 
“My ability to make new friends” loaded onto two factors; intimacy and social 
relationships (r=0.48) and appearance-related concerns (r=0.52). After a discussion 
with a second researcher who developed the ESSQ (HM) it was agreed that “My 
ability to make new friends” should be included in the intimacy and social 
relationships subscale as this made more conceptual sense. Three items that loaded 
onto two factors were retained in the factor that made conceptual sense i.e. “My 
ability to move around the house” and “My double vision” were retained in the 
visual functioning subscale and “My ability to form new intimate relationships” was 
retained in the intimacy and social relationships subscale. There were moderate 
correlations between the factors measuring visual function and appearance concern 
(r=0.58), between appearance concern and intimacy and social relationships (r=-
0.44) and between visual function and intimacy and social relationships (r=0.43), 






















Item Pattern Coefficients Structure Coefficients 












5. Move around the house 0.96 -0.31  0.92 0.65 0.41 
6. Perform domestic duties 0.96   0.91 0.64 0.40 
9. Watch TV T1 0.85   0.91 0.6 0.39 
4. Drive  0.83   0.89 0.38 0.49 
10. Use the computer 0.82   0.88 0.34 0.49 
8. Read 0.82   0.87 0.59 0.43 
12. Walk outdoors  0.79   0.85 0.69 0.54 
1. Vision 0.76   0.84 0.61 0.32 
7. Engage in my hobby or pastime 0.64   0.80 0.49  
13. Double vision 0.61   0.74 0.59 0.41 
11. Work at my usual job 0.59   0.74 0.60 0.32 
23. Mask the changes in my appearance  0.90  0.67 0.93 0.55 
22. Willingness to appear in photographs  0.83  0.60 0.92 0.51 
15. Self confidence  0.77  0.60 0.90 0.62 
2. Appearance of my eyes   0.77  0.69 0.90 0.41 
21. Other people's reactions to my TED   0.76  0.53 0.90 0.39 
3. Appearance of my face 0.30 0.68  0.72 0.88 0.49 
14. Ability to obtain a job  0.53  0.55 0.76 0.72 
16. Ability to make new friends  0.52 0.48 0.46 0.66 0.41 












19. Relationship with my current friends   0.85 0.35 0.46 0.87 
20. Relationship with my current partner/wife/husband   0.70 0.39 0.38 0.75 
17. Ability to form new intimate relationships   0.33 0.44 0.52 0.60 0.64 




The 23 item Expectations of TED Surgery Questionnaire (E-TEDS) consisted of 
three subscales. Expectations of visual functioning (VF) was made up of 11 items, 
intimacy and social relationships (ISR) contained 5 items, and appearance-related 
concerns (AC) contained 7 items. Responses on each item were mean scored for 
each subscale, with possible mean scores ranging from 1 to 5. Consultation with the 
authors of the ESSQ resulted in a suggested cut-off of mean scores of 1 to 2 
(inclusive) indicated that patients expected surgery to make visual functioning, 
intimacy and social relationships, and appearance-related concerns worse, scores of 
>2 to <4 indicated that patients expected these areas to remain the same after 
surgery, and scores of 4 or above indicated that patients expected these areas to 
improve after their surgery.  Mean scores in this sample were 3.5 (SD=1.2) for AC, 
3.3 (SD=0.9) for VF, and 3.2 (SD=0.8) for ISR.  
 
Table 11. The 23-item Expectations of TED Surgery Questionnaire (E-TEDS) 
 
Using the five point scale below please rate how you expect surgery to change various 










1. My vision  1 2 3 4 5 
2. The appearance 
of my eyes  
1 2 3 4 5 
3. The appearance 
of my face  
1 2 3 4 5 
4. My ability to 
drive  
1 2 3 4 5 
5. My ability to 
move around 
the house  
1 2 3 4 5 




and cleaning)  
1 2 3 4 5 
7. My ability to 
engage in my 
hobby or 
pastime  
1 2 3 4 5 
8. My ability to 
read  
1 2 3 4 5 
9. My ability to 
watch TV  
1 2 3 4 5 
10. My ability to 1 2 3 4 5 






11. My ability to 
work at my 
usual job  
1 2 3 4 5 
12. My ability to 
walk outdoors  
1 2 3 4 5 
13. My double 
vision  
1 2 3 4 5 
14. My ability to 
obtain a job  
1 2 3 4 5 
15. My self 
confidence  
1 2 3 4 5 
16. My ability to 
make new 
friends  
1 2 3 4 5 




1 2 3 4 5 
18. The relationship 
with my family  
1 2 3 4 5 
19. The relationship 
with my current 
friends  
1 2 3 4 5 
20. The relationship 
with my current 
partner/ wife/ 
husband  
1 2 3 4 5 
21. Other people’s 
reactions to my 
TED  
1 2 3 4 5 
22. My willingness 
to appear in 
photographs 
because of my 
TED  
1 2 3 4 5 
23. My desire to 
mask the 
changes in my 
appearance as a 
result of my 
TED  
1 2 3 4 5 
 
6.6.4.3 Validity and reliability 
Four Consultant Ophthalmic Surgeons, a Professor of Health Psychology, a Health 
Psychologist and a patient with TED reviewed the items of the E-TEDS. There was 
consistent agreement between the experts that the items reflected the concepts 




represented by the subscales, the experiences of patients with TED, and were 
medically accurate, thus achieving content validity.   
 
Internal reliability of the subscales was high with Cronbach’s alphas all above 0.7 
(Table 12). 
Table 12. Internal reliability of the E-TEDS subscales 
 




121 7 0.958 
Expectations visual 
function 
121 11 0.964 
Expectations intimacy 
and social relationship 
121 5 0.871 
 
6.7 FACTORS ASSOCIATED WITH QUALITY OF LIFE IN TED 
This section of the thesis describes the results of two hierarchical multiple 
regressions that were performed to assess the ability of the demographic, clinical, 
intervening cognitive process and mood variables described to predict the variance in 
GO-QOL visual function and appearance subscales. A full description of the method 
used is described in section 5.10.4 (page 115) and Figure 9 shows the regression 
model used.  
6.7.1 GO-QOL visual function 
As described in Chapter 5, section 5.10.4, univariate linear regressions were 
performed for each IV to determine whether it predicted the DV before entering only 
significant predictors into a hierarchical multiple regression.  
 
These initial univariate regressions found that ten of the 36 variables significantly 
predicted GO-QOL visual functioning: age (F(1,119)=16.65, p<0.001, f2 =0.14), optic 
neuropathy (F(1,119) =15.77, p<0.001, f2 = 0.15), worse eye LogMAR (F(1,119)=15.58, 
p<0.001, f2 =0.12), previous immunosuppressant therapy (F(1,119) =11.13, p=0.001, f2 
=0.09), asymmetrical TED (F(1,119)=6.12, p=0.015, f2 = 0.05), hydraulic orbit 
(F(1,119)=9.22, p=0.003, f2 =0.06), diplopia (F(1,119)=7.77, p=0.006, f2 =0.07), CAS 
(F(1,119)=6.22, p=0.014, f2 =0.05), social anxiety and avoidance (F(1,119)=3.95, 




p=0.049, f2 =0.06), anxious mood (F(1,119)=12.87, p<0.001, f2 =0.11), and depressed 
mood (F(1,119)=41.63, p<0.001, f2 =0.36).  
 
When entering these variables in the order of entry described in section 5.10.4, 55% 
of the observed sample variation in GO-QOL visual function was accounted for by 
the regression model (adjusted R2=0.45, F(1,119)=9.89, p<0.001, f2 = 0.8). Beta 
coefficients indicated that age, asymmetrical TED and depression all made 
significant unique contributions to the model (Table 13). Poorer quality of life was 
associated with being older, having asymmetrical proptosis and more depressed 
mood. 




Table 13. Results of the hierarchical multiple regression model used to identify 
predictors of GO-QOL visual function 
 
  B SE B t p 
Step 1         
Constant 98.16 9.53 10.30 .000** 
Age -0.79 0.20 -4.03 .000** 
Step 2     
Constant 94.07 9.84 9.56 .000** 
Age -0.39 0.21 -1.85 .065 
LogMAR -15.88 7.65 -2.08 .038* 
CAS -0.84 1.49 -0.56 .574 
Asymmetry -2.55 1.30 -1.96 .050 
Optic neuropathy -6.01 12.07 -0.50 .620 
Hydraulic orbit 0.92 7.69 0.12 .904 
Previous immunomodulation -8.13 5.20 -1.57 .118 
Diplopia -6.16 5.05 -1.22 .222 
Step 3         
Constant 129.01 14.78 8.73 .000** 
Age -0.54 0.21 -2.60 .009* 
LogMAR -14.72 7.41 -1.99 .047* 
CAS -1.64 1.47 -1.12 .265 
Asymmetry -2.96 1.27 -2.34 .019* 
Optic neuropathy -4.68 11.44 -0.41 .684 
Hydraulic orbit 2.15 7.45 0.29 .773 
Previous immunomodulation -5.17 4.99 -1.04 .300 
Diplopia -5.63 4.86 -1.16 .247 
DAS24 -0.56 0.18 -3.06 .002* 
Step 4         
Constant 119.49 13.78 8.67 .000** 
Age -0.50 0.19 -2.63 .009* 
LogMAR -11.28 6.45 -1.75 .080 
CAS -1.92 1.31 -1.46 .144 
Asymmetry -2.25 1.13 -2.00 .046* 
Optic neuropathy -4.09 9.54 -0.43 .669 
Hydraulic orbit 2.55 6.47 0.39 .694 
Previous immunomodulation -6.79 4.90 -1.38 .168 
Diplopia -4.39 4.29 -1.02 .307 
DAS24 0.05 0.21 0.23 .815 
HADS Anxiety -0.69 0.58 -1.20 .231 
HADS Depression -2.41 0.59 -4.10 .000** 
Note: R2 = .12 for Step 1 (p <0.001), R2 = .28 for Step 2 (p<0.05), R2=.40 for Step 3 (p < 
0.001), R2 = .55 for Step 4 (p < 0.001) 
*p<0.05, **p<0.001 
  




A post-hoc power calculation conducted in G*Power 3.1.2 indicated that for 10 
predictor variables, a sample size of 121, and an effect size of 0.8, 100% power was 
achieved.  
6.7.2 GO-QOL appearance 
The preliminary univariate linear regressions found 13 variables significantly 
predicted GO-QOL appearance: age (F(1,119)=5.42, p=0.022, f2 = 0.05), gender 
(F(1,119) =8.13, p=0.005, f2 = 0.07), previous eyelid or orbital surgery (F(1,119) =5.55, 
p=0.020, f2 =0.06), family support (F(1,119)=5.12, p=0.025, f2 = 0.04), support from 
friends (F(1,119)=7.39, p=0.008, f2 =0.06), fear of negative evaluation (F(1,119)=58.76, 
p<0.001, f2 =0.52), social comparison (F(1,119)=12.23, p=0.001, f2 =0.11), DAS24 
(F(1,119)=60.03, p<0.001, f2 =0.59), salience of appearance (F(1,119)=64.65, p<0.001, f2 
=0.51), valence of appearance (F(1,119)=98.86, p<0.001, f2 =0.76), perceived visibility 
(F(1,119)=27.47, p<0.001, f2 =0.24), anxious mood (F(1,119)=42.25, p<0.001, f2 = 0.39), 
and depressed mood (F(1,119)=70.50, p<0.001, f2 =0.57).  
 
When entering the variables in the same method of entry as described in section 
5.10.4 (page 115) and Figure 8, 75% of the observed sample variation in GO-QOL 
appearance was accounted for by the regression model (adjusted R2=0.70, 
F(13,107)=20.70, p<0.001, f2 = 2.3). Beta coefficients indicated that gender, 
appearance-related social anxiety and social avoidance, salience of appearance, 
valence of appearance, perceived visibility of TED and depression all made 
significant contributions to the model (Table 14). Poorer appearance-related quality 
of life was associated with being female, having greater appearance-related social 
anxiety and avoidance, greater value being placed on appearance, a more negative 
evaluation of appearance, greater perceived visibility of TED, and being more 
depressed. 




Table 14. Results of the hierarchical multiple regression model use to identify 
predictors of GO-QOL appearance 
 
  B SE B t p 
Step 1         
Constant 12.40 8.40 1.48 .140 
Age 0.43 0.17 2.51 .012* 
Gender 14.04 4.68 3.00 .003* 
Step 2         
Constant 16.04 8.52 1.88 .060 
Age 0.39 0.17 2.30 .022* 
Gender 13.43 4.62 2.91 .004* 
Previous surgery -14.89 6.76 -2.20 .028* 
Step 3     
Constant 54.38 15.75 3.45 .001* 
Age 0.22 0.15 1.50 .133 
Gender 11.97 3.93 3.04 .002* 
Previous surgery -5.52 6.53 -0.85 .399 
BFNE -1.29 0.24 -5.29 .000** 
INCOM 0.03 0.30 0.11 .915 
MSPSS Family 0.13 0.45 0.30 .765 
MSPSS Friends 0.97 0.49 1.97 .049* 
Step 4         
Constant 134.27 14.30 9.39 .000** 
Age 0.05 0.11 0.43 .666 
Gender 8.41 3.07 2.74 .006* 
Previous surgery -5.62 5.20 -1.08 .283 
BFNE -0.21 0.22 -0.93 .354 
INCOM 0.05 0.24 0.19 .849 
MSPSS Family -0.08 0.34 -0.22 .823 
MSPSS Friends 0.76 0.38 1.99 .047* 
DAS24 -0.54 0.12 -4.34 .000** 
CARSAL -1.40 0.34 -4.12 .000** 
CARVAL -0.69 0.22 -3.19 .001* 
Perceived visibility -2.89 0.99 -2.92 .004* 
Step 5         
Constant 132.09 13.84 9.55 .000** 
Age 0.11 0.11 0.94 .346 
Gender 6.56 3.02 2.17 0.03* 
Previous surgery -5.04 5.08 -0.99 .325 
BFNE -0.23 0.22 -1.03 .302 
INCOM 0.01 0.23 0.06 .950 
MSPSS Family -0.29 0.34 -0.87 .382 
MSPSS Friends 0.56 0.37 1.53 .127 
DAS24 -0.39 0.13 -2.93 0.004* 




CARSAL -1.23 0.33 -3.69 0.000** 
CARVAL -0.58 0.21 -2.76 0.006* 
Perceived visibility -2.75 0.96 -2.86 0.004* 
HADS Anxiety -0.05 0.39 -0.14 .891 
HADS Depression -1.12 0.43 -2.60 0.009* 
Note: R2 = .11 for Step 1 (p <0.05), R2 = .15 for Step 2 (p<0.05), R2=.43 for Step 3 (p < 
0.001), R2 = .71 for Step 4 (p < 0.001), R2 = .75 for Step 5 (p < 0.05) 
*p<0.05, **p<0.001 
 
A post-hoc power calculation conducted in G*Power 3.1.2 indicated that for 13 
predictor variables, a sample size of 121, and an effect size of 2.3, 100% power was 
achieved.  
6.7.3  Regression assumptions 
The VIF and tolerance statistics for all 10 imputations were inspected as a pooled 
result was not produced by SPSS. All tolerance values were above 0.2 and VIF 
values were well below 10. Therefore it can safely be concluded that there was no 
multicollinearity within the data for either model. Furthermore, the residuals were 
inspected using histogram and normal probability plots and showed a normal 
distribution for both the GO-QOL subscales with a mean of 0.    
6.8 DISCUSSION 
This study investigated the demographic, clinical and individual psychosocial factors 
that might predict quality of life in a sample of patients with TED presenting for 
orbital decompression surgery. Factors associated with quality of life were identified 
using hierarchical multiple regression analyses. It was found that prior to surgery a 
range of demographic, clinical and psychosocial factors were associated with both 
vision-related and appearance-related quality of life. The representativeness of the 
study sample in comparison to other TED samples and the wider population of 
patients with TED will now be discussed. Following this, the results of the present 
study will be discussed in relation to previous research in section 6.8.2, and a 
discussion of the strengths and weaknesses of this study will be provided in section 
6.8.3.  




6.8.1 Representativeness of the study sample 
6.8.1.1 Demographic & clinical factors 
The demographic composition of the study sample was similar to the general TED 
population. The percentage of females in this study reflects the percentage from 
other TED studies in the UK (Edmunds, Huntbach & Durrani, 2014), and orbital 
decompression surgery in non-UK samples (Terwee et al., 2001; Tehrani et al., 
2004). In terms of the mean age of the sample, the present study is comparable to 
other studies evaluating orbital decompression surgery (EUGOGO et al., 2009; 
Terwee et al., 2001). The literature on ethnic differences in TED is limited, however 
the current study presents an ethnic distribution that is comparable to another UK 
sample of TED patients (Edmunds, Huntbach & Durrani, 2014). Audit data from 
MEH suggests that approximately 46% of patients with TED referred to MEH 
between the period of August 2013 and July 2014 were White (MEH Performance 
Information, 2014), making the current study sample skewed towards those of White 
ethnicity, thus potentially reducing the generalizability of these findings to the wider 
population of patients with TED at MEH. This may have occurred in part due to the 
exclusion of patients who were not English speaking because of using questionnaires 
that required a fluent understanding of psychological concepts in English. 
 
Disease duration varied greatly between participants, with a range similar to TED 
samples in previous studies investigating quality of life (Terwee et al., 1998; Terwee 
et al., 2001; Terwee et al., 2002). The large range may be in part due to the difficulty 
in diagnosing TED for some, particularly for patients with unilateral disease 
(Wiersinga et al., 1989). This might also be because orbital decompression surgery is 
only offered in a small number of TED speciality clinics and some patients have 
anecdotally reported that their GP was not aware of this corrective surgery available 
to them through the NHS and so did not seek further treatment for several years. 
Whilst others are identified quickly and if they live near to MEH (a specialty clinic), 
they would be more likely to be referred rapidly. Perros et al. (2012) indeed found 
that patients who lived further away from a specialty clinic were significantly less 
likely to have orbital decompression surgery than patients registered to primary care 
trusts closer to those clinics.  
 




The proportion of patients in this study with unilateral TED was similar to previous 
TED populations (Kashkouli et al., 2011b). Previous studies investigating quality of 
life in patients with TED undergoing orbital decompression surgery have not 
reported stability of thyroid function, but the proportion in this sample with unstable 
thyroid function was lower than in previous patient groups (Ponto et al., 2011). 
However, as orbital decompression surgery is normally only offered to patients once 
GD has been controlled through antithyroid drugs or thyroidectomy, this would 
make sense for this sample. The majority of the patients in this study had a CAS 
score lower than 3, indicating inactive TED, which would be expected in patients 
listed for orbital decompression surgery, as this surgery tends only to be offered to 
patients whose TED has “burnt out”, or reached a phase of stability. The high 
exophthalmometry readings in this sample are comparable to other samples of 
patients with TED before decompression surgery (EUGOGO et al., 2009; Terwee et 
al., 2002). The high number of patients in this sample with diplopia is also similar 
for patients with TED seeking surgery (EUGOGO et al., 2009; Terwee et al., 2002), 
as is the proportion of patients with optic neuropathy (Edmunds, Huntbach & 
Durrani, 2014; Perros et al., 1993).  
6.8.1.2 Socio-cognitive factors 
Participants in this sample scored 9 points higher on the fear of negative evaluation 
measure (BFNE; Leary, 1983), than a published normal threshold for a non-clinical 
community sample (Collins et al., 2005). The scores were, however, similar to 
samples of patients with psoriasis (Leary et al., 1998) and panic disorder (Collins et 
al., 2005), but lower than patients with identified social phobia (Collins et al., 2005; 
Weeks et al., 2005). This suggests that fear of negative evaluation was particularly 
high in patients with TED, but comparable to other visible conditions including 
ptosis (Richards et al., 2014) and strabismus (McBain et al., 2014).  
 
The mean scores on the social comparison measure (INCOM; Gibbons & Buunk, 
1999) indicated the tendency of this sample to make social comparisons is 
comparable to a group of patients with a range of ophthalmic conditions (n=98) 
including ptosis, TED, strabismus, ocular cancer and trauma (James et al., 2011), 
although not as high as a sample of US college students (Gibbons & Buunk, 1999). 




The latter may be particularly influenced by social pressure and their age is also 
likely to be an important influence on the tendency for social comparison.  
 
Scores on the perceptions of social support (MSPSS; Zimet et al., 1988) subscales 
Family, Friends, and Significant Other are particularly high relative to the general 
population with scores approximately 10 points higher on each subscale than a 
general population sample (Zimet et al., 1988). This may be due to patients being 
dependent and relying on support from loved ones, particularly if vision has had an 
impact on activities of daily life, and if changes in appearance have led to social 
withdrawal.  
6.8.1.3 Appearance-specific cognitions 
Mean appearance-related social anxiety and avoidance (DAS24; Carr, Moss & 
Harris, 2005) scores were high, particularly when compared to normative data from 
the general population (Harris & Carr, 2001). Scores were also higher in this sample 
than in patients who had identified themselves as having a particular concern about a 
feature of their head and neck region and their nose, as shown in Figure 12 (Carr, 
Moss & Harris, 2005). Normative data on the DAS24 for men and women are 
available (Carr, Moss & Harris, 2005) and scores in this sample are higher than men 
and women in the general population (Figure 12). In particular, men with TED 
scored almost twice as high as men from the general population (Carr, Moss & 
Harris, 2005). Scores for this sample are also around 10 points higher for both men 
and women than a sample of patients with a range of ophthalmic concerns (James et 
al., 2011) and are comparable to a sample of individuals having elective plastic 
surgery (Rumsey et al., 2004). 
 





Figure 12. DAS24 scores for men and women at baseline for the current study (Δ) 
compared to norm values from Carr, Moss & Harris (2005) (*) 
 
As the salience and valence of appearance scales (CARSAL and CARVAL; Moss & 
Rosser, 2012) used in this study were amended versions that have only recently been 
published (Moss & Rosser, 2012), there are no normative values for these two 
measures available. In terms of perceived visibility, participants reported that their 
TED was highly visible to others, with a mean score of 5.7 and 43% of the sample 
rating visibility as a 7 (the highest possible score), and only 1 patient (1%) reporting 
perceived visibility to be a 1 (the lowest possible score). The same scale has been 
used in a recent study evaluating quality of life in strabismus and participants in this 
study perceived TED to be more visible than strabismus (McBain et al., 2014). 
6.8.1.4 Mood 
The mean anxiety scores (HADS; Zigmond & Snaith, 1983) for the current sample 
were higher than a UK general population (Crawford et al., 2001) and patients with 
strabismus (McBain et al., 2014; Jackson et al., 2006), and other facial 
disfigurements (Martin & Newell, 2004). Mean depression scores (HADS; Zigmond 
& Snaith, 1983) in this sample were higher than for patients with other 
disfigurements including those caused by rheumatic conditions, burns, head and neck 
cancer, and dermatological conditions, but lower than patients having plastic surgery 






















The high levels of possible clinical caseness in this sample (25.6% of depression and 
37% of anxiety) were far higher than the 3% clinical levels of anxiety and 1% 
clinical depression in the general population (Crawford et al., 2001). The percentages 
were however similar for depression and less for anxiety compared to a sample of 
individuals with facial disfigurements (Martin & Newell, 2004). A lower proportion 
of this sample of patients with TED were found to have possible clinical levels of 
anxiety than a German group of patients with TED, although depression levels were 









   
 
Figure 13. Bar chart displaying mean HADS subscale scores from this sample 
compared to normative scores from other populations 
 
It remains possible that other psychological co-morbidities not assessed in this study 
could have explained the high percentage of possible clinical mood disorders. For 
example, Wong & Yu (2013) found that as many as 32% of TED patients had a 
current psychiatric disorder including panic disorder, agoraphobia, obsessive-
compulsive disorder (OCD) and post-traumatic stress disorder (PTSD), all of which 
affect mood. 
6.8.1.5 Quality of life 
Quality of life in relation to visual functioning in this sample was comparable to a 












the development of the GO-QOL (Terwee et al. 2001). Appearance-related quality of 
life in the present sample was, however, found to be several points lower than in the 
Dutch study (Figure 14).  
 
                       
Figure 14. GO-QOL subscale scores for the current sample at baseline compared to 
scores from a previously studied TED sample (Terwee et al., 2001) 
 
 
Large variation was found between patients in their visual function and appearance-
related quality of life suggesting that whilst some patients adjusted well, others were 
on the extreme end of the scale. For some, TED had had a detrimental impact on 
their activities of daily living and perceptions of their appearance. This is in line with 
a number of previous studies (Jensen & Harder, 2001; Estcourt et al., 2008; Ponto et 
al., 2011; Choi et al., 2012). However, the current study investigated this 
phenomenon further by exploring the potential for intervening psychosocial 
processes to better explain quality of life than clinical and demographic factors.  
6.8.2 Factors associated with quality of life in TED 
It has been widely documented that individuals with facial disfigurements can 
experience poor psychological adjustment as a result of changes in appearance. 
Research in recent years has begun to challenge the idea that psychosocial 
adjustment can be predicted from clinical severity alone, and it is now considered 
that the experience of living with a facial disfigurement as multifaceted and 

























selected for this study were significantly associated with quality of life as predicted.. 
This section of the thesis presents the results of the analyses and discusses them in 
relation to previous literature. 
6.8.2.1 Demographic factors 
Demographic factors were found to predict quality of life in this sample, with older 
adults with TED experiencing poorer vision-related quality of life than younger 
patients. This finding contradicts previous studies that have reported appearance 
related distress, anxiety and depression to generally reduce with age in people with 
disfiguring conditions (ARC, 2008; Rumsey et al., 2003; James et al., 2011). In 
contrast the finding in this study corresponds to that in strabismus where being older 
has been found to be associated with increased levels of depression (McBain et al., 
2014). It is also consonant with a study in TED, where older patients were found to 
have poorer visual related quality of life (Terwee et al., 1999). The similarity in these 
findings which are specific to the eyes and visual system might suggest that the 
general finding in disfigurement research in relation to age and depression is not 
supported where eyes are involved. However, a more plausible suggestion is that the 
relationship is related to severity as older age is one factor that is associated with 
more severe TED (Kendler, Lippa & Rootman, 1993).  
 
Appearance-related quality of life was significantly associated with gender. One 
previous study in TED involving the development of the GO-QOL also found 
females to report more problems in appearance-related quality of life (Terwee et al., 
1999). Being female has been found to be associated with poorer appearance-related 
quality of life in other disfiguring conditions (Rumsey et al., 2003; James et al., 
2011; ARC, 2008). It might be that for women, the eyes are more central in 
perceived attractiveness and changes in appearance to the eyes have had a 
detrimental influence on self-confidence and willingness to appear in photographs. 
Concealment of TED has been found to be common in women in previous TED 
studies (Estcourt et al., 2008; Jensen & Harder, 2010; Terwee et al., 1999) and this 
sample of patients appear to be no exception.   
6.8.2.2 Clinical factors 
Asymmetrical disease was found to predict vision-related quality of life. Visual 
function has been found to be associated with eye symmetry, or lack thereof, and the 




degree of burden from this factor, individual to each patient, has been found to 
influence GO-QOL scores in a previous TED study (Terwee et al., 1999). Of note, 
no other clinical variables accounted for the variance in either visual function or 
appearance-related quality of life. Intervening cognitive processes explained more 
variance in quality of life than the clinical factors included in this study. This is in 
contrast to other studies in TED that have found a significant relationship between 
clinical and psychological factors, although there are methodological flaws in these 
studies that may have biased the results, (See Chapter 4, section 4.3.1.2) (Yeatts, 
2005; Park et al., 2004; Son et al., 2014).  
6.8.2.3 Intervening psychosocial factors 
It was predominantly the intervening psychosocial factors that explained the variance 
in appearance-related quality of life in this study. The finding that increased 
appearance-related social anxiety and avoidance predicts poorer visual related and 
appearance related quality of life is supported by a recent study in strabismus. In the 
strabismus study social anxiety and social avoidance scores were significantly 
associated with both function and psychosocial quality of life (McBain et al., 2014). 
Another study has found that people with disfiguring conditions commonly avoid 
social activities that involve exposing their condition to others (Rumsey, Clarke & 
Musa, 2002). The issue of exposure would have significant implications for patients 
with disfiguring eye conditions where they are often met with questions, comments 
and staring from others (Clarke, 1998; Clarke et al., 2000; Jensen & Harder, 2001; 
Estcourt et al., 2008). Some previous studies have conceptualised appearance-related 
social anxiety and avoidance to be behavioural outcomes in adjusting to having a 
disfiguring condition (e.g. Richards et al., 2014). However, the results of this study, 
in addition to McBain et al.’s (2014), support the notion that these are intervening 
cognitive factors that strongly predict quality of life adjustment. Increased 
importance of appearance-related information, as well as having a poorer evaluation 
of one’s own appearance, were also found to significantly predict quality of life in 
this sample. This also supports the findings of McBain et al. (2014) for patients with 
strabismus. Appearance-related quality of life was also predicted by a tendency to 
perceive one’s own TED to be highly visible to others. In a recent study 
investigating perceptions of TED severity in different groups of observers, in 
addition to patients themselves, Terwee et al. (2003b) found that clinicians tended to 




underrate, and patients overrate, the severity of TED. Perceptions of particularly high 
noticeability have also been found in patients with strabismus (McBain et al., 2014), 
head and neck cancer, skin conditions, and individuals seeking elective plastic 
surgery for appearance concerns (Rumsey, Clarke & White, 2003).  
 
Expectations about upcoming rehabilitative surgery for a disfiguring condition are 
understandably high (Dawn & Lee, 2004; Kiyak, Vitaliano & Crinean, 1988; 
Estcourt et al., 2008). Estcourt et al. (2008) investigated the well-being of patients 
with TED in a recent qualitative study and found patients to have unrealistically high 
expectations that surgery will enable them to return to the life they had before TED. 
This was the first study in TED to measure patients’ expectations of surgery and 
developed the E-TEDS questionnaire to achieve this task. Furthermore, this was the 
first study to the researcher’s knowledge that has tested the potential for expectations 
to explain variability in adjustment using the ARC (2008) framework. However, 
expectations for post-surgical visual function, appearance concerns, or intimacy and 
social relationship outcomes were not associated with quality of life in this sample. 
There may be issues with measuring quality of life in relation to patients’ 
expectations. A recent literature review has highlighted that expectations are 
complex, highly specific to each patient and are closely related to people’s 
relationships to their changing environments (Carr, Gibson & Robinson, 2001). Thus 
expectations may change over time and over the course of their illness trajectory.  
 
Depression was found to be a strong predictor of both visual function and 
appearance-related quality of life. This is consistent with quality of life in other 
chronic disease groups, including diabetes (Goldney et al., 2004), multiple sclerosis 
(Karatepe et al., 2011) and myocardial infarction (Mayou et al., 2000) as well as in 
strabismus (McBain et al., 2014).  
 
To conclude, this is one of the largest sample of patients with TED assessed on 
quality of life to date, and the only study to have investigated the potential of a range 
of intervening cognitive processes to explain quality of life in this patient group. 
Appearance-related quality of life was found to be particularly poor in this sample, 
but variation was found in both appearance and vision-related quality of life. This 
variation was predominantly accounted for by intervening cognitive processes as 




opposed to clinical severity, activity, treatment history or duration of the condition. 
There was some evidence that age and asymmetrical disease might predict vision-
related quality of life in patients with TED. A higher proportion of possible caseness 
of anxiety and depression was found in this population than other patients with other 
facial disfigurements, and depression was found to be a strong significant predictor 
of both visual function and appearance-related quality of life.  
 
This highlights the importance of measuring levels of depression and quality of life 
in this patient group prior to surgery. It would be valuable for clinicians to be aware 
of the significant detrimental impact of having TED on patients’ lives, and the ability 
of psychosocial processes individual to each patient to predict who adjust 
particularly poorly, over and above clinical factors, so that they may be examined in 
the clinical interview, and appropriate intervention and support provided.  
6.8.3 Strengths and weaknesses of the study 
This cross-sectional study found a range of demographic, clinical and intervening 
psychosocial processes variables were associated with quality of life in this TED 
sample. However, as the design was cross-sectional, it is difficult to establish causal 
direction for the factors that are associated with quality of life. Longitudinal studies 
that follow patients up over time are needed to identify predictors of quality of life.  
 
An adequately powered sample size of 121 was reached for this study making this 
one of the largest samples in any TED study. Sufficient power was also achieved for 
to find an effect for the hierarchical multiple regression analyses. The sample was 
representative of the wider TED population in terms of age, gender distribution, and 
indicators of activity and severity, but not for ethnicity.  
 
The DVs for this study were found to be non-normally distributed, which can pose a 
problem when conducting regressions analyses, as generalising findings from the 
model beyond the sample becomes difficult (Field, 2009). These can be dealt with by 
transforming the data, but transformations are not without their own limitations and 
often produce results that are non-interpretable (Grayson, 2004), thus were avoided 
in this study. The non-normally distributed DVs may therefore have weakened the 
results of the current study. However, the normality of the residuals were also 




checked after the regressions were performed and these were found to be 
satisfactory.  
 
The Expectations of TED Surgery Questionnaires (E-TEDS) was developed for the 
purposes of examining patient expectations of orbital decompressions surgery in this 
cross-sectional study. It was assessed for internal reliability and content validity, 
both of which were found to be high. However validity and reliability of the measure 
should be further established to confirm the robustness of the measure, including 
test-retest measures to ensure the stability of what is measures over time, and 
discriminant validity checks against measures that theoretically measure different, or 
the same, concepts (Pallant, 2007). The cut-off scores indicating expectations to be 
made worse, remain the same, or improve that have been suggested in this chapter 
also need further testing to establish their suitability.  
 
This is one of few studies to examine quality of life in patients presenting for orbital 
decompression in the UK using the GO-QOL and to systematically examine 
demographic, clinical and psychosocial predictors of adjustment to TED.  The 
findings from this study have a number of implications for clinical practice, which 
are described in more detail in Chapter 10 section 10.3. 
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7. A QUALITATIVE STUDY OF PATIENT EXPECTATIONS OF 
ORBITAL DECOMPRESSION SURGERY FOR TED 
7.1 PROLOGUE 
The previous chapter of this thesis described the results of a cross-sectional study 
investigating the demographic, clinical and psychosocial factors associated with 
quality of life of patients with TED presenting for orbital decompression surgery. 
This study found that intervening cognitive processes predominantly were associated 
with quality of life in this patient group, rather than clinical factors. It has been 
discussed in Chapter 4 of this thesis (section 4.3.2.7) that expectations of treatment 
are likely to impact on adjustment to having a disfiguring disease. Expectations were 
thus measured in the cross-sectional quantitative study described in Chapter 6 in 
relation to their association with quality of life. However, expectations for medical 
care are complex and are worthy of more in-depth exploration. The present chapter 
outlines the results of a qualitative study that explored patients’ expectations of 
orbital decompression surgery further. Semi-structured interviewing and thematic 
analysis were used to further our understanding of the expectations patients had 
about their upcoming decompression surgery for TED.  
 
To date only two studies have used qualitative methods to explore the patient 
perspective in TED and both investigated the impact of TED on well-being (Jensen 
& Harder, 2011; Estcourt et al., 2008). One study highlighted the difficulty people 
with TED face in communicating with others and maintaining social relationships, 
thus they tend to withdraw socially (Jensen & Harder, 2011). The other study 
reported that some patients have unrealistic expectations that surgery will enable 
them to go back to the life they had before their TED (Estcourt et al., 2008). To date, 
no studies have explored this issue further. This is therefore the first study to 
specifically investigate patient expectations of the impact of surgery for TED.   
7.2 AIMS & OBJECTIVES  
This study used semi-structured interviews with the objective of capturing the views 
and experiences of patients with TED approaching surgery regarding:  
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• Their expectations of the outcome of orbital decompression surgery, or of the 
actual procedure • The factors that might influence their expectations 
 
A full description of the study design, procedure and analytic methods are described 
in Chapter 5, sections 5.4, 5.9, and 5.11 respectively.   
7.3 RESULTS 
7.3.1 Sample characteristics 
A total of 22 patients were identified as being eligible for this study and were 
approached by the clinical researcher at BMEC between October 2012 and February 
2014. Of these, 3 could not be contacted by telephone after multiple attempts. Of the 
19 patients contacted by telephone, 5 could not attend an interview prior to surgery 
because of other commitments. Fourteen patients in total were interviewed. This is 
considered to be a sample size deemed adequate for theory-based interview studies 
(Francis et al., 2010), and importantly at which point no new themes were emerging 
from the interviews, i.e. data saturation was reached. The characteristics of the 





Table 15. Characteristics of the patients who took part in semi-structured interviews 
 














01 F British 53 Married Full time GCSE 12 Bilateral Yes OS 
02 M British 64 Married Full time GCSE 480 Bilateral No RAI; OD 
03 M British 71 Single Retired GCSE 12 Unilateral Yes OS 
04 F British 76 Married Retired HE Degree 144 Bilateral No N 
05 M British 29 Single Full time A Level 36 Bilateral No RAI; OD 
06 F Chinese 37 Married Full time Postgraduate 
Degree 
36 Bilateral No OS; OD 
08 F British 44 Married Homemaker GCSE 42 Bilateral Yes RAI; OS 
13 F Caribbean 34 Single Unemployed A Level 30 Bilateral Yes N 
16 M British 53 Married Full time GCSE 24 Bilateral Yes OS 
17 F British 47 Divorced Full time GCSE 10 Bilateral No RT; IS 
18 F British 55 Married Semi-Retired HE Degree 24 Bilateral Yes IS; OS 
19 F African 37 Married Student GCSE 24 Bilateral Yes N 
20 F British 38 Married Homemaker None 14 Bilateral Yes OS 
21 F Pakistani 23 Lives with 
partner 
Full time HE Degree 18 Bilateral No N 
* ID – Identification number  
         









The interviews lasted between 16 and 101 minutes. The pilot interview was 
retained for the thematic analysis, as the data generated was relevant to the 
research questions. The pilot interview led to small alterations in the topic guide 
to include some additional areas deemed to be important to be raised in further 
interviews. The final topic guide can be seen in Figure 8, page 111.  
7.3.3 Coding 
Thematic analysis was used to code the transcripts, a description of which can be 
found in Chapter 5, section 5.11.1.2 (page 121). A comprehensive thematic 
coding framework was developed during the initial stages of coding (as 
described in section 5.11.1.2, page 123) and was applied and re-applied to all the 
data transcripts until no new codes were generated and all relevant extracts of 
data had been coded. An independent researcher with a health psychology 
background coded three of the interview transcripts without prior knowledge of 
the thematic coding framework. The coding of these transcripts were compared 
to those previously coded by the current researcher and no major inconsistencies 
were found. The only discrepancies were the second researcher used the codes 
“attitudes towards surgery”, and “avoidance of additional information”. After a 
discussion it was agreed that “attitudes towards surgery” had been captured in 
the original coding framework, as either “confidence in the surgical process” or 
“fear of surgery”, and “avoiding information” had been captured in the original 
coding framework as “information about orbital decompression”.   
7.3.4 Themes 
A thematic map was developed during phase 4 of the thematic analysis, or 
reviewing of the themes (Figure 16). Two overarching processes were identified 
within the data; the first referred to dialogue regarding the factors which 
influenced the formation of expectations, and the other was about the 
expectations of the surgery and its outcomes. Overarching themes have been 
identified in previous qualitative research investigating experiences of living 
with rheumatoid arthritis, with further themes, and sub-themes, within these 
overarching processes (Flurey, 2012).  





Three main themes were identified within the process of forming expectations: 
(1) consequences of living with TED, (2) influence of others, and (3) impact of 
information about the surgery. Four main themes were identified within the 
expectations themselves: (1) expectations about the surgical process, (2) 
expectations about recovery, (3) expectations about post-surgical appearance 
outcomes; and (4) expectations about post-surgical functional outcomes. Within 
these themes were a number of sub-themes (Figure 15), which will be described, 
along with their evidence, in the following sections. 
 
Theme - Consequences of living with TED 
Theme -  Influence of others 
Theme - Impact of information 
Sub-theme: Sources of information 
Sub-theme: Degree of understanding 
Theme -  The surgical process 
Sub-theme: Risk perception 
Sub-theme: Confidence in surgeons and healthcare system 
Sub-theme: Timing of surgery 
Theme -  Recovery 
Theme -  Appearance outcomes 
Sub-theme: Vague expectations 
Sub-theme: Social interaction 
Sub-theme: Restoring normality 
Sub-theme: Timeline to rehabilitation 
Theme -  Functional outcomes 
 






Figure 16. The developed thematic map, showing the two overarching processes (forming expectations, and expectations themselves) and the seven 
main themes within these processes





7.3.4.1 The consequences of living with TED 
A majority of participants recounted their decision to have surgery, and what 
factors influenced this decision. Many participants described being motivated to 
have the surgery because of the impact TED had had on their lives, in terms of 
both appearance and unpleasant eye symptoms. For many participants the 
decision wasn’t a difficult one: surgery was seen as inevitable. They described 
the surgery as the “next step along” having tried other treatments surgery was 
their “last option” and for some even the “cure” to restoring appearance.  
 
“We had no choice, we tried everything. Different medications, 
radiotherapy, that didn’t work. Everything was just taking it so far and not 
curing it, surgery was the last resort. Well surgery’s got to cure it anyway. 
In the end you’ve got to have surgery to straighten it up and put it back” – 
16 
 
“The last time we went [the consultant] said “we’ve talked about surgery 
before as a possibility, I think that might be the next stage along.”  And I 
said… OK, if that’s what we have to do then so be it” – 17  
 
Participants spoke about their expectations of what surgery would help them to 
achieve in their lives, emphasising the influence these expectations had on their 
decision to have surgery. A common narrative running through participants’ 
dialogue was the desire to achieve a sense of “normality”, primarily referring to 
this in relation to their life before developing their TED. These participants 
talked about “hope” and now being “the right time” to have surgery. 
 
“I’ve been on the prednisolone now for nearly two years and I can’t see 
that much difference from then to now… so my hope is that this will almost 
speed the process up of getting back to normality and being able to do the 
things that I want to do and get off all the tablets and, you know, get back 
to being a normal me” – 18 
 




“The big thing for me is obviously when you’re getting married, being the 
bride everybody’s looking at you… and they say that I’m young and can 
get married in a few years but then there’s other things, you want to spend 
time together and then have kids so the longer I’m leaving it it’s just 
prolonging it, it’s just taking too long.  So if there’s a chance with the 
operation that they can actually go back to the way they were then yeah, I 
would like to do that” – 21 
 
“My eyes were sore, they were running. My vision wasn’t perhaps as good 
as it could have been. But more the sore eyes, and the swelling I suppose 
as well my age, it was time to - that probably played a part - to get it 
sorted” – 02 
7.3.4.2 Influence of others 
A number of participants described the influence of significant others and family 
members on their decision to have surgery. Some participants described actively 
involving others in their decision, including family, who were found to be 
supportive but for one participant, sometimes unsupportive.  
 
“My brother is a doctor in Hong Kong… he personally thinks that I 
shouldn’t have the operation. He thinks that the prominence is not very big 
and because of the risk he thinks I shouldn’t have it…it’s because it’s so 
uncommon in Hong Kong, that’s why [my brother] doesn’t think that I 
should have it” – 06  
 
“I talked to my family…and they’ve been supportive. I was told about the 
side effects, or risks, but I’d like another appointment to make sure that I’m 
making the right decision with the surgery. My brother’s a doctor and he 
said he’d come with me to my next appointment to make sure I understand 
everything and I know fully what decision I’m making” – 21 
 
One participant described being heavily influenced by a friend who had 
undergone orbital decompression with the same surgeon, and was very positive 
about their experience. This had a direct impact on their feelings about the 




surgery, which included excitement, as well as forming positive expectations 
about surgical outcomes.  
 
“I’d say a big influence really has been from what [my friend] said about 
[my surgeon] doing the surgery…the outcome, she said, it’s been fantastic.  
And I said to my husband, I can’t wait” – 20 
 
For other participants it was discussing the surgery with healthcare professionals 
that aided their decision. Three participants took time to decide to have surgery 
over a number of consultations with their surgeon. However, two others 
described believing it had been more their surgeon’s choice than their own to 
have surgery. 
 
“I don’t think they hide anything, not because it’s not worth it. I think they 
give you a full and frank picture of everything so you can make that 
conscious decision. If you don’t want to make it there and then you don’t 
have to. You can come away and you can go back. It’s all been like a big 
family, if you want to call it that. Where you can ask as many questions as 
you like and they don’t hold anything back” – 17 
 
“I’m kind of having second thoughts about the surgery and whether I 
should go through with it. The doctors told me that in time the eyes could 
go down… And like I said my right eye has gradually got better on its own 
so I’m not sure that I should go through with it now, or wait to see if they 
both go back…I’d like another appointment to make sure that I’m making 
the right decision with the surgery”- 21 
 
“Well it was [the consultant] really he said the last two or three visits we 
had, he said have you thought any more about it? And in the end I just 
decided well…we’ll come and have a chat and go from there”- 02 
 
“No I didn’t have a choice.  It was: you’re going for surgery” – 16 
 




“[The consultant] said about six months ago, just mentioned that the other 
thing they could do was a decompression. But I didn’t feel it was really my 
choice, it was whether I needed it or not. I said, well, if that’s what you 
think will help” – 18 
7.3.4.3 Impact of information 
All participants reported being given information about orbital decompression by 
healthcare professionals on the day of being listed for surgery. However, as 
described later in this chapter (section 7.3.4.3.2) the degree of understanding 
about what the surgery would involve varied between participants. The majority 
of participants found that searching for information from additional sources was 
necessary, and these sources are described in the section below. Participants 
generally found that the type of information from these searches had a direct 
impact on the development of their expectations of the surgery. This will be 
described in the following sub-themes.  
7.3.4.3.1 Sources of information 
Participants identified a number of sources of information about orbital 
decompression including Consultant Ophthalmologists, Nurses, others who had 
undergone the surgery, the surgeon’s website, online blogs and forums, and 
online videos of the surgery. Participants described the impact that this 
information had on both their emotions, and on their expectations of the surgery. 
Some participants described fear of the surgery increasing after hearing specific 
details about the surgery, particularly when it was described as “brutal” or 
“uncomfortable” 
 
“[The consultant] did describe the decompression, he said if we can sort 
this all out with other treatment, he said, because you don’t want to go 
down those lines because it can be quite brutal… and that put the fear of 
God into me” – 01 
 
“[The consultant] mentioned the numbing of the face. And I think my 
friend said that was something that wasn’t very comfortable, the face 
numbness she had. And what that lady on the Internet said was the same. 




The numbness of the face, she couldn’t eat, she couldn’t drink. And I’m 
thinking, oh gosh” – 20  
 
Some participants avoided watching online videos of the surgery, as they felt 
these were too graphic. Some suggested this was because it was no longer 
something “happening to somebody else” and this made watching it too “real”.  
 
“No way, anything visual I couldn’t look at. I’m happy doing research but 
I don’t want to do too much. Just knowing what they do is enough, I 
couldn’t look at it. It’s too much for me”- 21 
 
“Don’t type it into YouTube and look at it because it’s horrible and it 
scares the hell out of you. Definitely don’t sit there with your mother going, 
right, this is what I’m having, and watch it, because it’s not the nicest thing 
in the world” – 05 
 
“Now I know I’m on the waiting list it’s a little bit of a different ball game. 
I went a little bit hot and cold and thought, that is going to be me on the 
other end. I think the realisation of it’s not just something happening to 
somebody else it’s going to happen to me” – 01 
 
Three participants described being satisfied with the information they were given 
by healthcare professionals. Two of these expressed not wanting to know further 
details about the surgery and limited the amount of information from sources 
other than the professionals involved in their care 
 
“They explain it in detail I think, so you fully understand what you’re 
signing for. And they explained it really well, you know, to nip your bone 
here and up here and down here and what they actually do” – 17 
 
“I don’t really want to know more. No I’m happy, just happy for it to go 
ahead” – 03 
 




“I haven’t gone online. I know it can be dangerous to go online, you don’t 
know what you might see…I did go on [the surgeon]’s website and he has 
a video of the surgery. I haven’t watched it yet though” – 04 
 
A number of participants described a process of engaging in self-directed 
research leading up to the surgery. Using words such as “inquisitive”, 
“informative” and “knowledge”, these participants felt that the research they did 
online gave a clearer picture of what to expect in terms of the procedure, as well 
as outcomes. A number of these participants also suggested that the information 
they found online complimented what doctors had said.  
 
“I look things up on YouTube, and so I’d already gone on to YouTube and 
looked at what they do… I’m inquisitive like that. And look, if you’re going 
to put a knife to my face I want to know what you’re doing. So I did look it 
up first, so it wasn’t such a big impact when he told me… They haven’t 
said what to expect from it. It’s only been because I’ve looked online, and 
I’ve looked at things myself, that I’ve seen” – 08  
 
“Having done a bit of research into it and found out the facts I was more 
than confident to go ahead with the operations… being one of those pesky 
people that in this day and age as soon as they find something wrong with 
them they go on Google. You do, you Google it, it’s just one of those 
things” – 05 
 
“I think in the hospital they’ve given me informative information, what I 
need to know, but I do get the impression that they know everybody will go 
and try and find out a little bit more about it. And in some ways it helps 
because I think you see it and you know exactly what you’re in for… I think 
the more you understand about something I think the more informed you 
are, the more you can anticipate and expect what’s going to happen” – 01 
 
“And explaining what they actually do, I found that a bit cringe worthy, 
but it’s just part and parcel of having it done… But I think the fact that if 




as a person you can’t listen to that, you can still come home and you can 
Google it.  I think that’s a brilliant idea” – 17  
 
A few participants spoke about strategies they used to find relevant information 
online in order to gain insight into the surgery, which they felt would help them 
form realistic expectations. However, some participants in particular avoided 
online blogs about the surgery from overseas patients, describing these as 
unhelpful, because of perceived cultural differences and differences in healthcare 
systems.  
 
“I went on the Internet and it’s quite difficult because you have to be quite 
picky about which bit of information you read.  A lot of it that you pick up 
is American, and I don’t look at American sites because I think a lot of 
stuff they do is unnecessary and is all about getting money out of their 
patients. So I was quite particular about making sure it was British sites 
and that it was sites more medically orientated, rather than just what other 
people’s experiences are” – 18 
 
“I just Google searched it, some people said how upset they were, but 
fortunately those were in America” – 06 
 
“I generally went for a bit of a scattergun approach. I searched for the 
condition and then took bits from each different website really, to gain an 
overall impression… I think I’d expected to have the treatments closer 
together, the left and right eye. Because from the information I’d found 
from this woman in America’s blog, she had her one eye done one… in one 
month, then ten days later she had the other eye done” – 05  
 
A number of participants described comparing themselves to other patients with 
TED they encountered online. A number found “before-and-after” photos on the 
surgeon’s own website and on blogs, and others found forums, which seemed to 
influence their expectations of their own surgical outcomes. For some, this was 
done through a process of “downward comparison” whereby seeing patients who 




they perceived to have more severe TED than them have good surgical outcomes 
encouraged them to have high expectations for their own outcomes.  
 
[A doctor] told me, go on to [the surgeon]'s website and if you go on there 
you’ll see before and after pictures and of what you can expect…I looked 
at this one and his eyes was just horrendous…and the before and after 
results from his was good considering what they was like to begin with. So 
I look at mine and I think, no they’re not as bad. I haven’t got as much 
thyroid fat and everything where they’re really out, so I’m hoping just to 
look like, normal.” – 08  
 
 
“[My partner] showed me the before and after picture when he Googled it 
all, and you can see the woman’s face.  Yes her one side looks normal and, 
yes the other side looks slightly different but you can see the benefit of it. 
And I think that’s where I’m aiming for, to be more myself… that’s got to 
be a fantastic feeling.” – 17  
 
“I have read online a lot of people’s comments. I go on to a lot of forums 
and see what people had to say about recovery time and stuff like that.  
And there’s good and bad recovery I think across the board really. Some 
people might recover quicker than others. Hopefully I’m one of those that 
recover quicker” –08 
 
Many participants who did further research into the surgery also found out more 
about the doctors involved in their surgery and described finding this information 
reassuring, which helped build their confidence about the surgery 
 
“I did my research into…the treatments and a bit on the people who were 
treating me. I found out as much information as I could about the surgeons 
and the doctors who were in charge of what I was doing and found nothing 
but positive information about the people who were treating me. Which 
was a real reassurance”- 05  
 




I have Googled [the surgeon] and he has got a good reputation. And I 
think the fact that you can go on the Internet and see his surgery, if you 
choose to, is a really really good thing to do”- 17  
 
“I was speaking to an old colleague who knows [the surgeon]…she said of 
all the doctors, you’re in very safe hands. So I thought the surgery would 
be something that I could look forward to, you know?” – 04  
 
“When I found out I was going to be under [my consultant] and again the 
feedback I’ve had off a friend, it was more, made it more promising.  I 
thought, well, I’ve got a top surgeon” – 20  
7.3.4.3.2 Degree of understanding  
Information given by healthcare professionals tended to be repeated in the 
participants’ own words, with some confusion for a few participants about what 
the actual procedure would involve 
 
“They said they make an incision under the eye, and somehow break the 
bone to make space for the muscles” – 21  
 
“He said that the eye’s completely out of its socket now, so they’ll have to 
remove the muscle and the bone, because before that they could push it 
back, just take the muscle out and just push it back, but they said ‘cause 
it’s come out of its socket they would have to remove the bone and the 
muscles…and the eye nerves” – 13  
 
“I understand that there’s a small incision across the eye. And that there is 
a window taken from the orbital skull part there. What I’m not sure about 
is whether it just drops back or whether it gets stitched back into position” 
– 01 
 
“They explained to me that it's a cut and then they will try to open a space 
inside so there will be space for the pressure of the eyes” – 19  
 




Many participants described undertaking additional research to enhance their 
understanding of the information they had been given by healthcare professionals 
in hospital. Particularly given that initial pre-surgical consultations, where the 
surgery is first offered to patients, tended to be emotionally charged and thus 
specific details were not well recalled after the appointment. 
 
“Information is knowledge, and if you don’t fully understand what’s being 
explained to you, probably 50% of the people don’t fully listen to what a 
doctor’s telling you because you’re trying to digest the first part. OK, you 
don’t do this, you’re going to have no eyesight. OK my brain’s trying to 
sort that out, and they’re trying to explain to you everything else; you only 
digest a small amount of that information. You do not fully take it in” – 17 
 
“It was just basic really. I don’t think [my consultant] actually went into 
loads of detail. I just can’t, I can’t really remember what he said to me 
about it, I think I was in shock” – 20 
 
A few participants described seeking, or coming across, additional information 
online that had not been mentioned by healthcare professionals. When they came 
across this information it was often confusing and participants described wanting 
to find out more from their own healthcare professionals.  
 
 “What I’ve been reading, I don’t know what stage…I don’t what’s, 
because I’ve been reading is it, one wall, two wall, left? I don’t know. I 
don’t know all that. I don’t know what extent I’m having done” – 20  
 
“That was the sort of information I was looking for: what were the major 
complications? What were the risks of those major complications?  The 
only thing I found difficult to find was what were the risks if you didn’t 
have it done. That was the one thing that was difficult, it was if you don’t 
have this done what are the risks then?” – 18  




7.3.4.4 The surgical process 
Patients’ expectations of the surgical process reflected three key issues: 
perception of the risks associated with orbital decompression, confidence in the 
surgeon and in the healthcare system and the impact of the timing of surgery. 
Timing of surgery was described both in terms of the emotional impact of having 
to wait for surgery, and in terms of how the surgery fitted in with other life plans, 
including work and family commitments.  
7.3.4.4.1 Risk of surgical complications 
The majority of participants talked about the risks associated with orbital 
decompression surgery that had been described to them by surgeons, including  
“bleeding” and “blindness” and damage to facial nerves causing “numbness”.  
 
“They said in rare cases you could lose your eyesight, and said something 
about bleeding at the back. If the bone restructure doesn’t work, they said 
they do something with the eyelids” – 21 
 
Participants who felt that consultants discussed risk as more of a formality, 
tended to perceive the risk of these complications happening to them as low. 
 
“I was told that you can get some facial paralysis if it goes too low in the 
orbit… But that may very well get better and in most cases it does within a 
three month time period. There is a small risk that I could lose vision if 
they get a lot of bleeding I believe… but it’s a very low risk but I have to be 
warned about it” – 01  
 
Many participants described what they expected the benefits of surgery to be and 
felt that these tended to outweigh any risk of complication, despite some of the 
potential complications being severe, for example blindness.  
 
“I just want to move forward, and if that means taking a risk with one of 
my eyes, and I’m pretty sure that they wouldn’t recommend it if they didn’t 
have such a good success rate, and I think that’s a massive thing” - 17  
 




“I know there’s risks with the operation as well.  And it’s like, to me, the 
risks if I don’t have it done are definite…If I have the op done, it’s, yes 
there can be complications, but it’s not certain that you’ll get them.  But if 
you don’t have this done it’s probably certain that you’re going to have … 
some sight damage, even if you don’t lose the whole sight, you’re going to 
have some sight damage” – 18 
 
Several participants did however perceive the surgery as “risky”, not just in 
terms of the risk of complications, but also in terms of the risk of their 
expectations not being met in regards to their appearance. A number of 
participants likened these risks to gambling, and described the weighing up of the 
risks and benefits.   
 
“They do say there could be some damage to your sight…I know there is 
risk of losing my sight if something goes wrong. Fingers crossed that isn’t 
going to happen. I am scared if anything happened to my right eye…I 
would manage but if I lost the vision in my right eye, I wouldn’t need a 
white stick or anything, but I probably would need a guide dog. I just hope 
nothing happens to my right eye” – 04 
 
“I mean you have the operation it might go exactly the way you want it 
to… my eyes might go back to the way they were and I’d be over the moon 
if that happened, but then you’ve got to not think about the worst case 
scenario, kind of think OK, if that doesn’t happen could I live with it?” – 
21 
 
“Best case scenario I’d like my old eyes back.  However, I’m completely at 
terms with the fact that I might not get them back ever and that after the 
operations there might be the option for cosmetic surgery …depending on 
the feasibility and the availability of those operations, it may be a case that 
I’d prefer to live with the eyes that I have afterwards rather than 
potentially risk causing further trauma to them to gamble for the eyes that I 
started with, which is something that I have to make a decision on at a 
later stage” – 05 




7.3.4.4.2 Confidence in surgeons and the healthcare system 
A number of participants described their unquestioning belief in their surgeon 
and in the healthcare process, describing feeling “confident” and in “safe hands”. 
Many participants described feelings of trust in their surgeon and other 
healthcare professionals involved in the process. Such beliefs enabled 
participants to feel positive in the time leading up to surgery.  
 
“Well there are varying degrees of things that could go wrong or in the 
worst case I could lose an eye, but I’m in [the surgeon]’s hands…so I’m 
quite happy. I’m quite happy to have this job done” – 03  
 
“I’m very confident in [the surgeon] as a surgeon, and he’s sort of been 
truthful with me all the way through, and I’ve got no reason to believe that 
he would tell me anything that wasn’t the best for me.  So I said well OK, if 
that’s what it needs then that’s what it needs” – 18 
 
“I have every confidence in [the surgeon], for him to do it otherwise I 
would never have agreed to it, never in a million years I wouldn’t.  It’s too 
precious, isn’t it?  It’s your eyes” – 17  
 
“I’d go in with an open mind….you’ve just got to put your trust in them, 
you know?”– 04  
7.3.4.4.3 Timing of surgery 
Many participants described the timing of their surgery as an issue that was 
impacting on them emotionally. The majority of participants were still waiting 
for the date of their surgery to be confirmed and frequently described this time as 
“frustrating” and “annoying”. One participant’s surgery had been cancelled twice 
previously and this resulted in anger and low mood. Particularly as this group of 
patients were having surgery on one eye at a time and were facing an even longer 
journey towards rehabilitation.  
 
“I think when my first operation was cancelled, obviously through no fault 
of anyone, it’s broken equipment… but to me I worked myself up to that 




first surgery.  And obviously they rang the night before, and that was it. I 
must have been absolutely a living hell to live with, because I was crying 
all the time… it was my starting point to getting things sorted, because if 
they do that one they’ve got to do the second one and then I can try and get 
my life back on track” – 08 
 
“I’m looking forward to it, I really want it done.  It’s so annoying that I 
can’t be in the stream as it were because of this heart attack” – 03 
 
“They told me it’s one day…I was suggesting that why don’t they do it 
once so that there’s no further pain and they told me now they are doing 
one eye at a time. The operation, I can’t wait for it.  Even my sister she was 
asking me “oh is it soon?” I just want to know when this operation is 
because we can’t live like this” – 19 
 
An underlying narrative within many of the interviews was that the surgery 
couldn’t come quick enough. Participants were prepared to take cancellations 
and had already notified colleagues at work in case their surgery date came soon. 
Many expressed the desire to “get it out the way” and wanting to “move on”, but 
not having a date was making them feel held back.  
 
“I think it really does depend on how long the list is…But I’m quite happy 
to do cancellations and things like that, which I have expressed so….  I 
mean I’d have had it done yesterday if I could” – 01 
 
“We were at one stage asked if we’d take a cancellation and I obviously 
said yes, because we were asked about holidays and one thing and another 
and I said to the lady that did my pre op, oh yes I will.  And I thought we’ve 
got to get this done pretty quick, and it went on and on and on” – 02 
 
“I actually rung the hospital last week, because I think I need to get it 
done, move on, get it out the way. And I rung the hospital last week and I 
spoke to the receptionist there, and she said “oh I’ll give you the number”.  
Anyway, they give you a different number for the admin part who book 




surgeries, and it was constantly engaged and I was getting really 
frustrated.  I was like, all I said to them was I just want a date now. 
Because then I can think “OK I’ve got a date now”” – 17  
 
A number of participants had expected the surgical process to be much quicker 
because they had read information online that suggested it had been for other 
patients. This led to feelings of disappointment and surprise when patients had to 
wait longer than they’d hoped to have surgery on each eye individually.  
 
“I think I’d expected to have the treatments closer together, the left and 
right eye close together. Because from the information I’d found from this 
woman in America’s blog, she had her one eye done… in one month, then 
ten days later she had the other eye done.  So I was expecting a quick 
turnaround, which I didn’t get” – 05 
7.3.4.5 Recovery 
For the majority of participants, recovery time was an important theme. Many 
participants were concerned about how long they would be off work, and others 
were concerned about when bruising would subside and when they would see a 
change in their appearance. These participants were left with a number of 
questions even after their pre-surgical consultations, suggesting a lack of clarity 
regarding what to expect in terms of hospital stay, return to work, bruising and 
post-surgical follow-up appointments. Participants were mixed in their 
expectations of the recovery process, which may reflect the varied level of 
information they feel they received prior to surgery.  
 
“An overnight stay I think and a dressing for… I don’t know, some days… 
I don’t know. And follow up visits to the clinic and then I’m passed onto 
another specialist…I don’t know what that’s to do with? Perhaps an 
optical specialist, I don’t know” – 03  
 
“The last [consultant] that I saw, you know, she said “we can never say… 
either a surgery can go very well and somebody gets massive swelling and 




massive bruising… or somebody that has a really brutal one has hardly 
anything.” So I don’t hold out that mine will be good” – 01  
 
“I was more concerned I think when they said it was bilateral rather than 
unilateral, I thought oh blimey, that’s a bigger op then.  And then of course 
after that you think oh, well what’s going to be the healing time on that 
then? And how long will I be out of action?”- 18 
 
“One of the first questions I asked [the consultant] was how long am I 
going to be off work?  Because the summer time is my busy time, very busy 
time… and he said “well from my point of view you’ll be off for a week, but 
a fortnight ideally you ought to be able to go back to work”.  But…we 
decided against that” – 02 
 
“I’m hoping it might just be a small incision or something so it’s not that 
big that you can actually see it.  I think after the operation the main thing 
will be the bruising. And I think I would wait until it goes down before I go 
back to work”- 21  
7.3.4.6 Appearance outcomes 
Participants generally struggled to articulate exactly how they expected the 
surgery to change their appearance, tending to use “normal”, “better” and 
referring to their eyes as “going back in” rather than a concrete idea about how 
much they expected proptosis to reduce, or whether they would be left with any 
scarring. For some, specific reference was made to going back to how they 
looked before they had TED, which in turn would improve their social 
interactions and enable social reintegration. Despite expectations about physical 
appearance post-surgery not being fully formed for many, a number of 
participants spoke about how they expected their appearance-related cognitions 
and behaviours to change after surgery, including use of make-up, a change in 
general concern about appearance, a reduction in how noticeable they would 
perceive their eyes to be, and that they would evaluate their own appearance 
more positively after surgery.  




7.3.4.6.1 Vague expectations  
The majority of participants showed difficulty in expressing what they expected 
from their post-surgical appearance, with many disclosing that they didn’t know 
exactly what to expect.  
 
“I won’t have the bulge… the eyeball won’t be bulging out so much 
and I won’t have like the swollen eyelids and stuff like that” – 13 
 
“I’m hoping my eye will go back in” – 18  
 
“Hopefully the redness will go. And they will just go back to a more 
normal position” – 08 
 
“I don’t… to be honest I don’t really know what to expect. Other than 
my eyes are going to look better for people looking at me” – 02 
 
“The only thing I was expecting was the prominence will be less, 
that’s what I expect, but I don’t know to what extent. Will I look 
exactly like what I was before?” – 06  
 
Four participants described having low expectations about what the surgery 
could do for their appearance, suggesting they would look much the same, 
except that their eyes would be in a slightly less prominent position. Of 
note, three of these were male participants. These participants appeared to 
be unbothered by what the surgery would do in terms of changing their 
appearance, which may have been associated with a lack of concern about 
appearance more broadly.  
 
“It shouldn’t change my appearance at all. It’ll just push the eye back 
in…I don’t expect nothing until it’s over” – 16  
 
“I’m no beauty, I never was, so I’m not expecting too much…but if 
they can do something then that’s good” – 04  
 




“No… it shouldn’t change much. I expect there’ll be a scar. But it 
doesn’t…I don’t care. I’m too old to worry about what I look like” – 
03  
 
For a number of patients, not knowing how much their eyes were likely to 
improve their appearance was a cause for much anxiety and concern. Some 
participants had put plans on hold until they knew the outcome of the 
surgery. A few participants suggested their inability to fully imagine what 
their eyes would look like after the surgery was because they hadn’t had 
enough information from surgeons about what exactly to expect, and that 
this lack of information was worrying.  
 
“I do worry about how much it’s going to go back. Because nobody’s 
actually said, we take it back to this millimetres… so there’s no like 
reassurances or telling me how much it’s going to go back and how much 
physically it’s going to look different”- 01 
 
“That’s why I can’t make really any plans because I don’t know how the 
surgery’s going to go” – 13 
 
“When I was due to have it done in December I was looking towards the 
summer, this year, thinking, oh it will all be done by then.  Because they 
told me within six months you’d have that one done, that one done, your 
eyelids done, everything will be fine.  So then I was thinking what I’ll be 
doing in the summer.  But obviously now that has gone by”- 08 
 
“Actually I think I don’t really know what to expect after the surgery. 
I know that it should get better but compared to my old self, will I 
look completely… well exactly the same or is still a bit different? In 
terms of that I don’t think it’s very clear and I think it would be very 
helpful if before the surgery the doctor could tell the patients, well, or 
maybe give them some photos to show them” – 06  




7.3.4.6.2 Restoring normality 
A number of references were made to expecting to look “more normal”. In the 
absence of specific measurement guidelines from surgeons, for many this meant 
looking like they did before they had TED.  
 
“I would like my eyes to go back to the way they were. I think that 
out of everything that’s what I would like, I mean, looking at the way 
I was previously it was, you know, there wasn’t anything that I 
would’ve changed in terms of my eyes or anything like that. So me 
personally I would love for them to go back to the way they were” – 
21 
 
“Normal. How they were before I had the eye disease…No swelling, 
just normal” – 20  
 
“The first thing is the physical side of it, the look of them. I don’t want 
people to look at my eyes and see them as any different to anybody else’s”- 
01  
 
The process of surgery for many was like a ‘gateway’ to achieving the goals they 
have for their appearance. For some their expectations generalised to every 
aspect of their lives, from the ability to carry out their normal job, to spending 
more time with their families. Many participants suggested that looking “normal” 
would result in regaining a sense of “normality” in their lives 
 
“I just want to live a normal life and just take my grandson to the safari 
park and just… and those are exciting things. And so having this surgery 
it’s, I would, do you know what I would go as far as to say my whole life 
depends on this surgery, it’s having this surgery. And the outcome of it is 
to how I will lead my life in the future” – 08  
 
“I know when I’m serving somebody or I’m dealing with a complaint or 
whatever, they’ve stopped talking to my face because they’re looking at my 
eyes. And I have to push that to the back of my head and think, OK, it’s my 




job, get on with it. You know they’re not looking at you any more because 
you look different.  I don’t want to look different any more.  I just want to 
get up, go to work, deal with general public and go out and be… normal” 
–17 
 
“My quality of life, you know what I mean? Spend more time with my 
children, take them out and go on day trips, take them to the park, that’s 
what I’m hoping for” – 20 
 
A number of female participants talked about expecting a change in their 
appearance after surgery to enable them to enhance their eyes in the ways they 
had before TED, such as wearing make-up. Some of these participants described 
attempting to use make-up to conceal their TED, but found this not to work, only 
drawing more attention to their eyes. Some participants described hoping not to 
“stand out” amongst others after their surgery. This reflected their desires to go 
back to who they used to be before they had TED. Participants talked about how 
they looked forward to no longer having to conceal their eyes after surgery.   
 
“If I go out somewhere, just to be able to put that bit of make up on that 
doesn’t look odd because if you've got different shaped eyelids, it’s really 
difficult to get them to look right. It’s a silly thing I know, but it means 
quite a bit…if you're going out somewhere nice, you want to make the best 
of your appearance. Just silly things like that, putting on a bit of make-up, 
getting rid of my fringe that’s pulled over that eye more” – 18 
 
“I have got a goal.  It’s to go on holiday and lie on that beach in my bikini 
without my glasses, looking normal” – 17 
 
“Well hopefully I’ll be able to wear make-up again and not…look strange.  
I think it looks strange, because obviously when you put mascara on and 
you put eyeliner on, I just think it enhances your eyes, that’s what it’s 
meant to do.  But when your eyes are already protruding it just makes them 
look as if you’re looking through the end of a milk bottle. So it’s just to 
look normal” – 08 




7.3.4.6.3 Social interaction  
Furthermore, the majority of participants talked about how difficult they found 
social interactions with TED, including facing members of the public, attending 
family occasions, and socialising with friends. Some participants described 
experiencing negative evaluations from others and had since withdrawn socially 
because of fear of this happening again. They often described expectations about 
their appearance post-surgery in terms of how others would react to them after 
their appearance had been “restored”. Participants also discussed how they 
expected an increase in social reintegration once they’d had surgery, using terms 
such as “confidence” and “looking at the whole of me” and again making 
references to “not looking different anymore”. 
 
“If it’s like big scars I won’t really go out, I don’t go out much now.  
Hopefully it’ll be a lot better. I don’t mind them calling me Scarface or 
whatever … it’s just the Popeye thing.  Hopefully it will improve, what 
people say”- 13 
 
“I’m hoping soon I will start going out with my friends again”- 19 
 
“Hopefully I can hold my head up, look at someone in the eye and have a 
conversation with them, rather than look at the floor, look at the table, or 
have a conversation with my daughter because she knows what my eyes 
looks like…I’ll probably be looking forward just to socialising more, 
instead of having to miss out on things” – 08 
 
“I have a lot of face to face contact with people so I’m hoping that I won’t 
look any different to the person sitting at the side of me, they’ll just see me 
for who I am and not someone that stands out” – 01 
7.3.4.6.4 Timeline to rehabilitation 
Some participants described a realistic insight into what the surgery could and 
could not do for their appearance and the potential need for further surgery after 
decompression to help restore their appearance further. An underlying narrative 
for many participants was an understanding that their appearance was not going 




to be restored overnight and having a realistic expectation for the process of 
operations to be a long one.  
 
“I know it’s not a quick fix. I know that, and I’ve always said I know it’s 
not a quick fix. And I know that it’s going to take time. Obviously whether 
it be swelling, bruising, and how long that might take. So I’m not, I know 
it’s not going to be immediate, but having it done I know that it is going to 
happen” – 08  
 
“Once I’ve got the surgery done that’s another milestone and there’s just 
different things for me to sort of aim for to try and get me back to where I 
was.  But I don’t expect it to happen overnight, I don’t expect that.  I know 
it’s going to be a long process”- 01  
 
“Well I have to have the surgery to push it back in and then once that’s 
healed I presume go and see the squint surgeon, then once that’s healed 
I’ve got to have cosmetic surgery…because all my skin’s stretched here, 
over the eyelid”- 16 
 
There was a sense that participants would rather it was a quicker process, but 
were patiently accepting of what needed to be done. 
 
“Not look at [my eyes] but look at the whole of me and think, yes, that’s 
what I look like…  So I think that gives you the confidence to say yes to 
having the next lot of surgery done and the next one after that because you 
know in here and up here you are going to get a goal, and that’s your goal, 
to think, OK, I haven’t got to ask anybody to take me anywhere … I’ll just 
walk in a crowd with everybody else and not “oh, God, do you see her 
eyes?””- 17 
 
“I’m hoping in a year’s time I would have had both eyes done then, and my 
eyes will be perfectly perfect basically. That’s what I’m hoping.  But again, 
with it being such a long drawn process, I’ll probably end up having my 




right eye done first, wait a few months have my left eye done.  And knowing 
me I’ll end up having more surgery”- 20  
 
“I’d like to think I’ve sort of, got past it and been done with it.  I like to 
think I’m a very confident person and like I need to be, especially with the 
work, you need to have confidence and assured of what you’re doing in 
your abilities.  So I think I’ve taken it in my stride and just dealt with it as, 
yeah, it’s one of those things I’ve got and it’s there for now but…it’s being 
dealt with”- 05 
7.3.4.7 Functional outcomes 
Participants appeared to be mixed in their understanding of what orbital 
decompression surgery could do for their visual function. Their understanding 
impacted on their expectations of surgical outcomes. For instance, a number of 
participants were clear that decompression would not necessarily improve double 
vision and that further surgery would be required, whilst others described an 
expectation that orbital decompression would cure their double vision. 
 
“So my eyesight itself, I’m not expecting anything to be different because 
that’s a different surgery. That’s the next one along. Mine, so I understand, 
is more getting them back into position before they can do anything else. 
It’s no good doing the double vision surgery because there’s still too much 
going on at the back of my eyes” – 17  
 
“I have to have the surgery to push it back in and then I go… once that’s 
healed I presume go and see the squint surgeon”- 16  
 
“I was quite looking forward to having this done, to having the eye put 
back so that I haven’t got double vision”- 03 
 
“I’m hoping that it is going to help with the vision as well, though I do 
understand that there may be other surgery afterwards that may be needed 
to help with the vision… but I do know that that could be a little bit further 




down the line even after that, I do understand that, I know it’s going to be 
a slow process”- 01 
 
Participants had desires to be able to return to work and their usual hobbies. A 
common narrative was that improvements in visual function would increase 
confidence in abilities such as sewing and driving. Some participants spoke 
about the surgery enabling them to not have to rely on others so much, for 
instance to be driven somewhere, and gain back some independence and control 
in their lives. Again, participants spoke about reaching a level of “normality” 
closer to their lives before TED.  
 
“Just to give me a bit of my confidence back … to go to work and stuff.  To 
get my confidence back. To be more like independent…because I have to 
depend on the family a lot now because I can’t see properly some days”- 
13 
 
“I just want to get back to normal reading and I notice when I’m in a 
theatre and I’m sitting at one side I’ve still got double vision…because of 
the angle I’m looking, I’m not looking straight at the stage.  So I really do 
want to get back to being able to see properly” – 04  
 
“I just want to improve my way of life.  I’m just hoping it will make me 
better. My vision, you know, it’s not poor poor, but with the prisms in this 
just controls double vision…  So I’m just hoping all round when I have the 
surgery, it just improves… well, I am hoping everything” – 20 
 
Of note, all four male participants spoke more about concerns regarding post-
operative functional outcomes, specifically in terms of return to work and 
hobbies, than about their post-surgical appearance 
 
“As long as I can still drive and I can still, you know, enjoy life, enjoy 
doing things, that’ll suit me. You know, I’m not expecting miracles” - 02 
 




“When I was told that I’d be listed for the second one and that it might be 
a matter of months and I was initially thinking, well hang on, I’m going to 
have one eye that’s in focus and one eye that’s not in focus because of the 
difference in the pressure I thought I’m not going to be able to see 
properly” – 05 
 
“I really do want to get back to being able to see properly” - 03 
7.4 DISCUSSION 
The aim of this study was to explore the expectations of patients with TED listed 
for orbital decompression surgery and to understand what may influence the 
formation of these expectations. The overall narrative was that participants 
lacked clarity on exactly what to expect from the surgical procedure, recovery, 
and their post-operative appearance. This caused concern for many participants. 
However, participants were generally confident in their surgeon’s abilities, 
perceiving the risks of surgery as low. Despite not knowing exactly what to 
expect from their post-surgical appearance, participants had high expectations for 
the surgery to enable them to regain “normality” in their lives including 
appearance, independent living and social reintegration. Each of these themes 
will now be discussed in relation to previous research, and a discussion of the 
strengths and weaknesses of this study will be provided in section 7.4.8. The 
implications of these findings in relation to research and clinical practice will be 
discussed in Chapter 10. The findings from this study in combination with the 
quantitative results from the cross-sectional study described in Chapter 6 will be 
discussed in Chapter 8.  
7.4.1 Consequences of living with TED 
All participants spoke about the impact TED had had on their lives, and the 
influence this had on their decision to have surgery. The consequences of TED 
ultimately formed their expectations of what surgery would help them to achieve. 
Participants generally felt that surgery was the next step and the “last resort” in 
their treatment, following a range of drug treatments that failed to improve 
appearance, vision, or both. Surgery was generally considered necessary in 
enabling participants to achieve their goals and to return to some level of 




“normality”. Understandably, many patients with disfiguring conditions opt to 
have rehabilitative surgery to help restore their appearance to “normal” (Denford 
et al., 2011; Bramwell, Morland & Garden, 2007; Bhty, 1999; Harcourt & 
Rumsey, 2001).  
7.4.2 Influence of others 
Participants spoke about the impact of shared-decision making with healthcare 
professionals, or lack thereof, in forming their expectations and decisions to have 
surgery. For some, consultations did not involve as much shared decision-
making, but rather patients felt that they didn’t have a choice about having the 
surgery. Similar findings have been reported in the context of reconstructive 
surgery following breast mastectomy, with patients reporting that surgeons 
expected them to have breast reconstruction rather than giving them the option 
and were shocked when patients were inclined not to have surgery (Noone et al., 
1982; Harcourt & Rumsey, 2004). In contrast, many participants felt they had 
been given time to make an informed choice and could return to the hospital for 
further consultations if they needed them. This division in response to the 
consultation supports findings from a previous qualitative study where patients 
with TED felt disengaged from their care if they had difficult encounters with 
healthcare professionals, but felt empowered in their treatment process if they 
felt actively involved in consultations (Estcourt et al., 2008). 
 
Participants generally felt that family and friends had been supportive of them 
having surgery. For one, a friend who recommended the surgery had a big impact 
on their decision to go ahead with the procedure and ultimately this influenced 
their expectations for positive surgical outcomes. However, another participant 
recounted that her medically trained brother disagreed with the necessity of her 
operation. This is particularly important given that a recent literature review 
found a lack of support from significant others about having surgery can predict 
poor psychological outcomes after surgery (Honigman, Phillips & Castle, 2004). 
Whilst having others who are able to support a decision to undergo surgery 
enhances feelings of confidence about the decision, going against the advice of 
someone close to you could impact on psychological well-being following 
surgery.   




7.4.3 Impact of information 
The information needs of the majority of participants appeared to be high. Many 
participants described themselves as “inquisitive” and exploring additional 
sources of information following information given by healthcare professionals. 
Participants described a number of sources of information in addition to 
healthcare professionals, including other patients who had had the surgery, and 
the Internet, which was the source for forums, blogs, medical websites, and 
videos of the surgery.  
 
Participants expressed confusion in relation to the information given by 
healthcare professionals and often struggled to articulate exactly what they had 
been told about the surgery. This has previously been found after patients are 
given information about surgery, particularly when this consists of medical 
jargon and technical terms that they find hard to understand (Newell et al., 2004). 
Information accessed online has also tended to raise further questions, 
particularly if patients found it difficult to understand new information that 
healthcare professionals hadn’t mentioned before. In a recent study by Edmunds 
et al. (2013), online information about TED was identified using a Google search 
and assessed for readability using the Flesch-Kincaid Readability Score and the 
Gunning-Fog Index. Edmunds et al. (2013) found information to be written for 
comprehension levels higher than is recommended by published guidelines, with 
no significant differences between countries of origin of the web page. This is an 
important issue because if information is difficult to understand, patients 
misinterpret health guidelines (Walsh & Volsko, 2008). It is therefore 
unsurprising that this group of patients were left with further questions about the 
surgery, and there is a risk that misinterpreting health guidelines may give rise to 
unrealistic expectations.  
 
A number of participants, however, found that using the Internet for additional 
information complimented what surgeons had told them in prior consultations, as 
well as giving them questions to ask in future consultations to further their 
understanding. Online information about the surgery therefore has the potential 
to assist with understanding and managing patients’ expectations. However, due 




to the uncontrolled nature of the Internet, there is a need for healthcare 
professionals to understand what information patients have accessed and where 
possible provide additional comprehensible information. 
 
Some participants described difficulty recalling information given by their 
surgeon, as the pre-surgical consultations tended to be emotionally charged, 
where patients felt overwhelmed and unable to “take it all in”. Difficulty in 
absorbing information has been found to be related to consultations that are 
emotive and packed with information about diagnoses and treatment, particularly 
in appearance changing conditions including head and neck cancer (Newell et al., 
2004) and breast reconstructive surgery (Harcourt & Rumsey, 2001). This is an 
important issue that healthcare professionals need to be aware of. Checking 
understanding after each piece of information is given to the patients, and being 
compassionate when patients become emotional are skills that have been found 
to be effective at increasing information retention and compliance with medical 
treatment after healthcare consultations (Ong et al., 1995; Girgis & Sanson-
Fisher, 1995). These skills could therefore be useful in the management of 
patient expectations of surgery.  
 
Participants who did consult the Internet found that “before-and-after” photos on 
online blogs and positive information about the surgeon increased expectations, 
tended to reduce fear, and increase excitement about potential surgical 
appearance outcomes. One participant described how seeing another patient who 
they perceived as “worse off” prior to surgery who then had a good aesthetic 
surgical outcome increased expectancy that their own outcome could only be 
good. A rise in demand for, and accessibility of, “real life” information about 
surgical procedures including online videos and “reality TV”, have led 
researchers to begin to explore the impact of such information on patient 
expectations. In studies of women who had undergone breast enlargement, 
accessing the media has been found to play a significant role in women’s 
conceptualisation of surgical outcomes, with women reporting that television 
programmes influenced them to pursue cosmetic surgery (Byram et al., 2001; 
Crockett, Pruzinsky & Persing, 2007).  
 




In contrast, videos of the surgery accessed online increased fears about the 
surgery in some patients, as it made surgery feel “too real”. The influence of 
videos in patients’ decisions to have surgery has been highlighted by one study 
that found subsequently lower surgery rates for back problems in patients who 
watched an interactive video compared to those who only read a booklet (Deyo 
et al., 2000). However, quality of life did not reduce in patients who did not have 
surgery compared to those who did (Deyo et al., 2000), suggesting the 
importance of ensuring patients are fully informed before making a decision to 
have surgery. In particular, this suggests that deciding not to have surgery will 
not necessarily result in poorer quality of life outcomes. Additionally, Zvara et 
al. (1996) found that using surgical videos as a teaching tool in patients awaiting 
surgery did not increase knowledge or patient well-being. This further highlights 
the importance (but difficulty) for healthcare professionals to help manage 
patient expectations by providing accurate information. This also demonstrates 
the various sources of information about surgery that may be accessed by 
patients and the variation in knowledge attainment and influence on decision to 
have surgery from these sources.  
 
For many, accessing information about the surgery online helped to enhance 
understanding in future consultations with surgeons. With more perceived 
knowledge came a less anxious patient with more concrete expectations of the 
procedure. Women who regularly watch “reality TV” shows about cosmetic 
surgery have been found to report higher degrees of self-perceived knowledge 
about the surgery after consultations with surgeons than women who watched at 
lower-intensities (Crockett, Pruzinsky & Persing, 2007). “Real life” accounts of 
surgical outcomes can be helpful for some patients in terms of reducing anxieties 
and increasing expectations; however if such accounts are only ever examples of 
“best case scenarios” and tend to consistently be in favour of such procedures, 
this might generate unrealistic expectations. Furthermore, whilst surgical videos 
might increase perceived knowledge, they do not always increase factual 
knowledge (Zvara et al., 1996). This highlights the importance for healthcare 
professionals to attempt to ensure that expectations of orbital decompression are 
realistic, particularly if patients are relying heavily on “before-and-after” photos 
to present them with a realistic idea of what to expect from their surgery. 




7.4.4 The surgical process 
All but one of the participants was waiting for a date for their surgery and many 
found themselves to be waiting far longer than they had expected. This resulted 
in feelings of frustration, anger and disappointment. Many described putting 
various plans on hold until they knew when their surgery would be, such as 
holidays, and even weddings. Patients with TED often face a delay in their 
treatment and the rehabilitative process is commonly a long one (Estcourt et al., 
2009). On the basis of the finding s in this study, it would seem valuable 
therefore, for patients to be made aware of potential delays to the surgery at the 
earliest time possible.  
 
Participants in this study appeared to be aware of the risks involved in orbital 
decompression surgery, which ranged from the more rare risk of blindness, to 
more common complications including facial numbness and double vision. 
Participants tended to perceive these to be low and many were happy to go ahead 
with the surgery regardless. One or two patients however were anxious about the 
risks and had thus booked additional appointments with healthcare professionals 
prior to surgery to discuss these further. The tendency to anticipate many 
problems (“vigilant coping”) versus the tendency to anticipate few problems 
(“avoidant coping”) is a common finding in studies investigating expectations 
prior to major surgery (Kiyak et al., 1988; Cohen & Lazarus, 1973). 
Interestingly, avoidant coping prior to surgery has been found to be associated 
with better post-surgical outcomes, including fewer problems with recovery and 
better mood, than vigilant coping (Kiyak et al., 1988).  
 
Low perceptions of risk were often associated with having great trust in surgeons 
and the surgical process. Patients in this study often described themselves as 
being in “safe hands”. This contradicts previous research in TED that has 
suggested that patients find it hard to develop trust and confidence in healthcare 
professionals (Estcourt et al., 2011; Estcourt et al., 2008). Studies in women who 
have undergone breast surgery found that patients perceiving their surgeon to be 
caring, reassuring, and available to answer their questions enabled them to trust 




their surgeon, feel confident about their surgery, and form realistic expectations 
about what the procedure can achieve (Klassen et al., 2009; Snell et al., 2010).     
7.4.5 Recovery 
Expectations about recovery after the surgery were a source of anxiety for many. 
The majority were uncertain about how their recovery would go, and many 
continued to ask questions even after their consultations. Participants did 
however seem to have clear expectations with regards to recovery and talked 
about anticipating bruising, pain, and for recovery to take a long time and to 
require at least two weeks off work. Many anticipated having to take more time 
off work than the two weeks the surgeon had suggested, particularly if their jobs 
involved a potential risk to further damage to their eyes, such as working on a 
construction site, or working at a computer for long hours. This is particularly 
important given that accurate expectations for recovery prior to surgery and a 
sense of perceived control have been found to lead to fewer postoperative 
difficulties (Johnston, 1986). However, postoperative recovery has been found to 
be slower, and distress greater, in patients who are highly anxious prior to 
surgery (Johnston, 1986). This highlights the importance for surgeons to identify 
patients that go beyond a realistic insight of what post-operative symptoms and 
side effects to expect into anxiously anticipating the worst, in order to enhance 
post-operative outcomes.  
7.4.6 Appearance outcomes 
This study found that some participants did not know what to expect in regards 
to their post-surgical appearance. Many participants were used phrases like “less 
prominence”, and indicated the desire to know exactly what they would look 
like. Similar findings have been reported in a study of women awaiting breast 
reconstructive surgery, where patients often described vague expectations 
(Mazza, 2014). One reason for participants being tentative about their 
expectations regarding their post-surgical appearance might be because having 
high expectations could lead to disappointment if surgery didn’t meet their 
expectations. This hypothesis is supported by a study that found women were 
unable to articulate their expectations for their outcomes from surgery for 
gynaecological cancer, for fear of having too high expectations (Bhty, 1999). For 




many, the post-surgical change in appearance would mean their lives would be 
“back on track”. The majority of participants reflected on their expectations for 
surgery to enable them to look how they did before they had TED. It has been 
found in a number of studies on outcomes after reconstructive surgery that 
expectations for surgeons to “recreate lost looks” (Partridge, 2006, p. 956) can 
cause disappointment, dissatisfaction, and even distress with the outcome 
(Partridge, 2006; Snell et al., 2010; Harcourt & Rumsey, 2001). Patients with 
TED might therefore face similar disappointment if surgery does not meet their 
high expectations. 
 
Some people in this study felt that their whole lives depended on having orbital 
decompression surgery. Orbital decompression was described in terms of it being 
a ‘gateway’ to achieving goals in appearance and re-gain a “normal” appearance. 
This is particularly important as patients who expressed disappointment after 
surgery for TED in a previous study had unrealistic expectations that the surgery 
would enable them to go back to the life they had before TED (Estcourt et al., 
2008).  
 
Patients with TED consistently report that the change in appearance of their eyes 
causes problems in social interaction, including feeling others avoid them, or 
misinterpret their facial expressions (Jensen & Harder, 2010; Terwee et al. 
1998). It is therefore unsurprising that participants in this study had high hopes 
for being able to reintegrate socially after surgery. Participants in this study 
reported high levels of social avoidance and withdrawal due to TED, and were 
expecting this to change after their surgery in a number of ways. They expressed 
hopes not to stand out, or look different from others after surgery. A number of 
female participants had a desire to stop concealing their eyes in public and were 
expecting surgery to enable them to do so. Participants generally felt surgery 
would bring back their confidence to make eye contact with others, face the 
public, socialise with friends and family, and be accepted by others. How quickly 
this is likely to happen has been raised by Partridge (1990) who suggests that 
social reintegration following a disfiguring condition or injury requires a process 
of learning new communication skills, which is unlikely to happen overnight. For 
participants who expect to look exactly as they did before TED it might be a 




shock to find they might still need to adjust to slight differences in their 
appearance even after surgery by making efforts to manage the occasional 
comment from others.  
7.4.7 Functional outcomes 
A number of participants described expecting many aspects of their lives to 
improve after the surgery, including work, family life, hobbies, and re-gaining 
independence. This was not only from a change in appearance but also from 
improvements in visual function. More than half the sample had double vision 
and some expressed expecting orbital decompression to improve their vision, 
despite the fact that this surgery often does not resolve double vision and may 
even make it worse (EUGOGO et al., 2009). Research on expectations of 
cataract surgery has found similarly high preoperative expectations about 
postoperative function, with 60% expecting to achieve near perfect vision.  Post-
surgical realities however failed to meet expectations with only around 60% 
achieving expected outcomes (Pager, 2004; Tielsch et al., 1995). This further 
highlights that discrepancies often exist between pre-surgical expectations for 
improvements in function and post-surgical outcomes. 
 
The finding that male participants appeared to be more concerned about their 
functional outcomes than appearance outcomes is in line with previous studies 
that have found for men the biggest impact of having a disfiguring disease are 
physical limitations rather than changes in appearance (Andreasen & Norris, 
1972; Brown et al., 1988). Estcourt et al. (2008) found men with TED did not 
report feeling socially inhibited because of changes in their appearance. This 
supports the notion that men with disfiguring conditions are more concerned with 
functional limitations as their appearance changes do not appear to inhibit them 
socially. It is also possible that in TED, where men are often found to have more 
severe clinical symptoms than women, express more concern about these issues.   
 
This qualitative study has highlighted the complexity of the expectations of 
patients with TED prior to rehabilitative surgery. As with all studies, findings 
need to be interpreted in light of limitations of the methods used. The next 




section of this chapter will therefore describe the strengths and weaknesses of the 
methodology used.  
7.4.8 Strengths and weaknesses of the study 
As semi-structured interviews depend on participants’ willingness to guide the 
interview and describe their experiences in depth, they may vary in their quality 
and length. Interviews also rely on participants’ understanding of the topics and 
concepts initiated by the researcher. However, complex psychological concepts, 
such as issues of expectations and quality of life are important to explore using 
qualitative methodology but could pose a problem for participants with poor 
education or for whom English is not a first language.  
 
As the researcher had prior experience collecting data about quality of life and 
other psychosocial issues in TED, they may have formed pre-conceptions about 
what participants would talk about in interviews. It is possible that the 
researcher’s preconceived notions of what the data would reveal might have 
influenced the content of the interview guide and the way questions were asked 
during interviews. To a certain extent this would have been overcome by the 
asking the supervisory team to review the topic guide before interviews 
commenced, and again when it was amended after the pilot interview. This is 
also commonly overcome by keeping a reflective diary after each interview 
(Shauver & Chung, 2010), which was done for this study and can be found in 
Appendix Q.  
 
A sample size of 14 patients was interviewed for this study, which might be 
considered too small to be generalizable to a wider population of patients with 
TED. The sample was, however, diverse in their age (which ranged from 23 to 
76), disease duration, and their treatment history reflected the typical history of a 
patient with TED being offered orbital decompression surgery. The gender 
distribution of the sample reflected a ratio typically found in samples of patients 
with TED and in the wider population of patients with TED. In addition 
saturation was achieved with the number available. 
 




Three of the participants included in this study had had orbital decompression on 
one eye prior to their interview and were awaiting decompression on their other 
eye. This was unavoidable due to time restrictions to recruit the desired number 
of patients for this study and as BMEC perform around 10 to 15 decompression 
surgeries each year (Perros et al., 2012). The experiences of these patients of 
prior decompression are likely to have influenced their expectations of surgery. 
For example, their expectations may have been better formed than patients at 
other stages of their treatment trajectory. However, this sub-sample were also 
considered too small a group to analyse their data separately. Furthermore their 
prior experience did not affect the quality of their answers in interviews about 
their expectations and the data they provided was still considered relevant and 
valuable for this study.  
 
One criticism of qualitative research is that “anything goes” (Braun & Clarke, 
2006, p95). However, the phases of thematic analysis have been clearly outlined 
in recent years and the analysis methods were rigorously applied. Validity checks 
were undertaken, including applying the COREQ checklist (Tong, Sainsbury & 
Craig, 2007), for example that a variety of participant quotations were presented 
to illustrate themes/ findings and to add transparency to the data and 
interpretations. In addition, a second researcher independently coded 20% of the 
interviews to ensure accuracy of the coding process and that nothing was missed 
by the researcher. In addition the researcher kept a reflective diary during 
interviews and the analysis in an attempt to understand the influence they might 
have had on the data collected and the analysis of the results.  
 
The present study did not deal with patient experiences after surgery, so it is 
uncertain whether patient expectations of orbital decompression for TED were 
met, had an impact on mood and quality of life after surgery, or changed over 
time. As a result no definitive conclusions can be made about whether 
expectations were unrealistic, or resulted in dissatisfaction with post-surgical 
outcomes.  





The aim of this study was to explore patients’ expectations of orbital 
decompression surgery for TED. This was the first qualitative study in TED to 
explore patients’ expectations of their upcoming surgery. The overall narrative 
was that participants perceived surgery to be inevitable, and the gateway to 
restoring their appearance and enabling them to get back to the life they had 
before TED. Participants lacked clarity over exactly what to expect of the 
procedure, and of post-surgical appearance outcomes, remaining tentative and 
hopeful for “best case” scenarios they had viewed online. Participants commonly 
referred to a desire to re-gain a sense of “normality” in all aspects of their lives. 
Participant felt frustrated at having to wait so long for surgery, but remained 
trusting of the healthcare process and confident in their surgeon’s abilities to help 
them achieve their goals in terms of both functional and appearance-related 
quality of life.  
 
The ability of healthcare professionals to manage patient expectations of surgery 
for TED depends on their understanding of patients’ beliefs, concerns, and the 
impact on patients of accessing certain information about the surgery online, or 
hearing from others. Only with such knowledge can they give clear, relevant, 
information about the surgery that patients need, given in terms they can 
comprehend. In the context of this study it appears it is important that patients 
feel able to return for consultations prior to surgery in order to ask questions, and 
talk about their fears about the surgery so healthcare professionals can dispel any 
myths or correct any misinterpreted information. The results of this study could 
help to inform shared decision making between patients with TED and their 
surgeons in future consultations.  
7.5 REFLEXIVE ACCOUNT 
The researcher has prior experience interviewing participants for qualitative 
health psychology projects. The researcher is female and is educated to 
postgraduate level. The researcher had spoken to each of the participants on the 
phone to arrange the interviews; no further relationship was established prior to 
the interviews. The aims of the study and instructions for interviews were 
explained clearly before each interview, and understanding checked, to ensure 




that participants weren’t surprised by any questions or unclear about the study. 
The researcher introduced herself as a PhD student at City University London 
and made it clear to participants that she did not have medical training. On any 
occasion where participants asked medical questions during the interviews, the 
researcher urged participants to speak to the healthcare professionals involved in 
their care.   
 
As the researcher had prior experience recruiting patients with TED for 
quantitative studies, she understood that TED can cause significant anxiety, 
depression and appearance concern for many patients and was aware of the need 
to approach topics sensitively and compassionately. During three of the 
interviews, participants became upset when they recalled particular experiences 
with their disease. The researcher gave these participants the opportunity to have 
a break from the interview, or indeed to terminate the interview if the participant 
felt this was necessary. On all such occasions, participants wanted to continue 
with the interview after a short break. The researcher approached this study with 
the understanding that qualitative data is rich in detail and felt it inappropriate to 
interrupt participants during interviews even if they were going slightly off-topic. 
This may explain the length of some of the interviews. Similarly, the researcher 
felt uncomfortable pushing participants into giving great detail where they 
clearly found it difficult to articulate their views. This may explain the short 
length of some of the interviews.  
 
At the end of each interview, the researcher ensured that participants were not 
left in a distressed or emotional state. The researcher offered participants the 
contact details of two TED charities, which offer information, advice and support 
to patients. 
 
Reflective notes that were taken during the thematic analysis, which position the 
researcher within the analytic process, can be viewed in Appendix Q. 
 
Chapter 8 will now bring together the findings from this qualitative study, along 
with the results of the cross-sectional study reported in Chapter 6, to discuss the 
areas of new knowledge and the implications for research, theory and practice.  
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8. SYNTHESIS OF THE QUANTITATIVE AND QUALITATIVE FINDINGS 
IN PATIENTS WITH TED PRESENTING FOR ORBITAL 
DECOMPRESSION SURGERY 
8.1 PROLOGUE 
The following chapter will present the key similarities and differences between the 
results of the cross-sectional quantitative and qualitative studies investigating 
demographic, clinical and psychosocial factors in patients with TED presenting for 
orbital decompression surgery. Embedding a qualitative study within the quantitative 
investigation of patients prior to surgery provided valuable insight into participants’ 
beliefs and expectations about their upcoming surgery, which have provided 
additional detail to the research findings. Interpreting these embedded results in 
relation to the results from the main quantitative study is a key stage of good quality 
mixed methods research in health sciences (O’Cathain, Murphy & Nicholl, 2008).  
8.2 DEMOGRAPHICS 
The quantitative study found that being female was associated with poorer 
appearance-related quality of life. The findings from the qualitative study supported 
this, with female participants talking extensively about their hopes for their 
appearance outcomes after surgery. Gender was not found to be associated with 
vision-related quality of life in the quantitative study, despite male participants in the 
qualitative study referring more to their expectations for their visual function after 
surgery. The findings from the qualitative study support previous research in the 
field of visible differences, where men have been found to be more concerned about 
the functional limitations of their visible disfigurement compared to women, whom 
it is suggested were more concerned about appearance-related issues (Andreasen & 
Norris; 1972; Brown et al., 1988). However, with only four male participants in the 
qualitative study, it is difficult to confirm these findings.   
 
Interestingly, despite men appearing to be less concerned about appearance 
outcomes post-surgery in the qualitative study, the quantitative study found no 
significant difference between men and women in their levels of appearance-related 
distress and social avoidance, as measured by the DAS24 (Carr, Harris & Moss, 
2005). This discrepancy may be due to the bias associated with these different 
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methodologies. It might be that during interviews, men felt more socially inclined to 
minimise the impact of their condition on their perceptions of their appearance, as 
men are commonly expected to be less concerned about their appearance. Whereas 
questionnaires completed anonymously at home might allow for more honest 
responses.   
8.3 CLINICAL FACTORS 
The only clinical factor prior to surgery found to be associated with quality of life in 
the quantitative study was having asymmetrical TED. This finding was unsurprising 
as having asymmetrical TED can impact on visual function (Terwee et al., 1999). No 
other clinical characteristic provided a unique contribution to explaining variance in 
quality of life in the quantitative study. Participants in the qualitative study rarely 
referred to clinical characteristics when discussing the formation of expectations, or 
even their expectations of surgery. The only exceptions were when they referred to 
not knowing exact millimetres to expect orbital decompression to reduce their 
proptosis by and double vision: 
 
“I do worry about how much it’s going to go back. Because nobody’s actually 
said, we take it back to this millimetres… so there’s no like reassurances or 
telling me how much it’s going to go back and how much physically it’s going 
to look different” 
 
Participants expressed a desire to know more about how their eyes would look after 
surgery, to enable them to form expectations about their objective appearance post-
surgery. Additionally, participants in the qualitative study spoke about hoping that 
their vision would improve after the surgery. However, they related these hopes to 
activities of daily living that had been affected by their double vision due to having 
TED rather than having specific clinical expectations, such as expecting double 
vision to change from “constant” to “intermittent” or “inconstant”, which is one 
potential clinical outcome from orbital decompression (Terwee et al., 2001; 
EUGOGO et al., 2009). 
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8.4 INTERVENING COGNITIVE PROCESSES 
8.4.1 Appearance related social anxiety and avoidance 
Both studies have offered insight into the psychosocial consequences of living with 
TED. The quantitative study found that appearance-related social anxiety and 
avoidance were associated with quality of life. Similarly, the majority of participants 
in the qualitative study raised the issue about the consequences of living with TED, 
in particular that a change in their appearance had affected their ability to interact 
with others as normal and had resulted in a number of patients withdrawing from 
social participation. The findings from both these studies are consistent with other 
studies in TED (Estcourt et al., 2008) and other types of facial disfigurements 
(Rumsey et al., 2004). They also support Newell’s (1999) fear avoidance model in 
that anticipated unpleasant encounters with others have led to social withdrawal in 
TED. The qualitative study also found that many patients expected orbital 
decompression to enable them to engage in social activities as they had before they 
developed TED. This was in all aspects of their life, including facing the public, 
attending family occasions and socialising with friends.  
8.4.2 Salience and valence of appearance 
Evaluating their appearance more negatively was found to be associated with poorer 
appearance-related quality of life in the quantitative study. This was supported by the 
qualitative study where many participants gave reasons for having surgery that 
included wanting their appearance to improve.  
8.4.3 Perceived noticeability 
Perceived visibility of TED was found to be associated with appearance-related 
quality of life in the quantitative study. Furthermore, many participants in the 
qualitative study discussed the issue of feeling that their TED was highly noticeable 
to others, fearing negative evaluations because of this, and placing great hope on the 
surgery reducing the noticeability of their TED. The basis for reconstructive surgery 
for a disfiguring condition is founded on the belief that an improvement in 
appearance and noticeability of a disfigurement will lead to a better quality of life 
(Ong et al., 2007). It has, however, been previously suggested that patient 
satisfaction with the outcome and reduced levels of distress will only follow if 
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surgery reduces subjective noticeability of the condition regardless of the objectively 
successful result (Moss, 2005). 
8.4.4 Mood 
Previous studies in TED have reported low mood in patients, with around a quarter 
found to have possible clinical levels of depression (Kahaly et al., 2005), a finding 
consistent in the current quantitative study. Depression was found to be strongly 
associated of the variance in both visual- and appearance-related quality of life in the 
quantitative study. Participants in the qualitative study indicated that levels of low 
mood were associated with the frustration of having to wait longer than expected for 
surgery, as well as the impact of their visual function and change in appearance. This 
could be one explanation for the high levels of depression found in the quantitative 
study where patients were awaiting surgery.   
8.4.5 Expectations of surgery 
No study to date has explored in detail patient expectations of orbital decompression 
surgery. The quantitative study aimed to investigate what demographic, clinical and 
psychosocial factors are associated with quality of life in this patient group. It has 
been suggested in previous studies that expectations are complex psychological 
processes and expectations of treatment outcomes might impact on patients’ 
perceptions of the success of treatment. It was therefore deemed important to explore 
whether expectations were potential intervening cognitive process that might be 
associated with variation of quality of life in TED prior to surgery.  
 
The E-TEDS was developed for this purpose as no other questionnaire existed that 
measured expectations of surgery for TED. However, expectations measured using 
the E-TEDS were not significantly associated with quality of life. There appeared to 
be differences in the importance of some concepts associated with expectations of 
surgery between the two studies. For instance, the item regarding expectations of the 
relationship with eye doctors was removed from the E-TEDS as it did not correlate 
well with the other items in each subscale (appearance concern, visual function and 
intimacy and social relationship). However, the results of the qualitative study gives 
some indication that their relationship with healthcare professionals was more 
closely related to information provision and confidence in their care; concepts that 
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were not captured by the E-TEDS. Furthermore, patient’s interactions with 
healthcare professionals have been found to influence their perceptions of and 
satisfaction with their care in TED (Estcourt et al., 2008). It could be argued that the 
23-item expectations questionnaire did not capture the full scope of patients’ 
expectations of orbital decompression surgery. As argued by Dawn and Lee (2004) 
in a recent literature review of patient expectations in ophthalmology, “patients’ 
expectations are complex and require further inquiry” (p.519) and this seems to have 
been supported by the qualitative study in this thesis.  
8.4.5.1 Information about orbital decompression 
The impact of information about orbital decompression patients had sought, or 
received, was found to heavily influence the formation of patient expectations of 
surgery in the qualitative study. A number of recent studies have found that patients 
place high priority on communication with healthcare professionals and explanation 
of medical information when undergoing surgery (Dawn & Lee, 2004; Newell et al., 
2004). When participants did not find out everything they wanted to know from 
healthcare professionals, they accessed other sources of information, including the 
Internet. For some, this helped clarify what had been said in previous consultations 
but for many these raised further questions and fears about the surgery. Information 
patients had received about surgery was not something that was measured in the 
quantitative study so it is unclear how different levels and understanding of treatment 
information might predict psychological adjustment. This would be an important 
area of further enquiry, particularly as detailed and comprehensive information about 
surgery can help to manage patient expectations (Newell et al., 2004; Houtman, 
2000).  
8.4.5.2 Managing expectations 
Because ophthalmologists are involved in both medical and surgical management of 
TED, it has been argued that knowledge and management of patients’ expectations 
are even more important in ophthalmology than other specialities (Dawn & Lee, 
2004). Whilst the quantitative study suggested that expectations of the outcome of 
surgery in terms of appearance, function and intimacy and social relationships, were 
not associated with quality of life in patients presenting for surgery. The qualitative 
study found that expectations are either under-developed, or optimistic and bordering 
on unrealistic, leading to the potential for unmet expectations to impact on quality of 
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life post-surgery. The qualitative study highlights the value that patients place on 
healthcare professionals in the formation of their expectations and as the “gateway” 
to enabling them to go back to the “normality” of life before TED, and in whom they 
have great confidence to help them reach these goals. The need for healthcare 
professionals to manage patient expectations prior to surgery for TED has been 
highlighted by the qualitative study. Initial research has found that interventions that 
manage patients’ expectations are effective at increasing postoperative satisfaction 
with the outcome (Dawn & Lee, 2004). This study implies the need for healthcare 
professionals to understand patients’ beliefs, concerns, and the impact on of 
accessing information about TED surgery on the Internet, and to give clear, relevant 
information about the surgery in terms they can comprehend. 
8.5 STRENGTHS AND WEAKNESSES OF USING MIXED METHODS  
The concurrent embedded approach used within this thesis is characterised by one 
approach being more dominant (Curry et al., 2013); in this case the qualitative study 
was embedded within the quantitative design, which was the dominant method. 
However this is one method of many within mixed methods research: the synthesis 
of quantitative and qualitative methods is a rapidly growing area of research 
methodology and new techniques are likely to arise in the future (Pope, Mays & 
Popay, 2007).  
 
One limitation of the current study was the ordering of the quantitative and 
qualitative elements. The research program might have benefited from conducting 
the quantitative study after the qualitative study, as the results of the qualitative study 
could have informed the development of a more comprehensive expectations 
questionnaire. However, due to the need to complete this research in a specified time 
frame so as to accommodate the constraints in the data collection period it was 
necessary for the two studies to run concurrently. Despite this, the results of the 
qualitative study largely confirmed what had been measured in the quantitative study 
and the results are unlikely to have been drastically different.  
 
The experiences of people with TED are complex and involve limitations in visual 
functioning as well as the psychological impact of a changed appearance. This is 
further complicated by the need for a range of drug treatments and radiotherapy 
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which, if ineffective, can lead to the requirement for major and multiple surgeries to 
rehabilitate appearance and improve visual outcomes. Due to the complexity of the 
condition and its treatment a mixed methods approach enabled the researcher to gain 
insight into variable individual experiences and to assess patterns and similarities 
across patients, perhaps beyond what would have been achieved through the use of 
only one method or the other.  
 
This section of the thesis has explored cross-sectionally the quality of life and 
expectations of patients presenting for orbital decompression surgery. The next 
Chapter describes the results of a longitudinal follow-up study that examined 
whether clinical and psychosocial factors change after orbital decompression 
surgery, and what factors might predict quality of life outcomes after surgery.  
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9. THE PSYCHOSOCIAL AND CLINICAL IMPACT OF ORBITAL 
DECOMPRESSION SURGERY FOR TED 
9.1 PROLOGUE 
This chapter presents the results of the study that has investigated the following 
research questions: 
(3) Does quality of life change from pre- to post- decompression surgery? 
(4) Which clinical and psychosocial factors change from pre- to post-
decompression surgery? 
(5) What demographic, clinical and psychosocial patient characteristics at 
baseline predict change in quality of life from pre- to post-decompression 
surgery? 
(6) Which changes in clinical and psychosocial factors from pre- to post 
decompression surgery predict change in quality of life from pre- to post-
surgery? 
 
Chapter 4 described how the basis for reconstructive surgery for a disfiguring 
condition is founded on the belief that an improvement in appearance and 
noticeability of the disfigurement will lead to a better quality of life (Ong et al. 
2007).  It has, however, been previously suggested that patient satisfaction with the 
outcome and reduced levels of distress will only follow if surgery reduces subjective 
noticeability of the condition regardless of an objectively successful result (Moss, 
2005). The systematic review in this thesis (Chapter 3) reported that past studies 
evaluating orbital decompression in terms of clinical and quality of life outcomes 
have failed to capture other psychosocial variables that might impact on quality of 
life and help to explain the variability in quality of life outcomes (EUGOGO et al., 
2009; Tehrani et al., 2004; Terwee et al., 2001; Kashkouli et al., 2011b; Fichter, 
Krentz & Guthoff, 2013). This study, therefore, aimed to evaluate the effects of 
orbital decompression surgery on clinical and psychosocial outcomes using the 
framework of adjustment to disfiguring conditions (ARC, 2008) to guide the 
analytical model (Figure 9, page 117).  
 
Data for this study was collected at three time points: prior to surgery, 6 weeks post-
surgery and 6 months post-surgery. The analysis described in the following 3 
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sections of this chapter focuses on change over time from pre- to post-surgery. 
Research questions (3) and (4) have been addressed by analysing change across all 
three time points (see section 5.10.4.2 for a detailed summary of the methods used). 
Research questions (5) and (6) have been addressed by evaluating change from pre- 
to 6 months post-surgery (see sections 5.10.4.3 and 5.10.4.4 for a detailed summary 
of the methods used).  
9.2 DATA ASSUMPTIONS 
9.2.1 Scale reliability 
All scales were found to be highly reliable at each time point (i.e. α > 0.7, Table 16)  






Table 16. Internal reliability of psychosocial scale variables at all 3 study time points 
 
 Baseline 6 weeks 6 months 












HADS Anxiety 7 .874 7 .865 7 .880 
HADS Depression 7 .851 7 .863 7 .838 
DAS24 24 .943 24 .927 24 .936 
GOQOL Visual function 9 .917 9 .920 9 .952 
GOQOL Appearance 8 .870 8 .886 8 .912 
CARSAL 5 .898 5 .850 5 .876 
CARVAL 8 .890 8 .865 8 .934 
MSPSS Friends 4 .935 4 .951 4 .932 
MSPSS Family 4 .915 4 .941 4 .939 
MSPSS Significant other 4 .967 4 .971 4 .965 
BFNE 12 .855 12 .864 12 .895 
INCOM 11 .865 11 .801 11 .860 
E-TEDS VF 11 .968 - - - - 
E-TEDS AC 7 .965 - - - - 
E-TEDS ISR 5 .915 - - - - 
 
 




The Shapiro-Wilk statistic was significant (p<0.05) for all scales and subscales, apart 
from the E-TEDS visual function subscale and DAS24 at baseline and BFNE and 
INCOM at all time points, which were normally distributed (Table 17). However, as 
this test can be sensitive to small deviations in normality (Field, 2009), histograms 
and normal probability plots were also assessed. Normal distributions were observed 
for the majority of the variables in histograms and normal probability plots. 
However, histograms indicated that data for the HADS depression subscale was 
skewed to the left at 6 week and 6 month follow-ups. Salience (CARSAL), valence 
(CARVAL), GO-QOL visual function and the three MSPSS subscales were skewed 
to the right at all time points.  
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 Baseline 6 week 6 month 
Scale & Time point Statistic df p Statistic df p Statistic df p 
E-TEDS AC  .869 96 .000** - - - - - - 
E-TEDS VF  .983 82 .350 - - - - - - 
E-TEDS ISR  .933 85 .000** - - - - - - 
CARSAL  .808 77 .000** .913 54 .001* .890 63 .000** 
CARVAL  .803 55 .000** .951 61 .016* .948 71 .005* 
HADS Anxiety  .975 106 .043* .966 77 .039* .958 86 .007* 
HADS Depression  .960 106 .003* .939 81 .001* .931 84 .000** 
DAS24  .953 45 .065 .936 50 .009* .929 64 .001* 
GOQOL Visual function  .934 109 .000** .911 83 .000** .841 85 .000** 
GOQOL Appearance .950 109 .000** .969 84 .039* .948 85 .002* 
Perceived visibility  .804 106 .000** .922 77 .000** .918 77 .000** 
MSPSS Family  .890 109 .000** .863 81 .000** .891 84 .000** 
MSPSS Friends  .908 108 .000** .905 81 .000** .919 84 .000** 
MSPSS Significant other  .800 107 .000** .779 80 .000** .785 85 .000** 
BFNE  .989 100 .607 .978 80 .186 .980 78 .274 
INCOM  .989 102 .576 .975 80 .114 .992 83 .893 
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9.3 CHARACTERISTICS OF THE STUDY SAMPLE 
Participants from the cross-sectional study described in Chapter 6 were followed up 
after their surgery at two time points: 6 weeks and 6 months post-surgery.  
9.3.1 Dropouts & loss to follow-up 
Dropouts at follow-up are a common problem in longitudinal healthcare studies. Of 
the 121 participants in the cross-sectional study, a proportion did not respond to one 
of the follow-up questionnaire packs, and a small number did not respond to either 
follow-up (Figure 17). Orbital decompression was cancelled for 11 participants after 
the pre-surgical assessment and one participant failed to complete more than 50% of 
the data in their follow-up questionnaires. Seventy-three (60.1%) participants 
completed questionnaires at all three time points. Eleven participants filled in only 
baseline and 6 week follow-up questionnaires (9.8%) meaning that 84 participants 
were followed up at 6 weeks after surgery. Thirteen participants filled in only 
baseline and 6 month follow-up questionnaires (10.6%), meaning that 86 participants 
in total were followed up 6 months after surgery. 
 
The one participant with over 50% data missing was removed from the follow-up 
analysis. Multiple imputations were not performed for the analyses described in this 
chapter as MLM, the analytical method used to investigate research questions (3) 
and (4), is able to handle missing data. MLM uses all available information for the 
analysis and can be performed on unbalanced sample sizes at each time point, or for 
each scale (Quené & van den Bergh, 2004). This is in contrast to pairwise or listwise 
deletions, which retain cases but do not analyse missing variables (pairwise) or 
remove entire cases with at least one variable missing (listwise). For consistency 
with all follow-up analyses investigating changes over time, the same dataset was 
used to answer research question (5), i.e. the investigation of what baseline factors 
predict change in quality of life from pre- to post-surgery, and research question (6), 
i.e. the investigation of what changes over time in clinical and psychosocial factors 
predict change in quality of life over time, from pre- to post-surgery. Pairwise 
deletion was used in these analyses in order to retain valuable data.  
 
 



































Figure 17. A flow diagram showing participation rates and losses to follow-up based on 
CONSORT guidelines (Schultz et al., 2010) 
 
9.3.1.1 Differences between responders & non-responders 
A sensitivity analysis was conducted to assess whether there were any differences 
between patients that responded to follow-up questionnaires and those who did not. 
T-tests and Pearson’s chi square tests were performed to compare patients who had 
only completed a baseline questionnaire with patients who completed a baseline 
Did not consent (n=57) 
• Did not have surgery (n=14) • Declined to participate (n=15) • Did not respond to invitation or 
follow up call (n=28) 
Baseline analysis 
Follow-up analysis 
Loss to follow-up (1) (n=12) • Did not receive surgery (n=11) • Returned questionnaires but over 
50% missing data for full dataset 
(n=1) 
Drop outs (n=14) • Did not return baseline 
questionnaire (n=12) • Returned questionnaires but 
over 50% missing data at 
baseline (n=2) 
Assessed for eligibility  
(n=192) 
 
Completed Time 2 questionnaire (n=84) 





Loss to follow-up (2) (n=13) • Did not return either follow-up 
questionnaire (n=13) 
Enrolment 
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questionnaire and at least one follow-up questionnaire on clinical and psychosocial 
variables. Odds ratios were calculated, which are a common useful measure of effect 
size for categorical data (Field, 2009). White patients were found to be more likely to 
respond to follow-up than other ethnic groups χ2 (1) = 4.79, p<0.05, with the odds 
being 2.9 more likely if the patient was White. Non-smokers were more likely to 
complete follow-up questionnaires χ2 (3) = 11.43, p<0.05, with the odds being 2.8 
more likely if patients did not smoke.   
9.3.2 Side effects from surgery 
Patients’ subjective experiences of side effects (pain, swelling, scarring and redness) 
were measured 6 months post-surgery on a scale of 0 to 10 (a full description of this 
measure is provided in section 5.8.1.4.2, page 108). Eighty-four participants 
responded to this item (missing n=2). The majority of patients experienced either no 
side effects, or very low level of severity in each of the four side effects measured 
(Figure 18). Of the four side effects, a higher proportion of patients reported scarring 
to be a mild to moderate problem 6 months after surgery than any other side effect.  
 
Figure 18. Severity of side effects from surgery including pain, swelling, scarring and 
redness (n =84) 
 
Participants were also asked to rate how their experience of these symptoms 
compared to their expectations prior to surgery. A high proportion of patients 
experienced much less pain than they had expected (43%), with only 3% finding that 
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they had expected (33%) and scarring was generally found to be less than expected 
(35%). Of the four side effects, participants most frequently reported swelling to be 




Figure 19. Percentage of each response to item asking patients to compare the 
experience of their symptoms to what was expected prior to surgery (n=84) 
 
9.3.3 Patient satisfaction with surgery 
Patient satisfaction with surgery was assessed using 3 single item measures at 6 
months post-surgery. Generally, patients reported high levels of satisfaction with 
orbital decompression, with the majority reporting that they did not regret having the 
surgery (Figure 20), would be willing to go through the operation again (Figure 21) 
and would be willing to recommend the surgery to others who might need it in the 
future (Figure 22). The majority of participants were satisfied with the information 
given to them prior to surgery (85.5%) and the remaining felt they were given too 
little information (Figure 23).   
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Figure 20. Frequency and percentage of responses to the question "Do you regret 
having surgery?" at 6 months post-surgery (n=84) 
 
 
Figure 21. Frequency and percentage of responses to the item "Would you go through 
the operation again?" at 6 months post-surgery (n=84) 
 



























































Figure 22. Frequency and percentage of responses to the item "Would you recommend 
the operation to others?" at 6 months post-surgery (n=84) 
 
 
Figure 23. Frequency and percentage of responses to the item "Were you given the 
right amount of information preoperatively?" at 6 months post-surgery (n=83) 
 
9.3.4 Further surgery 
A total of 37 patients required further surgery after orbital decompression, which 
included eyelid lengthening, strabismus surgery and a small number of patients were 
due to have a second orbital decompression (n=3) on the opposite eye.  
63 (75%)
16 (19%)
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9.4 WHICH CLINICAL AND PSYCHOSOCIAL FACTORS CHANGE 
AFTER SURGERY? 
To examine the effects of orbital decompression surgery on clinical and psychosocial 
factors, as well as quality of life outcomes, multilevel modelling (MLM) was 
performed. ICCs were all found to be above 0.05 and therefore MLM was deemed 
suitable to examine change over time for all the variables measured in the study 
(Stride, 2009).   
9.4.1 Clinical outcomes 
Table 18 presents adjusted means and standard deviations (SDs) for continuous 
clinical variables at each time point. As SPSS generated standard errors, these were 
converted into standard deviations as described in section 5.10.4.2, page 144. F-test 
results for the analyses present the effects of time, from pre- to post-surgery. Partial 
eta squared (ŋ2p) was calculated to establish each effect size as described in section 
5.10.4.2 (page 144) and these results have also been provided in the tables presented. 
Differences in change scores between baseline and each post-surgical follow up, and 
differences in scores between the two follow ups, were examined using pairwise 
comparisons, which are also presented in Table 18. 
 
Table 19 presents proportions and predicted probabilities for categorical clinical 
predictor variables. MLM analysis for categorical variables was implemented, which 
involved examining whether patients changed from ‘present’ to ‘not present’. In 
Table 19 β represents the log odds coefficients and Exp(β) represents effect sizes as 
described in section 5.10.4.2, page 145.  
9.4.2 Intervening psychosocial processes 
Table 20 presents adjusted mean scores and SDs for the psychosocial process 
variables, F-test results for the effects of time analyses, effect sizes (ŋ2p), differences 
in change scores between baseline and each post-surgical follow-up and differences 
in scores between the two follow-ups. 
 
Statistical tests for which results were significant are presented in bold. 






Table 18.Adjusted means for continuous clinical outcomes at baseline and follow-up and F-test results for the effect of time 
 




6 months  
(M±SD)  
Effect of Time  Effect 
size (ŋ2p) 
Baseline to 6 
weeks 
Baseline to 6 
months 
Exophthalmometry  23.69±2.45 19.28±2.41 19.11±2.39 F 2, 149.80= 252.33, p<0.001** 0.77 4.41, p<0.001** 4.58, p<0.001** 
Asymmetry  1.84±1.48 0.83±1.48 0.75±1.47 F 2, 161.90= 20.18, p<0.001** 0.20 1.02, p<0.001** 1.09, p<0.001** 
LogMAR  0.08±0.25 -0.00±0.25 -0.01±0.24 F 2, 160.40= 4.53, p<0.05* 0.05 0.08, p=0.029* 0.09, p=0.031* 
MRD1  6.00±1.82 5.29±1.78 5.29±1.79 F 2,145.94= 8.26, p<0.001** 0.10 0.71, p=0.001* 0.71, p=0.004* 
MRD2 6.77±1.25 5.46±1.25 5.47±1.25 F 2,156.65= 46.45, p<0.001** 0.37 1.31, p<0.001** 1.30, p<0.001** 
CAS 1.17±1.44 0.64±1.42 0.40±1.43 F 2,155.20= 9.41, p<0.001** 0.11 0.53, p=0.007* 0.77, p<0.001** 
Estimated marginal means 















Table 19.Frequencies of categorical clinical outcomes at baseline and follow-up and probabilities of presence over time 
 
 









n(%) β SE Wald ᵡ 2 p Exp(β) 
95%CI for 
Exp(β) 
Optic neuropathy 12(11.2) 4(3.7) 2(1.9) 
      Intercept 
   
-2.07 0.31 45.67 <0.001** 0.13 0.069, .230 
6 weeks vs baseline 
   
-1.13 0.50 5.08 0.024* 0.32 0.121, .863 
6 months vs baseline 
   
-1.55 0.61 6.33 0.012* 0.21 0.064, .711 
Corneal SPK 33(72) 27(25.2) 13(12.1) 
   
 
  Intercept 
   
-0.77 0.21 13.77 <0.001** 0.46 0.307, .695 
6 weeks vs baseline 
   
-0.22 0.27 0.66 0.418 0.80 0.469, 1.369 
6 months vs baseline 
   
-1.02 0.34 8.91 0.003* 0.36 0.185, .705 
Diplopia 56(52.3) 51(47.7) 38(35.5) 
      Intercept 
   
0.08 0.19 0.15 0.696 1.08 0.74, 1.571 
6 weeks vs baseline 
   
-0.03 0.22 0.02 0.891 0.97 0.637, 1.481 
6 months vs baseline 
   
-0.50 0.23 4.58 0.032* 0.61 0.383, .959 
Hydraulic orbit 20(18.7) 3(2.8) 5(4.7) 
      Intercept 
   
-1.43 0.25 33.27 <0.001** 0.24 0.146, .388 
6 weeks vs baseline 
   
-2.03 0.65 9.61 0.002* 0.13 0.037, .474 
6 months vs baseline 
   
-1.43 0.52 7.57 0.006* 0.24 0.086, .662 






Table 20. Adjusted means for continuous psychosocial outcomes at baseline and follow-up and F-test results for the effect of time 
 
Estimated marginal means 
* p<.05, ** p<.001  
 
 




6 months  
(M±SD)  
Effect of Time  Effect 
size 
(ŋ2p) 
Baseline to 6 
weeks 




63.42±29.32 65.02±27.42 71.43±27.78 F 2, 130.52=5.30, p=0.006* 0.08 -1.60, p=0.873 -8.02, p=0.008* 
GOQOL Appearance 35.42±26.19 48.66±24.70 54.89±25.08 F 2, 131.55=31.02, p<0.001** 0.32 -13.23, p<0.001** -19.46, p<0.001** 
HADS Anxiety  9.43±4.52 7.23±4.20 7.04±4.29 F 2, 156.80= 27.05, p<0.001** 0.26 2.21, p<0.001** 2.40, p<0.001** 
HADS Depression  7.87±4.52 6.09±4.21 5.81±4.32 F 2,120.04= 14.92, p<0.001** 0.20 1.77, p<0.001** 2.06, p<0.001** 
DAS24  52.19±14.15 44.08±14.34 41.15±15.35 F 2, 68.01= 17.18, p<0.001** 0.34 8.11, p<0.001** 11.04, p<0.001** 
CARSAL 25.35±5.41 23.40±4.92 23.18±5.28 F 2, 102.71= 5.96, p=0.004* 0.10 1.95, p=0.006* 2.17, p=0.013* 
CARVAL 41.26±9.66 34.02±9.65 31.76±9.88 F 2, 90.99= 21.94, p<0.001** 0.33 7.24, p<0.001** 9.50, p<0.001** 
Visibility 5.76±1.68 4.01±1.62 3.75±1.63 F 2, 157.24= 58.62, p<0.001** 0.43 1.76, p<0.001** 2.01, p<0.001** 
MSPSS Friends 15.32±3.86 15.31±3.56 15.52±3.66 F 2, 110.52= 0.23, p=0.794 0.01 0.01, p=1.000 -0.20, p=0.935 
MSPSS Family 15.50±4.12 16.14±3.84 15.60±3.91 F 2, 131.88= 1.95, p=0.147 0.03 -0.64, p=0.195 -0.10, p=0.991 
MSPSS Significant 
other 
15.94±4.69 16.03±4.26 16.23±4.43 F 2, 161.38= 0.27, p=0.766 0.01 -0.29, p=0.987 -0.29, p= 0.858 
BFNE 38.13±8.95 36.68±8.28 36.11±8.39 F 2,102.80= 3.93, p=0.023* 0.07 1.46, p=0.054 2.02, p=0.033* 
INCOM 35.91±6.80 35.14±6.46 35.56±6.54 F 2,133.57= 0.73, p=0.485 0.01 0.77, p=0.545 0.35, p=0.936 
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As shown in Table 18 and Table 19 all clinical variables changed significantly pre- 
to post-surgery, suggesting that in this sample orbital decompression led to 
improvements in all clinical outcomes. Improvements in all continuous clinical 
variables were observed from baseline to 6 weeks post-surgery and baseline to 6 
months post-surgery but there were no statistically significant changes from 6 weeks 
to 6 months indicating that the bulk of improvements occurred in the first 6 weeks 
after surgery. Of the categorical clinical variables, this effect was observed for optic 
neuropathy and hydraulic orbit. However for corneal SPK and diplopia, changes in 
the probability of reducing from ‘present’ to ‘absent’ were not observed until 6 
months after surgery. Of note, a number of outliers were observed for these clinical 
variables (Appendix R) and the analysis was repeated with and without these 
participants by means of a sensitivity analysis. As the results were consistent, these 
participants were retained to avoid reducing the sample size and losing important 
data. The effect sizes for the effect of time in the clinical variables were small to 
large (0.05 to 0.77),  
 
Improvements were observed in all psychosocial variables apart from the MSPSS 
subscales (friends, family and significant other) and social comparison (INCOM) 
(Appendix S). For HADS anxiety, HADS depression, DAS24, CARSAL, CARVAL 
and perceived visibility improvements were observed as early as 6 weeks after 
surgery. This improvement was maintained at 6 months post-surgery with no 
statistically significant additional improvement observed between 6 week and 6 
month follow-ups. BFNE and GO-QOL visual function scores did not improve 
significantly until 6 months post-surgery. Significant differences were found 
between 6 week and 6 month follow-ups for the GO-QOL visual function (mean 
difference -6.41, p<0.05); however the improvement in this score did not reach the 
MCID for the GO-QOL (Terwee et al., 2001). The GO-QOL appearance subscale 
however improved as early as 6 weeks after surgery and continued to significantly 
improve up to 6 months after surgery (mean difference -6.23, p<0.05). The MCID 
was observed in the GO-QOL appearance subscale at the 6 week follow-up. The 
effect sizes for the effect of time in the psychosocial variables ranged from small to 
moderate (0.07 to 0.43). 
 




Figure 24. Graphical representation of change over time in GO-QOL subscale 
scores with error bars 
 
9.5 BASELINE PREDICTORS OF CHANGE IN QUALITY OF LIFE 
FROM PRE- TO POST-SURGERY 
To investigate which factors at baseline predict change in quality of life from pre- to 
post-surgery, residualised change scores were calculated for the GO-QOL subscales. 
These were calculated to capture the change from pre- to 6 months post-surgery, as 
the most amount of change was found at this postoperative time point. Two 
hierarchical multiple regressions were performed using baseline factors as the 
predictor variables (IVs) and the residualised change scores for the GO-QOL 
subscales as the DVs. A full description of the methods used has been provided in 
Chapter 5, section 5.10.4.3 page 120.  
 
As before, the number of predictors for the regression model was reduced by 
performing initial univariate linear regressions to examine the association between 
each baseline predictor variable and each DV. Only significant predictors were 
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9.5.1  GO-QOL visual function change  
Residualised change scores for the GO-QOL visual function subscale were 
calculated for the 85 participants who provided this data at both baseline and 6 
month follow-up. Univariate linear regressions indicated that four variables 
significantly predicted the improvement in GO-QOL visual function from pre- to 
post-surgery. The variables were: ethnicity (F(1,83)=5.11, p<0.05, f2 =0.06), hydraulic 
orbit (F(1,81) =6.24, p<0.05, f2 =0.08), diplopia (F(1,82)=4.74, p<0.05, f2 =0.06), and 
CAS (F(1,83) =11.13, p<0.05, f2 =0.10). No other variables significantly predicted 
change in GO-QOL visual function.  
 
Entry of variables into the regression was based on Figure 9. As only demographic 
and clinical variables were found to significantly predict GO-QOL visual function 
scores, all variables were entered into the regression at the same time. This model 
explained 16% of the observed variance in the change in GO-QOL visual function 
(adjusted R2=0.12, F(4,78)=3.74, p<0.05, f2 = 0.19). Beta coefficients indicated that 
whilst the overall model was significant, there were no significant unique predictors 
of GO-QOL visual function change (Table 21). Therefore improvements in GO-
QOL visual function after surgery were predicted by a combination of demographic 
and clinical factors, including being of non-White ethnicity, having a lower CAS 
score, not having hydraulic orbit and not having double vision. However none of 
these variables were unique predictors that explained a significant amount of 
variance over the other variables.   




Table 21. Results for the hierarchical multiple regression used to analyse baseline 
predictors of change in GO-QOL visual function scores 
 
  B SE B t p 
Step 1         
Constant 0.49 0.24 2.01 .048* 
Ethnicity  -0.60 0.27 -2.23 .028* 
Step 2         
Constant 0.69 0.25 2.75 .007* 
Ethnicity  -0.48 0.27 -1.82 .073 
CAS -0.11 0.07 -1.68 .097 
Hydraulic orbit -0.18 0.33 -0.54 .592 
Diplopia -0.26 0.22 -1.19 .237 
Note: R2 = .06 for Step 1 (p <0.05), R2 =.16 for Step 2 (p <0.05) 
  
9.5.2 GO-QOL appearance change  
Univariate linear regressions indicated that five variables significantly predicted 
change in GO-QOL appearance from baseline to 6 months post-surgery. The 
variables were: ethnicity (F(1,83)=4.75, p<0.05, f2 = 0.06), previous radiotherapy, 
(F(1,74)=4.19, p<0.05, f2 = 0.06), hydraulic orbit (F(1,81) =4.72, p<0.05, f2 = 0.06), 
diplopia (F(1,82)=8.46, p<0.05, f2 = 0.10), and CAS (F(1,83) =7.88, p<0.05, f2 = 0.09). 
No other variables were significant predictors of GO-QOL appearance change.  
 
As before, as only demographic and clinical variables significantly predicted GO-
QOL appearance scores, variables were entered into the regression at the same time. 
This model accounted for 20% of the observed sample variation in the change in 
GO-QOL appearance (adjusted R2=0.14, F(4,70)=3.17, p<0.05, f2 = 0.25). As found 
for GO-QOL visual function change, beta coefficients indicated that whilst the 
overall model was significant, there were no significant unique predictors of GO-
QOL appearance change (Table 22). Hence the significant improvement in GO-QOL 
appearance was predicted by a combination of demographic and clinical factors 
including being of ethnic origin other than white, not having had previous 
radiotherapy, absence of hydraulic orbit and diplopia and lower CAS score, with no 
unique predictors.  
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Table 22. Results for the hierarchical multiple regression used to analyse baseline 
predictors of change in GO-QOL appearance scores 
 
  B SE B t p 
Step 1         
Constant 0.47 0.26 1.85 .068 
Ethnicity 
-0.58 0.28 -2.06 .043* 
Step 2         
Constant 0.80 0.26 2.94 .004* 
Ethnicity 
-0.50 0.28 -1.80 .077 
Previous radiotherapy -0.60 0.40 -1.41 .164 
Hydraulic orbit -0.01 0.34 -0.02 .987 
Diplopia -0.37 0.23 -1.59 .118 
CAS -0.10 0.07 -1.54 .127 
Note: R2 = .05 for Step 1 (p <0.05), R2 = .20 for Step 2 (p <0.05) 
 
9.5.3 Regression assumptions 
The VIF and tolerance statistics were analysed for each multiple regression analysis 
described in this section to ensure tolerance values were above 0.2 and VIF values 
were well below 10. This was found to be the case for both regressions. Therefore it 
can be concluded that there was no collinearity within the data for any model used. 
9.6 CHANGES IN CLINICAL AND PSYCHOSOCIAL FACTORS AS 
PREDICTORS OF CHANGE IN QUALITY OF LIFE FROM PRE- 
TO POST-SURGERY 
To investigate whether the change in clinical and psychosocial factors from pre- to 6 
month post-surgery could predict improvement in quality of life from pre- to 6 
month post-surgery, residualised change scores were calculated for each clinical and 
intervening cognitive process variable in addition to the previously calculated change 
scores for the quality of life variables. Two further hierarchical multiple regressions 
were performed with the GO-QOL subscale residualised change scores as the 
dependent variables and the residualised change scores on the intervening 
psychosocial variables as IVs. As before, univariate linear regressions were 
performed for each IV and the DV to assess whether any were significant predictors 
that could be included in the regression analysis.    
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9.6.1 Change predictors of GO-QOL visual function change  
To control for significant baseline predictors of GO-QOL visual function change, 
ethnicity was entered into this model. Further univariate linear regressions indicated 
that nine variables in total significantly predicted the improvement in GO-QOL 
visual function from baseline to 6 months post-surgery. The variables were: ethnicity 
(F(1,83)=5.11, p<0.05, f2 = 0.06), change in diplopia (F(1,72)=5.88, p<0.05, f2 =0.08), 
support from significant others (F(1,81) =5.51, p<0.05, f2 =0.07), change in fear of 
negative evaluation (F(1,71)=5.30, p<0.05, f2 =0.07), change in social comparison 
(F(1,77)=4.36, p<0.05, f2 =0.06), change in social anxiety and social avoidance 
(F(1,28)=6.26, p<0.05, f2 =0.22), change in valence of appearance (F(1,39)=6.86, 
p<0.05, f2 =0.18), change in anxious mood (F(1,82)=10.56, p<0.05, f2 =0.13), and 
change in depressed mood (F(1,79)=20.51, p<0.001, f2 =0.26). These variables were 
entered into the hierarchical multiple regression model in the order as stipulated by 
the ARC framework (Figure 9). This involved entering demographic variables in 
block 1, clinical variables in block 2, socio-cognitive variables in block 3, 
appearance cognitions in block 4 and mood in block 5. 
 
The regression model for change in GO-QOL visual function was not significant 
(adjusted R2=-0.01, F(9,15)=0.97, p=0.50, f2 = 0.59). Although the univariate 
regressions between each of the IVs and DV were statistically significant, the 
clinical and psychosocial variables did not contribute significantly to the regression 
model. Apparently improvements in GO-QOL visual function 6 months after surgery 
were not well predicted by change in the clinical or psychosocial variables from pre- 
to post-surgery (Table 23). 
Chapter 9 The Psychosocial and Clinical Outcomes of Orbital Decompression  
 
 229 
Table 23. Results of the hierarchical multiple regression used to analyse change 
predictors of change in GO-QOL visual function 
 
  B SE B t p 
Step 1         
Constant 0.49 0.46 1.07 .295 
Ethnicity -0.60 0.51 -1.19 .246 
Step 2     
Constant 0.44 0.45 0.98 .338 
Ethnicity -0.55 0.50 -1.09 .289 
Diplopia -0.26 0.20 -1.27 .217 
Step 3         
Constant 0.35 0.47 .75 .462 
Ethnicity -0.43 0.52 -0.83 .419 
Diplopia -0.28 0.21 -1.33 .200 
MSPSS Significant other 0.17 0.20 0.84 .411 
BFNE -0.19 0.24 -0.80 .433 
INCOM -0.13 0.25 -0.53 .603 
Step 4         
Constant 0.19 0.48 0.40 .696 
Ethnicity -0.23 0.54 -0.44 .669 
Diplopia -0.29 0.24 -1.20 .246 
MSPSS Significant other 0.11 0.21 0.55 .589 
BFNE -0.05 0.25 -0.19 .855 
INCOM -0.22 0.27 -0.80 .435 
CARVAL 0.00 0.29 0.01 .991 
DAS24 -0.36 0.27 -1.31 .207 
Step 5         
Constant 0.19 0.50 0.39 .705 
Ethnicity -0.24 0.56 -0.42 .680 
Diplopia -0.27 0.26 -1.02 .324 
MSPSS Significant other 0.09 0.22 0.43 .676 
BFNE -0.02 0.27 -0.07 .948 
INCOM -0.19 0.29 -0.65 .524 
CARVAL 0.01 0.31 0.03 .978 
DAS24 -0.26 0.31 -0.84 .414 
HADS Anxiety  -0.06 0.28 -0.23 .824 
HADS Depression  -0.15 0.29 -0.54 .598 
Note: R2 = .06 for Step 1 (p =0.246), R2 = .12 for Step 2 (p =0.217), R2 = .24 for Step 3 (p 
=0.416), R2 = .34 for Step 4 (p =0.292), R2 = .37 for Step 5 (p =0.764) 
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9.6.2 Change predictors of GO-QOL appearance change 
As before, ethnicity was entered into this model to control for its predictive value of 
change in GO-QOL appearance. Further univariate linear regressions indicated that 
in total, thirteen variables significantly predicted improvement in GO-QOL 
appearance from baseline to 6 months post-surgery. The variables were: ethnicity 
(F(1,83)=4.75, p<0.05, f2 =0.06), previous radiotherapy (F(1,74)=4.19, p<0.05, f2 =0.06), 
change in upper eyelid retraction (F(1,69)=4.54, p<0.05, f2 =0.07), change in hydraulic 
orbit (F(1,73)=4.94, p<0.05, f2 =0.07), significant others support (F(1,81) =7.22, p<0.05, 
f2 =0.09), family support (F(1,82) =5.72, p<0.05, f2 =0.07), change in fear of negative 
evaluation (F(1,71)=9.88, p<0.05, f2 =0.14), change in valence of appearance 
(F(1,39)=51.86, p<0.001, f2 =1.3), change in social anxiety and social avoidance 
(F(1,28)=19.67, p<0.001, f2 =0.70), change in perceived visibility (F(1,75)=17.08, 
p<0.001, f2 = 0.23), change in anxious mood (F(1,82)=11.71, p=0.001, f2 =0.14), and 
change in depressed mood (F(1,79)=29.57, p<0.001, f2 =0.37). These variables were 
entered into the hierarchical multiple regression as previously outlined (Figure 9).  
 
This model accounted for 81% of the observed sample variation in the change in 
GO-QOL appearance from baseline to 6 months (adjusted R2=0.58, F(13,11)=3.52, 
p<0.05, f2 = 4.3). Beta coefficients indicated that an improvement in a person’s 
subjective evaluation of their own appearance uniquely predicted the improvement in 
GO-QOL appearance from pre- to 6 months post-surgery (Table 24). 
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Table 24. Results of the hierarchical multiple regression used to analyse change 
predictors of change in GO-QOL appearance 
 
  B SE B t p 
Step 1         
Constant 0.47 0.46 1.03 .312 
Ethnicity -0.58 0.51 -1.15 .263 
Step 2         
Ethnicity 0.46 0.47 1.00 .334 
Previous radiotherapy -0.50 0.51 -0.98 .340 
MRD1 -0.68 0.74 -0.92 .367 
Hydraulic orbit -0.19 0.21 -0.95 .355 
Step 3         
Constant 0.28 0.44 0.64 .529 
Ethnicity -0.26 0.49 -0.53 .605 
Previous radiotherapy -0.88 0.69 -1.27 .221 
MRD1 -0.33 0.20 -1.65 .119 
Hydraulic orbit -0.21 0.19 -1.09 .292 
INCOM -0.30 0.24 -1.23 .235 
BFNE -0.11 0.24 -0.47 .648 
MSPSS Significant other 0.15 0.22 0.65 .523 
MSPSS Family 0.27 0.24 1.10 .288 
Step 4         
Constant 0.14 0.33 0.43 .676 
Ethnicity -0.21 0.36 -0.57 .576 
Previous radiotherapy 0.34 0.59 0.58 .571 
MRD1 -0.21 0.17 -1.28 .222 
Hydraulic orbit 0.06 0.16 0.36 .726 
INCOM -0.08 0.19 -0.40 .697 
BFNE -0.15 0.18 -0.84 .414 
MSPSS Significant other 0.12 0.17 0.75 .470 
MSPSS Family -0.11 0.20 -0.52 .610 
CARVAL -0.64 0.21 -3.01 .010* 
DAS24 -0.26 0.20 -1.28 .223 
Perceived visibility 0.00 0.17 0.01 .991 
Step 5         
Constant 0.10 0.32 0.30 .767 
Ethnicity -0.16 0.36 -0.46 .657 
Previous radiotherapy 0.41 0.60 0.70 .501 
MRD1 -0.24 0.16 -1.47 .169 
Hydraulic orbit 0.07 0.17 0.43 .678 
INCOM -0.05 0.19 -0.25 .809 
BFNE -0.20 0.18 -1.11 .292 
MSPSS Significant other 0.10 0.17 0.59 .565 
MSPSS Family -0.15 0.20 -0.73 .479 
Chapter 9 The Psychosocial and Clinical Outcomes of Orbital Decompression  
 
 232 
CARVAL -0.71 0.22 -3.26 .008* 
DAS24 -0.27 0.23 -1.21 .251 
Perceived visibility 0.05 0.18 0.29 .779 
HADS Anxiety 0.26 0.19 1.42 .183 
HADS Depression -0.21 0.19 -1.09 .301 
Note: R2 = .05 for Step 1 (p = 0.263), R2 = .19 for Step 2 (p=0.373), R2=.45 for Step 3 (p=0.153), R2 = 
.76 for Step 4 (p <0.05), R2 = .81 for Step 5 (p = 0.339) 
 
9.6.3 Regression assumptions 
Analysis of the distribution of the residualised change scores showed a normal 
distribution for all the scales apart from MSPSS subscales, BFNE and CARSAL 
(Table 25). The VIF and tolerance statistics were analysed for each multiple 
regression analysis to ensure tolerance values were above 0.2 and VIF values were 
well below 10, which was found to be the case. Therefore it can be concluded that 
there was no collinearity within the data for any model used. 
 
Table 25. The normality (Shapiro-Wilk) of the residualised change scores used to 














Scale  Statistic df p 
CARSAL  .884 39 .001* 
CARVAL  .950 41 .073 
HADS Anxiety  .982 85 .268 
HADS Depression  .984 82 .392 
DAS24  .969 30 .517 
GOQOL Visual function  .971 85 .052 
GOQOL Appearance .989 85 .715 
Perceived visibility  .964 77 .027* 
MSPSS Family  .921 84 .000** 
MSPSS Friends  .914 83 .000** 
MSPSS Significant Other  .902 83 .000** 
BFNE  .950 73 .006* 
INCOM  .976 79 .153 




This study aimed to establish which clinical and psychosocial factors changed after 
surgery. Another aim was to investigate whether any demographic, clinical or 
psychosocial variables at baseline predicted the change in GO-QOL subscale scores 
between baseline and 6 months post-surgery. Finally, the study also aimed to 
examine whether the changes in clinical and psychosocial factors from baseline to 6 
months post-surgery explained variance in the change in GO-QOL subscale scores.  
 
This section of the thesis will discuss the results of the analyses presented in this 
chapter within the context of these aims. It will then discuss the strengths and 
weaknesses of the study. Comparisons of the findings of this study in relation to 
previous literature will also be made.  
9.7.1 Demographic variables 
Ethnicity was the only demographic factor found to predict change in visual function 
and appearance-related quality of life from before to after surgery.  Non-white 
patients experienced greater improvements in quality of life in both these areas in 
comparison to White patients. People from non-White backgrounds have been found 
to report more worry about their appearance and an increase in perceived 
noticeability when they have a visible difference, compared to White individuals 
(Rumsey et al., 2004). Research into the perceptions of individuals belonging to 
South Asian communities has reported that beliefs about the causes of 
disfigurements are sometimes founded within religious or cultural myth and 
superstition and that having a facial disfigurement can cause shame and burden on 
families (Hughes et al., 2009). This suggests that improvements in appearance might 
have additional implications for an individual who belongs to a particular cultural or 
ethnic group.  Taking this previous research into account it is therefore unsurprising 
that particular ethnic groups might benefit more than others psychologically from 
their surgery. However, when entered into the regression model with other 
predictors, ethnicity was not found to significantly explain any of the variance in 
change in quality of life above other predictors, suggesting that other factors might 
be more important in explaining changes in quality of life after surgery.  
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Contrary to pre-surgery findings, where age predicted quality of life related to visual 
function and gender predicted quality of life related to appearance, these 
demographic variables did not predict the change in quality of life scores from 
baseline to 6 months post-surgery. This supports findings in strabismus (Jackson, 
Morris & Gleeson, 2013), where age and gender were not found to be associated 
with a change in postoperative quality of life, highlighting the limitations in such 
factors in predicting which patients might improve in quality of life after eye 
surgery.  
9.7.2 Clinical variables 
A number of clinical factors patients present with prior to surgery appeared to 
predict some of the variation in change in quality of life from pre- to post-surgery. 
Specifically, a lower CAS score and an absence of hydraulic orbit and diplopia 
predicted better vision-related quality of life outcomes after surgery. Not having had 
previous radiotherapy, absence of hydraulic orbit and diplopia and a lower CAS 
score predicted better appearance-related quality of life. However, none of these 
variables provided a significant unique contribution to each model. Only 16% of the 
variance in GO-QOL visual function change and 20% of the variance in GO-QOL 
appearance change were explained by these factors. It appears that there are other 
factors not measured at baseline in this study that might better explain change in 
quality of life. It is therefore not possible to predict which patients might benefit the 
most from rehabilitative surgery for TED from the clinical or psychosocial factors 
assessed in this study prior to surgery. This finding has been supported to an extent 
by studies that have investigated quality of life outcomes following surgery for 
aesthetic improvement. These authors have argued the difficulty in defining who will 
adjust positively after surgery from the factors that people present with prior to 
surgery (Pruzinsky, 2004; Castle, Honigman & Phillips, 2002). No other TED study 
has explored the factors that patients present with prior to surgery that might predict 
adjustment after surgery.  
 
All clinical factors improved after orbital decompression surgery. A number of the 
clinical factors were found to significantly improve as early as 6 weeks after surgery. 
These included proptosis, eyelid retraction, asymmetry between the eyes, clinical 
activity, optic neuropathy, visual acuity, and hydraulic orbit, although with these 
Chapter 9 The Psychosocial and Clinical Outcomes of Orbital Decompression  
 
 235 
variables, there was no significant further improvement between 6 week and 6 month 
follow-ups. Some other variables appear to take longer to demonstrate any 
improvement, including corneal SPK and diplopia suggesting that orbital 
decompression does not immediately resolve these factors. These findings are in line 
with previous TED studies evaluating clinical and quality of life outcomes of orbital 
decompression 6 months post-surgery (EUGOGO et al., 2009; Fichter et al., 2013). 
Terwee et al., (2001) found no significant difference in diplopia 3 months after 
orbital decompression surgery and a significant difference emerged only after eye 
muscle (strabismus) surgery was performed to correct this.   
 
Vision-related quality of life did not significantly change until 6 months after 
surgery. Although it may be considered that this may in part be due to corneal SPK 
and double vision not improving until this time, the model was not found to 
significantly explain any variance in change in vision-related quality of life. Thus 
indicating that no changes in clinical variables from pre- to post-surgery predicted 
change in visual related quality of life. Furthermore, improvements in eyelid 
retraction and hydraulic orbit no longer predicted change in appearance-related 
quality of life when entered into the model with intervening cognitive process 
variables. These findings reflect those of previous studies in TED that have 
evaluated the relationship between clinical and quality of life outcomes after surgery. 
For instance, Jellema et al. (2014) found a weak correlation between double vision 
and GO-QOL visual function scores after strabismus surgery for TED, however no 
relationship was found to exist between double vision and appearance-related quality 
of life. Terwee et al. (2001) found weak correlations between postoperative clinical 
characteristics and changes in visual function-related quality of life including double 
vision and visual acuity and between changes in appearance-related quality of life 
and eyelid retraction, proptosis and orbital inflammation. However, the authors have 
not reported whether these relationships were found to be statistically significant, nor 
which type of surgery is associated with each specific characteristic. Other studies 
that have evaluated clinical and quality of life outcomes of orbital decompression 
surgery have failed to examine the relationship between changes in clinical variables 
and change in quality of life pre- to post-surgery (Fichter et al., 2013). A study that 
investigated the relationship between clinical and psychological outcomes following 
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treatment for facial lipoatrophy also failed to find any a relationship (Ong et al., 
2007).  
9.7.3 Intervening psychosocial outcomes 
The majority of intervening psychosocial factors improved after surgery. 
Appearance-related social anxiety and avoidance, importance of appearance, 
personal evaluation of appearance, perceived visibility of TED, anxiety and 
depression were all found to improve as early as 6 weeks after surgery but did not 
significantly improve beyond this time point. These findings are consistent with 
other studies investigating psychosocial outcomes following elective cosmetic 
surgery (Moss & Harris, 2009) and surgery for strabismus (Jackson, Morris & 
Gleeson, 2013) where improvements in anxiety, depression, appearance-related 
social anxiety and avoidance and quality of life were found not to improve 
significantly beyond 3 months post-surgery. 
 
Fear of negative evaluation was found not to improve until 6 months after surgery. 
This suggests that the emotions associated with social factors take some time to 
evolve after surgery. This is in line with previous research that has found patients 
often need to adjust to changes in facial appearance and might still feel unsure about 
the reactions of others following orthognathic surgery (Cadogen & Bennun, 2011). It 
is therefore likely that it takes time for people to gain confidence and reduce their 
fear that others may react to their appearance. This may relate to their early 
experiences after surgery. 
 
Perceptions of social support from friends, family and significant other remained the 
same over time. This is the first study to have evaluated these psychological 
constructs in patients with TED prior to and after surgery. This implies that for the 
group as a whole family and friends did not provide significantly more, or less, 
support post-surgery. The tendency to make social comparisons was also found not 
to change significantly after surgery. It is possible that this is a more stable trait and 
therefore may not be expected to change significantly over time. Some research has 
linked the tendency to make social comparisons with personality styles (Gibbons & 
Buunk, 1999; VanderZee, Buunk & Sanderman, 1996), including in patients with 
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multiple sclerosis (Hemphill & Lehman, 1991), providing some support for this 
hypothesis. 
 
A change for GO-QOL visual function was only observed 6 months post-surgery and 
did not reach a MCID. A number of variables were found to independently predict 
the change in GO-QOL visual function including significant other support, fear of 
negative evaluation, social comparisons, appearance-related social anxiety and 
avoidance, evaluation of appearance, and mood. However, when these variables 
were entered into the regression, the model was found not to be significant and thus 
did not adequately predict change in visual function quality of life. Terwee et al. 
(2001) found GO-QOL visual function scores not to change significantly after 
surgery when orbital decompression was performed to improve appearance. 
However they did find a significant improvement in these scores when 
decompression was performed to restore sight. Kashkouli et al. (2011b) also failed to 
find a significant improvement in GO-QOL visual function scores in their sample 6 
months after surgery. As the current study only included 15 patients with optic 
neuropathy, patients having orbital decompression to correct appearance probably 
dominated the sample. However, as patients with optic neuropathy also often have 
symptoms that cause a change in their appearance it would be unreasonable to 
assume these patients are not also adjusting to a change in their appearance. This 
makes it difficult to distinguish between patients having orbital decompression for 
proptosis and orbital decompression only for sight loss, when orbital decompression 
for sight loss also leads to improvements in appearance.  
 
Appearance-related quality of life improved significantly at 6 weeks and continued 
to significantly improve 6 months post-surgery, reaching a large MCID. Significant 
improvements in appearance-related quality of life have been observed after orbital 
decompression surgery in previous studies (Terwee et al., 2001; Fichter et al., 2013), 
although vision-related quality of life was found to show more improvement in 
previous studies (Fichter et al., 2013; Kashkouli et al., 2011b; EUGOGO et al., 
2009). However, sample sizes for these studies were notably small. There does 
appear to be a need for studies with larger samples when investigating TED surgery.  
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A large amount of variance in GO-QOL appearance change was explained by the 
analytical model in the current study, which included a range of demographic, 
clinical, socio-cognitive, appearance cognitions, and mood. However, an 
improvement in personal evaluation of appearance was the only unique predictor of 
improvements in appearance-related quality of life from baseline to 6 months post-
surgery. Personal evaluation of appearance has been found to be an important factor 
in predicting adjustment above other clinical factors associated with strabismus 
(McBain et al., 2014). Personal evaluation of appearance following cosmetic 
surgeries including breast enlargement, breast reduction, liposuction, 
abdominoplasties and eyelid surgery has been found to improve to levels of a non-
clinical sample 5 years after surgery (von Soest et al., 2011). However, the study in 
this thesis appears to be the first to have evaluated changes in evaluation of 
appearance (as measured by the validated CARVAL; Moss & Rosser, 2012) in terms 
of the ability to predict changes in quality of life following surgery for TED. This 
suggests that changes in appearance-related quality of life are not well predicted by 
demographic or changes in clinical factors, but rather intervening psychosocial 
processes and in particular, significant changes in appearance evaluation. This 
supports the outcome of the cross-sectional study presented in this thesis that found 
pre-surgical quality of life was more often associated with psychosocial rather than 
clinical factors. 
9.7.4 Strengths and weaknesses of the study 
A number of factors contributed to the strengths and weaknesses of this study.   
 
A common problem in longitudinal research is drop out over time and this study was 
no exception with a 60% response rate for all three time points. However, the follow-
up response rate for this study was similar to other studies following patients up after 
cosmetic surgery and treatments for TED (e.g. von Soest et al., 2011; Terwee et al., 
2002) and the sample size at follow-up was still more than adequate when compared 
to studies that have investigated quality of life outcomes following orbital 
decompression for TED (EUGOGO et al., 2009; Terwee et al., 2001; Fichter et al., 
2013; Kashkouli et al., 2011b). 
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As different levels of orbital decompression were performed on patients, from one-
wall to 3-wall approaches for more severe TED, these might have impacted on 
quality of life scores. As suggested by EUGOGO et al. (2009), it is possible that 
different types of orbital decompression could have led to varying changes in quality 
of life in the current study. However, the approaches to decompression were not 
greatly different in the current study with one of three approaches used depending on 
the number of bony walls removed, and no surgeon used the coronal approach. 
Furthermore, by reducing patients into sub-groups this would have reduced the 
sample size and ignored potential similarities and overlaps between 1, 2 and 3-wall 
approaches.  
 
Orbital decompression surgery is part of a treatment sequence and a number of 
patients continued to have further surgery after this surgery. A 6 month follow-up 
might not have allowed the study to gain insight into the longer term benefits of 
orbital decompression, or whether quality of life continued to improve after further 
surgery, such as eyelid lengthening and/or strabismus surgery. Terwee et al. (2001) 
suggest that minor invasive surgeries such as strabismus and eyelid lengthening do 
not change quality of life outcomes significantly. If this is the case then it raises 
questions as to the necessity of such surgery from the patients’ perspective. 
Pruzinsky (2004) argues that it is not at all clear to what extent multiple 
rehabilitative surgeries for disfiguring conditions could facilitate change in body 
image perceptions. It would be useful to establish the longer-term benefits of such 
surgery so that patients can be fully informed of how much they can expect a 
combination of these rehabilitative surgeries to improve their perceptions of their 
own appearance and, ultimately, quality of life.   
 
Expectations of orbital decompression were measured prior to surgery, with some 
promising results. However, follow-up interviews were not conducted to explore 
whether expectations of orbital decompression are met and if this is linked with post-
surgical outcomes. A follow-up interview study might have further established the 
mechanisms that predict and explain variance in post-surgical quality of life 
outcomes. Preoperative beliefs and assumptions related to expectations of 
rehabilitative surgery for an acquired disfigurement will influence adaptation to a 
changed body image (Pruzinsky, 2004). In support of this hypothesis pre-operative 
Chapter 9 The Psychosocial and Clinical Outcomes of Orbital Decompression  
 
 240 
expectations have been found to influence and predict psychological outcomes after 
breast reconstruction surgery following mastectomy for breast cancer (Snell et al., 
2010; Klassen et al., 2009; Mazza, 2014). In addition, a recent literature review 
found that unrealistic expectations predicted poor psychosocial outcomes after 
cosmetic surgery (Honigman, Phillips & Castle, 2004). 
 
The prevalence of co-morbid psychiatric disorders were not formally measured in 
this study. Body dysmorphic disorder (BDD) is characterised by a preoccupation 
with particular body features that are objectively absent or minimal and has been 
found to be one of few factors to predict poor subjective satisfaction with cosmetic 
surgery outcomes (Castle, Honigman & Phillips, 2002; Honigman, Phillips & Castle, 
2004). Psychiatric morbidities prior to surgery have been linked with poor 
postoperative psychological outcomes, including historical depression and anxiety 
disorders and personality disorder (Honigman, Phillips & Castle, 2004). These may 
have accounted for some of the variance in change in quality of life in the current 
sample. 
 
This is one of few studies to evaluate quality of life after orbital decompression and 
the first to systematically examine predictors of change in psychological outcomes 
following orbital decompression.  The findings from this study have a number of 
implications for clinical practice, which are described in more detail in Chapter 10, 
section 10.3.  
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10. OVERALL DISCUSSION 
The results of each study have been discussed separately in this thesis. In this chapter 
the main findings from the literature reviews and systematic review reported in 
Chapters 2 to 4 and the quantitative and qualitative studies reported in Chapters 6 to 
9, are highlighted in order to integrate the results of the thesis. The aims of the thesis 
will be discussed in relation to the studies novel contribution to both the TED and 
the visible differences bodies of literature. This chapter will also describe the 
implications these findings have for practice, describe the overall strengths and 
weaknesses of the thesis and make recommendations for future research.  
10.1 THESIS AIMS 
This thesis aimed to establish not only the quality of life of patients with TED 
presenting for orbital decompression surgery but also the demographic, clinical and 
psychosocial factors that might be associated with quality of life in this population at 
presentation. It also set out to examine changes in quality of life after surgery. The 
specific aims of the thesis were: • To investigate what demographic, clinical and psychosocial factors are 
associated with quality of life in patients presenting for orbital 
decompression surgery. • To explore patients’ expectations of orbital decompression surgery, and what 
influences these expectations.  • To investigate which clinical and psychosocial factors improve after surgery. • To establish whether any demographic, clinical and psychosocial 
characteristics patients present with prior to surgery can predict the 
variability in patients’ improvement in quality of life after surgery. • To identify any factors that change after surgery that might predict the 
variability in patients’ improvement in quality of life after surgery. 
10.2 NOVEL CONTRIBUTIONS TO THE LITERATURE 
10.2.1 Factors associated with quality of life in TED  
This is the first study to apply the ARC (2008) framework in attempting to further 
understand the psychosocial factors that might vary between patients with TED, and 
how these might account for the variability of quality of life in TED. To the 
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researcher’s knowledge only one study has looked at multiple psychological factors 
associated with quality of life in TED. Kahaly et al. (2005) found that physical 
quality of life was related to depression, blurred vision, diplopia, depressive coping 
and age, whereas mental quality of life was associated with depression, anxiety, 
depressive coping, hyperthyroidism, blurred vision, age and stressful life events. 
However Kahaly et al’s (2005) study did not use the TED-specific GO-QOL, which 
has advantages over generic HRQL measures as described in Chapter 2, section 2.3.2 
of this thesis. Furthermore, the study in this thesis has investigated additional 
intervening psychosocial factors to account for the variability adjustment to TED, 
and how these factors change over time after treatment.  
 
There has been debate within the literature about whether demographic or clinical 
characteristics are associated with adjustment in people living with a visible 
difference. Whilst some studies in TED have failed to find a relationship (e.g. Kulig 
et al., 2009; Kashkouli et al., 2011b), a number of other studies have suggested a 
relationship between clinical severity including proptosis, diplopia and disease 
activity, and quality of life (e.g. Terwee et al., 2001; Yeatts, 2005; Park et al., 2005; 
Choi et al, 2012). Appearance researchers generally argue that levels of psychosocial 
distress related to having a disfigurement are not well associated with severity of the 
condition (Rumsey, Clarke & White, 2003; Rumsey et al, 2004; Thompson & Kent, 
2001). Although some research suggests that location of the disfiguring condition 
may play a role in adjustment for some. In particular, conditions that affect the eyes 
have been found to complicate social interaction and increase perceived visibility 
(Rumsey et al, 2000; McBain et al, 2014), leading to high levels of social anxiety 
and social avoidance in these patient groups (Clarke & Wyn-Williams, 2000). This 
appears to be the case in the current study, with both men and women with TED 
reporting higher levels of appearance-related distress than the general population.  
 
This study found that prior to surgery, predominantly intervening psychosocial 
factors are associated with quality of life in TED including appearance-related social 
anxiety and avoidance, salience of appearance-related information, personal 
evaluation of appearance, perceived visibility of TED and depression. Only one 
clinical factor was associated with vision-related quality of life, thus highlighting the 
importance of the intervening psychosocial factors first suggested by the ARC 
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(2008) in predicting how well, or poorly, patients adjust to having TED. 
Demographic factors including being female and older age were associated with 
poorer appearance-related and vision-related quality of life, respectively, prior to 
surgery. Women have consistently been found to adjust poorly to changes in their 
appearance due to disfiguring conditions (Rumsey et al., 2003; James et al., 2011; 
ARC, 2008). Where the work in this thesis differed from other studies on eyes was 
on the finding for age. Previous studies in strabismus found that older people were 
less concerned about appearance and demonstrated less appearance-related distress 
and social anxiety (James et al, 2011; Nelson et al, 2008). This study, however, 
found that being older was associated with poorer vision-related quality of life.  
 
However as this study was cross-sectional, it is not possible to infer causal direction 
of the effects. A postoperative follow-up study was required to investigate the 
predictors of quality of life over time. This would be difficult to perform without an 
intervention as these patients were recruited prior to their surgery. The following 
section deals with the novel findings from the thesis regarding predictors of quality 
of life over time with surgery occurring between assessments, thus enabling an 
analysis of the effects of surgery.   
10.2.2 Expectations of surgery 
By the time patients have made a decision to undergo rehabilitative surgery for TED 
they have gone through a range of processes that appear quite variable. Patients’ 
expectations of their surgery are influenced by a desire to return to the life they had 
before TED, healthcare professionals who felt they should have surgery, other 
patients who have had the surgery, and forums, blogs, and websites found on the 
Internet that recommended the surgery. Thus expectations appeared to be high in this 
group of patients. 
 
The studies in this thesis found that patients expect recovery to take longer than 
healthcare professionals suggest and expect the time of recovery to affect their 
working lives. Some discrepancy was found between certain side effects being 
expected prior to surgery and those experienced after surgery. Participants in the 
qualitative study spoke about their expectations for scars and bruising but did not 
mention swelling. The quantitative follow-up study indicated that around a quarter of 
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patients experienced post-operative swelling that was worse than they had expected, 
indicating this may be a particular side effect that is not well addressed by sources of 
information prior to surgery.  
 
This study also highlighted patients’ awareness that further surgery after orbital 
decompression could be necessary to further rehabilitate their appearance and 
participants described their treatment journey as a long and frustrating process. The 
majority of patients expected to look exactly as they did before TED, often referring 
to returning to “normality”, which would enable them to reintegrate socially and 
increase their subjective evaluation of their own appearance, supporting the findings 
of Estcourt et al. (2008). However, Rumsey and Harcourt (2004) stress the 
importance of consultations between healthcare professionals and patients prior to 
multiple surgeries as these may conflict with “the patient’s need to accept a less than 
perfect outcome” (p.92).  
10.2.3 Impact of treatment for TED on psychosocial factors 
The systematic review in Chapter 3 suggested that orbital decompression is 
associated with large improvements in both visual function and appearance-related 
quality of life. However it also found that long-term benefits in quality of life were 
found after treatment using selenium. Although this raises questions for the necessity 
of major surgery to improve quality of life when non-invasive natural remedies can 
lead to similar improvements, the quality of the evidence is generally poor. The poor 
reporting of methods and results of the studies included in the systematic review 
made it impossible to make definite conclusions about which treatments were most 
effective for improving quality of life outcomes. The systematic review highlighted 
the lack of studies that have evaluated clinical and psychosocial outcomes after 
orbital decompression surgery using validated measures. Furthermore, the need to 
attempt to identify predictors of quality of life in the longer term to consider how 
these may be influenced to improve outcomes in TED was emphasised by the 
review.  
 
This was the first study to conduct a multilevel analysis of change over time in 
factors from pre- to post-surgery for TED. Previous studies have failed to take into 
account the fact that measures are taken from the same participant at different time 
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points, thus data from adjacent time points are likely to be correlated. MLM analyses 
account for the within-participant variation and correlation in scores over time 
(Cartwright, Traviss & Blance, 2012; Heck, Thomas & Tabata, 2014).  
 
The results of the follow-up study described in Chapter 9 suggested significant 
improvements in all clinical characteristics following orbital decompression.  
However, not all psychosocial factors improved after surgery. Perceptions of social 
support and a tendency to make social comparisons with others remained the same 
over time, and fear of negative evaluations from others did not improve until 6 
months after surgery. The ‘delay’ in change in fear of negative evaluation is perhaps 
not surprising considering that patients with TED have reported high levels of fear of 
negative evaluation in the cross-sectional study of this thesis, comparable to samples 
of patients with panic disorder (Collins et al., 2004). Prior to surgery, patients also 
reported the tendency to make social comparisons that were comparable to a group 
of patients with a range of ophthalmic conditions in a previous study (James et al., 
2011). Some research has linked the tendency to make social comparisons with 
personality styles (Gibbons & Buunk, 1999; VanderZee, Buunk & Sanderman, 1996; 
Hemphill & Lehman, 1991). Such studies suggest social comparison might be a 
more stable trait that cannot be resolved through surgery.   
 
Despite appearance-related social anxiety and avoidance (measured by the DAS24) 
improving immediately after surgery, it appears that more general social anxieties 
take some time to evolve after surgery. Participants in the qualitative study described 
high expectations to feel accepted by others and returning to the social activities they 
enjoyed before TED to happen after surgery, although they did not indicate how 
quickly they expected this to happen. Whilst there was some indication that fear of 
being evaluated negatively by others began to diminish 6 months after surgery, it is 
likely that the tendency to make social comparisons could take longer to reduce. 
 
The results of this thesis suggest that intervening psychosocial processes better 
explain variability in quality of life, both prior to and 6 months after surgery, than 
clinical or demographic factors. In particular, it is improvement in subjective 
evaluation of own appearance that predicts improvement in appearance-related 
quality of life after surgery. Having a negative evaluation of one’s own appearance 
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was significantly associated with quality of life prior to surgery and improvements in 
this factor have strongly predicted improvements in quality of life. This supports 
appearance research that has found significant improvements in appearance 
evaluation after cosmetic surgery, and appearance satisfaction being the most 
common reason people state for undergoing cosmetic surgery (von Soest et al., 
2011). This is the first study to identify the importance of this factor in patients with 
TED.  
10.2.4 Information needs of patients with TED 
Previous studies have indicated that the information needs of patients with TED are 
high (Estcourt et al., 2008; Edmunds et al., 2013). This was supported in the follow-
up study in this thesis that found no participants reported receiving “too much” 
information prior to surgery and 14% reported not receiving enough. Furthermore, 
the qualitative study in this thesis described the information-seeking practices that 
patients engage in prior to surgery form their expectations, which often lead to 
confusion and misunderstanding of what surgery could achieve. 
 
Accessing comprehensible information appears to be a problem for patients with 
TED. One previous study has evaluated the readability of web pages related to TED 
and has found them to be aimed at reading levels higher than the average patient 
(Edmunds et al, 2013), raising concerns for possible misinterpretation if information 
is not well understood. Patients were found to place particular value on websites that 
provide “before-and-after” photos of other patients who have had orbital 
decompression surgery as they were perceived to give a good sense of what to expect 
from changes in their appearance. However, when such websites only include 
examples of ideal case scenarios, this can raise expectations that might be unrealistic.  
10.3 RECOMMENDATIONS FOR PRACTICE 
The systematic review raised questions for clinical practice over optimal treatments 
to improve quality of life. In particular, IV methylprednisolone appeared to lead to 
better quality of life outcomes than oral methylprednisolone and lower doses of the 
steroid than those used in clinical management of TED could be more affective at 
improving appearance-related quality of life than higher doses, which are more 
costly and lead to more adverse effects.  However limitations of some of the studies 
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reviewed make it impossible to draw clear conclusions about the most effective TED 
treatments for improving quality of life and this question was not the focus of this 
systematic review. 
 
Surprisingly few studies evaluating treatment for TED to date have used the GO-
QOL or other available tools to measure other psychosocial constructs. The GO-
QOL has been recommended as a primary outcome measure in RCTs evaluating 
treatments for TED (Wiersinga, 2012) and its authors have emphasised the 
importance of assessing the impact of treatments on the quality of life of patients. 
However, with the growing recognition that quality of life outcomes are an essential 
component of the outcome set for clinical trials, more data on quality of life changes 
is likely to become available. The findings of the systematic review and the follow-
up study described in Chapter 9 suggest that clinicians need to be aware when 
planning rehabilitative treatments such as surgery that there is variability in the 
effects they have on quality of life. Considering the discrepancy between 
ophthalmologist-evaluated and patient-evaluated severity of TED (Terwee et al, 
2003b), it is important that assumptions are not made about the impact TED might 
have on a patients’ perceptions of their appearance. Patients need to be fully 
informed that whilst the aim of treatment is to improve clinical symptoms, not all 
treatments will improve their quality of life, particularly with regards to their 
concerns about their appearance. 
 
The findings of the cross-sectional study prior to surgery suggest that healthcare 
professionals could identify patients with TED who are likely to adjust poorly to the 
change in their appearance and limitations in vision resulting from their condition by 
evaluating their levels of appearance-related distress and mood at the time of 
diagnosis. This could be done by routinely administering psychosocial measures 
including the HADS (Zigmond & Snaith, 1983), DAS24 (Carr, Moss & Harris, 
2005), CARSAL and CARVAL (Moss & Rosser, 2012).  
 
Overall however, the results from the study that assessed the impact of surgery, 
suggest that it is difficult to predict which patients will adjust well after surgery for 
TED from the factors they present with at baseline. Whilst a combination of ethnicity 
and clinical factors including low clinical activity scores, absence of hydraulic orbit 
Chapter 10 Overall Discussion 
 248 
and diplopia and, for appearance-related quality of life an addition of not having had 
prior radiotherapy, significantly predicted variation in quality of life, the proportion 
of variance explained by these factors was strikingly small (16% for visual function 
and 20% for appearance-related quality of life).  
 
The results of the qualitative study could help to inform shared decision making 
between patients with TED and their surgeons in future consultations prior to 
surgery. This study highlighted the importance of healthcare professionals managing 
expectations by giving comprehensible, relevant information tailored to each patient. 
It would be valuable to patients for healthcare professionals to understand their 
beliefs, concerns, and the impact of accessing certain information about the surgery 
online. Healthcare professionals could therefore dispel any myths or correct any 
misinterpreted information in consultations prior to surgery, thus enabling patients to 
have realistic expectations of what surgery may or may not do for their appearance, 
vision, or both. This recommendation has been made before for clinicians working 
with patients with TED (Lane, 2006).  
10.4 RECOMMENDATIONS FOR FUTURE RESEARCH 
Some initial research has suggested that adjustment to having a visible difference 
fluctuates over time (ARC, 2008; Harcourt & Rumsey, 2012). This is particularly 
pertinent when the visible difference fluctuates over time as it does when there are 
interventions such as surgery. Whilst this was one of few studies that have evaluated 
quality of life in TED for as long as 6 months after surgery, this is still a relatively 
short time after surgery and longer-term follow-ups might provide some useful 
insight into how quality of life might change over time, and whether different factors 
predict quality of life when assessed over a longer time period. 
 
The follow-up study in the present thesis found that none of the measures of changes 
in clinical or psychosocial outcomes predicted change in vision-related quality of 
life. This suggests that other variables not measured in this study could explain the 
variation in change in vision-related quality of life. One possible area that could 
explain change in quality of life is the change in expectations over time, i.e. whether 
pre-surgical expectations were met. Unmet post-surgical expectations have been 
widely explored in the contexts of appearance and living with a disfigurement and 
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have consistently been found to be associated with post-surgical dissatisfaction and 
impaired quality of life (Snell et al., 2010; Klassen et al., 2009; Honigman, Phillips 
& Castle, 2004; Dawn & Lee, 2004; Finlay, Atkinson, & Moos, 1995; Finlay et al., 
1995; Pager, 2004; Bhty, 1999). In patients who were bitterly disappointed in the 
outcome of orbital decompression for appearance it would be likely to find little or 
no improvement in quality of life at 6 months post-surgery. Particularly as the 
qualitative study in this thesis found expectations for visual function to be 
unrealistically high, and considering that orbital decompression often does not cure 
double vision, and in some cases making it worse (EUGOGO et al., 2009).  
 
Therefore a useful area of future research would be to examine whether expectations 
after surgery were met. As this was the first study to examine expectations of 
patients with TED about their surgery, it was useful to explore this new area using 
both quantitative and qualitative methods. For instance, confidence in healthcare 
professionals and expectations for recovery were important areas for participants in 
the qualitative study, which were not included in the E-TEDS developed for the 
quantitative study. It might be useful to take a similar methodological approach to 
investigating whether expectations are met after surgery, or indeed whether they 
change over time.  
 
The qualitative study in this current thesis found expectations were heavily 
influenced by the type and source of information patients received, or sought, before 
surgery. Estcourt et al. (2011) have suggested that patients often have difficulty 
interacting with healthcare professionals and in an earlier study (Estcourt et al. 2009) 
found that only around half of patients were satisfied with their treatment for TED. 
Furthermore this study found that patients were often influenced to have orbital 
decompression by others, including other patients who had had the surgery and a 
positive result, family, and surgeons themselves, with some patients feeling they 
were expected to have orbital decompression by others. Others influence on patients’ 
decisions to have cosmetic surgery has been found to have negative effects on 
patients’ personal evaluation of surgical outcomes (von Soest et al., 2011). Patients’ 
interactions with healthcare professionals and their satisfaction with information 
received after surgery were not measured in the present study and might have had an 
impact on post-surgical quality of life. Therefore another useful factor to explore in 
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future studies would be the influence of others in the decision-making process to 
have surgery and their influence on post-surgical psychological outcomes.  
 
Moss and Rosser (2012) urge researchers to move on to the integration of findings 
about theory to produce testable interventions with practical application. Appearance 
researchers have begun to deliver therapeutic interventions to improve outcomes in 
people with disfiguring conditions. Therapeutic interventions for people with visible 
differences aim to reduce distress and increase social skills and psychological well-
being (Jenkinson, 2012). Such interventions have taken the forms of social 
interaction skills training (SIST), cognitive behavioural therapy (CBT), acceptance 
commitment therapy (ACT), and support groups, amongst others. In particular, 
social skills training and cognitive behavioural therapies have shown promising early 
results (Jenkinson, 2012; Thompson & Kent, 2001). This is perhaps partly explained 
by the difficulties people with visible differences encounter often being related to 
social interactions (Rumsey et al., 2004). Social skills training involves preparing 
someone with a visible difference to deal with staring, comments, and questions 
from others, and to be assertive and outgoing in social situations (Clarke, 1998; 
Borwick & Khanche, 2012). These skills have shown to be effective at increasing 
mood and reducing social avoidance and distress in people with facial 
disfigurements (Robinson, Rumsey & Partridge, 1996).  
 
CBT in the context of visible difference involves encouraging people to re-evaluate 
the importance of appearance and gradual exposure to social situations (Jenkinson, 
2012; Rumsey & Harcourt, 2004). CBT in this form has been provided in face-to-
face individual and group-based sessions (Bessell & Moss, 2007), and more recently 
online (Bessell et al, 2012). Both face-to-face and online modes of delivery have 
been found to effectively reduce anxiety and appearance-related distress for people 
with facial disfigurements (Bessell et al, 2012). However, interventions often fail to 
identify the specific behaviour change techniques that make the different approaches 
effective and studies need to be clear about what constructs the intervention is 
targeting and the specific strategies used (Thompson & Kent, 2001).  
 
Only 27% of patients with TED in the UK feel that they’ve been helped to deal with 
the psychosocial impact of their condition (Estcourt et al., 2009). Many patients have 
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expressed wanting to talk to a professional about their psychological issues, however 
whilst patients are routinely offered support after the loss of an eye, patients with 
TED are not commonly offered support following their diagnosis of TED (Clarke et 
al., 2003). Considering that some of the highest levels of appearance-related distress 
and social avoidance are seen amongst patients with disfiguring eye conditions 
(Clarke et al., 2003; Richards et al., 2014), a finding that this study has supported, it 
is likely that patients with TED would benefit from psychological support designed 
specifically for these patients. At a recent patient and public involvement (PPI) event 
for TED in the UK, patients identified improving psychological support as a key 
priority for future research (Smith et al., 2014). The next logical step for the research 
programme would therefore be to use the results of this thesis to guide the 
development of a psychosocial intervention specifically targeted towards patients 
with TED.  
10.1 OVERALL STRENGTHS AND WEAKNESSES OF THE THESIS 
As with all studies there were variables that were not included in the study. 
Socioeconomic status wasn’t measured in the quantitative study and this might have 
highlighted some potential differences in quality of life in patients with TED. 
However, socioeconomic status has not been found to affect appearance concern in 
the general population (Harris & Carr, 2001) and there was not a sufficient rationale 
for measuring it in TED, particularly as studies evaluating treatment for TED have in 
the past failed to report socioeconomic status (e.g. Kahaly et al., 2005; Terwee et al., 
2001, Fichter et al., 2013; Kashkouli et al., 2011b). Level of education was recorded 
for the qualitative study but not for the quantitative study, making it difficult to 
comment on whether the findings from each sample were representative of one 
another. Furthermore, the sample in the quantitative study appeared to be 
overrepresented by participants of White British backgrounds and did not match the 
ethnic diversity of patients with TED that attend MEH each year.  
 
Due to the number of patients having orbital decompression surgery each year at 
MEH, time constraints on recruitment, and not wanting participants being 
interviewed to be influenced by their answers on questionnaires, or vice versa, it was 
necessary to recruit patients from an additional site. However, recruiting patients for 
the quantitative and qualitative studies from two different centres has its limitations. 
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As the patients were not recruited from the same population it is difficult to be 
certain that any inferences about the two studies is not due to cultural factors. It is 
however uncommon to suggest cultural differences between cities but the 
socioeconomic status of patients from Birmingham and its surrounding areas may be 
different to patients living in London and its surrounding counties.  
 
Asking patients to fill in a questionnaire pack that takes up to 40 minutes to complete 
on three different occasions might have caused participant burden, which is one 
potential reason for drop-outs at follow-up time points. However, the researcher 
attempted to avoid this where possible by using any available validated short form 
versions of patient-reported psychosocial measures, including the Brief Fear of 
Negative Evaluation scale (BFNE; Leary, 1983), and single item measures of 
perceived visibility and patient satisfaction.  
 
It is possible that some of the psychosocial measures touched on patients’ emotional 
reactions to their disease, for example the DAS24 and GO-QOL included items on 
the topic of feeling distressed by their appearance and rejected by others. For any 
participants particularly distressed by the change in their appearance the contact 
numbers for a variety of support and information charities available to patients, 
including Changing Faces, The Healing Foundation, and the Thyroid Eye Disease 
Charitable Trust (TEDcT) were provided at the end of every questionnaire pack 
(Appendix G). In addition, the ordering of the questionnaires in the questionnaire 
pack might have influenced patients’ answers on subsequent measures and ordering 
effects were not controlled for in this study. However, as far as the researcher is 
aware this did not cause any extreme emotional responses.  
 
Notably, a small number of participants in the quantitative studies were still 
suffering from unstable thyroid function when they were listed for orbital 
decompression. Thyroid hormone state has been linked to a number of psychological 
issues as described in Chapter 2, section 2.4. Whilst potentially unstable thyroid 
function was controlled for in the regression analyses that assessed predictors of 
variation in quality of life, it is possible that this might have accounted for some of 
the mood disturbance in participants included in the study, as measured by the 
HADS.  
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A total of 11 participants did not have surgery, which, it could be argued, might have 
been followed up as a control group to assess change in quality of life in patients 
who did not receive orbital decompression surgery. However, this sample would not 
have been big enough to assess as a suitable comparison group and it would make a 
better study to have a large control sample. Furthermore, the aim of the current study 
was to evaluate predictors of quality of life specifically in patients undergoing orbital 
decompression surgery where a gap in the literature was identified.  
 
Psychological co-morbidities other than anxiety and depression were not formally 
assessed when recruiting patients for this study. It is possible that unidentified co-
morbid or historical severe psychiatric disorders might have influenced the high 
prevalence of anxious and depressed mood in the current sample, as found in Wong 
& Yu’s (2013) study. Additional psychiatric morbidities prior to surgery have been 
linked with postoperative satisfaction with outcomes and quality of life (Honigman, 
Phillips & Castle, 2004) and might have accounted for some of the variance in 
change in quality of life in the current sample. Furthermore, the prevalence of BDD 
was not measured in the current study. Studies investigating psychological outcomes 
following elective cosmetic surgery have highlighted the prevalence of BDD in these 
samples, and that it has been found to predict poor subjective satisfaction with 
cosmetic surgery outcomes (Castle, Honigman & Phillips, 2002). However, the 
present thesis focused on rehabilitative surgery for TED rather than cosmetic surgery 
on features of minimal or non-existent abnormality.  
 
Finally, this study was not able to control for levels of appearance-related distress 
prior to developing TED as it was not possible to assess patients prior to them 
presenting for surgery. It would also have been unreliable to retrospectively capture 
appearance-related distress and social anxiety prior to developing TED. It is 
therefore unclear whether high levels of appearance-related distress had manifested 
in patients who had previously had low levels of distress, or whether patients with 
low levels of distress had always been relatively unconcerned about their 
appearance. Available data from the general population was used as a possible 
comparison. This is a common approach in assessing levels of appearance concern in 
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different patient groups (Harris & Carr, 2001; Rumsey et al., 2004; Clarke et al., 
2003; James et al., 2011).  
10.2 OVERALL CONCLUSIONS 
This thesis has made a number of novel contributions to the literature, in particular 
the application of a framework of adjustment to living with a disfiguring condition to 
patients with TED. The cross-sectional study demonstrated that predominantly 
intervening psychosocial processes explain variation in quality of life in patients 
with TED. Ethnicity and a group of clinical variables patients present with prior to 
surgery were found to predict a small proportion of the variability in change in 
quality of life from pre- to post-surgery. Changes in subjective evaluation of 
appearance predicted a large proportion of the variability in change in appearance-
related quality of life from pre-to post-surgery, however no factors measured by the 
study significantly predicted change in visual functioning. This study added to our 
understanding of patient’s expectations of surgery; however further research is 
required to establish whether expectations are met after surgery, and whether this 
predicts quality of life outcomes in relation to both appearance and visual 
functioning. Implications for clinical practice need to be considered in light of the 
limitations of this thesis. This thesis does however highlight potential intervening 
cognitive processes amenable to change that can be targeted in future psychological 
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Appendix A. Systematic Review Search Strategy: Ovid MEDLINE Example 
 
Ovid MEDLINE  
thyroid eye disease.af OR 
thyroid-associated ophthalmopathy.af OR  
graves ophthalmopathy.af OR  
graves orbitopathy.af OR  





psychosocial.af OR  
psychological.af OR 
psych*.af OR  
"quality of life".af OR  
depression.af OR  
anxiety.af OR  






surgery.af OR  
decompression.af OR  
"orbital decompression".af OR  
radiotherapy.af OR 
radiation.af OR  
surgical intervention.af or  
steroid*.af or  
rituximab.af or  









Year   
Title  
Peer-reviewed journal  
Country   
Objectives/ aims  
 
Study design  
Retrospective  
Cross-sectional   






Case control  
 
Study characteristics 
Study population.  
Sample size   




Definition of treatment 
groups  
 
If control group used, 
number of people & 
characteristics 
 
Eligibility criteria  
Exclusion criteria  
 
Participants 
Age range  
Gender  
Occupation  
Duration of TED  
Severity of TED at baseline 
reported? Measure(s) used? 
 




How was TED diagnosed?  
Previous treatments   
Smoking status  
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Co-morbidities reported?   
 





measured & measures used 
 
Assessment methods  
Reliability & validity of 
each measure discussed? 
 
Reliability & validity 
reported in this sample? 
 
If RCT, method of 
randomisation? Was it 
blind? 
 
Length of follow-up, 









Type and appropriateness of 
data analysis – are they 
measuring differences over 
time?  
  
Analysis of differences at 
baseline? 
 
Any missing data? How did 




Participants: numbers at 
each stage (potentially 




Number of withdrawals  
Reasons for withdrawal  
Number of exclusions  
Characteristics of those 
excluded from analysis 
 
Results from analysis at 
baseline – if reported 
 
Key Findings (i.e. 
relationships between 
psychosocial factors, 





Other important findings 
(e.g. effects of treatment on 
clinical factors) 
 
Effect size (means, r, etc)   





Conclusions made by 
authors 
  
Generalisability of findings  
Implications for clinical 
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Aims and objectives 
clearly described 
                  
Main outcomes clearly 
described in the 
Introduction or Methods 
section 
                  
Patient characteristics 
clearly described (i.e. 
Inclusion and exclusion 
criteria are given) 
    -        -     - 
Interventions clearly 
described 
     -  - -    - -     
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Distributions of principal 
confounders in each group 
clearly described 
    / -  -       - / -  / - / - / - 
Main findings clearly 
described 
                  
Estimates of random 
variability in the data 
provided 
- -  -   - -       -    
Adverse events have been 
reported 
-       - - -  - - -  -   
Characteristics of patients 
lost to follow-up have been 
described 
        -        - - 
Actual probability values 
have been reported except 
where p< 0.001 
   - - -      -  -   -  
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The subjects approached 
for the study were 
representative  
-                 - 
The subjects who were 
prepared to participate 
were representative 
- -    - - - - -  - - - - - - - 
The staff, places, and 
facilities where the patients 
were treated were 
representative 
    -   - -  -    -   - 
Subjects were blinded -    - - - - - -   - -  - - - 
Those measuring the main 
outcomes were blinded 
-    - -  - - -   - -  - - - 
Any unplanned analyses 
were reported (if done) 
                  
The analyses adjust for 
different lengths of follow-
up of patients 
             -  -   
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Statistical tests were 
appropriate 
-             - -    
Compliance with the 
interventions was reliable 
-  -  -      -  - - -    
Outcome measures were 
valid and reliable 
       - -          
Subjects in different 
intervention groups were 
recruited from the same 
population 
   -  -         -    
Subjects in different 
intervention groups were 
recruited over the same 
period of time 
   - -       - - -     
Subjects were randomised     - -  - - -   - -  - - - 
Randomisation was 
concealed from both 
patients and health care 
staff 
-    - - - - - -   - -  - - - 
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Adequate adjustment for 
confounding in the 
analyses 
    - - -      -   - - - 
Losses of patients to 
follow-up were taken into 
account 
     -             
The study had sufficient 
power 
- -  - - - - - - - - - - - - - - - 




Appendix E. Patient Information Sheet for the Quantitative Study 
Project ID number:  11- H0724- 6    
Date: 06.01.12  
 
PATIENT INFORMATION SHEET 
 
Study title: Psychosocial and clinical outcomes of surgery for Thyroid Eye Disease 
(TED)  
 
Investigators:    Prof S Newman Tel.  
Dr Daniel Ezra, Tel.   
Mrs Hayley McBain, Tel.  
        Ms Sadie Wickwar, Tel   
 
You are being invited to take part in a research study.  Before you decide, it is 
important for you to understand why the research is being done and what it will 
involve.  Please take time to read the following information carefully and discuss it 
with others if you wish.  Ask us if there is anything that is not clear or if you would 
like more information.  Take time to decide whether or not you wish to take part. 
 




1.  Why is the research taking place? 
 
Thyroid Eye Disease (TED) can impact upon not only a person’s appearance and 
vision, but the way they feel. Orbital decompression surgery is often performed to 
improve vision and/or cosmetic appearance.  
 
There has, however, been very little research looking at how people feel before and 
after surgery so this research aims to investigate how surgery impacts upon a 
person in the long term.  
 
We hope that this research will help us to provide better care for people who come 
for surgical decompression in the future, by helping to develop appropriate means of 
support for those affected.  The research will be conducted over 3 years by 
healthcare professionals at Moorfields Eye Hospital and researchers from City 
University London.  
 
2.  Why have I been invited? 
 
You are being invited to participate because you are a patient attending for orbital 
decompression surgery at Moorfields Eye Hospital. We are seeking a total of 172 
people over the age of 18 to take part in this study.   
 
3. Do I have to take part? 
 
No, taking part is voluntary.  It is up to you to decide whether or not to take part.  If 
you do decide to take part, please keep this information sheet. You are still free to 
withdraw at any time and without giving a reason. Nobody will be upset if you do 
decide not to take part. Please be reassured that deciding to withdraw at any time or 
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choosing not to take part at all will not affect the standard of care you receive at any 
time, either now or in the future.  
 
4. What will happen to me if I take part? 
 
On the day of your surgical pre-assessment appointment, a researcher will be 
present in the clinic to discuss the study with you. If you agree to take part, they will 
give you a questionnaire to complete. This will include various questions about how 
you feel with regards to your Thyroid Eye Disease and the surgery you are about to 
receive. We do not anticipate that this will take you more than 40 minutes to 
complete. You can choose to complete the questionnaire whilst you are at the clinic 
or take the questionnaire home, along with a stamped addressed envelope for you 
to return it to us. You will then be asked to complete another questionnaire a few 
weeks after surgery and then again 6 months later; this is to see how you feel over 
time. 
 
5. What will I have to do? 
 
If you consent to taking part in the study, you will be asked to complete a series of 3 
questionnaires: one before your surgery, then again after surgery, and again 6 
months later. The researchers may contact you at home, by telephone, if they have 
not received your questionnaire.  
 
6. What are the possible disadvantages and risks of taking part? 
 
We are always required to tell you about any risks to you, should you agree to take 
part in research. However, in this instance we are not aware of there being any such 
risks to you. It does not involve any additional medical treatment. It consists only of 
completing a series of questionnaires. 
 
7. What are the possible benefits of taking part? 
 
We do not expect there to be any personal benefits for you in taking part, but we 
expect that the information we get from this study will help us to provide more 
appropriate support to people who are to have this surgery in the future. 
 
8. What if there is a problem? 
 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. The detailed information on this is 
given in Part 2. 
 
9. Will my taking part in this study be kept confidential? 
 
All information which is collected from you during the course of the research will be 
kept strictly confidential and will only be used for research purposes.   
 
If you agree, we would like to inform your GP that you are taking part. This is as a 
matter of courtesy, but rest assured that they will not know what information you 
have given to us.  
 
 




If the information in Part 1 has interested you and you are considering taking 






1. What will happen if I don’t want to carry on with the study? 
 
If you decide at any point during your participation in the study that you wish to 
withdraw from the study, you can contact the research or clinical team to discuss 
this. It would be useful for us to use the information you have given us up until that 
point in the study; however, if you wish for us to destroy this data, this can also be 
arranged. 
 
2. What if there is a problem? 
 
If you have a concern about any aspect of this study, you should speak to the 
researchers who will do their best to answer your questions. You can do so either at 
your next appointment or contact them at  or by email at 
. If you remain unhappy and wish to complain formally, 
you can do this through the Complaints Manager, Moorfields Eye Hospital NHS 
Foundation Trust, 162 City Road, London EC1V 2PD, Telephone: . 
Please quote the project number at the top of this information sheet. 
 
 
3. Will my taking part in this study be kept confidential? 
 
We need permission to access your medical records which relate directly to this 
study. All the information collected during the study will be held securely in the 
strictest confidence and will only be used for research purposes.   
 
If you agree, we would like to inform your GP that you are taking part. This is as a 
matter of courtesy, but rest assured that they will not know what information you 
have given to us.  
 
The data that we collect will be kept anonymously on password-protected 
computers and in locked filing cabinets. Only members of the research team will see 
this anonymous information, and the researcher will be the only person who will 
have access to identifiable data. 
 
4. What will happen to the results of the research study? 
 
The findings of this research will be reported in professional publications or at 
meetings, but you will not be identified in any report or publication. If at any point 
during the study you lose capacity to take part, the data you have provided up until 
that point will remain within the study, but only with the permission of your next of 
kin. 
 
5. Who is organising the research? 
 
This research is being organised by researchers at City University London, along 
with surgeons at Moorfields Eye Hospital. 
 




This study has been reviewed and approved by the North London Research Ethics 
Committee REC2. 
 
7. Further Information and contact details 
 
If you want some general information about taking part in research please contact 
the Patient Advice Liaison Service (PALS) on  or , or 
by email on  
. 
If you have any questions about this study and what you are being asked to 
consider, please contact one of the research team.  
 
If you would like any further information about this research or if you have any 
queries at any time in the future, please contact Sadie Wickwar in Health Services 








Appendix F. Consent Form for the Quantitative Study 
Project ID number: 11-H0724-6     
    




Title of Project:  The psychosocial and clinical outcomes of surgery for thyroid eye 
disease (TED) 
 
Name of Principal Investigator: Professor Stanton Newman 
 
1. I confirm that I have read and understood the information sheet dated 




   
2.  I confirm that I have had sufficient time to consider whether or not want to 
be included in the study.  
 
 
   
3. I understand that my participation is voluntary and that I am free to withdraw 
at any time, without giving any reason, without my medical care or legal 
rights being affected. 
 
   
 
4. 
I understand that relevant sections of my medical notes and data collected 
during the study may be looked at by individuals from regulatory authorities 
or from the NHS Trust, where it is relevant to my taking part in this research. 
I give permission for these individuals to have access to my records. 
 




I agree to take part in the above study. 
 
 
   
6. I give my permission for my GP to be informed that I am taking part in this 







    7.     I understand that taking part in this research project will involve completing a 
questionnaire on one or more occasions.   
 
 















    
Name of patient  Date  Signature 





    
Name of person taking consent  
( if different from researcher) 
 Date  Signature 





    
Researcher  
(to be contacted if there are any 
problems) 
 Date  Signature 
 
Comments or concerns during the study  
If you have any comments or concerns you may discuss these with the 
investigator. If you wish to go further and complain about any aspect of the 
way you have been approached or treated during the course of the study, 
you should write or get in touch with the Complaints Manager at Moorfields 
Eye Hospital, details for which can be found on the information sheet.  
Please quote the project number at the top this consent form. 
 
1 form for Patient  
1 to be kept with hospital notes 




Appendix G. Pre-surgery Questionnaire Pack  
Project ID number:  11- H0724- 6    




PSYCHOSOCIAL AND CLINICAL OUTCOMES OF 




We are a team of researchers from City University London and Moorfields Eye 
Hospital, conducting a study investigating the impact of orbital decompression 
surgery. We hope that this research will help us to provide better care for people 
who come for this type of surgery in the future by developing appropriate means 
of support for those affected. 
 
If at any point during completing this questionnaire you feel any distress, details 
of support groups are provided at the end of the questionnaire. Similarly, if you 
wish to discuss any aspect of the project, contact details for the research team 
are also provided at the end of the questionnaire.  
 
If you are happy to complete the questionnaire then please turn over and work 
through the booklet, completing all questions. This shouldn’t take more than 40 
minutes. If you are unable to complete this on your own, please contact the 
research team to assist you.  
 
Please respond to EACH statement by circling the response that best reflects 
how you feel.  
 
Circle only ONE response for each statement. 
 





















[1] What is your gender?  (please circle) 
 
   Male   Female 
 
[2] What is your age? (please write in)  _______________ 
 
[3] How would you describe your ethnic background? (please circle 
one) 
 
 1  Bangladeshi   2  Indian 
 3 Pakistani   4 Other Asian background 
 5 White British   6 White Irish 
 7 Other White background 8 Black Caribbean 
 9 Black African             10       Other Black background 
 11  Chinese   12       Other ethnic group  
 







5 Living with partner 
6 Other 
 




[6]  Have you ever had surgical treatment for your Thyroid Eye 
Disease? (please circle) 
 
   Yes   No 
 
If yes how many?              ..................................... 
 
Date/Year of your first       ..................................... 
 












The following questions are about your general mood in the past week.  Please 
read each item below and then place a tick in the box next to the reply which 
comes closest to how you have been feeling in the past week.  Try to give your 
first reaction.  This will probably be more accurate than spending a long time 
thinking about an answer 
 
1) I feel tense or wound up   2) I feel as if I am slowed down 
Most of the time   [ ] Nearly all the time        [     ] 
A lot of the time   [ ] Very often        [     ] 
Time to time, occasionally    [ ] Sometimes        [     ] 
Not at all   [ ] Not at all        [     ] 
 
3) I still enjoy the things I used to enjoy 4) I get a sort of frightened 
feeling like  
   "butterflies" in my stomach   
Definitely as much   [ ] Not at all        [     ] 
Not quite so much   [ ] Occasionally        [     ] 
Only a little   [ ] Quite often        [     ] 
Hardly at all   [ ] Very often        [     ] 
 
5) I get a sort of frightened feeling as if 6) I have lost interest in my something 
awful is about to happen                appearance 
Very definitely & quite badly   [ ] Definitely [     ] 
Yes, but not too badly                   [      ]      I don't take as much care as I should  [     ] 
A little, but it doesn't worry me     [      ]        I may not take quite as much care [     ] 
Not at all   [      ] I take just as much care as ever [     ] 
 
7) I can laugh and see the funny side  8) I feel restless as if I have to be on the move 
of things 
As much as I always could    [ ] Very much indeed  [    ]  
Not quite so much now   [ ] Quite a lot  [    ]          
Definitely not so much    [ ] Not very much  [    ] 
Not at all   [ ] Not at all  [    ] 
   
9) Worrying thoughts go through my mind  10) I look forward with enjoyment to 
things  
A great deal of the time   [ ] As much as I ever did    [     ] 
A lot of the time   [ ] Rather less than I used to  [     ] 
From time to time but not often [ ] Definitely less than I used to  [     ] 
Only occasionally    [ ] Hardly at all [       ] 
 
11) I feel cheerful   12) I get sudden feelings of panic 
Not at all   [ ] Very often indeed  [    ] 
Not often   [ ] Quite often  [    ] 
Sometimes   [ ] Not very often  [    ] 




13) I can sit at ease & feel relaxed   14) I can enjoy a good book or TV  
   programme  
Definitely   [ ] Often  [    ] 
Usually   [ ] Sometimes  [    ] 
Not often   [ ] Not often  [    ] 




The following questions are concerned with the way you feel or act.  They are all 
simple.  Please circle the answer that applies to you. If the item does not apply 
to you at all, circle the N/A (not applicable option).  Don’t spend long on any 
one question. 
 
a. How confident do you feel? 
 
Not at all Slightly Moderately Extremely 
  
b. How distressed do you get when you see yourself in the 
mirror/window?  
 
Extremely Moderately A Little   Not at all 
Distressed 
 




Sometimes Often Almost 
always 
 
d. How hurt do you feel?  
Extremely Moderately Slightly Not at all   N/A 
 









f. How distressed do you get when you go to the beach?   
 
N/A Not at all A little Moderately Extremely 
 








h. How feminine/masculine do you feel?  
 
Not at all Slightly Moderately Extremely 
 




Sometimes Often Almost 
always 
 
j. How irritable do you feel?   
 
Not at all Slightly Moderately Extremely 
 
k. I adopt certain gestures (e.g. folding my arms in front of other 




Never/almost never Sometimes Often Almost always 
 








m.  How distressed do you get by shopping in department 
stores/supermarkets?   
 
N/A Not at all Slightly Moderately Extremely 
 
n. How rejected do you feel? 
 
Not at all Slightly Moderately Extremely 
 




Sometimes Often Almost 
always 
 
p. How distressed do you get while playing sports/games? 
 
Extremely Moderately Slightly Not at all   N/A 
 
q. I close into my shell:  
 
Almost always Often Sometimes Never/Almost never 
 
r. How distressed are you by being unable to wear your favourite 
clothes?  
 
Extremely Moderately Slightly Not at all   N/A 
 
s. How distressed do you get when going to social events?  
 
N/A Not at all Moderately A fair amount Extremely 
 
t. How normal do you feel?   
 
Not at all Slightly Moderately Extremely 
 









v. I avoid going out of the house:  
 
Almost always Often Sometimes Never/Almost never 
 
w. How distressed do you get when other people make remarks about 




N/A Not at all Moderately A fair amount Extremely 
 








y. My feature causes me physical pain/discomfort:  
 
Never/almost never Sometimes Often Almost always 
 
z. My feature limits my physical ability to do the things I want to do: 
 









































The GO-QOL is a short questionnaire with statements about how your Thyroid 
Eye Disease may affect you in your everyday life.  
 
Please focus on the past week while answering these questions. During the 
past week, to what extent were you limited in carrying out the following 
activities, because of your Thyroid Eye Disease? 
 





 Yes, seriously 
limited 
Yes, a little 
limited 
No, not at all 
limited 
Driving (no driver’s licence 
□ ) 1 2 3 
At work (usual job) 1 2 3 
Performing domestic duties 
(e.g. cooking and cleaning) 1 2 3 
Moving around the house 1 2 3 
Walking outdoors 1 2 3 
Reading 1 2 3 
Watching TV 1 2 3 
Hobby or pastime, 
i.e. _____________ 
 
1 2 3 
 Yes, severely 
hindered 
Yes, a little 
hindered 
No, not at all 
hindered 
During the past week, did 
you feel hindered from 
something that you wanted 
to do because of your 
Thyroid Eye Disease? 
1 2 3 
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The following questions deal with your thyroid eye disease in general 
 
 Yes, very 
much so 
Yes, a little  No, not at all  
Do you feel that your 
appearance has changed 
because of your thyroid eye 
disease? 
1 2 3 
Do you feel that you are 
stared at in the streets 
because of your thyroid eye 
disease? 
1 2 3 
Do you feel that people react 
unpleasantly because of 
your thyroid eye disease? 
1 2 3 
Do you feel that your thyroid 
eye disease has an influence 
on your self confidence? 
1 2 3 
Do you feel socially isolated 
because of your thyroid eye 
disease? 
1 2 3 
Do you feel that your thyroid 
eye disease has an influence 
on making friends? 
1 2 3 
Do you feel that you appear 
less often on photos than 
before you had thyroid eye 
disease? 
1 2 3 
Do you try to mask changes in 
appearance caused by your 
thyroid eye disease? 




These questions are trying to examine how aware you are of your physical 
appearance. Please indicate how much you agree with each statement below by 















Sometimes, the way 
I look is the furthest 
thing from my 
thoughts 
1 2 3 4 5 6 
It is not often that I 
think about how the 
way I look comes 
over to people 
1 2 3 4 5 6 
For me, my 
appearance is an 
important part of 
who I am. 
1 2 3 4 5 6 
I am often aware of 
the way that I look to 
other people. 
1 2 3 4 5 6 
In most situations, I 
find myself aware of 
the way my face and 
body look. 
1 2 3 4 5 6 
I often think about 
the impression that 
the appearance of 
my face and body 
make. 
1 2 3 4 5 6 
The look of my face 
and body is not 
something that often 
comes to mind for 
me. 
1 2 3 4 5 6 
I am usually 
conscious of my 
appearance. 
1 2 3 4 5 6 
I don’t usually give 
much thought to my 
appearance. 
1 2 3 4 5 6 
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These questions assess how you feel about your appearance.  Please indicate 
how much you agree with each statement below. (Please circle one response 














I am satisfied 
with my physical 
appearance 
1 2 3 4 5 6 
I don’t like the 
way I look 1 2 3 4 5 6 
The way I look 
makes me feel 
good about 
myself 
1 2 3 4 5 6 
The way I look 
makes me 
unattractive 1 2 3 4 5 6 
My body and 
face look pretty 
much the way I 
would like 1 2 3 4 5 6 
I feel bad about 
my body and my 
appearance 1 2 3 4 5 6 
I like the way I 
look 1 2 3 4 5 6 
My appearance 
makes me feel 
attractive 
1 2 3 4 5 6 
 
How visible do you feel your proptosis (bulging eyes) is to other people?  
 
Not at all   Moderately   Extremely 
visible   visible   visible 
1 2 3 4 5 6 7 
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We are interested in how much you feel you are supported by your friends, 
family, and a special person in your life. Please circle one of the five numbers to 









There is a special 
person who is around 
when I am in need 
1 2 3 4 5 
There is a special 
person with whom I 
share my joys and 
sorrows 
1 2 3 4 5 
My family really tries 
to help me 1 2 3 4 5 
I get the emotional 
help and support I 
need from my family 
1 2 3 4 5 
I have a special 
person who is a real 
source of comfort to 
me 
1 2 3 4 5 
My friends really try to 
help me 1 2 3 4 5 
I can count on my 
friends when things 
go wrong 
1 2 3 4 5 
I can talk about my 
problems with my 
family 
1 2 3 4 5 
I have friends with 
whom I can share my 
joys and sorrows 
1 2 3 4 5 
There is a special 
person in my life who 
cares about my 
feelings 
1 2 3 4 5 
My family is willing to 
help me make 
decisions 
1 2 3 4 5 
I can talk about my 
problems with my 
friends 




Using the five point scale below please rate how you expect surgery to change 









the same Improve 
Considerably 
Improve 
My vision 1 2 3 4 5 
The appearance of my 
eyes 1 2 3 4 5 
The appearance of my 
face 1 2 3 4 5 
My ability to drive  1 2 3 4 5 
My ability to move 
around the house 1 2 3 4 5 
My ability to perform 
domestic duties (e.g. 
cooking and cleaning) 
1 2 3 4 5 
My ability to engage in 
my hobby or pastime 1 2 3 4 5 
My ability to read 1 2 3 4 5 
My ability to watch TV 1 2 3 4 5 
My ability to use the 
computer 1 2 3 4 5 
My ability to work 
(usual job) 1 2 3 4 5 
My ability to walk 
outdoors 1 2 3 4 5 
My double vision 1 2 3 4 5 
My dry eyes 1 2 3 4 5 
My headaches/ eye 

























the same Improve 
Considerably 
Improve 
My ability to obtain a 
job 1 2 3 4 5 













































My ability to make 
new friends 1 2 3 4 5 
My ability to form 
new intimate 
relationships 
1 2 3 4 5 
The relationship with 
my family 1 2 3 4 5 
The relationship with 
my current friends 1 2 3 4 5 
The relationship with 
my current 
partner/wife/husband 
1 2 3 4 5 
The relationship with 
my eye doctor 1 2 3 4 5 
Other people’s 
reactions to my TED 1 2 3 4 5 
My willingness to 
appear in 
photographs 
because of my TED 
1 2 3 4 5 
My desire to mask 
the changes in my 
appearance as a 
result of my TED 























































































I worry about what other people 
will think of me even when I 
know it doesn’t make any 
difference 
1 2 3 4 5 
I am  unconcerned even if I 
know people are forming an 
unfavourable impression of me 
1 2 3 4 5 
I am frequently afraid of other 
people noticing my 
shortcomings 
1 2 3 4 5 
I rarely worry about what kind 
of impression I am making on 
someone 
1 2 3 4 5 
I am afraid that others will not 
approve of me 1 2 3 4 5 
I am afraid that other people 
will find fault with me 1 2 3 4 5 
Other people’s opinions of me 
do not bother me 1 2 3 4 5 
When I am talking to someone, I 
worry about what they may be 
thinking of me 
1 2 3 4 5 
I am usually worried about what 
kind of impression I make 1 2 3 4 5 
If I know someone is judging 
me, it has little effect on me 1 2 3 4 5 
Sometimes I think I am too 
concerned with what other 
people think of me 
1 2 3 4 5 
I often worry that I will say or 





It is natural at times to compare yourselves with others.  For example, you may 
compare the way you feel, your opinions, your abilities, and/or your situation 
with those of other people.  There is nothing particularly ‘good’ or ‘bad’ about 
this type of comparison, and some people do it more than others.  I would like to 
find out how often you compare yourself with other people in relation to your 
appearance. 
 
Please indicate how much you agree with each statement below. (please circle 








Agree  Strongly 
agree 
I often compare how my loved 
ones (boy or girlfriend, family 
members) are doing with how 
others are doing. 
1 2 3 4 5 
I always pay a lot of attention to 
how I do things compared with 
how others do things. 
1 2 3 4 5 
If I want to find out how well I 
have done something, I 
compare what I have done with 
how others have done. 
1 2 3 4 5 
I am not the type of person who 
compares often with others. 1 2 3 4 5 
I often compare how I am doing 
socially (e.g., social skills, 
popularity) with other people. 
1 2 3 4 5 
I often compare myself with 
others with respect to what I 
have accomplished in life. 
1 2 3 4 5 
I often like to talk with others 
about mutual opinions and 
experiences. 
1 2 3 4 5 
I often try to find out what others 
think who face similar problems 
as I face. 
1 2 3 4 5 
I always like to know what 
others in a similar situation 
would do. 
1 2 3 4 5 
If I want to learn more about 
something, I try to find out what 
others think about it. 
1 2 3 4 5 
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I never consider my situation in 
life relative to that of other 
people. 




Thank you very much for completing this questionnaire.  Please return the 
questionnaire to us using the freepost envelope provided, once you feel happy 
to do so.  
 
By taking part in this research you have contributed to a study that we anticipate 
will benefit many people. The findings from this research will help guide and 
develop new treatment techniques that will aid people with Thyroid Eye Disease 
(TED) to deal with appearance-related issues. The research findings will also 
increase our knowledge of the experiences people face when dealing with TED. 
 
If at any point you wish to discuss the project or any other issues around the 
subject of appearance, please do not hesitate to contact the research team on 
the number provided below. Similarly, if you have more general concerns about 
appearance related issues, the charities Changing Faces and The Healing 
Foundation provide specialist advice and resources about differences in 
appearance. Contact details for these organisations are also provided below.  
 
If you wish to talk to someone regarding this project, please do not hesitate to 
call Ms Sadie Wickwar in the department of Health Services Research at City 
University, Tel  or e-mail  
 
If you have concerns relating to an appearance-related condition or have 
experienced any distress completing this questionnaire then you can contact 
either of the following organisations for expert and confidential advice:  
 
Changing Faces on Tel: 0845 4500 275 or email: info@changingfaces.org.uk 
 
The Healing Foundation on Tel. 020 7869 6920 or email: 
info@thehealingfoundation.org 
 
















Project ID number:  11- H0724- 6    
Dear  
 
RE: [PATIENT NAME], D.O.B: [PATIENT D.O.B] 
 
Research title: Psychosocial and clinical outcomes of surgery for 
Thyroid Eye Disease (TED) 
 
6. Your patient has agreed to take part in some research that aims to 
investigate the psychosocial and clinical factors which contribute to 
successful adaptation after surgical decompression. The study has been 
approved by the Research Ethics Committee and is open to all patients 
over the age of 18 who have opted for surgical decompression at 
Moorfields Eye Hospital, London.  
 
7. Your patient will be completing a series of questionnaires over a 6 
month period. Any information provided will be treated as strictly 
confidential. Be assured that your patient will always receive the best 
possible treatment available. The research is being conducted in 
collaboration with the department of Health Services Research, City 
University London. 
 
8. The study does not involve any additional treatment and your 
patient is free to withdraw from the study at any time. They are able to 
contact the researcher with any questions or concerns about the research 
at any time during or after the study.  Similarly, if you have any questions 
about the research please contact Sadie Wickwar at City University on 
Tel  or via email    
 
Thank you for reading this.  If you have any questions or require further 









                 Tel: 020 7253 3411 









Appendix I. Patient Information Sheet for the Qualitative Study 
 
 
Project ID number:  11- H0724- 6    
 
PATIENT INFORMATION SHEET 
9.  
Study title: Patient expectations of surgery for Thyroid Eye Disease 
(TED)  
 
Investigators:    Prof S Newman Tel.  
        Mr Omar Durrani, Tel.  
        Ms Sadie Wickwar, Tel.  
                  Mr Matthew Edmunds, Tel.  
    
You are being invited to take part in a research study.  Before you decide, 
it is important for you to understand why the research is being done and 
what it will involve.  Please take time to read the following information 
carefully and discuss it with others if you wish.  Ask us if there is anything 
that is not clear or if you would like more information.  Take time to decide 
whether or not you wish to take part. 
 




1. Why is the research taking place? 
 
Thyroid Eye Disease (TED) can impact upon not only a person’s 
appearance and vision, but the way they feel. Orbital decompression 
surgery is often performed to improve vision and/or cosmetic appearance.  
 
There has, however, been very little research looking at how people feel 
before and after surgery so this research aims to investigate how surgery 
impacts upon a person in the long term.  
 
We hope that this research will help us to provide better care for people 
who come for surgical decompression in the future, by helping to develop 
appropriate means of support for those affected.  The research will be 
conducted over 3 years by healthcare professionals at Moorfields Eye 
Hospital, Birmingham and Midland Eye Centre and researchers from City 
University London.  
 
2. Why have I been invited? 
 
You are being invited to participate because you are a patient attending 
for orbital decompression surgery at Birmingham and Midland Eye 
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Centre. We are seeking up to 25 people over the age of 18 to take part in 
this study.   
 
3. Do I have to take part? 
 
No, taking part is voluntary.  It is up to you to decide whether or not to 
take part.  If you do decide to take part, please keep this information 
sheet. You are still free to withdraw at any time and without giving a 
reason. Nobody will be upset if you do decide not to take part. Please be 
reassured that deciding to withdraw at any time or choosing not to take 
part at all will not affect the standard of care you receive at any time, 
either now or in the future.  
 
4. What will happen to me if I take part? 
 
On the day of your surgical pre-assessment appointment, a researcher 
will be present in the clinic to discuss the study with you. If you agree to 
take part, you will be asked to meet with the researcher for an interview 
within the next two weeks, and again 5-6 months after your surgery. Both 
interviews will be arranged at a time that is convenient for you. Each 
interview should last no longer than one hour.  
 
10. What will I have to do? 
 
If you consent to taking part in the study, you will be asked to take part in 
two interviews that will last no longer than one hour each. You will be 
asked a series of questions about your thyroid eye disease and 
scheduled surgery. We will ask you if we can tape record each interview, 
however you do not have to agree to this and the researcher can take 
notes instead. Any tape recorded interviews will be kept secure and any 
data from the interviews will be made anonymous so that it cannot be 
linked to you.  
 
6. What are the possible disadvantages and risks of taking part? 
 
We are always required to tell you about any risks to you, should you 
agree to take part in research. However, in this instance we are not 
aware of there being any such risks to you. It does not involve any 
additional medical treatment. It consists only of taking part in two 
interviews. 
 
7. What are the possible benefits of taking part? 
 
We do not expect there to be any personal benefits for you in taking part, 
but we expect that the information we get from this study will help us to 
provide more appropriate support to people who are to have this surgery 
in the future. 
 




Any complaint about the way you have been dealt with during the study 
or any possible harm you might suffer will be addressed. The detailed 
information on this is given in Part 2. 
 
9. Will my taking part in this study be kept confidential? 
 
All information which is collected from you during the course of the 
research will be kept strictly confidential and will only be used for 
research purposes.   
 
This completes part 1. 
 
If the information in Part 1 has interested you and you are 
considering taking part, please read the additional information in 




8. What will happen if I don’t want to carry on with the study? 
 
If you decide at any point during your participation in the study that you 
wish to withdraw from the study, you can contact the research or clinical 
team to discuss this. It would be useful for us to use the information you 
have given us up until that point in the study; however, if you wish for us 
to destroy this data, this can also be arranged. 
 
9. What if there is a problem? 
 
If you have a concern about any aspect of this study, you should speak to 
the researchers who will do their best to answer your questions. You can 
do so either at your next appointment or contact them at 0207 040 0876 
or by email at sadie.wickwar.1@city.ac.uk. If you remain unhappy and 
wish to complain formally, you can do this through the Complaints 
Department, Sandwell & West Birmingham Hospital NHS Trust, City 
Hospital, Dudley Road, Birmingham B18 7QH, telephone:  
; e-mail . Please quote the project 
number at the top of this information sheet. 
 
10. Will my taking part in this study be kept confidential? 
 
We need permission to access your medical records which relate directly 
to this study. All the information collected during the study will be held 
securely in the strictest confidence and will only be used for research 
purposes.   
 
The data that we collect will be kept anonymously on password-protected 
computers and in locked filing cabinets. Only members of the research 
team will see this anonymous information, and the researcher will be the 





11. What will happen to the results of the research study? 
 
The findings of this research will be reported in professional publications 
or at meetings, but you will not be identified in any report or publication. If 
at any point during the study you lose capacity to take part, the data you 
have provided up until that point will remain within the study, but only with 
the permission of your next of kin. 
 
12. Who is organising the research? 
 
This research is being organised by researchers at City University 
London, along with surgeons at Moorfields Eye Hospital and Birmingham 
and Midland Eye Centre 
 
13. Who has reviewed the study? 
 
This study has been reviewed and approved by the North London 
Research Ethics Committee REC2. 
 
14. Further Information and contact details 
 
If you want some general information about taking part in research please 
contact the Patient Advice Liaison Service (PALS) on , or 
by email on  
 
If you have any questions about this study and what you are being asked 
to consider, please contact one of the research team.  
 
If you would like any further information about this research or if you have 
any queries at any time in the future, please contact Sadie Wickwar in 
Health Services Research, City University London on  or 
via email at   
 




Appendix J. Consent Form for the Qualitative Study 
 
 
Project ID number: 11-H0724-6        





Title of Project:  Patient expectations of surgery for thyroid eye disease 
(TED) 
1.  
Name of Principal Investigator: Professor Stanton Newman 
 
1. I confirm that I have read and understood the information sheet dated 
07.11.11 (version 4) for the above study and have had the 






2.  I confirm that I have had sufficient time to consider whether or not 
want to be included in the study.  
 
 
   
3. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical 
care or legal rights being affected. 
 
   
 
4. 
I understand that relevant sections of my medical notes and data 
collected during the study may be looked at by individuals from 
regulatory authorities or from the NHS Trust, where it is relevant to 
my taking part in this research. I give permission for these individuals 
to have access to my records. 
 




I agree to take part in the above study. 
 
 
   
6. I understand that taking part in this research project may involve 
taking part in two interviews; one before my surgery, and another 5-6 
months after my surgery. I am happy for the researcher to contact me 
to arrange a further interview at a time that is suitable for me.  
 
 
   
 













    
Name of patient  Date  Signature 





    
Name of person taking consent  
( if different from researcher) 
 Date  Signature 





    
Researcher  
(to be contacted if there are any 
problems) 
 Date  Signature 
 
Comments or concerns during the study  
If you have any comments or concerns you may discuss these 
with the investigator. If you wish to go further and complain about 
any aspect of the way you have been approached or treated 
during the course of the study, you should write or get in touch 
with the Complaints Manager at Birmingham and Midland Eye 
Centre, details for which can be found on the information sheet.  
Please quote the project number at the top this consent form. 
 
1 form for Patient  
1 to be kept with hospital notes 




Appendix K. Clinical Data Form for the Quantitative Study 
PSYCHOSOCIAL AND CLINICAL OUTCOMES OF 
SURGERY FOR THYROID EYE DISEASE (TED) 
 
Clinical Data Collection Form 
Preoperative assessment 
 
Patient number: .........................  Date of assessment: .../..../..... 
 
Date of Birth: .../..../.....  Date of planned Surgery: .../..../..... 
 
Thyroid function stable? Y/N 
 




Previous treatments: Steroids/ Radiotherapy/ Immunomodulation/ Surgery/ None 
 
Previous decompression surgery? Y/N              If yes, date of previous……... 
 
Is patient currently taking steroids? Y/N 
 
Is patient currently smoking? Y/N             
 
Laterality of TED:   Left    Laterality of surgery:   Left 
    Right                 Right  Both                                      Both 
 
Right              Left 
........ Best Corrected Visual Acuity (Snellen) ....... 
 










Scleral show 1 
 
Scleral show 2 
 
Y/N Lagophthalmos  Y/N 
 
Y/N Corneal SPK Y/N 
  




Diplopia present?   Y/N 
 
 
CAS SCORE – PLEASE CIRCLE EACH YES OR NO: 
 
Pain: Y/N Painful oppressive feeling behind globe during last 4 
weeks 
   Y/N Pain on eye movements in last 4 weeks 
Redness:  Y/N Redness of eyelid 
Y/N Diffuse redness of conjunctiva, covering at least 1 
quadrant 
Swelling:  Y/N Swelling of the eyelid 
   Y/N Chemosis 
   Y/N Swollen caruncle 
Y/N Increase of proptosis > 2mm during a period of 1-3 
months 
Impaired function Y/N Decrease of eye movements in any direction in the 
last 3 months 
   Y/N Decrease of visual acuity  >1 line in last 3 months 
 








Topics to cover– current impact of illness on daily activities; current feelings 
about appearance; treatment options; personal reasons for having surgery; 
goals for surgery/ outcomes; motivation for going forward with corrective 
surgery; what has influenced decision to go for surgery; what preparations might 
they have made for surgery; expectations of results; expectations about the 
recovery process; expectations for appearance; expectations about social 
encounters; expectations for daily activities 
 




14) Can you tell me about the impact your thyroid eye disease (TED) might 
have had on your daily activities? 
15) Can you tell me how you feel about the impact that your TED might have 
had on your appearance? 
16) Can you tell me how you feel about the impact that your TED might have 
had on how you feel about yourself? 
 
B. Motivation(s) for having surgery 
 
17) When did you first start thinking about having surgery? 
18) Did you consider alternative treatment options? If so, reasons for 
choosing surgery over others 
19) What do you feel your reasons might be for having surgery? 
20) Could you tell me what is motivating you to have this surgery? 
21) Are there any particular goals you hope to achieve by having surgery? 
22) Can you tell me what you think might have influenced your decision to 
have surgery? Who in your life has influenced your decision to have 
surgery? 
23) Could you tell me about what you might have done to prepare for your 
surgery, or that you plan on doing to before your surgery? 
 
C. Expectations of surgery 
 
24) Can you tell me what you might be expecting from your surgery? 
25) Do you think surgery might change your appearance? If so, in what 
ways? 
26) Do you think surgery might change your daily life? If so, in what ways? 




Appendix M. Demographic Data Form for Qualitative Study 
 
Project ID number: 11-H0724-6  
REC Approved: 29.10.12 
 
Patient Identification Number for this study:   
 
Demographic Details Questionnaire 
 
[1] What is your gender?  (please circle) 
 
   Male   Female 
 
[2] What is your age? (please write in)  _______________ 
 
[3] How would you describe your ethnic background? (please circle one) 
 
 1  Bangladeshi   2  Indian 
 3 Pakistani   4 Other Asian background 
 5 British    6 Irish 
 7 Other White background 8 Caribbean 
 9 African             10       Other Black background 
 11  Chinese   12       Other ethnic group  
 







11 Living with partner 
12 Other _______________________ 
 
[5]  How would you describe your employment status? (please circle one 
number) 
1 Full time work 
2 Part time work 
3 Full time homemaker 
4 Unemployed 
5 Other ______________________ 
 
Job Title (where applicable) _______________________ 
 
[6] What is your highest qualification? (please circle one number) 
 
1 None 
2 GCSE / O Level / equivalent 
3 A Level / equivalent 
4 HNC / HND / equivalent 
5 Degree / equivalent 








[8]  Have you ever had surgical treatment for your Thyroid Eye Disease 
before this planned surgery? (please circle) 
 
   Yes   No 
 
If yes how many?              ..................................... 
 
Type of previous surgery   ..................................... 
 
Date/Year of your first       ..................................... 
 




Appendix N. Thematic Coding Framework 
 







Talk about feelings 
towards others with 
TED, including those 
with more severe 
TED, other 
conditions, and 
others who look 
‘more normal’ 
See description Well when I went on there, 
there was… I looked at 
this one and he… his eye… 
his eyes was just 
horrendous.  I think if my 
eyes looked like that, well, 
I don’t know what I’d do.  
But, so I know my eyes 






Impact of having 
TED on confidence 
and self-esteem 
before surgery 
Excludes talk about 
expectations in 
improvements in confidence 
after surgery – see 
‘expectations – post op 
confidence & appearance 
concern’ 







confidence in HCPs 
or the healthcare 
system or surgery 
See description I do find them very 
approachable, all of them, 
and I think that gives you 
the confidence…to be able 
to say, yes, OK, they’re 
offering me this and 
they’re explaining it fully 
and they wouldn’t be 
doing it if they didn’t think 
it was beneficial 
Coping strategies - 
negative 
Talk about dealing 
with TED by 
avoiding social 
situations, may stay 
in the house for 
example 
Including withdrawing 
within a social situation by 
for example covering the 
eyes and avoiding social 
situations e.g. by ‘not going 
out’ 
I just go down to my local 
supermarket. If obviously 
when I got to go to 
Birmingham I go there.  
But if I don’t have to go 
out, if it’s a choice, then 
I’m not going, I’d rather 
stay in 
Coping strategies - Coping/ adjusting 
positively to having 
All talk about coping 
positively, including 
But there again I think 
myself lucky, there are a 
Thematic Coding Framework - table developed using elements of a good 
thematic code described by Boyatzis (1998): 
 
1) A label (i.e. a name), 2) A definition of what the theme concerns (i.e. the 
characteristic or issue constituting the theme), 3) A description of how to know 
when the theme occurs (i.e. indicators on how to “flag” the theme), 4) A 
description of any qualifications or exclusions to the identification of the theme, 
and 5) Examples, both positive and negative, to eliminate possible confusion when 
looking for the theme. 
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positive TED and change in 
appearance 
stoicism ‘got to get on with 
it’, and how others may have 
helped them cope positively 
lot more things worse out 
there so that’s how I tend 
to counterbalance myself, 
it’s not life threatening, 
it’s just something I’ve just 






Any talk about a 
discrepancy between 
what doctor/ HCP/ 
others thinks about 
eyes e.g. 
measurements, which 
eye is worse, and 
patient's own 
perception 
Includes comments from 
others and talk that suggests 
patient doesn’t agree with 
others’ evaluation of their 
appearance 
I’m having my right one 
done first because 
apparently that one’s more 
protruding than my left, 
which is strange because 






Talk about further 
surgery after 
decompression and 
what patient expects 
in terms of the 
outcome from this. 
Will it be necessary? 
Will it be successful? 
How much surgery 
are they expecting to 
have? 
Includes all surgery after 
decompression 
…if it was something that, 
well OK I can cope with 
this then I may not go 
down the lines of having 
other surgery and I may 
just revert to having 
distance glasses and 
reading glasses rather 
than trying to have 
something 
Expectations - 




What patients are 
expecting from the 
NHS, the process of 
surgery, care from 
HCPs and so on.  
Includes talk about feelings 
of confidence in HCPs or 
the healthcare system or 
surgery 
I think it’s great that the 
NHS offer it to be honest 
because I honestly would 
have thought that it would 
have been well, you know, 
there’s nothing wrong with 






What patient expects 
from surgery in terms 




vision, dry eyes, and 
so on 
See description I’m hoping that 
when…when that’s… when 
the double vision’s gone, 
or when I’m finished with 
the eye hospital I can then 
have the treatment for the 
thyroid 
Expectations - 
post op change in 
appearance 
Talk about what 
patient expects in 
terms of a change in 
their appearance after 
the operation 
See description I’d like to go back to the 
way I was 
Expectations - 
post op daily life 
Expectations about 
the change in daily 
life after the surgery, 
such as work 
Includes expectations about 
any changes in mood 
expected after surgery 
I didn’t really have any 
expectations that it would 
affect any other aspects of 
my… of my career and my 
daily life, as you say 
Expectations - 
post op social 
interactions 
Patients’ expectations 
of how social 
interactions, 
including with 
members of the 
public, family and so 
on, will be after 
surgery 
See description Well again I have a lot of 
face to face contact with 
people so I’m hoping that I 
won’t look any different to 
the person sitting at the 
side of me 
Expectations - Expectations about a See description I’m sure after I’ve had the 
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second done it’ll be even 
more progression in 
my…sort of, self 
confidence 
Expectations – of 
disease & other 
treatments before 
surgery 
Talk about what was 
expected from TED 
and the impact it 
might have on daily 
life (before having 
orbital 
decompression), as 
well as about what 
patient expected 
other treatments to do 
before surgery 
Excludes any talk about 
what impact they expect 
TED to have after surgery – 
see above codes for those 
areas 
So then I was thinking, 
well how much worse can 
it get?! You know 
expecting, is it going to get 
a lot worse than this? 
Expectations - 
recovery process 
What patient is 




See description A couple of weeks 
apparently off work, an 
overnight stay 
Fear of operation Talk about being 
scared or fearful of 
having surgery, or 
what might happen 
on the day 
Includes fear of any 
operation discussed 
I think I always think the 
worst.  For me, the worst, 
before I wake up would be 
not waking up. 
Impact - change in 
appearance 
Impact that a change 
in appearance caused 
by TED has had, 
including talk about 
inability to wear 
make-up etc.  
Includes psychological 
impact – changes in 
evaluation of appearance, 
social encounters and so on. 
Physical impact of TED, 
such as functional problems 
as a result os eyes being 
pushed forward, is covered 
by other codes  
I do wish it hadn’t 
happened to me. I don’t 
look the way I used to 
look. I get sad when I look 
at old photographs 
Impact - change in 
appearance - loss 
of identity 
Talk about losing 
aspects of self that 
make up identity due 
to having TED, such 
as not being able to 
wear make-up that 
they would’ve worn 
every day previously 
See description I always used to wear 
makeup, always.  That was 
first and foremost I’d get 
up in the morning, 
makeup, hair… that was 
my first thing I used to do.  
But obviously where my 
eyes are protruding, when 
you put mascara on or eye 
makeup it just makes them 
even more like, in your 
face sort of thing 
Impact - diagnosis Talk about being 
diagnosed with TED, 
including emotions or 
feelings around this, 
adjustments that had 
to be made etc.  
Includes talk about being 
referred from doctor to 
doctor in order to be 
diagnosed 
I just expected to come 
and have some more eye 
drops and to be kept here 
all day and given that sort 




Ways that having 
TED or Graves’ 
disease has affected 
employment, such as 
Includes ways that 
colleagues at work have 
reacted to change in 
appearance caused by TED 
it’s my appearance, 
because of what, the 
qualifications, that I can 
do care work but I want to 
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getting a job, changes 
in responsibilities at 
work 
work with kids in a 
nursery but I know they 
would say, you know, 
“scary eyes” 
Impact - mood Talk about feelings 
of depression or 
anxiety due to having 
TED 
Excludes talk about 
confidence or self-esteem 
I don’t like the way 
my…my face now… the 
appearance of my face is 
and stuff.  It’s just 
depressing really. 
Impact - reactions 
from others - 
friends & family 
Any talk about 
comments or 
reactions from 
friends and family 
about changes in 
appearance or TED 
in general.  
See description No, I mean talking to my 
husband… he’s very 
supportive. But he has in a 
sort of a sideways… well 
you are going to have the 
surgery aren’t you? 
Impact - reactions 
from others - 
public  
Talk about reactions 
or comments about 
appearance or TED 
whilst out in the 
general public, such 
as comments or 
staring 
Excludes comments from 
colleagues at work, can 
include comments from the 
public whilst in a public 
facing role 
I notice if we do go out on 
occasions I do feel people 
are looking. 
Impact - reactions 
from others - work 
Staring or comments 
from colleagues at 
work (whether joking 
or otherwise), or 
difficulties 
experienced in 
public-facing roles  
Includes reactions from 
public when in public facing 
role, as this is related to 
reactions whilst at work 
And working in the NHS 
sector, people looking at 
you, I don’t like it. 
Impact - steroids Impact of taking 
steroids on daily life, 





Excludes impact of other 
treatments – see ‘other 
treatments’ 
…the physical changes 
with the eyes and also with 
my face because of being 
on the steroids so I’ve 
become very sort of 
‘moon-faced’ for want of a 
better word 
Impact – vision & 
other symptoms 
Impact of double 
vision and other 
unpleasant symptoms 
on daily life 
See description It’s a strain to read.  I can 
read for short periods and 
then I have to you know, 
stop, and then go back to it 




information given by 
HCPs and the process 
of obtaining or 
receiving 
information. This 
includes talk about 
doctor patient 
communication and 
the quality of 
information from 
HCPs 
Talk about any information 
from HCPs about any aspect 
of disease or surgery. Also 
includes all talk about 
process of receiving 
information from HCPs 
When it was offered to me 
really, I didn’t even realise 
they could do that. My 
specialist sent a letter to 
my GP. It was…my GP 
didn’t respond though 
Information - 
HCPs - orbital 
decompression 




including GP or 
hospital staff, 
Includes talk about 
information about surgeries 
following OD and 
treatments given after OD 
…he started talking about, 
you know, he’d got a 
model of the eye and he 
was very good, he 






HCPs - post op 
change in 
appearance 
Talk about what 
information was 
given by HCPs about 
what change patient 
should expect, 
including being 
unsure exactly how 
much to expect 
proptosis to reduce  
See description And I do worry about how 
much it’s gonna go back. 
Because nobody’s actually 
said, we take it back to this 
millimetres… 
Information – 
TED & orbital 
decompression - 
online 
Talk about finding 






Includes talk about anything 
patient found out about TED 
or Graves.  
on YouTube I found the 
video of the actual surgery 
taking place and that was 
a very… a graphic 
videoing of actually what 






Risks of surgery 
discussed, including 
weighing up pros and 
cons of having the 
surgery. Includes 
finding information 
online or that 
received from HCPs 
See description I was told that um you can 
get some facial paralysis if 





out or obtained from 
friends, relatives or 
others about orbital 
decompression 
See description …for my mother’s sake I’d 
say because she did some 
research on it and found 
that everyone, oh yeah, 
homeopathic Arnica, oh 
it’s brilliant 
Personal goals and 
life plans 
Patient’s goals or 
plans for their lives 
and how surgery or 
the process of going 
for the surgery fits 
into these goals and 
plans 
See description once I’ve got the surgery 
done that’s another 
milestone and there’s just 
different things for me to 
sort of aim for to try and 
get me back to where I was 
Personal reasons 
for having orbital 
decompression 
Talk about why 
patient feels they 
need surgery, their 
reasons for going for 
the surgery 
See description from an eyesight point of 
view and from a physical 
point of view I just, I just 
want to change 
Self-directed 
research 
Patient looks up 
further information 
about TED, Graves’ 




Patient might not specify 
where they ‘read up on it’, 
or they might describe the 
process of searching for 
more information, not 
necessarily online or about 
OD. If they specifically 
describe looking up 
information about OD 
online, also code as 
“information – OD – 
online” 
I’ve never sort of realised 
you could have it on one 
eye and then obviously 
since I’ve read up about it, 




Talk about how 
important eyes are, or 
being 'funny' about 
having an operation 
Evaluating eyes as best 
feature – this is evaluation 
of appearance 
I’m very funny about my 
eyes.  I know you’re dead 
when you’re dead but I 




on the eyes afterlife. 
Support from 
others 
Talk about friends 
and family being 
supportive 
Can include both positive 
and negative aspects of 
support – such as family 
members being overly 
worried about surgery 
I’ve got a very supportive 
family, a very supportive 
husband and I am a strong 
person 
Timing of surgery Impact of when 
surgery is booked, 
how this fits into 
daily life (e.g. plans 
changing), how this 
fits with their 
appearance 
cognitions and plan 
for change in 
appearance (e.g. 
being desperate to 
change appearance 
and operation can’t 
come soon enough), 
impact of waiting for 
surgery 
Includes any references to 
having OD one eye at a time 
and any impact this might 
have had 
We were at one stage 
asked if we’d take a 
cancellation… and… I 
obviously said yes, 
because we were asked 




TED & orbital 
decompression 
surgery 





Includes any talk that 
involves misconceptions 
about TED as well as talk 
that appears well informed 
I’m hoping that it is going 
to help with the vision as 
well, though I do 
understand that there may 
be other surgery 
afterwards that may be 
needed to help with the 
vision 
Making decision 
to have surgery 
Talk about the 
process of deciding 
whether to go for 
surgery, weighing up 
pros and cons, what 
makes patients decide 
to go through with it? 
 If I was offered the 
surgery, what are the 
chances that it’ll a) be 
better, be back to normal 
or b) could it make it 
worse?...I think that’s 
something I was assessing 
as and when I needed to 
really on my 




Appendix O. Screeplot Generated from the Principle Components Analysis 
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Appendix P. Pattern and Structure Matrix of the Original 26-item E-TEDS following PCA with Oblimin Rotation 
Item Pattern Coefficients Structure Coefficients 
  Factor 1 Factor 2 Factor 3 Factor 1 Factor 2 Factor 3 






















































































23. Mask the changes in my appearance .912 
 




22. Willingness to appear in photographs .896   .936 -.592 .550 




    
15. Self confidence .823 
 






2. Appearance of my eyes  .858 
 






21. Other people's reactions to my TED  .797 
 






3. Appearance of my face .722 
 






14. Ability to obtain a job .426 
 


















































24. Headaches/ eye pain .709 
 






25. Dry eyes .697 
 
















INITIAL IDEAS AND POTENTIAL CODES NOTED DURING 
TRANSCRIBING AND FAMILIARISATION WITH THE DATA 
 
Initial idea: patient is unsure exactly how much to expect proptosis to reduce/ 
appearance to change. Potential code: information (or lack of) about what physical 
change in appearance to expect. (ID 1 line 632-636 & ID 6 line 310-15) 
 
Initial idea/ potential code: positive coping styles/ cognitions (ID 1, line 704-5) 
(the same? ID 5, line 563-66 initial idea: resilience? Positive coping styles for 
dealing with upcoming surgery ; ID 17 line 309-312)  
 
Initial idea: Quality of information given by HCPs. Importance of doctor ensuring 
patient understands information prior to surgery (ID 1, line 715-18 & line 727-31) 
 
Initial idea: patient unsure what level of decompression they are having  (ID 20 line 
122-125) 
 
Initial idea: self-research into the surgery – equipping self to be ready to ask doctors 
specific question to get a deeper understanding of the surgery (ID 5, line 237-240, 
259-60, 290-93; ID 8 line 167-9)  
 
Initial idea: differentiating between a ‘good’ eye and ‘bad’ eye in terms of visual 
problems – and appearance concerns (ID 2; ID 4; ID 5 line 407-11) 
 
Initial idea: realistic understanding of what the decompression surgery can do (ID 5, 
line 467-9) 
 
Initial idea: understanding of further surgery post-decompression; the possibility of 
having this and what this can do (ID 5, line 470-73) 
 
Initial idea: the risk to appearance of going for further post-decompression surgery 
being like ‘gambling’ (ID 5 line 500-03, ID 6 line 183-90) 
 
Initial idea: contradiction/ conflict between understanding that appearance won’t go 
back to exactly how it was before, and still ‘desiring’ to look as before (ID 5, line 
591-94; ID 6 line 136; ID 8 line 279-81; ID 21 line 209-11) 
 
Initial idea: expecting appearance to go back to how it was before TED (ID 20 line 
539-40)   
 
Initial idea: stereotypical imagery attached to having eye disfigurements and eye 
surgery (ID 5, line 650-51) 
 
initial idea: comparing own severity to other patients’ and seeing self as less severe 
(ID 6, line 79-81; ID 8 line 250-52; ID 17 line 313-316) 
 
initial idea: patient’s perception that eyes are more severe than others without TED 




initial idea: patient’s own understanding of decompression surgery (ID 6 line 208-9; 
ID 8 line 184-87; ID 13 line 20-22) 
 
Initial idea: patients (mis)understanding of medical information about what the 
surgeons can do – double vision can be successful treated with strabismus surgery 
after decompression (ID 13 line 109-112 & line 238-39) 
 
Initial idea: decompression surgery as ‘safe’ (ID 6 line 214-6) 
 
potential code: seeking information online about the surgery (ID 6 line 254-5; ID 8 
line 163-66) 
 
Initial idea: patient expectation of success based on subjective cultural ideas (ID 6 
line 254-5) 
 
Initial idea: conflicting information about risks. UK doctors vs family member 
doctor overseas (ID 6, line272-3) 
 
Potential code: weighing up risks (ID 6 line 279-81) 
 
Initial idea: this supports previous research that finds others react to patient’s 
appearance in social situations – negative connotations of being on drugs when 
you’re not (ID 8 line 13-15) 
 
Initial idea: this supports previous quali research that has found patients report 
feeling uncoordinated because of limited eye movements or vision (ID 8 line 17-20; 
ID 13 line 84-87) 
 
Initial idea: strategies to hide appearance don’t always work – shift in wellbeing 
when they cease to work (ID 8 line 27-30; ID 13 line 49-52) 
 
Initial idea: extreme situation: social avoidance due to previous negative social 
interactions (ID 8 line 44-9) 
 
initial idea: losing previous identity due to TED (make up) (ID 8 line 63-66; ID 20) 
 
Potential code: effect of TED on mood/ depression (ID 8 like 93-4) 
 
Initial idea: COGNITIONS about negative consequences of social situations (ID 8 
line 130-34) 
 
initial idea: doctors relying on website to form realistic expectations (ID 8 line 239-
41) 
 
initial ideas: high expectations when others with more severe disease have greatly 
improved in appearance – on surgeon’s website! (ID 8 line 267-70) 
 
initial idea: COGNITIONS. Perceptions of negative social situations that haven’t 




initial idea: expectations for life to go back to how it was before TED, including 
‘silly little things’ like wearing make up (ID 8 line 513-15) 
 
initial idea: online forums of TED patients influencing expectations (ID 8 line 538-
40) 
 
initial idea: expecting recovery time/ time to notice a difference in appearance to be 
short (ID 8 line 551-54) 
 
initial idea: this supports research that suggests clinical measurements do not 
correlate with patient’s perceptions of appearance. Damaging to patients who feel 
their proptosis is less than measurements suggest (ID 8 line 563-68) 
 
initial idea: for social interactions to improve after surgery. Reduce social 
withdrawal & avoidance (ID 8 line 633-35) 
 
Potential code: social withdrawal avoidance. Initial idea: even avoiding family 
gatherings (ID 13 line 67-70) 
 
initial idea: As a parent feeling like your condition also affects your children (ID 17 
line 116-18) 
 
initial idea: involving family in pre-surgery consultations to increase understanding 
of medical information (ID 17 line 140-42) 
 
initial idea: using humour to cope with visual problems at work (ID 17 line 195-200) 
 
intial idea: wanting to avoid family occasions but feeling a duty to go; keeping head 
down to hide eyes (ID 8; ID 17 line 272-277) 
 
initial idea: this supports research that suggests patients only take in information 
from the beginning of medical consultations (ID 17 line 407-12; ID 20 line 132-35 
particularly when news is shocking) 
 
initial idea: TED affecting independence when problems with vision. Desire to be 
able to carry out simple everyday activities again – independence (ID 17 line 466-
67) 
 
initial idea: pain as a symptom of TED. This supports research (ID 17 line 630-33) 
 
initial idea: feeling more anxious about surgery on eyes because of important 




Appendix R. Boxplots with Error Bars Showing Changes Over Time on 







































Appendix S. Boxplots with Error Bars Showing Changes Over Time on 
Continuous Psychosocial Variables and Outliers 
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